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BACkGrOUnD 
Risk exposures (e.g., smoking, physical inactivity), health outcomes, and longevity have long 
been known to vary substantially from country to country.1,2 Recent research has highlighted 
substantial regional variation in risk exposures, health outcomes, and longevity within a wide 
range of countries.3–8 In the United States of America (US), differences in risk exposures, health 
outcomes, and longevity have been well documented at the state level.9,10 Previous research 
at the county level has consistently found an even greater degree of variation among coun-
ties than among states, much of which occurs within state borders.11–14 However, variation in 
risk exposures, health outcomes, and longevity has not been as thoroughly described at this 
level as for more aggregate geographies. 
County-level measurement of risk exposure, health outcomes, and longevity is important for 
at least three reasons. First, local information is valuable to public health practitioners and 
policy-makers. Most local public health departments in the US are organized by county,15 
making county-level information particularly important. Geographically precise information 
on risk factors, for example, can help public health officials and policy-makers better target 
prevention and treatment efforts and to allocate limited resources to the most pressing local 
needs. Second, geographic differences in health outcomes may indicate avoidable health 
disparities. Fine-grained, local-level measurement of health outcomes facilitates identifying 
these avoidable disparities so that they may be addressed. Moreover, tracking changes in 
geographic differences in health outcomes overtime is critical (though not, by itself, suffi-
cient) to ensuring that future health gains are equitably distributed. Third, an understanding 
of how specific health outcomes vary on a fine-scale geographically may lead to new or 
deeper insights into the underlying drivers of ill health and variation in outcomes. In some 
cases, maps of health outcomes may suggest particular mechanisms which deserve further 
study; in other cases, this information could be used in ecological analyses to provide further 
support of (or contradict) existing hypotheses. 
The purpose of this thesis is to develop methods for estimating exposure to risks, health 
outcomes, and longevity at the county level in the US, to use the resulting estimates to evalu-
ate whether geographic disparities in health at the county level are increasing or decreasing 
over time, and to explore the drivers of variation in longevity among counties. The remainder 
of this chapter focuses on a discussion of geographic disparities in the US and an overview of 
the methodological challenges of estimating exposure to risks, health outcomes, and longev-
ity at the county level. The chapter concludes with the specific research questions for this 
thesis and an overview of the remaining chapters. 
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GeOGrAPHIC DISPArITIeS In HeALTH In THe US
Disparities in health outcomes have long been recognized among different regions and 
states in the US. Routine tracking of mortality and cause of death statistics by the federal 
government dates to the early 20th century (although not all states participated until the 
1930s) and has consistently shown substantial differences in fatal health outcomes among 
states and large cities.16,17 Growing recognition of regional differences in risk exposure, the 
prevalence of chronic conditions such as diabetes, cardiovascular diseases, and respiratory 
diseases, and of functional limitations led to the establishment in the early 1980s of health 
surveys designed to track these health-related indicators at the state level.18 
At the county level, life expectancy is the best described measure of health outcomes, 
although there are limitations to the methods that have been used, to date, to estimate 
county-level trends in life expectancy. Murray et al.19 first estimated county-level differentials 
in life expectancy in the late 1990s, and identified counties along the southern half of the 
Mississippi river, throughout much of the southeast, in central Appalachia, and in counties 
in South and North Dakota with Native American reservations where life expectancy was 
substantially lower than the national average for both men and women. Overall, Murray et 
al. reported that life expectancy varied by up to 16.5 years for men and 13.0 years for women 
among counties in 1990. Subsequent analyses by Ezzati et al.20 and Kulkarni et al.21 also found 
similar spatial patterns and large geographic disparities in life expectancy among counties, 
while an analysis by Wang et al.14 confirmed these earlier findings and presented evidence 
that county-level geographic disparities in life expectancy have increased in recent decades. 
Existing analyses of cause-specific mortality rates,22–27 chronic conditions,11,28,29 and risk fac-
tors12,13 have also found substantial geographic disparities among counties, both within and 
across state borders, though spatial patterns differ among different risk factors and outcomes. 
Quantifying and tracking temporal trends in geographic disparities
Geographic differences in risk factor prevalence, health outcomes, and longevity may 
indicate the presence of avoidable health disparities. Healthy People 2020, which describes 
national health goals for the US, includes “Achieve health equity, eliminate disparities, and 
improve the health of all groups” as one of its four overarching goals, and explicitly recognizes 
disparities by geographic location in addition to disparities by race, ethnicity, gender, sexual 
identity and orientation, and disability status.30 County-level estimation of health indicators 
can facilitate monitoring trends in geographic disparities and progress towards achieving 
better, more equitable health outcomes as envisioned by the Healthy People 2020 framework.
Several researchers14,20 have previously described increases in geographic disparities in 
life expectancy among counties in recent decades, but temporal trends in county-level 
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geographic disparities in the US for other health outcomes or for exposure to risks have not 
been described. Moreover, recent research31 on socioeconomic disparities in survival has 
highlighted different trajectories for different age groups, but no similar analysis has been 
undertaken with respect to geographic disparities.
Drivers of variation in health outcomes
Some of the variation in health outcomes at the county level is almost certainly due to dif-
ferences in the prevalence of individual-level risk factors for disease and death. This includes 
more proximal risks, such as smoking, excessive alcohol use, insufficient physical activity, 
poor diet, and risky sexual practices, but also more distal risk factors such as poverty, lack of 
education, immigrant status, or membership in a disadvantaged racial or ethnic group.32–34 
Contextual, ecological factors are likely also implicated in county-level differences in health 
outcomes.35,36 These include many of the same social and economic factors that operate at 
the individual level: for example, an individual’s health may be impacted not only by her 
own income, but also by the overall wealth of her community, as well as the distribution of 
wealth within her community. Physical and environmental features of the county37–39—such 
as altitude, sunlight, air pollution, and other environmental toxins—and features of the 
built environment40,41—such as building quality, transportation infrastructure, and the food 
landscape—may also play a role in determining health outcomes. Similarly, differences in 
health outcomes may be partially attributable to differences in public policies and regulatory 
structures42,43—such as public health funding; taxes and regulations related to smoking, alco-
hol, and sugar-sweetened beverages; and enforcement of traffic laws—as well as differences 
in access to and quality of health care.44,45 
There is potentially considerable (and complex) interplay among these different factors, 
including within the individual level (e.g., education status may impact smoking behavior46), 
within the contextual level (e.g., public policy may impact the prevalence of environmental 
risks or the quality of the built environment47), and between these two levels (e.g., features 
of the built environment may impact an individual’s level of physical activity48). Moreover, 
many of these factors are not static and individuals may move from one county to another in 
a way that either diminishes or increases apparent geographic disparities in health.49 Taken 
together, these dynamics dramatically complicate efforts to describe the relative importance 
of drivers leading to county-level differences in health. 
A number of previous studies have examined county-level correlates of life expectancy or 
some other measure of survival. These studies have found positive correlations at the county 
level between longevity and income, education, other measures of socioeconomic status, 
and access to quality health care and negative correlations at the county level between 
longevity and concentration of minority populations, prevalence of environmental expo-
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sures, and prevalence of behavioral and metabolic risk factors.38,39,50–52 Only a few studies 
have considered the cumulative effect of a wider range of potential drivers of county-level 
variation in longevity, however.53–55 The most comprehensive analysis of potential drivers of 
county-level variation in longevity found that between 72% and 86% (depending on sex and 
race) of the variation among counties in survival to age 70 could be explained by a suite 
of 22 socioeconomic and environmental variables and that among a subset of counties 
where data on risk factor prevalence were available, 86% to 90% of the variation in survival 
could be explained by variation in these same socioeconomic and environmental variables 
as well as variation in risk factor prevalence.53 None of these previous county-level studies 
systematically considered the relative importance of different potential drivers of geographic 
disparities in longevity, however.
MeTHODOLOGICAL CHALLenGeS
There are a number methodological challenges related to generating, utilizing, and interpret-
ing county-level estimates of risk exposures, health outcomes, and longevity. This section 
describes the data sources available for county-level analyses in the US and the main chal-
lenges related to generating estimates from these data that are addressed in this thesis. 
Data sources
Health data that can be used to describe county-level trends are limited. Most national health 
surveys do not sample respondents in all (or even most) counties, and many do not make 
geographic identifiers available due to privacy concerns. This thesis makes use of two data 
sources that are uniquely well suited to county-level analyses as well as a third that can be 
used in combination with county-level data. 
The National Vital Statistics System (NVSS) collects death certificate data from all US states and 
territories and includes information on effectively every death that occurs in the US, includ-
ing age at death, sex, place of residence, and underlying cause of death for each decedent.56 
County-level identifiers for NVSS data can be requested from the National Center for Health 
Statistics. In this thesis, NVSS data are used to estimate county-level trends in cause-specific 
mortality rates as well as county-level trends in life expectancy. 
The Behavioral Risk Factor Surveillance System (BRFSS) is an annual telephone survey con-
ducted in all US states and coordinated by the Centers for Disease Control and Prevention 
(CDC).57 The BRFSS collects information on behavioral and metabolic risk factors and chronic 
diseases as well as demographic data from between 100,000 and 500,000 thousand individu-
als each year and includes respondents in most counties. Until 2013, county-level identifiers 
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were publically available for BRFSS data, though this variable was suppressed in small coun-
ties. In this thesis, BRFSS data are used to estimate county-level trends in smoking, excessive 
alcohol use, diabetes, and self-reported health. 
The National Health and Nutrition Examination Survey (NHANES) is a household survey of 
approximately 5,000 respondents per year conducted in bi-annual cycles by the CDC.58 While 
publically available NHANES datasets lack geographic identifiers and cannot be used directly 
for county-level estimation, the NHANES includes detailed biometric data not available from 
most other data sources. In this thesis, NHANES data are used in conjunction with BRFSS data 
to estimate county-level trends in diabetes prevalence, including undiagnosed diabetes. 
Small area estimation
In cases where appropriate data for measuring risk factor exposure or health outcomes at the 
county level exist, a main barrier to producing precise estimates is the statistical challenges 
posed by small numbers. Standard statistical techniques for estimating population param-
eters rely on large sample sizes to reduce the influence of random fluctuations (i.e., stochastic 
“noise”). Most counties are relatively small, however, a problem that is compounded when 
working with survey data where only a fraction of the population of each county is sampled. 
In these cases, using only the data available for each county leads to highly imprecise esti-
mates, making it difficult to discern true differences between counties or time periods. 
Early research on county-level patterns of risk exposure or health outcomes typically em-
ployed one of two methods to overcome the issues posed by small numbers: synthetic esti-
mates, or pooling data. Synthetic estimates are constructed by first estimating a quantity of 
interest using all available data (i.e., data from all locations) stratified by relevant demographic 
features (e.g., sex, race), and then weighting these estimates by the observed demographic 
characteristics in each smaller area.59 This approach accounts for variation in the outcome of 
interest that is related to variation in the stratifying variables included in the construction of 
these estimates, but does not account for any other sources of variation and therefore likely 
often underestimates true variation. The second approach is more straightforward: data are 
pooled over multiple years to increase the available sample size, mitigating the effects of 
small numbers. The main limitation of this approach is that estimates constructed in this way 
do not refer to a specific, limited time period and are not useful for examining county-level 
temporal trends or changes in the magnitude of geographic disparities among counties over 
time. Moreover, estimates constructed this way in many cases are still based on a relatively 
small sample size and may not be sufficiently reliable in smaller counties.
More recently, researchers have used small area estimation (SAE) to address the challenges 
posed by small numbers.28,60,61 SAE utilizes mixed effects models that allow for “borrowing 
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strength” to increase the effective sample size available for each individual location and thus 
improve the precision of the estimates. These models typically borrow strength spatially 
(i.e., from neighbors or nearby areas) and often also borrow strength temporally and from 
external sources of information. Borrowing strength spatially and temporally is conceptually 
related to simply pooling data by aggregating areas or combining multiple years of data, 
but in an SAE framework the pooling is partial and the strength of the spatial and temporal 
relationships are estimated based on the data. Borrowing strength from external informa-
tion relies on the observation that many demographic and environmental characteristics of 
counties are already precisely known from censuses or other administrative data sources, and 
that these characteristics are often related to health outcomes of interest. Thus this external 
information can be incorporated into SAE in the form of covariates. 
In the US, researchers have previously used some form of SAE to generate estimates of life ex-
pectancy,14,21,51 mortality from select causes of death (e.g., drug overdose,25 heart disease,27,62 
and cancer26,63), prevalence of behavioral and metabolic risk factors (e.g., hypertension,12 
obesity and physical activity13), and chronic conditions (e.g., COPD29) at the county level. 
Model specification has varied widely, however, and not all approaches have been validated. 
Srebotnjak et al.28 describe a framework for validating county-level SAE models which could 
be used to assess model performance and aid in developing more precise methods for SAE 
in the US.
Data quality 
In addition to the challenges posed by small numbers, there are several issues specific to the 
data sources identified for county-level analyses. The primary concern related to NVSS deaths 
data relates to the quality of information available about the underlying cause of death for 
each decedent. Underlying cause of death is coded according to the International Classifi-
cation of Diseases and Related Health Problems (ICD).64,65 Previous research66,67 has identified 
a number of potential misuses of ICD codes as they relate to underlying causes of death, 
particularly codes that refer to an intermediate or immediate cause of death instead of an 
underlying cause (e.g., cardiopulmonary arrest) and codes that are insufficiently specific (e.g., 
malignant neoplasms of other and ill-defined sites). Collectively, these cause of death codes 
have been referred to in the literature as ‘garbage codes,’ recognizing their limited use for 
public health analyses.66 The likelihood that a death will be assigned a garbage code varies 
over time and by location as well as by true underlying cause of death, compromising the 
reliability of comparisons made across locations, years, or causes. Methods for redistributing 
garbage codes to likely true underlying causes of death have been developed for the Global 
Burden of Disease (GBD) project,1,67 but have not been previously utilized for county-level 
analyses. 
15
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BRFSS data are subject to a different set of limitations. Response rates are relatively low—in 
2012, they ranged from 27.7% to 60.4% among states68—raising the possibility of non-
response bias due to differences in the quantity of interest between respondents and non-
respondents. For national and state-level estimates, survey weights are used to mitigate the 
effects of non-response, however these survey weights are not calibrated for county-level 
estimates. For similar reasons, non-coverage bias is also a concern for the BRFSS, particularly 
with respect to individuals who can only be reached by mobile phone: prior to 2011, the BRFSS 
only sampled landlines and thus excluded both individuals without any phone (a relatively 
small population) as well as individuals with only a mobile phone (more than a quarter of the 
adult population in 201069). This compromises the integrity of estimates derived from data 
prior to 2011 and in some cases introduces substantial discontinuities between estimates 
in 2010 and 2011 that likely reflect these methodological changes rather than true changes 
in the population.70 Finally, the self-reported nature of the data poses challenges: in some 
cases, respondents may not accurately report, whether due to intentional misreporting (e.g., 
under-reporting weight71), misunderstanding of the questions (e.g., interpreting ‘average’ to 
mean ‘mode’ rather than ‘mean’ when asked about average number of alcoholic beverages 
consumed72), or lack of information (e.g., respondents with undiagnosed chronic conditions 
will not report those conditions73). 
Quantifying geographic disparities 
Many different metrics for quantifying disparities have been proposed that vary in terms of 
what aspects of a distribution are measured and whether comparisons are absolute or rela-
tive.74,75 These choices can have a substantive impact on the conclusions drawn from such 
analyses, impacting, for example, whether disparities appear to increase or decrease over 
time. To date, investigations of county-level geographic disparities in life expectancy in the 
US have focused on absolute measures of inequality, specifically the standard deviation or 
the range.14,20,51 Given the potential sensitivity of these conclusions to the metric used, more 
thorough consideration of various alternatives is warranted. 
reSeArCH QUeSTIOnS 
This thesis has three specific research questions:
1. Can methods be developed that both address small numbers issues and also account 
for known biases in available data, allowing for sufficiently precise estimates of health-
related risk factors and mortality for US counties? 
2. To what extent does the prevalence of health-related risk factors and health outcomes 
vary among counties in the US, and are inequalities increasing or decreasing over time?
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3. What proportion of the variation observed in mortality rates at the county level can be 
explained by variation in socioeconomic factors, behavioral and metabolic risk factors, 
and access to and quality of health care?
The remainder of this thesis is divided into seven chapters. Chapters 2–4 focus on county-
level variation in risk factors, specifically smoking (chapter 2), excessive alcohol use (chapter 
3), and diabetes (chapter 4). Chapters 5–7 focus on county-level variation in health out-
comes, including cause-specific mortality rates (chapter 5), life expectancy (chapter 6), and 
self-reported health (chapter 7). Chapters 2–5 explicitly address the first research question, 
developing and validating county-level small area estimation models and corrections for 
various biases in the underlying data sources utilized in these analyses. All chapters consider 
the second research question, describing and, in various ways, quantifying county-level geo-
graphic disparities in health. The third research question is specifically addressed in chapter 
6. Finally, chapter 8 contains a general discussion of the findings and implications of this 
thesis and proposes next steps.
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ABSTrACT
Background
Cigarette smoking is a leading risk factor for morbidity and premature mortality in the United 
States, yet information about smoking prevalence and trends is not routinely available below 
the state level, impeding local-level action.
Methods
We used data on 4.7 million adults age 18 and older from the Behavioral Risk Factor Sur-
veillance System (BRFSS) from 1996 to 2012. We derived cigarette smoking status from self-
reported data in the BRFSS and applied validated small area estimation methods to generate 
estimates of current total cigarette smoking prevalence and current daily cigarette smoking 
prevalence for 3,127 counties and county equivalents annually from 1996 to 2012. We ap-
plied a novel method to correct for bias resulting from the exclusion of the wireless-only 
population in the BRFSS prior to 2011.
results
Total cigarette smoking prevalence varies dramatically between counties, even within states, 
ranging from 9.9% to 41.5% for males and from 5.8% to 40.8% for females in 2012. Counties 
in the South, particularly in Kentucky, Tennessee, and West Virginia, as well as those with 
large Native American populations, have the highest rates of total cigarette smoking, while 
counties in Utah and other Western states have the lowest. Overall, total cigarette smoking 
prevalence declined between 1996 and 2012 with a median decline across counties of 0.9% 
per year for males and 0.6% per year for females, and rates of decline for males and females in 
some counties exceeded 3% per year. Statistically significant declines were concentrated in a 
relatively small number of counties, however, and more counties saw statistically significant 
declines in male cigarette smoking prevalence (39.8% of counties) than in female cigarette 
smoking prevalence (16.2%). Rates of decline varied by income level: counties in the top 
quintile in terms of income experienced noticeably faster declines than those in the bottom 
quintile.
Conclusions
County-level estimates of cigarette smoking prevalence provide a unique opportunity to 
assess where prevalence remains high and where progress has been slow. These estimates 
provide the data needed to better develop and implement strategies at a local and at a state 
level to further reduce the burden imposed by cigarette smoking.
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InTrODUCTIOn
Tobacco consumption is a leading risk factor for morbidity and premature mortality in the 
United States (US).1–4 While cigarette smoking prevalence has been declining at the national 
level, there is substantial variation across states within the US and reason to believe that even 
more variation may exist at local levels, such as counties.5–7 
Evidence-based and cost-effective strategies for reducing the burden of tobacco are avail-
able.8,9 States have differed in their uptake of these strategies, however, and have also seen 
varying degrees of success in reducing the prevalence of cigarette smoking and the associ-
ated disease burden, deaths, and costs to the health care system.10 In the US, local jurisdic-
tions have the ability to implement their own tobacco control policies and programs. Further, 
state-level policies may not be implemented or enforced evenly across all jurisdictions. 
Consequently it is essential that local estimates of current cigarette smoking prevalence 
are available for identifying areas that need further attention, for tracking progress, and for 
evaluating the effectiveness of control measures.
The US Centers for Disease Control and Prevention (CDC) routinely reports current cigarette 
smoking prevalence at the state level using data from the Behavioral Risk Factor Surveillance 
System (BRFSS).10,11 More local assessments have been published for some, but not all, juris-
dictions.12–15 The County Health Rankings & Roadmaps program14 incorporates county-level 
estimates of current cigarette smoking prevalence into their annual rankings of counties 
based on selected health outcomes and health behaviors. These estimates use BRFSS data 
but are averages over long time periods and do not provide the means to look at estimates 
for specific years or trends over time. The National Cancer Institute has produced estimates of 
current cigarette smoking prevalence for health service areas and counties for two periods, 
1997–1999 and 2000–2003, but these estimates have not been updated to include data 
from the last decade.16 Indeed, to our knowledge there has been no recent, comprehensive 
assessment of trends in current cigarette smoking prevalence at the county level using a 
consistent statistical methodology applied to all counties. In this study, we develop county-
level measurements of cigarette smoking prevalence for all counties in the United States 
annually from 1996 to 2012.
MeTHODS
Data
We utilize county-level data on cigarette smoking from the BRFSS. The BRFSS is a telephone 
survey in which trained interviewers in each state collect data on a large number of health-
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related behaviors and conditions for the noninstitutionalized adult population. The BRFSS is 
operated by state health departments in collaboration with the CDC, and all states implement 
the same core questionnaire. Beginning in 2011, the BRFSS incorporated cell phones into 
the sampling frame in addition to landlines in order to capture the growing segment of the 
population that only receives calls on a cell phone. Details on BRFSS methodology are avail-
able elsewhere,17,18 and questionnaires and data are available at www.cdc.gov/brfss. Alaska 
conducts a supplemental BRFSS using the same methodology as the standard BRFSS;19 data 
from the Alaska supplemental BRFSS on cigarette smoking were included from 2004 to 2012 
in addition to data from the standard BRFSS.
Cigarette smoking status was assessed using two questions from the BRFSS.20 Respondents 
were first asked, “Have you smoked at least 100 cigarettes in your entire life?” If a respondent 
answered yes, he or she was then asked, “Do you now smoke cigarettes every day, some 
days or not at all?” We used the responses to these two questions to classify respondents 
into three groups: nonsmokers (those who answer “no” to the first question or “not at all” 
to the second question), nondaily current smokers (those who answer “some days” to the 
second question), and daily current smokers (those who answer “every day” to the second 
question). We estimate the prevalence of current total cigarette smoking (both nondaily and 
daily combined; hereafter referred to as “total cigarette smoking prevalence”) as well as the 
prevalence of current daily cigarette smoking only (hereafter referred to as “daily cigarette 
smoking prevalence”).
Small area estimation models
We applied previously described small area models to estimate the prevalence of cigarette 
smoking for US counties.21–23 In brief, we constructed a family of logistic hierarchical mixed ef-
fects regression models for each outcome, stratified by sex. These models incorporate spatial 
and temporal smoothing and a series of county- and state-level covariates to improve predic-
tions for all counties, including those with limited data available in a given year from the 
BRFSS. More details on the regression models and the county- and state-level data sources 
incorporated in the models can be found in Additional files 1 and 2. These models allowed 
us to generate annual estimates of total and daily cigarette smoking prevalence for male and 
female adults (age 18 and older) in all US counties and county equivalents. All estimates were 
age-standardized following the age structure of the 2000 census.24 The uncertainty of the 
prevalence estimates was assessed using simulation methods.25
Model validation and performance assessment
We also used previously developed validation methods21–23 to select the best-performing 
model among a number of different plausible models. Our approach was as follows: for each 
sex we selected counties with at least 900 survey respondents between 2006 and 2010 (the 
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“validation set”); 900 was selected in previous investigations based on simulation studies as 
the number that generated sufficiently precise estimates for a wide range of outcomes. Using 
the pooled data for this time period, we calculated a “gold standard” estimate of cigarette 
smoking prevalence for each county in the validation set. We then created new datasets 
by generating random samples from counties in the validation set of size 10, 50, and 100 
respondents per year. Next, we used these “sampled-down” datasets to fit each model and 
compared the resulting prevalence estimates for counties in the validation set with the gold 
standard. We measured model performance using the concordance correlation coefficient, 
which is a measure of the agreement between the model predictions and the gold standard, 
and the root mean squared error, a measure of the magnitude of the deviation between the 
model predictions and the gold standard, expressed in the same units as the predictions.
Bias correction for wireless-only households
In 2011 cell phones were introduced into the BRFSS sampling frame in order to capture the 
growing share of the adult population that is “wireless-only” (36.5% as of the second half of 
2012)26 and cannot be reached by landline. Previous research has suggested that cigarette 
smoking prevalence is different among wireless-only respondents and respondents who 
can be reached by landline, and that omitting wireless-only respondents from a survey will 
bias estimates of cigarette smoking prevalence, most likely leading to underestimates.27,28 
We used two complementary approaches to address the omission of wireless-only re-
spondents from the BRFSS sampling frame prior to 2011. First, we incorporated a number 
of demographic characteristics—race, marital status, and educational achievement—that 
are related both to phone ownership and to cigarette smoking prevalence into the small 
area models. This allowed us to adjust our modeled estimates for each county to match the 
observed distribution of the population by these characteristics and to account for differ-
ences in the cigarette smoking prevalence between the wireless-only population and the 
general population that are due to differences in these factors. However, after making this 
adjustment, the prevalence estimates derived from the 2011 sample were higher than those 
derived from the 2010 sample, a marked and unlikely departure from trends observed in the 
recent past. Indeed, this suggested that differences in race, marital status, and education 
alone do not explain all of the difference in cigarette smoking prevalence between wireless-
only respondents and the rest of the population. To address this bias, we fit two separate 
small area models: the first to data from respondents with landlines in all years (1996–2012), 
and the second to data from all respondents, including wireless-only respondents, in 2011 
and 2012. In the second model, we included phone usage category (landline-only, dual, and 
wireless-only) to adjust estimates for the observed phone usage characteristics of the county. 
We compared the estimates for 2011 from the combined sample (the second model) to the 
estimates for the landline sample (the first model) to derive county-level measures of the 
bias introduced by not including wireless-only respondents in 2011. We assumed that this 
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bias has increased linearly with time from no bias in the year 2000 (when relatively few adults 
were wireless-only)29–31 to the level measured in 2011 and used this assumption to calculate 
corrected estimates in each year from 2001 to 2010. Estimates for 1996 to 2000 were based 
on the first model, without correction, while estimates for 2011 and 2012 were based on the 
second model.
Unit of analysis
Our unit of analysis was counties or county equivalents (e.g., parishes, census enumeration 
areas, boroughs, and independent cities). As of 2012 there were 3,143 counties and county 
equivalents. To account for changes over the study period, we merged some counties to get 
consistent areas, for a total of 3,127 counties. There were 4,738,256 respondents age 18 and 
over in the BRFSS from 1996 to 2012 who had complete data for all variables of interest. In 
2012 the combined response rate for cell and landline ranged from 27.7% to 60.4% with a 
median of 45.2% among the states. This response rate takes into account the likely number of 
eligible respondents among phone numbers for which eligibility could not be determined.32 
All analyses were carried out in R version 3.0.2.33
reSULTS
Model validation and performance
The concordance correlation for the selected model for male total cigarette smoking preva-
lence was 0.78, 0.83, and 0.87 at sample sizes 10, 50, and 100, respectively, compared to 0.90 
when all data were included (i.e., “in sample”). For women, the corresponding figures are 0.78, 
0.85, 0.88, and 0.91. The root mean squared error for the selected model for male cigarette 
smoking prevalence was 2.7, 2.5, 2.2, and 1.9 for sample sizes 10, 50, 100, and in sample, re-
spectively, while for women the root mean squared error was almost identical at 2.8, 2.4, 2.2, 
and 1.9 for the same sample sizes. Performance of the selected model for male and female 
daily cigarette smoking was similar to that for total cigarette smoking.
Bias correction for wireless-only households
We compared model predictions for 2011 that incorporated respondents who could only be 
reached by cell phone with model predictions that did not incorporate these respondents 
in order to derive a correction for earlier years in which the wireless-only population was 
excluded. In 2011, the median difference in total cigarette smoking prevalence between 
modeled estimates with and without wireless-only respondents included was 1.21 percent-
age points for men and 1.55 percentage points for women. In 2010, the last year without cell 
phones, where bias due to their exclusion is expected to be greatest, we corrected 57.3% and 
75.4% of counties for males and females, respectively, upward by at least one percentage 
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point and 4.7% and 16.3% of counties for males and females, respectively, upward by at least 
two percentage points for total cigarette smoking prevalence.
national total cigarette smoking prevalence
Figure 1 shows the national estimates for age-standardized total cigarette smoking preva-
lence derived from our models. Total cigarette smoking prevalence has declined for males 
by 1.3% (95% uncertainty interval: 1.2%–1.4%) per year, from 27.3% (26.9%–27.7%) to 22.2% 
(21.9%–22.5%), and for females by 1.4% (1.2%–1.5%) per year, from 22.2% (21.9%–22.6%) to 
17.9% (17.7%–18.2%). Most of this decline took place from 2002 onwards; trends from 1996 
to 2002 are relatively flat.
For comparison, direct (nonmodeled) estimates from the National Health Interview Survey 
(NHIS),34 a nationally representative household survey, are also plotted. These estimates have 
been reweighted to account for the distribution of the population by race, marital status, and 
educational attainment and then age-standardized; this is for consistency with the modeled 
BRFSS estimates. Estimates from the NHIS for total cigarette smoking confirm the declines 
observed in the modeled estimates based on BRFSS data. Further, while estimates from NHIS 
vary noticeably from year to year, on the whole the level of total cigarette smoking suggested 
by the NHIS is consistent with that from our models based on BRFSS data.
Figure 1: National age−standardized total cigarette smoking prevalence, 1996−2012
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figure 1. National age-standardized total cigarette smoking prevalence, 1996–2012.
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County-level total cigarette smoking prevalence
Figures  2 and 3 show the age-standardized total cigarette smoking prevalence for males 
and females, respectively, in 1996 and 2012. (Estimates for the top and bottom 10 counties 
in 2012 are presented in Tables 1 and 2 for males and females, respectively, and estimates 
for all counties in all years are presented in Additional file 3.) For males, regions with high 
levels of cigarette smoking are observed in the South and parts of the Midwest, particularly 
around Kentucky. High levels are also observed in parts of Alaska, South Dakota, Nevada, and 
Arizona. Regions of noticeably low cigarette smoking among males are observed in Utah, 
Colorado, Wyoming, California, Washington, and parts of New England. For females, the 
highest levels of cigarette smoking are concentrated in Kentucky, West Virginia, Tennessee, 
Missouri, Oklahoma, Arkansas, and Louisiana; this pattern is somewhat different from the 
pattern among males where a much larger portion of the South experienced elevated ciga-
rette smoking rates. Higher levels for females are also observed in parts of Alaska, Nevada, 
Arizona, North Dakota, and South Dakota, while the lowest levels are seen in Utah, Colorado, 
Wyoming, California, and along the Mexico-Texas border.
Table 1. Top- and bottom-ranked counties for male total cigarette smoking prevalence, 2012.
ranka County
Age-standardized total cigarette 
smoking prevalence (%)a
1 (1, 6) Falls Church City, VA 9.9 (8.1, 12.0)
2 (1, 4) Utah County, UT 9.9 (8.8, 11.3)
3 (2, 17) Davis County, UT 11.7 (10.2, 13.6)
4 (2, 21) Wasatch County, UT 11.8 (9.8, 14.0)
5 (2, 23) Arlington County, VA 11.8 (9.8, 14.2)
6 (3, 32) Summit County, UT 12.5 (10.6, 14.7)
7 (3, 37) Howard County, MD 12.7 (10.7, 15.1)
8 (3, 46) Whitman County, WA 12.8 (10.4, 15.4)
9 (3, 38) Cache County, UT 12.8 (10.8, 15.0)
10 (3, 49) Loudoun County, VA 13.1 (10.9, 15.6)
3,118 (2,866, 3,127) Issaquena County, MS 36.8 (31.9, 42.2)
3,119 (2,809, 3,127) East Carroll Parish, LA 37.0 (31.6, 42.4)
3,120 (2,898, 3,126) Clay County, KY 37.2 (32.3, 42.2)
3,121 (2,859, 3,127) Lee County, KY 37.4 (31.9, 42.2)
3,122 (2,946, 3,126) Bethel Census Area, AK 37.5 (33.1, 42.3)
3,123 (2,875, 3,127) Sioux County, ND 37.7 (32.1, 43.6)
3,124 (2,879, 3,127) Shannon County, SD 37.9 (32.2, 44.1)
3,125 (2,967, 3,126) Nome Census Area, AK 38.1 (33.1, 42.8)
3,126 (3,082, 3,127) Wade Hampton Census Area, AK 41.2 (35.9, 46.8)
3,127 (3,089, 3,127) Northwest Arctic Borough, AK 41.5 (35.9, 46.8)
aNumbers in parentheses are 95% uncertainty intervals.
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In 1996, the lowest total cigarette smoking prevalence for males was observed in Utah 
County, UT (15.5% [13.2%–17.6%]), while the highest was found in Northwest Arctic Borough, 
AK (42.6% [37.0%–48.5%]), a difference of 27.1 percentage points. In 2012, Falls Church City, 
VA had the lowest prevalence at 9.9% (8.1%–12.0%), while the highest prevalence was still 
found in Northwest Arctic Borough, AK at 41.5% (35.9%–46.8%), a 31.7 percentage point 
difference. For females, the lowest prevalence in 1996 was found in Utah County, UT at 9.0% 
(7.2%–10.8%), which is 27.8 percentage points lower than the highest-observed prevalence 
that year in Perry County, KY at 36.8% (31.7%–42.1%). In 2012, female cigarette smoking 
prevalence was still lowest in Utah County, UT (5.8% [4.9%–6.8%]), which was 35.1 percent-
age points lower than the highest prevalence in that year, in Northwest Arctic Borough, AK 
(40.8% [34.8%–46.8%]).
Figure 2: Age−standardized total cigarette smoking prevalence, males, 1996 and 2012
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figure 2. Age-standardized total cigarette smoking prevalence, males, 1996 and 2012.
Figure 3: Age−standardized total cigarette smoking prevalence, females, 1996 and 2012
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figure 3. Age-standardized total cigarette smoking prevalence, females, 1996 and 2012.
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Even within a single state there is often substantial variation among counties. The median 
gap between highest and lowest cigarette smoking prevalence among counties within the 
same state in 2012 was 14.7 percentage points for males and 13.6 percentage points for 
females. The largest gap for males in 2012 was observed in Virginia, where there was a 23.6 
percentage point gap in cigarette smoking prevalence for men between Sussex County 
(33.5% [28.6%–38.7%]) and Falls Church City (9.9% [8.1%–12.0%]). For females, the largest 
gap in 2012 was observed in Alaska, where there was a 25.4 percentage point gap for women 
between Northwest Arctic Borough (40.8% [34.8%–46.8%]) and Haines Borough (15.4% 
[12.3%–18.8%]).
In the vast majority of counties, males smoked cigarettes at higher rates than females (Fig-
ure 4): in 99.0% of counties in 1996 males had a higher cigarette smoking prevalence than 
females, while in 2012 the same was true in 96.4% of counties. The gap between male and 
female total cigarette smoking prevalence has changed with time, however: the median dif-
ference between male and female cigarette smoking was 5.4 percentage points in 1996 com-
pared to 3.4 in 2012. Across all counties in 1996, the gap between male and female cigarette 
Table 2. Top- and bottom-ranked counties for female total cigarette smoking prevalence, 2012.
ranka County
Age-standardized total cigarette 
smoking prevalence (%)a
1 (1, 2) Utah County, UT 5.8 (4.9, 6.8)
2 (1, 8) Wasatch County, UT 7.1 (5.7, 8.8)
3 (2, 21) Davis County, UT 8.3 (7.1, 9.9)
4 (2, 33) Hidalgo County, TX 8.6 (6.9, 10.8)
5 (2, 37) San Mateo County, CA 8.7 (6.9, 10.8)
6 (2, 42) Cameron County, TX 8.8 (6.9, 11.3)
7 (2, 37) Summit County, UT 8.9 (7.2, 10.8)
8 (3, 36) Santa Clara County, CA 9.0 (7.4, 10.8)
9 (3, 41) Cache County, UT 9.1 (7.4, 11.1)
10 (7, 32) Los Angeles County, CA 9.6 (8.6, 10.6)
3,118 (2,844, 3,126) Elliott County, KY 34.0 (28.2, 40.7)
3,119 (2,791, 3,126) Shannon County, SD 34.1 (27.6, 40.9)
3,120 (2,973, 3,126) Knox County, KY 34.7 (29.8, 39.8)
3,121 (2,924, 3,127) Buffalo County, SD 35.4 (29.2, 42.2)
3,122 (2,997, 3,126) Nome Census Area, AK 35.8 (30.2, 41.1)
3,123 (3,002, 3,127) Wade Hampton Census Area, AK 36.2 (30.4, 42.5)
3,124 (3,023, 3,127) Clay County, KY 36.2 (30.8, 41.9)
3,125 (3,014, 3,127) Menominee County, WI 36.5 (30.6, 42.5)
3,126 (3,067, 3,127) North Slope Borough, AK 37.5 (32.2, 43.0)
3,127 (3,110, 3,127) Northwest Arctic Borough, AK 40.8 (34.8, 46.8)
aNumbers in parentheses are 95% uncertainty intervals.
33
Chapter 2 - Cigarette smoking prevalence in US counties: 1996–2012
smoking ranged from -3.2 percentage points in Colonial Heights City, VA, to 15.3 percentage 
points in Jefferson County, MS. In 2012, the gap between male and female cigarette smoking 
ranged from -5.7 percentage points in Menominee County, WI, to 16.5 percentage points in 
Sunflower County, MS. The correlation between male and female cigarette smoking preva-
lence was 0.75 in 1996 and 0.81 in 2012.
Figures  5 and 6 show the change in age-standardized total cigarette smoking prevalence 
from 1996 to 2012, expressed in terms of the annualized rate of change; Tables 3 and 4 give 
the top and bottom 10 counties in terms of annualized rates of change. Amongst all counties, 
the median annualized rate of change was -0.9% for males and -0.6% for females. The greatest 
decline for males was 4.5% (2.6%–6.4%) per year in Falls Church City, VA, while the greatest 
for females was 4.1% (1.9%–6.4%) per year in Maverick County, TX. The largest increase for 
males was 1.1% (-0.2%–2.4%) per year in Issaquena County, MS, while the greatest increase 
for females was 1.7% (-0.4%–3.6%) per year in McMullen County, TX. Only 39.8% of counties 
for males and 16.2% of counties for females experienced statistically significant declines 
in cigarette smoking prevalence between 1996 and 2012, though an additional 57.3% of 
counties for men and 66.1% of counties for women experienced nonstatistically significant 
declines over this same period. Counties with statistically significant declines represent a 
disproportionate share of the population, however, such that 74.4% of the adult male popu-
lation and 61.1% of the adult female population in 2012 lived in counties where the decline 
Figure 4: Difference between male and female age−standardized total cigarette smoking prevalence, 1996 and 2012
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figure 4. Difference between male and female age-standardized total cigarette smoking prevalence, 1996 
and 2012.
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Figure 5: Annualized rate of change in age−standardized total cigarette smoking prevalence, 1996−2012
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figure 5. Annualized rate of change in age-standardized total cigarette smoking prevalence, 1996–2012.
Figure 6: Annualized rate of change in age−standardized total cigarette
smoking prevalence, females compared to males, 1996−2012
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figure 6. Annualized rate of change in age-standardized total cigarette smoking prevalence, females com-
pared to males, 1996–2012.
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in total cigarette smoking prevalence was statistically significant. There were statistically 
significant increases in only one county for males and in only three counties for females. The 
correlation between male and female annualized rates of decline in the same county was 
moderate at 0.55. In most counties, males and females saw cigarette smoking prevalence 
move in the same direction (Figure  6), however, in 16.1% of counties males experienced 
declines while females experienced increases and, conversely, in 1.4% of counties females 
experienced declines while males experienced increases. For both males and females, the 
correlation between the level of cigarette smoking prevalence in 1996 and the rate of decline 
between 1996 and 2012 was low: 0.26 for males and 0.15 for females.
Total cigarette smoking prevalence as well as changes in total cigarette smoking prevalence 
varied between counties with different mean income levels.35 Table  5 shows the median 
total cigarette smoking prevalence in 1996 and 2012 and the annualized rate of decline in 
total cigarette smoking prevalence over this period among counties in each income quintile 
(defined in terms of income in 1996). In both 1996 and 2012, the median cigarette smok-
Table 3. Top- and bottom-ranked counties for annualized rates of change in male total cigarette smoking 
prevalence, 1996–2012.
ranka County
Annualized rate of change in total 
cigarette smoking prevalence (%)a
1 (1, 87) Falls Church City, VA -4.5 (-6.4, -2.6)
2 (1, 555) Arlington County, VA -3.2 (-4.7, -1.7)
3 (1, 687) San Francisco County, CA -3.1 (-4.5, -1.6)
4 (2, 755) Loudoun County, VA -2.9 (-4.3, -1.5)
5 (2, 629) New York County, NY -2.8 (-4.1, -1.7)
6 (3, 745) Orange County, CA -2.8 (-3.9, -1.6)
7 (2, 981) Dallas County, IA -2.8 (-4.2, -1.3)
8 (4, 486) Rockingham County, NH -2.8 (-3.9, -1.8)
9 (2, 883) San Mateo County, CA -2.8 (-4.2, -1.4)
10 (3, 702) Utah County, UT -2.8 (-4.0, -1.6)
3,118 (1,795, 3,125) Lincoln County, AR 0.4 (-0.8, 1.7)
3,119 (1,791, 3,125) Lee County, AR 0.5 (-0.8, 1.7)
3,120 (1,625, 3,126) Claiborne County, MS 0.5 (-0.9, 1.8)
3,121 (1,908, 3,126) Benson County, ND 0.5 (-0.7, 1.8)
3,122 (1,784, 3,126) Wheeler County, GA 0.6 (-0.8, 1.9)
3,123 (2,031, 3,127) East Carroll Parish, LA 0.7 (-0.6, 2.0)
3,124 (2,321, 3,126) Hardy County, WV 0.7 (-0.4, 1.8)
3,125 (2,177, 3,127) Bent County, CO 0.8 (-0.5, 2.1)
3,126 (2,229, 3,127) Meagher County, MT 0.9 (-0.5, 2.3)
3,127 (2,550, 3,127) Issaquena County, MS 1.1 (-0.2, 2.4)
aNumbers in parentheses are 95% uncertainty intervals.
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Table 4. Top- and bottom-ranked counties for annualized rates of change in female total cigarette smok-
ing prevalence, 1996–2012.
ranka County
Annualized rate of change in total 
cigarette smoking prevalence (%)a
1 (1, 441) Maverick County, TX -4.1 (-6.4, -1.9)
2 (1, 527) Hidalgo County, TX -3.7 (-5.6, -1.8)
3 (1, 596) San Luis Obispo County, CA -3.7 (-5.5, -1.7)
4 (1, 892) Falls Church City, VA -3.7 (-6.1, -1.3)
5 (1, 622) Webb County, TX -3.6 (-5.7, -1.5)
6 (1, 722) Santa Barbara County, CA -3.5 (-5.5, -1.5)
7 (2, 711) San Francisco County, CA -3.5 (-5.3, -1.5)
8 (1, 707) San Mateo County, CA -3.4 (-5.3, -1.5)
9 (1, 710) Wasatch County, UT -3.4 (-5.2, -1.5)
10 (7, 303) Chittenden County, VT -3.3 (-4.3, -2.2)
3,118 (2,208, 3,118) Sullivan County, TN 1.2 (-0.1, 2.5)
3,119 (1,806, 3,124) Adair County, OK 1.2 (-0.4, 2.8)
3,120 (2,002, 3,123) Hampshire County, WV 1.2 (-0.2, 2.7)
3,121 (1,559, 3,125) Grant County, WV 1.2 (-0.6, 3.0)
3,122 (1,837, 3,126) Benson County, ND 1.3 (-0.4, 3.1)
3,123 (1,693, 3,126) Bristol City, VA 1.4 (-0.5, 3.2)
3,124 (2,105, 3,126) Allen Parish, LA 1.4 (-0.1, 3.1)
3,125 (2,148, 3,125) Muskogee County, OK 1.4 (-0.1, 3.0)
3,126 (2,116, 3,126) Mineral County, WV 1.6 (-0.1, 3.2)
3,127 (1,888, 3,127) McMullen County, TX 1.7 (-0.4, 3.6)
aNumbers in parentheses are 95% uncertainty intervals.
Table 5. Total cigarette smoking prevalence and annualized rate of change by income quintile, 1996–2012.
Income 
quintile, 
1996
Median 
annualized 
rate of change, 
1996–2012 (%)a
Median age-
standardized total 
smoking prevalence, 
1996 (%)a
Median age-
standardized total 
smoking prevalence, 
2012 (%)a
Counties with 
statistically significant 
declines between 1996 
and 2012 (%)
M
al
es
1st quintile -0.5 (-2.4, 1.1) 32.1 (22.8, 40.7) 29.6 (17.5, 37.9) 14.1
2nd quintile -0.8 (-2.3, 0.7) 30.5 (20.4, 39.5) 27.2 (18.1, 34.8) 22.7
3rd quintile -0.9 (-2.4, 0.4) 29.4 (19.7, 41.5) 25.6 (14.8, 41.2) 34.6
4th quintile -1.1 (-2.8, 0.3) 29.0 (17.5, 37.9) 24.5 (12.8, 37.5) 52.2
5th quintile -1.4 (-4.5, 0.0) 27.3 (15.5, 42.6) 21.8 (9.9, 41.5) 75.4
Fe
m
al
es
1st quintile -0.3 (-4.1, 1.4) 24.6 (14.0, 36.8) 23.6 (8.6, 36.5) 4.2
2nd quintile -0.4 (-2.5, 1.6) 24.8 (14.3, 35.7) 23.2 (11.7, 32.4) 5.1
3rd quintile -0.5 (-2.7, 1.1) 24.4 (13.6, 33.2) 22.2 (11.8, 36.2) 8.2
4th quintile -0.7 (-3.0, 1.7) 23.9 (11.0, 35.1) 21.4 (9.1, 31.9) 18.4
5th quintile -1.2 (-3.7, 0.9) 22.5 (9.0, 36.7) 18.7 (5.8, 40.8) 45.2
aNumbers in parentheses are the minimum and maximum.
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ing prevalence decreased as mean income in 1996 increased. Moreover, the median rate of 
change between 1996 and 2012 was more negative for higher income quintiles than for lower 
income quintiles. As a consequence, more counties in higher income quintiles experienced 
statistically significant declines from 1996 to 2012: for males only 14.1% of counties in the 
bottom income quintile experienced statistically significant declines compared to 75.4% of 
counties in the top income quintile; for females only 4.2% of counties in the bottom income 
quintile experienced statistically significant declines compared to 45.2% of counties in the 
top income quintile.
County-level daily cigarette smoking prevalence
Daily cigarette smoking prevalence is given for all counties in Additional file 4. When we 
examined the correlation between total and daily cigarette smoking it was very high: 0.95 
across both sexes and all years combined. By definition, daily cigarette smoking is always less 
than total cigarette smoking prevalence, but the median difference between total and daily 
cigarette smoking among counties increased from 4.3 to 6.6 percentage points in males and 
3.6 to 5.4 percentage points in females from 1996 to 2012. This was due to the fact that daily 
cigarette smoking prevalence has declined faster than total cigarette smoking prevalence: 
the median annualized rate of decline for daily cigarette smoking prevalence was 1.9% per 
year for males and 1.4% per year for females, compared to 0.9% per year and 0.6% per year 
for total cigarette smoking prevalence for males and females, respectively. Rates of decline 
in total and daily cigarette smoking over the period from 1996 to 2012 are highly correlated, 
however: 0.93 for both males and females. In 2012 the gap between daily and total cigarette 
smoking prevalence ranged from 2.7 (Utah County, UT) to 15.3 (Wade Hampton Census Area, 
AK) percentage points for males and from 1.4 (Utah County, UT) to 11.8 (Wade Hampton 
Census Area, AK) percentage points for females.
DISCUSSIOn AnD COnCLUSIOnS 
Our study is the first to report on nationwide cigarette smoking prevalence and change in 
cigarette smoking prevalence at the county level from 1996 to 2012. Moreover, we derived 
these estimates using a systematic model selection and validation process. Additionally, we 
report on a novel method to adjust BRFSS estimates to take into account recent changes 
in the BRFSS methodology, which allows for analysis of trends both before and after these 
changes. The BRFSS has informed data users about these changes and their potential impact 
on the estimates and trends but has not provided a means to adjust the data. Our correction 
method provides a solution and allows for the seamless use of pre-2011 and post-2011 BRFSS 
data for research and policy analysis across the US. Our approach provides county health 
officials with reliable and comparable estimates of cigarette smoking prevalence for males 
38
and females in their jurisdiction and, perhaps more importantly, provides an assessment of 
trends in the last 17 years to assess whether a county is making as much progress as other 
similar counties in the US.
Our study reveals dramatic differences in cigarette smoking prevalence across the country 
that would not be apparent from national estimates or even state-level estimates. Indeed, 
within-state variation in cigarette smoking sometimes rivals variation seen in the country as 
a whole. State-level estimates of cigarette smoking prevalence, while useful for beginning 
to explore differentials within the US and indispensable for informing state-level tobacco 
control policies, do not provide the same level of resolution as our county estimates and 
hence mask important local differences in both the current level of smoking prevalence and 
in trends.
County-level estimates of cigarette smoking prevalence reveal pockets of high-risk popula-
tions. Our results support previous studies that have shown that cigarette smoking rates are 
associated with income, educational achievement, and race/ethnicity.13,36,37 We find that very 
high rates of cigarette smoking appear to be a particular problem for poorer communities 
and those with large populations of Native Americans and Alaska natives, while lower rates 
of cigarette smoking are found in more affluent counties and counties with large shares of 
Mexican immigrants. We also find considerable geographic variation, even within states, in 
smoking prevalence.
Our results support previously reported findings on a decline in the prevalence of cigarette 
smoking in the US as a whole. However, examining trends at the county level reveals that not 
all counties have contributed to this decline. In reality, a relatively small proportion of coun-
ties (though representing a disproportionately large share of the population) experienced 
statistically significant declines over this period. We find that rates of decline in smoking 
prevalence at the county level for men generally exceeded those for women. We also find 
that declines over this period were related to income: counties in higher income brackets 
tended to have more rapid declines than counties in lower income brackets.
These findings illustrate the importance of county-level estimates of smoking prevalence. 
Progress in reducing cigarette smoking will be limited as long as so many communities are 
left behind. A wide range of effective tobacco control policies and programs have been 
developed, including excise taxes, smoke-free policies, restriction of tobacco promotion ac-
tivities, quitline interventions, mass-media advertising campaigns, and policies that reduce 
the out-of-pocket costs related to cessation treatments.8,9,38,39 Our estimates uniquely provide 
the means to assess where existing state-level policies may not be adequately enforced and 
where new county-level policies may be called for in lieu of or in addition to action at the 
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state level. Further, as the tobacco industry seeks to maintain or increase sales, marketing of 
tobacco products is increasingly taking place at the local level.40 Our county-level estimates 
provide a means of assessing and tracking the impact of such efforts.
These local, annual measurements of cigarette smoking prevalence can be an important 
stimulus to local public health decision-making and community engagement. Moreover, 
our methodology could be used to produce local estimates for other leading risk factors for 
the burden of disease and incorporated into a scoring system to rank counties in terms of 
their health performance. These kinds of county health profiles would enable local and state 
health officials to prioritize and target high-risk counties while spending local, state, and 
federal funds more wisely on prevention and treatment programs. Maintenance of health 
profiles over time will also allow tracking progress in confronting major risk factors. Being 
able to compare counties on a dollar-spent-per-point-reduction in prevalence will create 
positive competition and allow identification of best practices.
Recent work on global trends in daily smoking prevalence deserves mention despite the 
difference in definition of smoking prevalence employed (all types of tobacco, not just 
cigarettes as in the current study).41 For males, the counties with the lowest daily smoking 
prevalence are comparable to those countries with the lowest daily smoking prevalence 
globally: indeed, less than 0.5% of countries have lower male daily smoking prevalence than 
these counties. At the same time, counties with the highest daily smoking prevalence are 
comparable to countries with moderately high daily smoking prevalence globally: slightly 
more than one-third (36.9%) of countries have higher smoking prevalence among men than 
these counties. For females the comparison is quite different: 48.1% of countries have lower 
female daily smoking prevalence than the lowest daily smoking prevalence in any county in 
the US. At the same time, only 1.6% of countries have higher female daily smoking prevalence 
than the highest daily smoking prevalence among counties in the US.
We have used the BRFSS to develop county-level measurements of cigarette smoking 
prevalence, and its limitations need to be taken into account when using or interpreting our 
results. First, the BRFSS is a telephone survey and is subject to bias as a result of excluding 
the population that has no phone line. This represents a relatively small proportion of the 
population (less than 2%),26 however, so the potential for bias is limited. Second, the BRFSS 
relies on self-reported smoking status and is therefore subject to self-reporting bias, which 
may vary by sex and by age. Third, while CDC makes BRFSS data available for all respondents 
in each survey, not all county identifiers are released: in particular, the county identifier for 
respondents from very small counties is typically masked. In some cases we have been able 
to obtain data directly from states and recover the county of residence for these respondents. 
However, we have not been able to do this for all respondents, particularly in recent years, 
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and consequently are not able to make use of the entire BRFSS dataset in this analysis. Finally, 
the statistical models that we employ are also subject to error. While we have rigorously vali-
dated the model, this validation is internal to the dataset used for modeling—BRFSS—and 
cannot assess how well the model will perform in the presence of errors or biases in the 
BRFSS data. While estimates from the NHIS for total smoking are relatively consistent with 
our modeled estimates based on BRFSS data, there is still room for further research into why 
these two data sources are not more closely aligned. Further, while the correction method 
we employ for addressing the exclusion of wireless-only respondents prior to 2011 has the 
expected effect and brings our estimates of total smoking more closely in line with those 
from the NHIS, we have not been able to validate this methodology as thoroughly as we have 
the small area models, nor are we able to verify the assumption that bias due to exclusion of 
wireless-only respondents has increased linearly with time.
Over the past two decades, states and counties have introduced a number of policies and 
programs to address the tobacco epidemic. We find, however, that in a troublingly large 
number of counties there has been relatively little progress in reducing cigarette smoking 
prevalence. Many areas of the country are still smoking at levels found in previous decades 
when cigarette smoking was not yet widely recognized as a major risk factor for morbidity 
and premature mortality. Smoking is a leading cause of death and deserves acute attention 
by health and medical professionals. Public health is local, and we believe that our study 
provides the necessary tools to understand and measure patterns of smoking at the local 
level with existing data.
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ADDITIOnAL fILe 1
Small area models
We consider four families of logistic regression models for estimating smoking prevalence 
in each county. The first family, which we call the “naïve” model, contains only an intercept, 
demographic characteristics, a linear time trend, and county-level random slopes and inter-
cepts: 
Yi,k,t ~ Binomial(Ni,k,t, pi,k,t)
logit(pi,k,t) = νi,k,t = β(0) + β(1) ⋅ t + βk(2) + γi(0) + γi(1) ⋅ t
where i indicates county, k indicates demographic group (e.g., age, race, etc.), and t indicates 
calendar year. This model borrows strength by using all data to estimate the mean level (β(0)), 
the effect of certain demographic characteristics (given by the βk(2) terms), and the temporal 
trends (β(1)) while still allowing for county-level variation through inclusion of the random 
intercept (γi(0)) and slope (γi(1)). 
The second model family, the “covariate” model, includes everything in the naïve model as 
well as a series of county-level covariates: 
logit (pi,k,t) = νi,k,t = β(0) + β(1) ⋅ t + βk(2)+ β(3) ⋅ Χi,t + γi(0) + γi(1) ⋅ t
where Χi,t is a matrix of county- and state-level covariates and β(3) is a vector of regression 
coefficients corresponding to these covariates. This model borrows strength from external 
data, making use of variables available at the county level which are related to smoking 
prevalence. We selected covariates for our model from among those available by performing 
an exhaustive search: we fit logistic regression models with all combinations of all available 
covariates and selected the best model based on the Akaike information criterion (AIC). For 
smoking prevalence, the covariates we selected were proportion of the county population 
that is black, proportion of the county population that is American Indian or Alaska native, 
proportion of the county population that is Hispanic, the proportion of the county popula-
tion that holds a bachelor’s degree, the proportion of the county population in poverty, the 
proportion of the county population that is rural, the county-level number of doctors per 
capita, the county-level unemployment rate, and the state-level cigarette sales per capita. 
For daily smoking prevalence the same variables were selected except for unemployment. 
Details of sources for these variables are available in table S1. 
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The third model family, the “geospatial” model, includes everything in the naïve model as well 
as an additional geospatial term which captures spatial information present in the value of 
the county-level random effects from the naïve model: 
logit (pi,k,t) = νi,k,t = β(0) + β(1) ⋅ t + βk(2) + β(4) ⋅ δ¯1 + γi(0) + γi(1) ⋅ t
where for each county δ¯1 is the mean of the estimated γi(0) for all neighbors (defined by adja-
cency) from the naïve model. This model borrows strength spatially: we expect that smoking 
prevalence varies somewhat smoothly in space, so for each county the smoking prevalence 
of the neighbors is also informative. 
The final model family, the ‘full’ model, includes everything in the previous three models: 
logit (pi,k,t) = νi,k,t = β(0) + β(1) ⋅ t + βk(2) + β(3) ⋅ Xi,t + β(4) ⋅ δ¯1 + γi(0) + γi(1) ⋅ t
where all variables are defined as above, except that δ¯1 is calculated based on γi(0) from the 
covariate model. 
Because we are considering an extended time-period (17 years, from 1996 to 2012), we do 
not expect that the time trends will be linear over the entire period or that the effect of 
covariates will necessarily be the same over the entire period. We therefore fit the models 
using a ‘moving window’ approach: each model is fit multiple times, using all data in suc-
cessive, overlapping windows 5 years in length (i.e. 1996–2001, 1997–2002, …, 2008–2012). 
We then predict for each year using the model centered on that year except for the first two 
years (1996 and 1997) which use the model fit to the earliest data (1996–2000). In addition 
to the models fit on 5-year windows, two additional models are fit to just the data from 2011 
and 2012 for the purposes of calculating a correction for the omission of cell phones in earlier 
years, as described in the main text: one that includes all respondents, and one that includes 
only respondents who can be reached on a landline phone. 
We include age in all models as one of the demographic characteristics. Age is grouped into 
12 bins: 18–24 years, and then 5-year bins from ages 25 to 74 (i.e. 25–29, 30–34, …, 70–74), 
and a final bin containing all respondents age 75 and over. We considered inclusion of three 
other sets of demographic characteristics: race/ethnicity (white non-Hispanic, black non-
Hispanic, Hispanic, American Indian or Alaska native, and other), marital status (currently 
married, formerly married, and never married), and educational attainment (less than high 
school, high school grad, some college, and college grad). In all four cases, these variables 
were introduced into the model as a series of indicator covariates where one reference group 
was absorbed into the overall intercept (age 18–24, white non-Hispanic, formerly married, 
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and less than HS served as the reference groups). Using the validation methods described 
in the main text, we tested all four model families with all combinations of including or ex-
cluding these three sets of demographic characteristics (race, marital status, and education). 
The models that included education noticeably outperformed the models that excluded 
education; models that included race and marital status slightly outperformed models that 
excluded these variables. We therefore considered only models that included all three sets of 
demographic characteristics. In addition to these demographic characteristics, models were 
stratified (fit separately) by sex as smoking patterns are known to differ between males and 
females. 
Based on the fitted values of all parameters we are able to generate predictions for every 
county, sex, age, race, marital status, educational attainment group in each year. We collapse 
these estimates to county, sex, and age, by year, by finding the weighted mean of the predic-
tions using the county’s population by race, marital status, and educational attainment as the 
weights (see table S1 for details on the source of these populations). Because county-level 
populations stratified by all these variables simultaneously are not available, we assume that 
within a given county, sex, and age group for a given year the distributions of the population 
by race, by marital status, and by educational attainment are independent of each other. 
Once we have collapsed the estimates to county, sex, age by year, we age-standardize the 
estimates using the 2000 census population. State and national estimates for each year 
are derived by population weighting the county-level estimates in the corresponding year. 
Similarly, estimates for both sexes combined are a weighted average of the male and female 
estimates using the observed distribution of the adult population by sex in the 2000 census. 
The small area models employed require that we have data from each respondent in the 
BRFSS on their demographic characteristics (i.e. age, sex, race, marital status, and educational 
attainment), their county of residence, and their smoking status. Table S2 gives information 
on the total number of respondents and the number of respondents with complete data in 
each year of BRFSS data and Additional file 2 gives the number of respondents with complete 
data available in each county for each year. We perform all analyses on respondents who 
have complete data on all of the variables listed above. 
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Table S1. Data Sources.
Data Use Source notes
County changes Determining 
consistent county 
units of analysis.
Census Bureaua
County adjacencies Determining 
neighborhood 
structure for use in 
geospatial and full 
models. 
Census Bureaub
Proportion Black, 
Hispanic, American 
Indian or Alaska 
native, and Asian 
(county-level)
Covariate in 
covariate and full 
models. 
NCHS Bridged Race 
Filesc–e
Proportion with 
a college degree 
(county-level)
Covariate in 
covariate and full 
models. 
1990 Census,f 2000 
Census,g 2009–2012 
American Community 
Survey (ACS) 5-yr 
estimatesh
County-level data are available for 
1990, 2000, and 2007–2010. Linear 
interpolation is used to fill in missing 
years from 1990 to 2007 and the 2010 
values are used for all years after 2010. 
Percent rural (county-
level)
Covariate in 
covariate and full 
models.
1990 Census,i 2000 
Census,j 2010 Censusk
Linear interpolation was used to fill in 
intercensal years. 2010 values are used 
for all years after 2010. 
Poverty (county-
level)
Covariate in 
covariate and full 
models.
Small Area Income 
and Poverty Estimates 
(SAIPE)l
County-level data are available for 1989, 
1993, 1995, and 1997–2012. Linear 
interpolation was used to fill in missing 
years from 1990 to 2012. 
Doctors per capita 
(county-level)
Covariate in 
covariate and full 
models. 
Area Health Resource 
File (AHRF)m
County-level data are available for 1990, 
1995, 2000–2008, 2010, and 2011. Linear 
interpolation was used to fill in missing 
years from 1990 to 2011 and 2011 
values were used for 2011 and 2012. The 
variable for ‘Non-Federal MDs’ was used 
in place of all MDs as this was available 
for more years. 
Unemployment 
(county-level)
Covariate in 
covariate and full 
models. 
Local Area 
Unemployment 
Statistics (LAUS)n
Cigarette sales per 
capita (state-level)
Covariate in 
covariate and full 
models. 
State Tobacco 
Activities Tracking & 
Evaluation System 
(STATE)o
County population 
by age, sex, and race
Aggregation of 
model estimates.
NCHS Bridged Race 
Filesc–e
48
Table S1. Data Sources. (continued)
Data Use Source notes
County population 
by age, sex, and 
marital status
Aggregation of 
model estimates.
2000 Census,p 
2009–2012 American 
Community Survey 
(ACS) 5-yr estimatesq
County-level data are available from 
the census in 2000 and from the 5-year 
ACS estimates published in 2009–2012, 
corresponding to estimates in 2007–
2010. We use linear interpolation to fill 
in years between 2000 and 2007 and we 
use the value in 2000 for all years before 
2000 and the value in 2010 for all years 
after 2010. 
County population 
by age, sex, and 
educational 
attainment
Aggregation of 
model estimates.
2000 Census,r 
2009–2012 American 
Community Survey 
(ACS) 5-yr estimatess
County-level data are available from 
the census in 2000 and from the 5-year 
ACS estimates published in 2009–2012, 
corresponding to estimates in 2007–
2010. We use linear interpolation to fill 
in years between 2000 and 2007 and we 
use the value in 2000 for all years before 
2000 and the value in 2010 for all years 
after 2010. 
Phone usage patterns Aggregation of 
model estimates in 
2011–2012. 
Blumberg et al.t Data are available for 2011 only, so the 
2011 values are applied to 2011 and 
2012. Estimates are available for 93 non-
overlapping geographic areas consisting 
of states, counties, or groups of counties. 
We apply the estimate for each state, 
county, or group of counties to all 
counties in the aggregate. 
Age and sex standard Age standardizing 
model estimates 
and combining 
male and female 
estimates.
2000 Censusu
County and state 
shape files
Creating maps. SEER*Stat Bridgev
aUS Census Bureau. Substantial Changes to Counties and County Equivalent Entities: 1970–Present. Avail-
able from: http://www.census.gov/geo/reference/county-changes.html. 
bUS Census Bureau. United States County Adjacency 2010. Available from: http://www.census.gov/geo/
reference/county-adjacency.html. 
cNational Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC), US Census 
Bureau. United States Bridged-Race Intercensal Population Estimates 1990–1999. Hyattsville, United States: 
National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC), 2004. Avail-
able from: http://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm#july1999. 
dNational Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC), US Census 
Bureau. United States Bridged-Race Intercensal Population Estimates 2000–2009. Hyattsville, United States: 
National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC), 2012. Avail-
able from: http://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm#july2009. 
eNational Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC), US Cen-
sus Bureau. United States Vintage 2012 Bridged-Race Postcensal Population Estimates 2010–2012. Hyatts-
ville, United States: National Center for Health Statistics (NCHS), Centers for Disease Control and Preven-
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tion (CDC), 2013. Available from: http://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.
htm#vintage2012. 
fUS Census Bureau. 1990 US Census, Summary Tape File 3 (STF3), Table P057: Educational Attainment. Avail-
able from: http://www2.census.gov/census_1990/1990STF3.html. 
gUS Census Bureau. 2000 US Census, Summary File 3 (SF3), Table DP-2: Profile of Selected Social Character-
istics. Generated using American FactFinder: http://factfinder2.census.gov. 
hUS Census Bureau. 2009–2012 American Community Survey 5-year Estimates, Table S1501: Educational 
Attainment. Generated using American FactFinder: http://factfinder2.census.gov. 
iUS Census Bureau. 1990 US Census, Summary Tape File 1 (STF1), Table H004: Urban and Rural. Available 
from: http://www2.census.gov/census_1990/1990STF1.html. 
jUS Census Bureau. 2000 US Census, Summary File 1 (SF1), Table H002: Urban and Rural. Generated using 
American FactFinder: http://factfinder2.census.gov. 
kUS Census Bureau. 2010 US Census, Summary File 1 (SF1), Table H2: Urban and Rural. Generated using 
American FactFinder: http://factfinder2.census.gov. 
lUS Census Bureau. United States Small Area Income and Poverty Estimates 1989, 1993, 1995, 1997–2012. 
Washington, DC, United States: US Census Bureau, 2013. Available from: http://www.census.gov/did/www/
saipe/data/index.html. 
mUS Department of Health and Human Services, Health Resources and Services Administration. Area Health 
Resources File 2012–2013. Washington, DC, United States: US Department of Health and Human Services, 
Health Resource and Services Administration, 2013. Available from: http://arf.hrsa.gov/download.htm. 
nUS Bureau of Labor Statistics. Local Area Unemployment Statistics. 2013. Available from: ftp://ftp.bls.gov/
pub/time.series/la/. 
oCenters for Disease Control and Prevention (CDC). State Tobacco Activities Tracking and Evaluation Sys-
tem, Economics, Cigarette Sales. 2013. Available from: http://apps.nccd.cdc.gov/statesystem/TrendReport/
TrendReports.aspx. 
pUS Census Bureau. 2000 US Census, Summary File 3 (SF3), Table PCT007: Sex by Marital Status by Age 
for the Population 15 Years and Over. Generated using American FactFinder: http://factfinder2.census.gov. 
qUS Census Bureau. 2009–2012 American Community Survey 5-year Estimates, Table B12002: Sex by Mari-
tal Status by Age for the Population 15 Years and Over. Generated using American FactFinder: http://fact-
finder2.census.gov. 
rUS Census Bureau. 2000 US Census, Summary File 3 (SF3), Table PCT025: Sex by Age by Educational At-
tainment for the Population 18 Years and Over. Generated using American FactFinder: http://factfinder2.
census.gov. 
sUS Census Bureau. 2009–2012 American Community Survey 5-year Estimates, Table B15001: Sex by Age by 
Educational Attainment for the Population 18 Years and Over. Generated using American FactFinder: http://
factfinder2.census.gov. 
tBlumberg SJ, Luke JV, Ganesh, N, Davern ME, Boudreaux MH. Wireless Substitution: State-level Estimates 
from the National Health Interview Survey, 2010–2011. National Health Statistics Reports. 2012; 61. Avail-
able from: http://www.cdc.gov/nchs/data/nhsr/nhsr061.pdf. 
uUS Census Bureau. 2000 US Census, Summary File 1 (SF1), Table QTP1: Age Groups and Sex. Generated us-
ing American FactFinder: http://factfinder2.census.gov. 
vNational Cancer Institute. SEER Stat Bridge State and County FIPS Codes 2000–2004. Available from: http://
gis.cancer.gov/tools/seerstat_bridge/fips_vars/#sc_2000_2004.
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ABSTrACT
Objectives
We estimated the prevalence of any drinking and binge drinking from 2002 to 2012 and 
heavy drinking from 2005 to 2012 in every US county.
Methods
We applied small area models to Behavioral Risk Factor Surveillance System data. These 
models incorporated spatial and temporal smoothing and explicitly accounted for method-
ological changes to the Behavioral Risk Factor Surveillance System during this period.
results
We found large differences between counties in all measures of alcohol use: in 2012, any 
drinking prevalence ranged from 11.0% to 78.7%, heavy drinking prevalence ranged from 
2.4% to 22.4%, and binge drinking prevalence ranged from 5.9% to 36.0%. Moreover, there 
was wide variation in the proportion of all drinkers who engaged in heavy or binge drinking. 
Heavy and binge drinking prevalence increased in most counties between 2005 and 2012, 
but the magnitude of change varied considerably.
Conclusions
There are large differences within the United States in levels and recent trends in alcohol use. 
These estimates should be used as an aid in designing and implementing targeted interven-
tions and to monitor progress toward reducing the burden of excessive alcohol use.
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InTrODUCTIOn
Excessive alcohol consumption is associated with many adverse health outcomes, includ-
ing cancer, heart disease, stroke, liver cirrhosis, preterm birth, fetal alcohol syndrome, and 
unintentional and intentional injuries.1–7 In 2010, approximately 88,600 deaths in the United 
States were attributable to alcohol, and the cost of excessive drinking has been estimated to 
exceed $220 billion per year.8,9 In the United States, several ongoing surveys collect informa-
tion on alcohol use. Most of these surveys are designed to produce national-level estimates 
only, whereas the Behavioral Risk Factor Surveillance System (BRFSS) and the National Survey 
on Drug Use and Health are designed to produce state-level estimates. More local estimates 
would be useful for identifying high-risk populations and for policymaking. Below the state 
level, however, information on alcohol use is limited: existing estimates are generally for 
select metropolitan areas only10,11 or are derived by pooling data across a large number of 
years, making it difficult to assess trends.12
We estimated trends in alcohol use at the county level. Specifically, we assessed the preva-
lence of any drinking (at least 1 drink of any alcoholic beverage in the past 30 days) and 2 
measures of excessive alcohol use: the prevalence of heavy drinking (consuming, on average, 
more than 1 drink per day for women or 2 drinks per day for men in the past 30 days) and the 
prevalence of binge drinking (consuming at least 4 drinks for women or 5 drinks for men on a 
single occasion at least once in the past 30 days). We included both heavy and binge drinking 
because these 2 measures of excessive alcohol consumption are related to different health 
outcomes: binge drinking tends to increase the risk of short-term health effects (e.g., injuries6), 
whereas heavy drinking tends to increase the risk of long-term health effects (e.g., cancers,7 
liver cirrhosis5). Further, whereas most people who are heavy or binge drinkers according to 
these definitions do not suffer from an alcohol use disorder or alcohol dependence, these 
behaviors are associated with an elevated risk of developing these conditions.13,14
We used small area models to produce annual estimates of any drinking, heavy drinking, 
and binge drinking prevalence at the county level on the basis of BRFSS data. These models 
incorporate a series of corrections to account for changes in questionnaire items related to 
alcohol consumption and for methodological changes regarding cell phones. We also com-
bined these measures to estimate the prevalence of heavy or binge drinking among those 
who use any alcohol.
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MeTHODS
We used data on alcohol use from the 2002 to 2012 BRFSS.15 The BRFSS is a telephone survey 
implemented by state health departments with support from the Centers for Disease Control 
and Prevention. Details on BRFSS methodology are described elsewhere.16,17 In 2012 the 
median response rate among all states was 49.7% and ranged from 33.8% to 64.1%.18
The BRFSS includes numerous questions each year that solicit information on alcohol use in 
the past 30 days; however, the exact questions included vary somewhat from year to year 
(Figure 1). We assessed any drinking status using the DRNKANY and ALCDAY questions, which 
reflect whether respondents drank on at least 1 occasion within the past month and the 
number of days per week or per month on which alcohol was consumed, respectively. We 
classified respondents as “any drinkers” if they answered “yes” to the DRNKANY question in 
years when this question was included or if they responded 1 or more days to the ALCDAY 
question in other years. Estimated prevalence tends to be higher in years when reporting 1 
or more days in response to the ALCDAY question is used to define any drinking status than 
in years when responding “yes” to the DRNKANY question is used. Alcohol use is more likely 
more than 2 drinks per day for men. Average
daily consumption is typically calculated by mul-
tiplying the average number of drinking days
(reported in the ALCDAY question) by the
average number of drinks per drinking day
(reported in the AVEDRNK question) and then
dividing by 30; however, this method tends to
underestimate consumption.19 Part of this under-
estimation is thought to be because the respon-
dents reported a number closer to the mode
instead of the true mean number of drinks when
responding to the AVEDRNKquestion, effectively
missing alcohol consumed on less frequent occa-
sions when a lot of alcohol is consumed at once.
To correct for this, we implemented
a method called “indexing”20 and calculated
consumption separately for typical days and
for binge days according to the following
formula: (AQ ·AF + BQ · BF)/30. AQ
represents the typical quantity consumed as
given by the AVEDRNK question, whereas BQ
represents the quantity consumed on binge
drinking days and is given by the MAXDRNKS
question. Although the MAXDRNKS question
refers to the most drinks consumed in the past
30 days, rather than the average number of
drinks on binge drinking days, previous re-
search has shown these 2 quantitates to be
comparable.21 BF is the frequency of binge
drinking days and is given by the DRNKGE5
question, whereas the frequency of typical
drinking days (AF) is calculated by subtracting
DRNKGE5 from ALCDAY.
We assessed binge drinking status using the
DRNKGE5 question: we classiﬁed respondents
who reported 1 or more binge drinking epi-
sodes in the past 30 days as “binge drinkers.”
The cutpoint for binge drinking changed for
women in 2006 from 5 drinks to 4 drinks,
resulting in a large apparent increase in binge
drinking prevalence among women mostly
unrelated to actual changes in underlying
behavior.22 To account for this, we included
a correction in our model to adjust estimates
for women before 2006 for consistency with
estimates in later years.
We also extracted county identiﬁers and
demographic characteristics for each respon-
dent, including: gender, age group (21---29
years, 30---39 years, 40---49 years, 50---59
years, 60---69 years, and ‡ 70 years), race/
ethnicity (White non-Hispanic, Black non-
Hispanic, American Indian/Alaska Native non-
Hispanic, other non-Hispanic, and Hispanic),
marital status (formerly married, never mar-
ried, currently married), and education status
(less than high school, high school graduate,
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
DRNKANY
ALCDAY
AVEDRNK
DRNKGE5
MAXDRNKS
YearVariable 
name
During the past 30 days, what is the largest number of drinks you had on any occasion?
Considering all types of alcoholic beverages, 
how many �mes during the past 30 days did 
you have 5 or more drinks on an occasion?
Considering all types of alcoholic beverages, how many �mes during the past 
30 days did you have X [X = 5 for men, X = 4 for women] or more drinks on an 
occasion?
During the past 30 days, have you had at least one drink of any 
alcoholic beverage such as beer, wine, a malt beverage or liquor?
[Excluded]
During the past 30 days, how many days per week or per month did 
you have at least one drink of any alcoholic beverage?
During the past 30 
days, how many days 
per week or per 
month did you have 
at least one drink of 
any alcoholic 
beverage such as 
beer, wine, a malt 
beverage, or liquor?
[Excluded]
A drink of alcohol is 1 can or 
bo�le of beer, 1 glass of wine, 1 
can or bo�le of wine cooler, 1 
cocktail, or 1 shot of liquor. 
During the past 30 days, how 
many days per week or per 
month did you have at least one 
drink of any alcoholic beverage?
On the days when you drank, 
about how many drinks did you 
drink on the average?
[Excluded]
One drink is equivalent to a 12-
ounce beer, a 5-ounce glass of 
wine, or a drink with one shot of 
liquor. During the past 30 days, 
on the days when you drank, 
about how many drinks did you 
drink on the average?
One drink is equivalent to a 12-ounce beer, a 5-ounce 
glass of wine, or a drink with one shot of liquor. During 
the past 30 days, on the days when you drank, about 
how many drinks did you drink on the average? Note: A 
40 ounce beer would count as 3 drinks, or a cocktail 
drink with 2 shots would count as 2 drinks. 
Note. Vertical lines demarcate years when question text changed. Red is used to highlight the portions of the text unique to a given version of the question.
FIGURE 1—Behavioral Risk Factor Surveillance System survey questions on alcohol: United States, 2002–2012.
RESEARCH AND PRACTICE
June 2015, Vol 105, No. 6 | American Journal of Public Health Dwyer-Lindgren et al. | Peer Reviewed | Research and Practice | 1121
figure 1. Behavioral Risk Factor Surveillance System survey questions on alcohol: United States, 2002–
2012.
Note. Vertical lines demarcate years when question text changed. Red is used to highlight the portions of 
the text u ique to a given version of the question.
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to be underreported than overreported,19 so we included a correction in our model to adjust 
estimates for years when the DRNKANY question is used for consistency with years when the 
ALCDAY question is used.
We assessed heavy drinking status by first calculating average daily consumption for each 
respondent; we then classified respondents as “heavy drinkers” if average daily consumption 
was more than 1 drink per day for women or more than 2 drinks per day for men. Average 
daily consumption is typically calculated by multiplying the average number of drinking 
days (reported in the ALCDAY question) by the average number of drinks per drinking day 
(reported in the AVEDRNK question) and then dividing by 30; however, this method tends 
to underestimate consumption.19 Part of this underestimation is thought to be because the 
respondents reported a number closer to the mode instead of the true mean number of 
drinks when responding to the AVEDRNK question, effectively missing alcohol consumed on 
less frequent occasions when a lot of alcohol is consumed at once.
To correct for this, we implemented a method called “indexing”20 and calculated consump-
tion separately for typical days and for binge days according to the following formula: 
(AQ × AF + BQ × BF)/30. AQ represents the typical quantity consumed as given by the AVE-
DRNK question, whereas BQ represents the quantity consumed on binge drinking days and 
is given by the MAXDRNKS question. Although the MAXDRNKS question refers to the most 
drinks consumed in the past 30 days, rather than the average number of drinks on binge 
drinking days, previous research has shown these 2 quantitates to be comparable.21 BF is 
the frequency of binge drinking days and is given by the DRNKGE5 question, whereas the 
frequency of typical drinking days (AF) is calculated by subtracting DRNKGE5 from ALCDAY.
We assessed binge drinking status using the DRNKGE5 question: we classified respondents 
who reported 1 or more binge drinking episodes in the past 30 days as “binge drinkers.” The 
cutpoint for binge drinking changed for women in 2006 from 5 drinks to 4 drinks, resulting 
in a large apparent increase in binge drinking prevalence among women mostly unrelated 
to actual changes in underlying behavior.22 To account for this, we included a correction in 
our model to adjust estimates for women before 2006 for consistency with estimates in later 
years.
We also extracted county identifiers and demographic characteristics for each respondent, 
including: gender, age group (21–29 years, 30–39 years, 40–49 years, 50–59 years, 60–69 
years, and ≥70 years), race/ethnicity (White non-Hispanic, Black non-Hispanic, American In-
dian/Alaska Native non-Hispanic, other non-Hispanic, and Hispanic), marital status (formerly 
married, never married, currently married), and education status (less than high school, high 
school graduate, some college, college graduate). We excluded respondents who were miss-
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ing a county identifier, any of the demographic variables, or the alcohol variables of interest. 
We analyzed any drinking and binge drinking prevalence for 2002 to 2012, whereas we 
analyzed heavy drinking prevalence for 2005 to 2012 because the MAXDRNKS question was 
introduced only in 2005. In 2012 there were 3,143 counties; to address historical boundary 
changes we combined several counties and performed the analysis on a modified set of 
3,127 counties. The final analysis included 3,702,936 respondents for any drinking, 2,867,260 
respondents for heavy drinking, and 3,673,679 respondents for binge drinking. (Details on 
missingness and sample sizes can be found as a supplement to the online version of this 
article at http://www.ajph.org.)
Model specification
We applied small area models to the BRFSS data to estimate county-level alcohol use preva-
lence. These models are specified as follows:
Yi,t,a ~ Binomial(Ni,t,a, pi,t,a)
where Ni,t,a is the number of respondents and Yi,t,a is the number of alcohol users among 
these respondents in county i, year t, age group a. The prevalence of alcohol use (pi,t,a), the 
parameter of interest, is modeled as follows: 
logit (pi,t,a) = β0 + β1 · t + β2,a + β3 · Di,t,a + β4 · Xi,t + β5 · I + νi + ui + wt + δi,t
where β0 is an intercept, β1 is a slope on year intended to capture large-scale time trends in al-
cohol use, and β2,a is an effect for each age group a (21–29 years is absorbed in the intercept). 
Di,t,a is a vector of demographic characteristics and includes the proportion of the sample 
belonging to each race/ethnicity group (except White non-Hispanic), each marital status 
group (except formerly married), and each education group (except less than high school) 
as well as interactions between all these factors and age; β3 is the corresponding vector of 
parameters. We included these terms to account for the impact of these demographic factors 
on county-level alcohol use prevalence. 
Xi,t is a vector of time-varying county-level variables, and β4 is the corresponding vector of pa-
rameters. We included county-level variables to “borrow strength” from external data sources. 
We selected these factors on the basis of literature documenting a relationship with alcohol 
use as well as availability of appropriate data sources at the county level, and we included 
percentage of households in rural areas,23,24 percentage living in poverty,25 unemployment 
rate,26,27 drinking places and alcohol stores per capita,28,29 and the percentage mainline Prot-
estant, evangelical Protestant, Catholic, or Mormon.30,31 We did not include state-level alcohol 
sales (i.e., volume sold) because these estimates are not entirely comparable between states 
59
Chapter 3 - Drinking Patterns in US Counties, 2002–2012
and over time.32 (Details on data sources for all covariates can be found as a supplement to 
the online version of this article at http://www.ajph.org.) β5⋅I is included in the any drinking 
model and the binge drinking model for women only: I is an indicator for the preferred ver-
sion of the questionnaire item for a given outcome.
The remaining terms in the model account for spatial trends, temporal trends, and space-
time interactions beyond what is explained by the demographic variables and county-level 
covariates and allow borrowing strength over both time and space. νi  and ui  are county-level 
random effects: νi  is assigned an independent and identically distributed normal prior (vi|σv2 ~ 
Normal(0, σv2)) and is intended to capture variation that is not spatially structured, whereas ui 
is assigned an intrinsic conditional autoregressive prior, 
ui|uj, j ~ i, σu2 ~ Normal
⎛
⎝
1
⋅ ∑j~i uj, 
σu2 ⎞
⎠,ni ni
where j ~ i indicates that county j is adjacent to county i) and is intended to capture spatially 
structured variation.33 wt is a year-level random effect assigned a first order random walk 
prior (wt|wt-1, σw2 ~ Normal(wt-1, σw2)) and is intended to capture short-scale non-linear time 
trends beyond what is accounted for by β1.34 Finally, δi,t is a county year-level random effect 
that allows a space-time interaction. This random effect is assigned a prior that is the interac-
tion between an intrinsic conditional autoregressive spatial effect and a first-order random 
walk temporal effect.35 (Data available as a supplement to the online version of this article at 
http://www.ajph.org describe the procedure used for validating this model.)
Model fitting and prediction
We fit separate models for each gender and alcohol use measure. Additionally, to make fitting 
the models more tractable, we fit separate models for each of 8 census divisions (we combined 
the middle Atlantic and New England divisions, as they each have a relatively small number 
of counties).36 Consequently, 16 models were specified for each of the 3 alcohol metrics.
Models were fit using the INLA program in R version 3.0.1.37,38 We used proper but diffuse hy-
perpriors for all terms. Specifically, we used Normal(0, 1,000) hyperpriors for all fixed effects and 
Gamma(1, 0.01) hyperpriors for the precision parameter of all random effects. We generated 
1,000 draws for each county-year-age group from the approximate posterior distribution of the 
fitted model. For the purposes of generating these draws, we set Di,t,a, the vector of demographic 
variables, at the levels observed in the population rather than in the sample to adjust for differ-
ences between the composition of the sample and the underlying population. Similarly, for the 
any drinking and binge drinking models, we set I to 1 to produce predictions consistent with 
the preferred version of the questionnaire. We collapsed these draws to the county-year level 
by age-standardizing using the 2000 census age standard and to the state and national level by 
first population-weighting the county-level draws and then age-standardizing.
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We obtained final estimates by finding the mean of these draws and calculated the confidence 
intervals (CIs) by finding the 2.5th and 97.5th percentiles. We also estimated the proportion of 
all drinkers who are heavy drinkers or binge drinkers. To do this we divided the prevalence of 
heavy drinking and binge drinking by the prevalence of any drinking. To estimate uncertainty 
we carried out the same procedure using draws and found the 2.5th and 97.5th percentiles.
Accounting for wireless-only respondents
Before 2011 the BRFSS sampled only individuals who could be reached by landline, excluding 
the population that could be reached only by cell phone that had grown to 27.8% of adults 
by the second half of 2010.39 Previous research has shown that excluding individuals who can 
be reached only by cell phone biases estimates of alcohol use, typically downward, even after 
controlling for numerous demographic variables related to phone usage patterns.40 To ad-
dress this, we applied a previously described correction41; in short, we fit 2 versions of every 
model, 1 that includes only respondents who can be reached by landline, and 1 that includes 
both landline and cell phone respondents. We then compared county-level estimates for 
2011 between the 2 models and used these to derive estimates of the bias introduced by 
excluding respondents who could be reached only by cell phone. We then projected this 
bias backward, assuming that the wireless-only population was negligible in 2000 and has 
increased roughly linearly between 2000 and 2011.
reSULTS
At the national level in 2012, any drinking prevalence was 56.0% (95% CI = 55.6, 56.3), heavy 
drinking prevalence was 8.2% (95% CI = 8.0, 8.4), and binge drinking prevalence was 18.3% 
(95% CI = 18.1, 18.6). (Estimates for all counties in all years can be found as a supplement to 
the online version of this article at http://www.ajph.org.) There was considerable variability 
within the United States between counties in all 3 measures, however, with any drinking 
prevalence ranging from 11.0% to 78.7% (SD = 11.6); heavy drinking prevalence ranging 
from 2.4% to 22.4% (SD = 2.6); and binge drinking prevalence ranging from 5.9% to 36.0% 
(SD = 5.1). Maps of any, heavy, and binge drinking prevalence in 2012 (Figure 2) depict clear 
regional patterns. The prevalence of any drinking was relatively high in counties in the 
northern states of the West and Midwest as well as along the Pacific and in New England. By 
contrast, any drinking prevalence was much lower in the South and in a region of the West 
centered on Utah. Geographic patterns for heavy and binge drinking are broadly similar to 
those for any drinking, although there are localized differences. Although broad geographic 
patterns encompassing entire states are common, there are frequently sizeable differentials 
within states: the median gap between highest and lowest county-level prevalence within a 
state was 27.6, 6.3, and 9.8 percentage points for any, heavy, and binge drinking, respectively.
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Chapter 3 - Drinking Patterns in US Counties, 2002–2012
By all 3 measures, alcohol use prevalence is typically higher for men than for women (Figure 
3). Male and female alcohol use prevalences are most similar for any drinking: across all 
counties the median ratio of any drinking prevalence among men to any drinking prevalence 
among women in 2012 was 1.4 and ranged from 1.0 to 2.4. The difference was more dramatic, 
and also more variable, for heavy drinking: among all counties the median ratio of heavy 
drinking prevalence among men to heavy drinking prevalence among women was 2.0 and 
ranged from 0.8 to 7.8. This difference was even larger for binge drinking although it was 
somewhat less variable: across all counties, the median ratio of binge drinking prevalence 
among men to binge drinking prevalence among women was 2.3 and ranged from 1.1 to 
6.2. In 1.4% of counties for any drinking, 50.4% of counties for heavy drinking, and 69.9% of 
counties for binge drinking, the prevalence of alcohol use among men was at least twice that 
among women in 2012.
At the national level in 2012, 14.7% (95% CI = 14.4, 15.1) of all drinkers were heavy drink-
ers whereas 32.8% (95% CI = 32.3, 33.3) were binge drinkers. As with the other measures of 
alcohol use, this proportion varies widely between counties (Figure 4), ranging from 5.9% 
to 66.7% for heavy drinking and 20.2% to 86.2% for binge drinking. Much of this variation 
occurred within state borders.20.3) increase from 7.0% (95%CI = 6.9, 7.2) to
8.2% (95% CI = 8.0, 8.4) for heavy drinking
and an 8.9% (95% CI = 6.3, 11.6) increase
from 16.8% (95% CI = 16.5, 17.2) to 18.3%
(95% CI = 18.1, 18.6) for binge drinking.
Trends at the county level varied widely for all 3
measures (Figure 5). Although there was little
change in any drinking at an aggregate level, at
the county level changes ranged from a 25.7%
Ratio: 0.75 to 1 1 to 1.25 1.25 to 1.5 1.5 to 1.75 1.75 to 2 2 to 2.5 2.5 to 3 3 to 4 4 to 6 6 to 8
a b c
FIGURE 3—Ratio of male to female age-standardized alcohol use prevalence of (a) any drinking, (b) heavy drinking, and (c) binge drinking:
Behavioral Risk Factor Sur eillance System, United States, 2012.
Prevalence, %: 5 to 10 10 to 15 15 to 20 20 to 25 25 to 30 30 to 35 35 to 40 40 to 45 45 to 50 50 to 90
a b
FIGURE 4—Age-standardized prevalence among all alcohol users of (a) heavy drinking and (b) binge drinking: Behavioral Risk Factor Surveillance
System, United States, 2012.
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figure 4. Age-stan a diz d prevalence among all alcohol users of (a) h avy drinking and (b) binge drink-
ing: Behavioral Risk Factor Surveillance System, United States, 2012.
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We considered changes for all measures of alcohol use from 2005 to 2012 for consistency 
across measures. At the national level, we found no change in the prevalence of any drinking, 
but we found substantial increases for both heavy and binge drinking: a 17.2% (95% CI = 14.2, 
20.3) increase from 7.0% (95% CI = 6.9, 7.2) to 8.2% (95% CI = 8.0, 8.4) for heavy drinking and 
an 8.9% (95% CI = 6.3, 11.6) increase from 16.8% (95% CI = 16.5, 17.2) to 18.3% (95% CI = 18.1, 
18.6) for binge drinking. Trends at the county level varied widely for all 3 measures (Figure 
5). Although there was little change in any drinking at an aggregate level, at the county level 
changes ranged from a 25.7% decrease to a 43.5% increase (SD = 6.7). These differentials 
are even more remarkable for heavy drinking—range −39.2% to 155.2% (SD = 15.9)—and 
for binge drinking—range −28.7% to 73.4% (SD = 8.3). Changes in heavy and binge drinking 
were positively correlated with changes in any drinking prevalence (0.48 and 0.64, respec-
tively) and were also highly correlated with each other (0.72).
Despite these limitations, our analysis boasts
numerous unique strengths. Our small area
model simultaneously borrows strength spatially,
temporally, and from external data sources in-
cluded as covariates to improve predictions for
all areas, even those with limited sample sizes.
We also explicitly addressed numerous known
issues with the BRFSS data on alcohol. We
corrected for the underreporting of alcohol
consumption, which allowed us to more accu-
rately estimate heavy drinking prevalence. We
also adjusted for the change in the cutpoint used
to deﬁne binge drinking for women, which
allowed us to produce estimates back to 2002
that are consistent with the currently accepted
deﬁnition of binge drinking. Finally, we corrected
for the bias introduced by omitting individuals
who could be reached only by cell phone before
2011 from the BRFSS sampling frame. Collec-
tively, these additional methods allowed us to
improve the accuracy of our estimates and to
produce a more cogent time series.
Excessive consumption of alcohol is a major
risk factor for morbidity and mortality. Many
effective interventions and strategies to reduce
alcohol consumption and related harm are
policy based and can be implemented at state
and local levels.42,43 As drinking patterns vary
widely between and within states, county-level
estimates are essential for identifying areas of
greatest need and informing efforts to reduce
excessive alcohol use. We believe that the
methods and results we have presented pro-
vide an important tool to local public health
ofﬁcials and others seeking to reduce the loss
of health and life because of excessive alcohol
use. j
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FIGURE 6—Change in age-standardized alcohol use prevalence, by gender, of (a) any
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included.
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Changes in alcohol use prevalence were not uniform for men and women. Smoothed density 
plots of the change from 2005 to 2012 at the county level by gender (Figure 6) demonstrate 
that the prevalence of all alcohol use measures, but particularly heavy and binge drinking 
prevalence, tended to increase more for women than for men. The median increase in female 
heavy and binge drinking prevalence was more than twice the median increase in male 
heavy and binge drinking prevalence: 38.1% and 18.3%, respectively, for heavy drinking and 
18.9% and 7.3%, respectively, for binge drinking.
DISCUSSIOn
To our knowledge, this analysis is the first to comprehensively report on time trends in 
alcohol use prevalence at the county level. We found huge variations in drinking patterns 
among counties, even within a state. Indeed, state-level estimates would have masked the 
substantial variation between counties within states. Furthermore, we found huge variation 
among counties in the proportion of heavy or binge drinkers among all individuals who 
drink currently. Clearly, there is not some fixed proportion of drinkers who are binge or heavy 
drinkers. Further investigation into why the proportion of those who are heavy or binge 
drinkers varies so widely is certainly called for.
We found that although the overall prevalence of any drinking has not changed substantially 
in recent years, there is evidence of an increase in both heavy drinking and binge drinking. 
Changes in heavy and binge drinking are not evenly distributed throughout the country, 
however: in this study we identify areas that have experienced particularly dramatic increases 
in recent years and that warrant particular attention to attempt to reverse these trends. Simi-
larly, we found that increases in heavy and binge drinking prevalence in recent years have 
tended to be larger for women than for men, although women have not yet caught up to 
men in terms of current prevalence. These findings call for interventions intended specifically 
to address this increase among women.
Our study has numerous limitations. The BRFSS is a telephone survey; hence it excludes in-
dividuals without a telephone and those living in institutionalized settings. BRFSS response 
rates are also less than ideal; although we attempted to adjust our estimates to match the 
demographic composition of the underlying population, there was still the potential for 
bias because of nonresponse. Additionally, alcohol use is self-reported and typically under-
reported.19 Although we have attempted to correct for underreporting, it is likely we did not 
fully capture all consumption. Further, county identifiers are masked for residents of very 
small counties; we attempted to obtain data directly from states, but we were not able to do 
this for all respondents.
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Finally, although this analysis does explicitly correct for changes in the questions used to 
elicit data on alcohol use patterns, as well as the omission of cell phones from the BRFSS 
sample before 2011, it is difficult to validate these corrections and results on changes over 
time should be interpreted with caution. However, because we attempted to bring estimates 
in line with the methods employed by BRFSS in 2011 and 2012, our 2011 and 2012 estimates 
are not subject to this limitation.
Despite these limitations, our analysis boasts numerous unique strengths. Our small area 
model simultaneously borrows strength spatially, temporally, and from external data sources 
included as covariates to improve predictions for all areas, even those with limited sample 
sizes. We also explicitly addressed numerous known issues with the BRFSS data on alcohol. 
We corrected for the underreporting of alcohol consumption, which allowed us to more ac-
curately estimate heavy drinking prevalence. We also adjusted for the change in the cutpoint 
used to define binge drinking for women, which allowed us to produce estimates back to 
2002 that are consistent with the currently accepted definition of binge drinking. Finally, we 
corrected for the bias introduced by omitting individuals who could be reached only by cell 
phone before 2011 from the BRFSS sampling frame. Collectively, these additional methods 
allowed us to improve the accuracy of our estimates and to produce a more cogent time 
series.
Excessive consumption of alcohol is a major risk factor for morbidity and mortality. Many 
effective interventions and strategies to reduce alcohol consumption and related harm are 
policy based and can be implemented at state and local levels.42,43 As drinking patterns vary 
widely between and within states, county-level estimates are essential for identifying areas 
of greatest need and informing efforts to reduce excessive alcohol use. We believe that the 
methods and results we have presented provide an important tool to local public health 
officials and others seeking to reduce the loss of health and life because of excessive alcohol 
use.
Contributors
L. Dwyer-Lindgren, A. D. Flaxman, M. Ng, and A. H. Mokdad developed and applied the model. 
L. Dwyer-Lindgren, G. M. Hansen, and A. H. Mokdad performed the literature review. L. Dwyer-
Lindgren and A. H. Mokdad wrote the first draft. A. D. Flaxman and C. J. L. Murray advised on 
the modeling strategy. C. J. L. Murray and A. H. Mokdad designed the overall study and the 
analytical strategy. All authors revised the article and approved the final draft.
68
Acknowledgments
This research was supported by the State of Washington and the University of Wisconsin. The 
authors thank the Behavioral Risk Factor Surveillance System coordinators for their assistance 
in providing the data.
Human participant protection
Institutional review board approval was not required for this study because data were ob-
tained from secondary sources.
referenCeS
 1. Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: a 
meta-analysis. Addiction. 2000;95(10):1505–1523. 
 2. Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the 
risk of 15 diseases. Prev Med. 2004;38(5):613–619. 
 3. Patra J, Taylor B, Irving H, et al. Alcohol consumption and the risk of morbidity and mortality for 
different stroke types—a systematic review and meta-analysis. BMC Public Health. 2010;10:258. 
 4. Rehm J, Baliunas D, Borges GLG, et al. The relation between different dimensions of alcohol 
consumption and burden of disease: an overview. Addiction. 2010;105(5):817–843. 
 5. Rehm J, Taylor B, Mohapatra S, et al. Alcohol as a risk factor for liver cirrhosis: a systematic review 
and meta-analysis. Drug Alcohol Rev. 2010;29(4):437–445. 
 6. Taylor B, Irving HM, Kanteres F, et al. The more you drink, the harder you fall: a systematic re-
view and meta-analysis of how acute alcohol consumption and injury or collision risk increase 
together. Drug Alcohol Depend. 2010;110(1–2):108–116. 
 7. Consumption of Alcoholic Beverages. Lyon, France: International Agency for Research on Cancer; 
2012. 
 8. US Burden of Disease Collaborators. The state of US health, 1990–2010: burden of diseases, 
injuries, and risk factors. JAMA. 2013;310(6):591–608. 
 9. Bouchery EE, Harwood HJ, Sacks JJ, Simon CJ, Brewer RD. Economic costs of excessive alcohol 
consumption in the US, 2006. Am J Prev Med. 2011;41(5):516–524. 
 10. Centers for Disease Control and Prevention. SMART: BRFSS city and county data. Available at: 
http://apps.nccd.cdc.gov/BRFSS-SMART. Accessed May 22, 2014. 
 11. Nelson DE, Naimi TS, Brewer RD, Bolen J, Wells HE. Metropolitan-area estimates of binge drinking 
in the United States. Am J Public Health. 2004;94(4):663–671. 
 12. University of Wisconsin Population Health Institute. County health rankings & roadmaps. 2014. 
Available at: http://www.countyhealthrankings.org. Accessed May 22, 2014. 
69
Chapter 3 - Drinking Patterns in US Counties, 2002–2012
 13. Dawson DA, Grant BF, Li T-K. Quantifying the risks associated with exceeding recommended 
drinking limits. Alcohol Clin Exp Res. 2005;29(5):902–908. 
 14. Greenfield TK, Ye Y, Bond J, et al. Risks of alcohol use disorders related to drinking patterns in the 
US general population. J Stud Alcohol Drugs. 2014;75(2):319–327. 
 15. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Survey 
Data. Atlanta, GA: US Department of Health and Human Services; 2002–2012. 
 16. Mokdad AH, Stroup DF, Giles WH; Behavioral Risk Factor Surveillance Team. Public health sur-
veillance for behavioral risk factors in a changing environment. Recommendations from the 
Behavioral Risk Factor Surveillance team. MMWR Recomm Rep. 2003;52(RR-9):1–12. 
 17. Centers for Disease Control and Prevention. Methodologic changes in the Behavioral Risk Factor 
Surveillance System in 2011 and potential effects on prevalence estimates. MMWR Morb Mortal 
Wkly Rep. 2012;61(22):410–413. 
 18. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System: 2012 Sum-
mary Data Quality Report. Atlanta, GA: US Department of Health and Human Services; 2013. 
 19. Nelson DE, Naimi TS, Brewer RD, Roeber J. US state alcohol sales compared to survey data, 
1993–2006. Addiction. 2010;105(9):1589–1596. 
 20. Stahre M, Naimi T, Brewer R, Holt J. Measuring average alcohol consumption: the impact of 
including binge drinks in quantity-frequency calculations. Addiction. 2006;101(12):1711–1718. 
 21. Esser MB, Kanny D, Brewer RD, Naimi TS. Binge drinking intensity: a comparison of two measures. 
Am J Prev Med. 2012;42(6):625–629. 
 22. Chavez PR, Nelson DE, Naimi TS, Brewer RD. Impact of a new gender-specific definition for binge 
drinking on prevalence estimates for women. Am J Prev Med. 2011;40(4):468–471. 
 23. Jackson JE, Doescher MP, Hart LG. Problem drinking: rural and urban trends in America, 1995/1997 
to 2003. Prev Med. 2006;43(2):122–124. 
 24. Williams EC, McFarland LV, Nelson KM. Alcohol consumption among urban, suburban, and rural 
veterans affairs outpatients. J Rural Health. 2012;28(2):202–210. 
 25. Khan S, Murray RP, Barnes GE. A structural equation model of the effect of poverty and unemploy-
ment on alcohol abuse. Addict Behav. 2002;27(3):405–423. 
 26. Dee TS. Alcohol abuse and economic conditions: evidence from repeated cross-sections of 
individual-level data. Health Econ. 2001;10(3):257–270. 
 27. Popovici I, French MT. Does unemployment lead to greater alcohol consumption? Ind Relat 
(Berkeley). 2013;52(2):444–466. 
 28. Scribner RA, Cohen DA, Fisher W. Evidence of a structural effect for alcohol outlet density: a 
multilevel analysis. Alcohol Clin Exp Res. 2000;24(2):188–195.
 29. Campbell CA, Hahn RA, Elder R, et al. The effectiveness of limiting alcohol outlet density as a 
means of reducing excessive alcohol consumption and alcohol-related harms. Am J Prev Med. 
2009;37(6):556–569. 
70
 30. Holt JB, Miller JW, Naimi TS, Sui DZ. Religious affiliation and alcohol consumption in the United 
States. Geogr Rev. 2006;96(4):523–542. 
 31. Michalak L, Trocki K, Bond J. Religion and alcohol in the U.S. National Alcohol Survey: how impor-
tant is religion for abstention and drinking? Drug Alcohol Depend. 2007;87(2–3):268–280. 
 32. LaVallee RA, LeMay HA, Yi H. Apparent per Capita Alcohol Consumption: National, State, and 
Regional Trends. 1997–2011. Arlington, VA: National Institute on Alcohol Abuse and Alcoholism; 
2013. 
 33. Besag J, York J, Mollié A. Bayesian image restoration, with two applications in spatial statistics. 
Ann Inst Stat Math. 1991;43(1):1–20. 
 34. Clayton D. Generalized linear mixed models. In: W Gilks, S Richardson, D Spiegelhalter, eds. Mar-
kov Chain Monte Carlo in Practice. London, England: Chapman & Hall; 1996:275–302. 
 35. Knorr-Held L. Bayesian modelling of inseparable space-time variation in disease risk. Stat Med. 
2000;19(17–18):2555–2567. 
 36. US Census Bureau. Geographic terms and concepts: census divisions and census regions. 2010. 
Available at: https://www.census.gov/geo/reference/gtc/gtc_census_divreg.html. Accessed April 
30, 2014. 
 37. Rue H, Martino S, Chopin N. Approximate Bayesian inference for latent Gaussian models by using 
integrated nested Laplace approximations. J R Stat Soc Series B Stat Methodol. 2009;71(2):319–392. 
 38. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Founda-
tion for Statistical Computing; 2013. 
 39. Blumberg SJ, Luke JV. Wireless substitution: early release of estimates from the National Health 
Interview Survey, January–June 2013. 2013. Available at: http://www.cdc.gov/nchs/nhis.htm. 
Accessed April 8, 2014. 
 40. Blumberg SJ, Luke JV. Reevaluating the need for concern regarding noncoverage bias in landline 
surveys. Am J Public Health. 2009;99(10):1806–1810. 
 41. Dwyer-Lindgren L, Mokdad AH, Srebotnjak T, Flaxman AD, Hansen GM, Murray CJL. Cigarette 
smoking prevalence in US counties: 1996–2012. Popul Health Metr. 2014;12(1):5. 
 42. Community Preventive Services Task Force. Guide to community preventive services: preventing 
excessive alcohol consumption. 2012. Available at: http://www.thecommunityguide.org/alcohol/
index.html. Accessed August 29, 2014. 
 43. Xuan Z, Blanchette J, Nelson TF, Heeren T, Oussayef N, Naimi TS. The alcohol policy environment 
and policy subgroups as predictors of binge drinking measures among US adults. Am J Public 
Health. 2015;105(4):816–822. 
71
Chapter 3 - Drinking Patterns in US Counties, 2002–2012
SU
PP
Le
M
en
TA
L 
fI
Le
S
Ta
bl
e 
S1
. 
BR
FS
S 
Sa
m
pl
e 
Si
ze
 a
nd
 M
is
si
ng
ne
ss
.
Ye
ar
re
sp
on
de
nt
s,
 
ag
e 
21
+a
M
is
si
ng
ne
ss
Co
m
pl
et
e 
ob
se
rv
at
io
ns
b
Co
un
ti
es
 
re
pr
es
en
te
d
ra
ce
ed
uc
at
io
n
M
ar
it
al
 
st
at
us
Co
un
ty
A
ny
 
dr
in
ki
ng
H
ea
vy
 
dr
in
ki
ng
Bi
ng
e 
dr
in
ki
ng
A
ny
 
dr
in
ki
ng
H
ea
vy
 
dr
in
ki
ng
Bi
ng
e 
dr
in
ki
ng
20
02
23
2,
43
3
2,
16
4
(0
.9
%
)
42
2
(0
.2
%
)
55
0
(0
.2
%
)
3,
35
8
(1
.4
%
)
1,
25
5
(0
.5
%
)
N
A
1,
85
1
(0
.8
%
)
22
5,
11
1
(9
6.
8%
)
N
A
22
4,
56
1
(9
6.
6%
)
3,
10
4
20
03
24
9,
24
8
1,
95
8
(0
.8
%
)
49
2
(0
.2
%
)
63
1
(0
.3
%
)
3,
00
1
(1
.2
%
)
1,
05
1
(0
.4
%
)
N
A
1,
43
6
(0
.6
%
)
24
2,
58
1
(9
7.
3%
)
N
A
24
2,
19
8
(9
7.
2%
)
3,
09
9
20
04
29
0,
96
0
2,
59
5
(0
.9
%
)
61
0
(0
.2
%
)
83
2
(0
.3
%
)
3,
49
6
(1
.2
%
)
1,
76
1
(0
.6
%
)
N
A
1,
95
8
(0
.7
%
)
28
2,
29
2
(9
7.
0%
)
N
A
28
2,
11
1
(9
7.
0%
)
3,
10
6
20
05
34
3,
73
3
3,
04
0
(0
.9
%
)
74
0
(0
.2
%
)
1,
01
6
(0
.3
%
)
4,
50
0
(1
.3
%
)
3,
35
9
(1
.0
%
)
13
,4
13
(3
.9
%
)
6,
00
1
(1
.7
%
)
33
1,
82
3
(9
6.
5%
)
32
2,
30
0
(9
3.
8%
)
32
9,
34
9
(9
5.
8%
)
3,
10
3
20
06
34
0,
69
0
3,
28
4
(1
.0
%
)
79
7
(0
.2
%
)
1,
09
6
(0
.3
%
)
15
,1
55
(4
.4
%
)
5,
19
0
(1
.5
%
)
17
,1
73
(5
.0
%
)
9,
18
4
(2
.7
%
)
31
6,
71
1
(9
3.
0%
)
30
5,
77
0
(8
9.
8%
)
31
3,
07
0
(9
1.
9%
)
2,
80
8
20
07
41
6,
24
0
3,
71
8
(0
.9
%
)
1,
04
8
(0
.3
%
)
1,
23
8
(0
.3
%
)
21
,8
55
(5
.3
%
)
6,
05
8
(1
.5
%
)
19
,8
86
(4
.8
%
)
10
,7
91
(2
.6
%
)
38
4,
57
3
(9
2.
4%
)
37
2,
05
1
(8
9.
4%
)
38
0,
29
4
(9
1.
4%
)
2,
81
2
20
08
39
9,
64
8
3,
75
3
(0
.9
%
)
1,
04
9
(0
.3
%
)
1,
24
9
(0
.3
%
)
27
,8
71
(7
.0
%
)
4,
04
1
(1
.0
%
)
17
,0
01
(4
.3
%
)
8,
51
2
(2
.1
%
)
36
4,
46
3
(9
1.
2%
)
35
2,
88
7
(8
8.
3%
)
36
0,
50
8
(9
0.
2%
)
2,
40
6
20
09
41
7,
58
6
4,
18
0
(1
.0
%
)
1,
27
7
(0
.3
%
)
1,
46
1
(0
.3
%
)
33
,9
64
(8
.1
%
)
10
,1
61
(2
.4
%
)
21
,8
14
(5
.2
%
)
14
,1
76
(3
.4
%
)
37
0,
55
6
(8
8.
7%
)
36
0,
33
7
(8
6.
3%
)
36
7,
06
9
(8
7.
9%
)
2,
30
4
20
10
43
6,
54
9
5,
57
4
(1
.3
%
)
1,
33
7
(0
.3
%
)
1,
63
9
(0
.4
%
)
37
,4
78
(8
.6
%
)
6,
39
0
(1
.5
%
)
20
,2
37
(4
.6
%
)
11
,3
62
(2
.6
%
)
38
8,
04
9
(8
8.
9%
)
37
5,
96
9
(8
6.
1%
)
38
3,
74
7
(8
7.
9%
)
2,
29
8
20
11
48
6,
82
0
5,
36
5
(1
.1
%
)
1,
64
4
(0
.3
%
)
1,
99
6
(0
.4
%
)
45
,5
01
(9
.3
%
)
34
,1
84
(7
.0
%
)
44
,1
07
(9
.1
%
)
37
,0
72
(7
.6
%
)
40
5,
37
1
(8
3.
3%
)
39
6,
77
5
(8
1.
5%
)
40
2,
86
4
(8
2.
8%
)
2,
29
4
20
12
45
7,
00
2
5,
48
2
(1
.2
%
)
1,
57
8
(0
.3
%
)
2,
17
0
(0
.5
%
)
44
,3
40
(9
.7
%
)
17
,3
04
(3
.8
%
)
29
,1
21
(6
.4
%
)
21
,3
43
(4
.7
%
)
39
1,
40
6
(8
5.
6%
)
38
1,
17
1
(8
3.
4%
)
38
7,
90
8
(8
4.
9%
)
2,
27
7
To
ta
l
4,
07
0,
90
9
41
,1
13
(1
.0
%
)
10
,9
94
(0
.3
%
)
13
,8
78
(0
.3
%
)
24
0,
51
9
(5
.9
%
)
90
,7
54
(2
.2
%
)
18
2,
75
2
(5
.5
%
)
12
3,
68
6
(3
.0
%
)
3,
70
2,
93
6
(9
1.
0%
)
2,
86
7,
26
0
(8
6.
9%
)
3,
67
3,
67
9
(9
0.
2%
)
3,
12
7
a T
hi
s 
to
ta
l d
oe
s 
no
t i
nc
lu
de
 re
sp
on
de
nt
s 
w
ith
 a
 m
is
si
ng
 v
al
ue
 fo
r a
ge
. 
b T
he
se
 c
ol
um
ns
 g
iv
e 
th
e 
to
ta
l n
um
be
r o
f u
sa
bl
e 
ob
se
rv
at
io
ns
 fo
r e
ac
h 
ou
tc
om
e.
 T
he
se
 a
re
 re
sp
on
de
nt
s w
ho
 h
av
e 
no
n-
m
is
si
ng
 v
al
ue
s f
or
 ra
ce
, e
du
ca
tio
n,
 m
ar
ita
l s
ta
tu
s, 
co
un
ty
, t
he
 g
iv
en
 a
lc
oh
ol
 v
ar
ia
bl
e,
 a
nd
, f
or
 2
01
1–
20
12
 o
nl
y,
 p
ho
ne
 u
sa
ge
.
72
Ta
bl
e 
S2
. 
Ad
di
tio
na
l D
at
a 
So
ur
ce
s.
D
at
a
U
se
So
ur
ce
n
ot
es
Co
un
ty
 c
ha
ng
es
D
et
er
m
in
in
g 
co
ns
is
te
nt
 c
ou
nt
y 
un
its
 
of
 a
na
ly
si
s
Ce
ns
us
 B
ur
ea
ua
Co
un
ty
 a
dj
ac
en
ci
es
D
et
er
m
in
in
g 
ne
ig
hb
or
ho
od
 st
ru
ct
ur
e 
to
 u
se
 fo
r s
pa
tia
l r
an
do
m
 e
ffe
ct
s
Ce
ns
us
 B
ur
ea
ub
 
Pe
rc
en
t r
ur
al
 (c
ou
nt
y-
le
ve
l)
Co
va
ria
te
20
00
 C
en
su
s,c
 2
01
0 
Ce
ns
us
d
Li
ne
ar
 in
te
rp
ol
at
io
n 
w
as
 u
se
d 
to
 fi
ll 
in
 in
te
rc
en
sa
l y
ea
rs
. 
20
10
 v
al
ue
s 
ar
e 
us
ed
 fo
r a
ll 
ye
ar
s 
af
te
r 2
01
0.
 
Po
ve
rt
y 
(c
ou
nt
y-
le
ve
l)
Co
va
ria
te
Sm
al
l A
re
a 
In
co
m
e 
an
d 
Po
ve
rt
y 
Es
tim
at
es
 (S
A
IP
E)
e
U
ne
m
pl
oy
m
en
t (
co
un
ty
-le
ve
l)
Co
va
ria
te
Lo
ca
l A
re
a 
U
ne
m
pl
oy
m
en
t S
ta
tis
tic
s 
(L
AU
S)
f
D
rin
ki
ng
 p
la
ce
s 
(c
ou
nt
y-
le
ve
l)
Co
va
ria
te
Co
un
ty
 b
us
in
es
s 
pa
tt
er
ns
g
Bu
si
ne
ss
es
 c
la
ss
ifi
ed
 a
s ‘
D
rin
ki
ng
 P
la
ce
s 
(A
lc
oh
ol
ic
 
Be
ve
ra
ge
s)
’ (
N
A
IC
S 
co
de
 7
22
41
0)
. D
at
a 
ar
e 
av
ai
la
bl
e 
fo
r 
20
02
–2
01
1.
 2
01
1 
va
lu
es
 a
re
 u
se
d 
fo
r 2
01
2.
 
A
lc
oh
ol
 s
to
re
s 
(c
ou
nt
y-
le
ve
l)
Co
va
ria
te
Co
un
ty
 b
us
in
es
s 
pa
tt
er
ns
g
Bu
si
ne
ss
es
 c
la
ss
ifi
ed
 a
s ‘
Be
er
, W
in
e,
 a
nd
 L
iq
uo
r S
to
re
s’ 
(N
A
IC
S 
co
de
 4
45
31
0)
. D
at
a 
ar
e 
av
ai
la
bl
e 
fo
r 2
00
2–
20
11
. 
20
11
 v
al
ue
s 
ar
e 
us
ed
 fo
r 2
01
2.
 
Re
lig
io
us
 a
dh
er
en
ts
 (c
ou
nt
y-
le
ve
l)
Co
va
ria
te
Re
lig
io
us
 C
on
gr
eg
at
io
ns
 a
nd
 
M
em
be
rs
hi
p 
St
ud
yh
,i
D
at
a 
ar
e 
av
ai
la
bl
e 
fo
r 2
00
0 
an
d 
20
10
. L
in
ea
r i
nt
er
po
la
tio
n 
w
as
 u
se
d 
to
 fi
ll 
in
 v
al
ue
s 
be
tw
ee
n 
20
00
 a
nd
 2
01
0.
 2
01
0 
va
lu
es
 a
re
 u
se
d 
fo
r a
ll 
ye
ar
s 
af
te
r 2
01
0.
 
Co
un
ty
 p
op
ul
at
io
n 
by
 a
ge
, s
ex
, a
nd
 
ra
ce
Pr
ed
ic
tio
n 
(a
dj
us
tin
g 
fo
r d
iff
er
en
ce
s 
in
 d
em
og
ra
ph
ic
 c
om
po
si
tio
n 
of
 th
e 
sa
m
pl
e 
co
m
pa
re
d 
to
 th
e 
un
de
rly
in
g 
po
pu
la
tio
n)
 
N
CH
S 
Br
id
ge
d 
Ra
ce
 F
ile
sj,
k
Co
un
ty
 p
op
ul
at
io
n 
by
 a
ge
, s
ex
, a
nd
 
m
ar
ita
l s
ta
tu
s
Pr
ed
ic
tio
n 
(a
dj
us
tin
g 
fo
r d
iff
er
en
ce
s 
in
 d
em
og
ra
ph
ic
 c
om
po
si
tio
n 
of
 th
e 
sa
m
pl
e 
co
m
pa
re
d 
to
 th
e 
un
de
rly
in
g 
po
pu
la
tio
n)
 
20
00
 C
en
su
s,l
 2
00
9–
20
12
 A
m
er
ic
an
 
Co
m
m
un
ity
 S
ur
ve
y 
(A
CS
) 5
-y
r 
es
tim
at
es
m
Co
un
ty
-le
ve
l d
at
a 
ar
e 
av
ai
la
bl
e 
fr
om
 th
e 
ce
ns
us
 in
 
20
00
 a
nd
 fr
om
 th
e 
5-
ye
ar
 A
CS
 e
st
im
at
es
 p
ub
lis
he
d 
in
 
20
09
–2
01
2,
 c
or
re
sp
on
di
ng
 to
 e
st
im
at
es
 in
 2
00
7–
20
10
. W
e 
us
e 
lin
ea
r i
nt
er
po
la
tio
n 
to
 fi
ll 
in
 y
ea
rs
 b
et
w
ee
n 
20
00
 a
nd
 
20
07
 a
nd
 w
e 
us
e 
th
e 
va
lu
e 
in
 2
01
0 
fo
r a
ll 
ye
ar
s 
af
te
r 2
01
0.
 
73
Chapter 3 - Drinking Patterns in US Counties, 2002–2012
Ta
bl
e 
S2
. 
Ad
di
tio
na
l D
at
a 
So
ur
ce
s. 
(c
on
tin
ue
d)
D
at
a
U
se
So
ur
ce
n
ot
es
Co
un
ty
 p
op
ul
at
io
n 
by
 a
ge
, s
ex
, a
nd
 
ed
uc
at
io
na
l a
tt
ai
nm
en
t
Pr
ed
ic
tio
n 
(a
dj
us
tin
g 
fo
r d
iff
er
en
ce
s 
in
 d
em
og
ra
ph
ic
 c
om
po
si
tio
n 
of
 th
e 
sa
m
pl
e 
co
m
pa
re
d 
to
 th
e 
un
de
rly
in
g 
po
pu
la
tio
n)
 
20
00
 C
en
su
s,n
 2
00
9–
20
12
 A
m
er
ic
an
 
Co
m
m
un
ity
 S
ur
ve
y 
(A
CS
) 5
-y
r 
es
tim
at
es
o
Co
un
ty
-le
ve
l d
at
a 
ar
e 
av
ai
la
bl
e 
fr
om
 th
e 
ce
ns
us
 in
 
20
00
 a
nd
 fr
om
 th
e 
5-
ye
ar
 A
CS
 e
st
im
at
es
 p
ub
lis
he
d 
in
 
20
09
–2
01
2,
 c
or
re
sp
on
di
ng
 to
 e
st
im
at
es
 in
 2
00
7–
20
10
. W
e 
us
e 
lin
ea
r i
nt
er
po
la
tio
n 
to
 fi
ll 
in
 y
ea
rs
 b
et
w
ee
n 
20
00
 a
nd
 
20
07
 a
nd
 w
e 
us
e 
th
e 
va
lu
e 
in
 2
01
0 
fo
r a
ll 
ye
ar
s 
af
te
r 2
01
0.
 
Ph
on
e 
us
ag
e 
pa
tt
er
ns
Pr
ed
ic
tio
n 
(a
dj
us
tin
g 
fo
r d
iff
er
en
ce
s 
in
 c
om
po
si
tio
n 
of
 th
e 
sa
m
pl
e 
co
m
pa
re
d 
to
 th
e 
un
de
rly
in
g 
po
pu
la
tio
n)
 
Bl
um
be
rg
 e
t a
l.p
,q
 
Es
tim
at
es
 a
re
 a
va
ila
bl
e 
fo
r 9
3 
no
n-
ov
er
la
pp
in
g 
ge
og
ra
ph
ic
 a
re
as
 c
on
si
st
in
g 
of
 s
ta
te
s, 
co
un
tie
s, 
or
 g
ro
up
s 
of
 c
ou
nt
ie
s. 
W
e 
ap
pl
y 
th
e 
es
tim
at
e 
fo
r e
ac
h 
st
at
e,
 c
ou
nt
y,
 
or
 g
ro
up
 o
f c
ou
nt
ie
s 
to
 a
ll 
co
un
tie
s 
in
 th
e 
ag
gr
eg
at
e.
 
Ag
e 
an
d 
se
x 
st
an
da
rd
Ag
e 
st
an
da
rd
iz
in
g 
es
tim
at
es
 
an
d 
co
m
bi
ni
ng
 m
al
e 
an
d 
fe
m
al
e 
es
tim
at
es
20
00
 C
en
su
sr
Co
un
ty
 a
nd
 s
ta
te
 s
ha
pe
 fi
le
s
Cr
ea
tin
g 
m
ap
s
SE
ER
*S
ta
t B
rid
ge
s
a U
S 
Ce
ns
us
 B
ur
ea
u.
 S
ub
st
an
tia
l C
ha
ng
es
 t
o 
Co
un
tie
s 
an
d 
Co
un
ty
 E
qu
iv
al
en
t 
En
tit
ie
s:
 1
97
0–
Pr
es
en
t. 
Av
ai
la
bl
e 
fr
om
: h
tt
p:
//
w
w
w
.c
en
su
s.g
ov
/g
eo
/r
ef
er
en
ce
/c
ou
nt
y-
ch
an
ge
s.h
tm
l. 
b U
S 
Ce
ns
us
 B
ur
ea
u.
 U
ni
te
d 
St
at
es
 C
ou
nt
y 
Ad
ja
ce
nc
y 
20
10
. A
va
ila
bl
e 
fr
om
: h
tt
p:
//
w
w
w
.c
en
su
s.g
ov
/g
eo
/r
ef
er
en
ce
/c
ou
nt
y-
ad
ja
ce
nc
y.
ht
m
l. 
c U
S 
Ce
ns
us
 B
ur
ea
u.
 2
00
0 
U
S 
Ce
ns
us
, S
um
m
ar
y 
Fi
le
 1
 (S
F1
), 
Ta
bl
e 
H
00
2:
 U
rb
an
 a
nd
 R
ur
al
. G
en
er
at
ed
 u
si
ng
 A
m
er
ic
an
 F
ac
tF
in
de
r: 
ht
tp
://
fa
ct
fin
de
r2
.c
en
su
s.g
ov
. 
d U
S 
Ce
ns
us
 B
ur
ea
u.
 2
01
0 
U
S 
Ce
ns
us
, S
um
m
ar
y 
Fi
le
 1
 (S
F1
), 
Ta
bl
e 
H
2:
 U
rb
an
 a
nd
 R
ur
al
. G
en
er
at
ed
 u
si
ng
 A
m
er
ic
an
 F
ac
tF
in
de
r: 
ht
tp
://
fa
ct
fin
de
r2
.c
en
su
s.g
ov
. 
e U
S 
Ce
ns
us
 B
ur
ea
u.
 U
ni
te
d 
St
at
es
 S
m
al
l A
re
a 
In
co
m
e 
an
d 
Po
ve
rt
y 
Es
tim
at
es
 2
00
2–
20
12
. W
as
hi
ng
to
n,
 D
C,
 U
ni
te
d 
St
at
es
: U
S 
Ce
ns
us
 B
ur
ea
u,
 2
01
3.
 A
va
ila
bl
e 
fr
om
: h
tt
p:
//
w
w
w
.c
en
su
s.g
ov
/d
id
/w
w
w
/s
ai
pe
/d
at
a/
in
de
x.
ht
m
l. 
f U
S 
Bu
re
au
 o
f L
ab
or
 S
ta
tis
tic
s. 
Lo
ca
l A
re
a 
U
ne
m
pl
oy
m
en
t S
ta
tis
tic
s. 
20
13
. A
va
ila
bl
e 
fr
om
: f
tp
://
ft
p.
bl
s.g
ov
/p
ub
/t
im
e.
se
rie
s/
la
/. 
g U
S 
Ce
ns
us
 B
ur
ea
u.
 U
ni
te
d 
St
at
es
 C
ou
nt
y 
Bu
si
ne
ss
 P
at
te
rn
s 
20
02
–2
01
1.
 W
as
hi
ng
to
n,
 D
.C
., 
U
ni
te
d 
St
at
es
: U
S 
Ce
ns
us
 B
ur
ea
u.
 A
va
ila
bl
e 
fr
om
: w
w
w
.c
en
su
s.g
ov
/e
co
n/
cb
p/
do
w
nl
oa
d/
. 
h J
on
es
 D
E,
 D
ot
y 
S,
 G
ra
m
m
ic
h 
C,
 H
or
sc
h 
JE
, H
ou
se
al
 R
, L
yn
n 
M
, M
ar
cu
m
 J
P, 
Sa
nc
ha
gr
in
 K
M
, T
ay
lo
r R
H
. 2
00
2.
 R
el
ig
io
us
 C
on
gr
eg
at
io
ns
 a
nd
 M
em
be
rs
hi
p 
in
 th
e 
U
ni
te
d 
St
at
es
 
20
00
: A
n 
En
um
er
at
io
n 
by
 R
eg
io
n,
 S
ta
te
 a
nd
 C
ou
nt
y 
Ba
se
d 
on
 D
at
a 
Re
po
rt
ed
 fo
r 1
49
 R
el
ig
io
us
 B
od
ie
s. 
N
as
hv
ill
e,
 T
N
: G
le
nm
ar
y 
Re
se
ar
ch
 C
en
te
r. 
Av
ai
la
bl
e 
fr
om
: h
tt
p:
//
w
w
w
.
th
ea
rd
a.
co
m
/A
rc
hi
ve
/F
ile
s/
D
es
cr
ip
tio
ns
/R
CM
SC
Y.
as
p.
 
74
i G
ra
m
m
ic
h 
C,
 H
ad
aw
ay
 K
, H
ou
se
al
 R
, J
on
es
 D
E,
 K
rin
da
tc
h 
A
, S
ta
nl
ey
 R
, T
ay
lo
r R
H
. 2
01
2.
 2
01
0 
U
.S
. R
el
ig
io
n 
Ce
ns
us
: R
el
ig
io
us
 C
on
gr
eg
at
io
ns
 &
 M
em
be
rs
hi
p 
St
ud
y.
 A
ss
oc
ia
tio
n 
of
 S
ta
tis
tic
ia
ns
 o
f A
m
er
ic
an
 R
el
ig
io
us
 B
od
ie
s. 
A
ss
oc
ia
tio
n 
of
 S
ta
tis
tic
ia
ns
 o
f A
m
er
ic
an
 R
el
ig
io
us
 B
od
ie
s. 
Av
ai
la
bl
e 
fr
om
: h
tt
p:
//
w
w
w
.th
ea
rd
a.
co
m
/A
rc
hi
ve
/F
ile
s/
D
es
cr
ip
-
tio
ns
/R
CM
SC
Y1
0.
as
p.
 
j N
at
io
na
l C
en
te
r f
or
 H
ea
lth
 S
ta
tis
tic
s 
(N
CH
S)
, C
en
te
rs
 fo
r D
is
ea
se
 C
on
tr
ol
 a
nd
 P
re
ve
nt
io
n 
(C
D
C)
, U
S 
Ce
ns
us
 B
ur
ea
u.
 U
ni
te
d 
St
at
es
 B
rid
ge
d-
Ra
ce
 In
te
rc
en
sa
l P
op
ul
at
io
n 
Es
tim
at
es
 2
00
0–
20
09
. H
ya
tt
sv
ill
e,
 U
ni
te
d 
St
at
es
: N
at
io
na
l C
en
te
r 
fo
r 
H
ea
lth
 S
ta
tis
tic
s 
(N
CH
S)
, C
en
te
rs
 fo
r 
D
is
ea
se
 C
on
tr
ol
 a
nd
 P
re
ve
nt
io
n 
(C
D
C)
, 2
01
2.
 A
va
ila
bl
e 
fr
om
: 
ht
tp
://
w
w
w
.c
dc
.g
ov
/n
ch
s/
nv
ss
/b
rid
ge
d_
ra
ce
/d
at
a_
do
cu
m
en
ta
tio
n.
ht
m
#j
ul
y2
00
9.
 
k N
at
io
na
l C
en
te
r f
or
 H
ea
lth
 S
ta
tis
tic
s 
(N
CH
S)
, C
en
te
rs
 fo
r D
is
ea
se
 C
on
tr
ol
 a
nd
 P
re
ve
nt
io
n 
(C
D
C)
, U
S 
Ce
ns
us
 B
ur
ea
u.
 U
ni
te
d 
St
at
es
 V
in
ta
ge
 2
01
2 
Br
id
ge
d-
Ra
ce
 P
os
tc
en
sa
l 
Po
pu
la
tio
n 
Es
tim
at
es
 2
01
0–
20
12
. H
ya
tt
sv
ill
e,
 U
ni
te
d 
St
at
es
: N
at
io
na
l C
en
te
r f
or
 H
ea
lth
 S
ta
tis
tic
s 
(N
CH
S)
, C
en
te
rs
 fo
r D
is
ea
se
 C
on
tr
ol
 a
nd
 P
re
ve
nt
io
n 
(C
D
C)
, 2
01
3.
 A
va
il-
ab
le
 fr
om
: h
tt
p:
//
w
w
w
.c
dc
.g
ov
/n
ch
s/
nv
ss
/b
rid
ge
d_
ra
ce
/d
at
a_
do
cu
m
en
ta
tio
n.
ht
m
#v
in
ta
ge
20
12
. 
l U
S 
Ce
ns
us
 B
ur
ea
u.
 2
00
0 
U
S 
Ce
ns
us
, S
um
m
ar
y 
Fi
le
 3
 (S
F3
), 
Ta
bl
e 
PC
T0
07
: S
ex
 b
y 
M
ar
ita
l S
ta
tu
s 
by
 A
ge
 fo
r t
he
 P
op
ul
at
io
n 
15
 Y
ea
rs
 a
nd
 O
ve
r. 
G
en
er
at
ed
 u
si
ng
 A
m
er
ic
an
 
Fa
ct
Fi
nd
er
: h
tt
p:
//
fa
ct
fin
de
r2
.c
en
su
s.g
ov
. 
m
U
S 
Ce
ns
us
 B
ur
ea
u.
 2
00
9–
20
12
 A
m
er
ic
an
 C
om
m
un
ity
 S
ur
ve
y 
5-
ye
ar
 E
st
im
at
es
, T
ab
le
 B
12
00
2:
 S
ex
 b
y 
M
ar
ita
l S
ta
tu
s 
by
 A
ge
 fo
r t
he
 P
op
ul
at
io
n 
15
 Y
ea
rs
 a
nd
 O
ve
r. 
G
en
er
-
at
ed
 u
si
ng
 A
m
er
ic
an
 F
ac
tF
in
de
r: 
ht
tp
://
fa
ct
fin
de
r2
.c
en
su
s.g
ov
. 
n U
S 
Ce
ns
us
 B
ur
ea
u.
 2
00
0 
U
S 
Ce
ns
us
, S
um
m
ar
y 
Fi
le
 3
 (S
F3
), 
Ta
bl
e 
PC
T0
25
: S
ex
 b
y 
Ag
e 
by
 E
du
ca
tio
na
l A
tt
ai
nm
en
t f
or
 th
e 
Po
pu
la
tio
n 
18
 Y
ea
rs
 a
nd
 O
ve
r. 
G
en
er
at
ed
 u
si
ng
 
A
m
er
ic
an
 F
ac
tF
in
de
r: 
ht
tp
://
fa
ct
fin
de
r2
.c
en
su
s.g
ov
. 
o U
S 
Ce
ns
us
 B
ur
ea
u.
 2
00
9–
20
12
 A
m
er
ic
an
 C
om
m
un
ity
 S
ur
ve
y 
5-
ye
ar
 E
st
im
at
es
, T
ab
le
 B
15
00
1:
 S
ex
 b
y 
Ag
e 
by
 E
du
ca
tio
na
l A
tt
ai
nm
en
t f
or
 th
e 
Po
pu
la
tio
n 
18
 Ye
ar
s a
nd
 O
ve
r. 
G
en
er
at
ed
 u
si
ng
 A
m
er
ic
an
 F
ac
tF
in
de
r: 
ht
tp
://
fa
ct
fin
de
r2
.c
en
su
s.g
ov
. 
p B
lu
m
be
rg
 S
J, 
Lu
ke
 JV
, G
an
es
h,
 N
, D
av
er
n 
M
E,
 B
ou
dr
ea
ux
 M
H
. W
ire
le
ss
 S
ub
st
itu
tio
n:
 S
ta
te
-le
ve
l E
st
im
at
es
 fr
om
 th
e 
N
at
io
na
l H
ea
lth
 In
te
rv
ie
w
 S
ur
ve
y,
 2
01
0–
20
11
. N
at
io
na
l 
H
ea
lth
 S
ta
tis
tic
s 
Re
po
rt
s. 
20
12
; 6
1.
 A
va
ila
bl
e 
fr
om
: h
tt
p:
//
w
w
w
.c
dc
.g
ov
/n
ch
s/
da
ta
/n
hs
r/
nh
sr
06
1.
pd
f. 
q B
lu
m
be
rg
 S
J, 
G
an
es
h 
N
, L
uk
e 
JV
, G
on
za
le
s 
G
. W
ire
le
ss
 S
ub
st
itu
tio
n:
 S
ta
te
-le
ve
l E
st
im
at
es
 fr
om
 t
he
 N
at
io
na
l H
ea
lth
 In
te
rv
ie
w
 S
ur
ve
y,
 2
01
2.
 N
at
io
na
l H
ea
lth
 S
ta
tis
tic
s 
Re
po
rt
s. 
20
13
; 7
0.
 A
va
ila
bl
e 
fr
om
: h
tt
p:
//
w
w
w
.c
dc
.g
ov
/n
ch
s/
da
ta
/n
hs
r/
nh
sr
07
0.
pd
f.
r U
S 
Ce
ns
us
 B
ur
ea
u.
 2
00
0 
U
S 
Ce
ns
us
, S
um
m
ar
y 
Fi
le
 1
 (S
F1
), 
Ta
bl
e 
Q
TP
1:
 A
ge
 G
ro
up
s 
an
d 
Se
x.
 G
en
er
at
ed
 u
si
ng
 A
m
er
ic
an
 F
ac
tF
in
de
r: 
ht
tp
://
fa
ct
fin
de
r2
.c
en
su
s.g
ov
. 
s N
at
io
na
l C
an
ce
r I
ns
tit
ut
e.
 S
EE
R 
St
at
 B
rid
ge
 S
ta
te
 a
nd
 C
ou
nt
y F
IP
S 
Co
de
s 2
00
0–
20
04
. A
va
ila
bl
e 
fr
om
: h
tt
p:
//
gi
s.c
an
ce
r.g
ov
/t
oo
ls
/s
ee
rs
ta
t_
br
id
ge
/fi
ps
_v
ar
s/
#s
c_
20
00
_2
00
4.
75
Chapter 3 - Drinking Patterns in US Counties, 2002–2012
Model validation
We used previously developed validation methods1 to assess the performance of the small area 
models. Our approach was as follows: for each sex we selected counties with at least 900 survey 
respondents between 2006 and 2010. We refer to these counties as the “validation set”. For each 
county in the validation set we calculated a “gold standard” estimate of alcohol use for 2008 by 
pooling the available data over the period 2006 to 2010. We then created new datasets by generat-
ing random samples from counties in the validation set of size 10, 50, and 100 respondents per 
year. Each sample size was repeated 10 times, for a total of 30 “sampled-down” datasets. The model 
was fit on all 30 of these sampled-down datasets and used to estimate prevalence for each county 
in the validation set for 2008. The resulting prevalence estimates were then compared to the gold 
standard. We measured model performance using the concordance correlation coefficient (table 
S3), which is a measure of the agreement between the model predictions and the gold standard, 
and the root mean squared error (table S4), a measure of the magnitude of the deviation between 
the model predictions and the gold standard, expressed in the same units as the predictions. In 
both cases, the reported value for each sample size is the median across all 10 repetitions. 
references
 1. Srebotnjak T, Mokdad AH, Murray CJL. A novel framework for validating and applying standard-
ized small area measurement strategies. Population Health Metrics. 2010;8(1):26. 
Table S3. Model performance as measured by concordance correlation.
Alcohol use measure Sex
Sample size
10 50 100 In sample
Any drinking Males 0.91 0.93 0.94 0.95
Females 0.94 0.96 0.97 0.98
Heavy drinking Males 0.57 0.66 0.72 0.78
Females 0.67 0.75 0.77 0.83
Binge drinking Males 0.68 0.76 0.80 0.84
Females 0.71 0.75 0.78 0.81
Table S4. Model performance as measured by the root mean squared error.a 
Alcohol use 
measure
Sex
Sample size
10 50 100 In sample
Any drinking Males 3.32 2.88 2.68 2.47
Females 3.43 2.88 2.56 2.23
Heavy drinking Males 2.06 1.86 1.72 1.55
Females 1.47 1.33 1.27 1.13
Binge drinking Males 3.11 2.70 2.50 2.22
Females 2.08 1.90 1.80 1.68
aRoot mean squared error is expressed in terms of percentage points. 
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ABSTrACT
Objective
Previous analyses of diabetes prevalence in the U.S. have considered either only large geo-
graphic regions or only individuals in whom diabetes had been diagnosed. We estimated 
county-level trends in the prevalence of diagnosed, undiagnosed, and total diabetes as well 
as rates of diagnosis and effective treatment from 1999 to 2012.
research design and methods
We used a two-stage modeling procedure. In the first stage, self-reported and biomarker data 
from the National Health and Nutrition Examination Survey (NHANES) were used to build 
models for predicting true diabetes status, which were applied to impute true diabetes status 
for respondents in the Behavioral Risk Factor Surveillance System (BRFSS). In the second 
stage, small area models were fit to imputed BRFSS data to derive county-level estimates of 
diagnosed, undiagnosed, and total diabetes prevalence, as well as rates of diabetes diagnosis 
and effective treatment.
results
In 2012, total diabetes prevalence ranged from 8.8% to 26.4% among counties, whereas 
the proportion of the total number of cases that had been diagnosed ranged from 59.1% to 
79.8%, and the proportion of successfully treated individuals ranged from 19.4% to 31.0%. 
Total diabetes prevalence increased in all counties between 1999 and 2012; however, the rate 
of increase varied widely. Over the same period, rates of diagnosis increased in all counties, 
while rates of effective treatment stagnated.
Conclusions
Our findings demonstrate substantial disparities in diabetes prevalence, rates of diagnosis, 
and rates of effective treatment within the U.S. These findings should be used to target high-
burden areas and select the right mix of public health strategies.
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InTrODUCTIOn
Diabetes mellitus is a leading cause of death and poor health in the U.S. In 2013, diabetes was 
responsible for 74.9 thousand deaths (the seventh leading cause of death) and 1.85 million 
years lived with disability (the eighth leading cause of disability).1,2 Diabetes also exerts a 
large and rapidly increasing burden on the U.S. economy, with total costs in 2012 estimated 
at $245 billion.3
In addition to medical strategies for identifying and managing diabetes, there are a number 
of evidence-based public health strategies aimed at primary prevention, screening, and 
improved disease management.4,5 Effectively and efficiently deploying these strategies, espe-
cially given financial constraints and competing priorities, requires detailed local information 
about diabetes burden. This information can be used to define the scope of the problem 
as well as to identify high-need areas. In particular, information about both diagnosed and 
undiagnosed cases is essential in order to fully appreciate the population that is in need 
of services. Similarly, local information about rates of diagnosis and effective treatment are 
important inputs for determining the right mix of strategies to address the diabetes burden 
of a particular community.
National trends in diabetes prevalence are typically based on the National Health and 
Nutrition Examination Survey (NHANES).6 The NHANES comprises both an interview and 
a laboratory component, which includes collecting biomarkers for diabetes. This allows 
researchers to use NHANES data to describe trends in diagnosed and undiagnosed diabetes, 
as well as rates of diagnosis and effective treatment, but only at the national level. State and 
local trends,7–9 in contrast, are typically derived from the Behavioral Risk Factor Surveillance 
System (BRFSS),10 which has a much larger sample size and more comprehensive geographic 
coverage than the NHANES. The BRFSS does not include any biomarkers, however, and can 
only be used to track diagnosed diabetes prevalence.
Most local health departments are organized by county or groups of counties;11 however; 
only trends in diagnosed diabetes are available at this level.7–9 We combined NHANES and 
BRFSS data in order to estimate county-level prevalence of both diagnosed and undiagnosed 
diabetes in adults ≥20 years of age for each year from 1999 to 2012. We also calculated sev-
eral derived measures, including the proportion of diabetes case patients who have received 
a diagnosis and the proportion of case patients who have been effectively treated.
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Overview
For this analysis we used a two-stage approach to estimate five measures of diabetes preva-
lence (Table 1). In the first stage, we used NHANES data to fit a model for predicting high 
fasting plasma glucose (FPG) levels (≥126 mg/dL) and/or A1C levels (≥6.5% [48 mmol/mol])12 
on the basis of self-reported demographic and behavioral characteristics. We then applied 
this model to BRFSS data to impute high FPG and/or A1C status for each BRFSS respondent. 
In the second stage, we used the imputed BRFSS data to fit a series of small area models, 
which were used to predict the county-level prevalence of each of the five diabetes-related 
outcomes.
Table 1. Outcome measure definitions.
Measure Definition
Diagnosed diabetes 
prevalence
The proportion of adults ≥20 years of age who report a previous diabetes diagnosis. 
Undiagnosed diabetes 
prevalence
The proportion of adults ≥20 years of age who do not report a previous diabetes 
diagnosis and who have high FPG/A1C.a
Total diabetes 
prevalence
The proportion of adults ≥20 years of age who report a previous diabetes diagnosis 
and/or have high FPG/A1C;a total diabetes prevalence is equal to the sum of 
diagnosed and undiagnosed diabetes prevalence. 
Diabetes awareness The proportion of adults ≥20 years of age with a previous diabetes diagnosis and/
or high FPG/A1Ca who have received a diagnosis; diabetes awareness is equal to the 
ratio of diagnosed to total diabetes prevalence. 
Diabetes control The proportion of adults ≥20 years of age with a previous diabetes diagnosis and/or 
high FPG/A1Ca who currently do not have high FPG/A1C.a
aFPG ≥126 mg/dL and/or A1C ≥6.5% (48 mmol/mol).
Data
This analysis used NHANES and BRFSS data from 1999 to 2012. Over this period, the NHANES 
subsample that contains FPG measurement included 17,375 respondents ≥20 years of age; 
15,600 of these respondents (89.8%) had no missing values for any of the relevant variables 
and were incorporated into this analysis. Over the same period, the BRFSS included 4,620,693 
respondents ≥20 years of age; of these, 4,107,972 respondents (88.9%) had no missing values 
for any relevant variable and were included in this analysis. Several additional data sources 
were used, either as covariates in the small area models or for poststratification of estimates, 
as described below. Further details on all data sources are provided in the Supplementary 
Data.
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High fPG/A1C models
Following Danaei et al.13 and Olives et al.,14 we developed respondent-level logistic regres-
sion models for predicting high FPG and/or A1C status (referred to hereafter as “high FPG/
A1C”). Using NHANES data, the following model was fit separately for males and females, and 
for individuals who had previously received a diagnosis and had not received a diagnosis:
Yi ~ Bernoulli(pi)
logit(pi) = β0 + β1,ai + β2,ri + β3,ei + β4,mi + β5 · BMIi + β6 · BMIi
2 + β7 · Hi + β8 · Si
where Yi is 1 if individual i has high FPG/A1C and 0 otherwise; ai, ri, ei, mi, BMIi, and BMIi2 
are individual i’s age group (20–29, 30–39, 40–49, 50–59, 60–69, 70+ years), race/ethnicity 
(white, black, Hispanic, other), education status (less than high school, high school graduate, 
some college, college graduate), marital status (currently married, formerly married, never 
married), BMI, and squared BMI, respectively; and Hi and Si are indicators for whether or not 
individual i has health insurance and is a current smoker, respectively.
The fitted logistic regression models were used to impute current (at the time of survey) high 
FPG/A1C status for each BRFSS respondent. Ten separate imputed data sets were created 
using simulation methods15 to reflect the uncertainty in each BRFSS respondent’s true high 
FPG/A1C status.
The predictive accuracy of this model was assessed using cross-validation, as described in the 
Supplementary Data. The model was found to have high concordance overall—it correctly 
predicted high FPG/A1C status for ~9 of 10 respondents—however, the sensitivity (i.e., the 
proportion of true case patients identified) was relatively low (11.2–13.2%, depending on sex 
and previous diagnosis).
Small area models
Small area models were developed to estimate county-level diagnosed diabetes prevalence, 
undiagnosed diabetes prevalence, and uncontrolled (diagnosed and with high FPG/A1C) 
diabetes prevalence based on imputed BRFSS data. These models are designed to borrow 
strength across space and time, and from external information in the form of covariates 
in order to generate more precise estimates than those calculated directly from the small 
samples available in most counties.
Each of these models was specified as follows:
Yj,t,a,r,m,e ~ Binomial(pj,t,a,r,m,e, Nj,t,a,r,m,e)
logit(pj,t,a,r,m,e) = β0 + β1,a + β2,r + β3,m + β4,e + β5 · Xj,t + uj + wt + dj,t
82
where Nj,t,a,r,m,e, Yj,t,a,r,m,e, and pj,t,a,r,m,e are the number of individuals sampled, the number of 
case patients among those sampled, and the true prevalence, respectively, in county j, year 
t, age group a, race/ethnicity group r, marital status group m, and education group e; β0 is 
the global intercept; β1,a values are age group effects (20–29, 30–39, 40–49, 50–59, 60–69, 
and 70+ years); β2,r values are race/ethnicity effects (Hispanic, white non-Hispanic, black non-
Hispanic, native non-Hispanic, and other non-Hispanic); β3,m  values are marital status effects 
(currently married, formerly married, and never married); β4,e values are education effects 
(less than high school, high school graduate, some college, and college graduate); and β5 
is a vector of effects for three county-year-level covariates (Xj,t) (percentage of individuals 
living in poverty, percentage of rural households, and the number of doctors per capita). uj 
and wt are county- and year-level random effects, respectively, both of which are assumed 
to follow a conditional autoregressive distribution.16 dj,t is a county-year-level random effect 
that is also assumed to follow a conditional autoregressive distribution.17 Separate models 
were fit for males and females, and the procedure described by Dwyer-Lindgren et al.18 was 
used to correct for noncoverage bias in BRFSS data prior to 2011 when a cell phone sample 
was introduced.19
Models were fit using the Template Model Builder package20 in R version 3.2.4.21 Simulation 
methods15 were used generate 1,000 draws of diagnosed, undiagnosed, and uncontrolled 
diabetes prevalence from the fitted small area models. These draws were poststratified by 
race, marital status, and education and then age standardized. Point estimates were calcu-
lated from the mean of these 1,000 draws, whereas 95% uncertainty intervals were calculated 
from the 2.5th and 97.5th percentiles. Estimates of total diabetes prevalence, diabetes aware-
ness, and diabetes control were derived from the directly modeled quantities as follows: total 
= diagnosed + undiagnosed; awareness = diagnosed/total; control = 1 − uncontrolled/total. 
State- and national-level estimates of all quantities were derived by population weighting of 
county-level estimates.
Finally, in order to account for the uncertainty arising from using imputed data in the 
models for undiagnosed and uncontrolled diabetes, the entire procedure described above 
was repeated for each of 10 imputed data sets. Estimates were combined across data sets, 
and uncertainty intervals were recalculated to take into account the variation between the 
imputed data sets as well as the uncertainty from the small area models.22
The predictive accuracy of this small area model was assessed with reference to diagnosed 
diabetes using empirical validation methods, as described in the Supplementary Data. In 
general, model predictions were found to have lower error and bias for counties with larger 
sample sizes. However, even for counties where only a single individual was sampled each 
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year, the mean error (a measure of bias) was −0.3 percentage points, while the mean absolute 
error (a measure of precision) was 1 percentage point.
reSULTS
Diabetes prevalence in 2012
Age-standardized diagnosed diabetes prevalence for the U.S. as a whole was 10.2% (95% 
uncertainty interval 10.1%, 10.4%) in 2012, whereas undiagnosed diabetes prevalence was 
4.1% (3.6%, 4.5%), resulting in a total diabetes prevalence of 14.3% (13.8%, 14.7%). Among 
counties, diagnosed diabetes prevalence ranged from 5.6% to 20.4%, undiagnosed diabetes 
prevalence ranged from 3.2% to 6.8%, and total diabetes prevalence ranged from 8.8% 
to 26.4%. Figure 1 shows age-standardized diagnosed, undiagnosed, and total diabetes 
prevalence by county in 2012. Diagnosed diabetes prevalence was highest among counties 
in the deep South (excluding Florida), near the Texas-Mexico border, and in counties with 
Native American reservations in the four corners region of the Southwest and in North and 
South Dakota. In contrast, diagnosed diabetes prevalence was lowest among counties in the 
upper West and Midwest, parts of Alaska, and parts of New England. Undiagnosed diabetes 
prevalence similarly tended to be high among counties in the deep South, but also among 
counties in the Southwest and Alaska, whereas counties in New England and the upper West 
and Midwest tended to have lower undiagnosed diabetes prevalence. In both cases, there 
was significant variation among counties within as well as across states. At the county level, 
diagnosed and undiagnosed diabetes prevalence were positively correlated (Pearson cor-
relation coefficient 0.77), but more so for women (0.73) than for men (0.57).
At the national level, diagnosed diabetes prevalence was marginally higher among men 
(10.6% [10.4%, 10.8%]) than among women (9.9% [9.7%, 10.0%]), and undiagnosed diabetes 
prevalence was substantially higher among men (5.0% [4.5%, 5.5%]) than among women 
(3.2% [2.5%, 3.8%]). Consequently, at the national level total diabetes prevalence was also 
higher among men (15.6% [15.1%, 16.2%]) than among women (13.0% [12.3%, 13.7%]), a 
pattern that was reflected in 95.1% of counties.
Nationally, diabetes awareness was 71.6% (69.5%, 73.7%) in 2012, but varied by county, rang-
ing from 59.1% to 79.8%. Similarly, whereas at the national level 26.9% (23.3%, 30.6%) of 
individuals who had previously received a diagnosis of diabetes had brought their diabetes 
under control (i.e., FPG <126 mg/dL and A1C <6.5% [48 mmol/mol]), this ranged from 19.4% 
to 31.0% at the county level. Figure 2 depicts age-standardized diabetes awareness and 
control at the county level. Awareness was highly correlated with total diabetes prevalence 
(Pearson correlation coefficient 0.77) and tended to be highest in counties in the South and 
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[8.4, 9.4)
[9.4, 10.3)
[10.3, 11.2)
[11.2, 12.4)
[12.4, 20.5]
B
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[3.8, 3.9)
[3.9, 4.1)
[4.1, 4.4)
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C
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[13.2, 14.2)
[14.2, 15.2)
[15.2, 16.7)
[16.7, 26.4]
figure 1. Age-standardized diabetes prevalence by county, 2012. A: Diagnosed diabetes prevalence. B: 
Undiagnosed diabetes prevalence. C: Total diabetes prevalence.
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in eastern Kentucky and West Virginia; and lowest in counties in the upper West and Midwest, 
Alaska, and parts of New England. In contrast, there was a small negative correlation between 
control and total diabetes prevalence (Pearson correlation coefficient −0.08). Control tended 
to be highest among counties in the deep South and along the Atlantic coast; and lowest 
among counties in the West, Southwest, and Alaska. At the national level, both awareness 
and control were higher for women than for men (75.7% [72.0%, 79.4%] vs. 68.0% [65.8%, 
70.1%] for awareness; 30.7% [26.5%, 35.0%] vs. 23.2% [17.6%, 28.7%] for control), a pattern 
that was reflected in nearly all counties.
County-level estimates of all outcomes in all years are available from the authors upon re-
quest.
A
[59.0, 69.0)
[69.0, 70.8)
[70.8, 72.2)
[72.2, 73.3)
[73.3, 74.4)
[74.4, 79.9]
B
[19.3, 25.7)
[25.7, 26.3)
[26.3, 26.8)
[26.8, 27.2)
[27.2, 27.8)
[27.8, 31.1]
figure 2. Age-standardized diabetes awareness and control by county, 2012. Diabetes awareness (A) and 
diabetes control (B).
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Change in diabetes prevalence from 1999 to 2012
Between 1999 and 2012, total diabetes prevalence nationally increased by 40.0% (35.3%, 
44.8%), from 10.2% (9.7%, 10.7%) to 14.3% (13.8%, 14.7%). This reflects an increase in both 
diagnosed and undiagnosed diabetes, but the rate of increase was larger for diagnosed than 
undiagnosed diabetes: 56.8% (52.3%, 61.7%) compared with 10.3% (4.8%, 15.7%). Changes in 
diabetes prevalence varied at the county level, however, with increases ranging from 25.2% 
to 117.1% for diagnosed diabetes and from 18.9% to 72.0% for total diabetes. Changes in 
undiagnosed diabetes prevalence ranged from a decline of 11.6% to an increase of 37.5%. 
We estimated a decline in undiagnosed diabetes prevalence in 0.5% of counties; however, 
this decline was not statistically significant in any county (one-tailed test, α = 0.05). Figure 
3 shows the percentage changes in age-standardized diagnosed, undiagnosed, and total 
diabetes at the county level. Counties with relatively small and relatively large increases 
in diagnosed diabetes are distributed throughout the country, although concentrations 
of counties with large increases are seen in the West, Southwest, and southern half of the 
Midwest, whereas a large number of counties with relatively small increases in diagnosed 
diabetes can be found along the Atlantic coast and parts of the deep South. Similarly, below 
and above average increases in undiagnosed diabetes were realized throughout the country, 
although in general there is a higher concentration of counties with large increases in the 
South and West and in Florida, and a higher a concentration of counties with small increases 
in the North and East and in Alaska. The map for changes in total diabetes prevalence reflects 
the map for changes in diagnosed diabetes, because increases in total diabetes were in large 
part driven by changes in diagnosed rather than undiagnosed diabetes prevalence.
Nationally, awareness increased by 12.0% (10.4%, 13.6%) between 1999 and 2012, from 
63.9% (61.6%, 66.3%) to 71.6% (69.5%, 73.7%). At the same time, control has held roughly 
constant, increasing by 1.5% (−5.9%, 9.1%). from 26.5% (22.3%, 30.8%) to 26.9% (23.3%, 
30.6%). Over this same period, we found increases in awareness for all counties, ranging from 
4.8% to 38.2%. Changes at the county level in diabetes control were more mixed, however, 
ranging from a 12.3% decline to a 31.1% increase. Figure 4 shows the percentage changes 
in awareness and control at the county level. The largest gains in awareness were realized 
in counties in the Midwest, Southwest, Pacific Northwest, and Alaska, whereas the smallest 
gains were typically observed in the East and the South. Counties that increased control most 
dramatically tended to be clustered in and around Virginia, Oklahoma, and North Dakota, 
whereas those where control declined are somewhat concentrated along the coasts but also 
are well represented throughout the interior.
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[25.1, 49.2)
[49.2, 53.8)
[53.8, 57.5)
[57.5, 61.5)
[61.5, 66.8)
[66.8, 117.2]
B
[−11.7, 6.9)
[6.9, 8.0)
[8.0, 9.0)
[9.0, 10.0)
[10.0, 11.7)
[11.7, 37.6]
C
[18.8, 34.6)
[34.6, 37.6)
[37.6, 39.9)
[39.9, 42.5)
[42.5, 45.9)
[45.9, 72.0]
figure 3. Percentage change in age-standardized diabetes prevalence by county, 1999–2012. A: Diag-
nosed diabetes prevalence. B: Undiagnosed diabetes prevalence. C: Total diabetes prevalence.
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COnCLUSIOnS
The substantial and increasing health and financial burden of diabetes in the U.S. has been 
well documented.1,3 Existing estimates8,23 of county-level diagnosed diabetes have previously 
highlighted a dramatic variation in prevalence within the U.S. Our findings on diagnosed 
diabetes are very similar (for 2012, the correlation between the two sets of estimates is 0.79 
for men and 0.82 for women), but we were also able to report on undiagnosed and total 
diabetes prevalence, as well as on diabetes awareness and control at the county level. These 
results reveal significant variation within the U.S. and within states not only in undiagnosed 
and diagnosed diabetes prevalence, but also in local capacity to address the burden of dia-
betes through diagnosis and successful treatment. This type of local information is essential 
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[4.8, 10.0)
[10.0, 11.4)
[11.4, 12.5)
[12.5, 13.6)
[13.6, 15.0)
[15.0, 38.2]
B
[−12.3, −0.8)
[−0.8, 1.4)
[1.4, 3.1)
[3.1, 5.0)
[5.0, 7.3)
[7.3, 31.2]
figure 4. Percentage change in age-standardized diabetes awareness and control by county, 1999–2012. 
Diabetes awareness (A) and diabetes control (B).
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in order to identify the most impacted communities, and to enable public health officials to 
design targeted and effective intervention strategies.
This analysis is subject to a number of limitations. Most importantly, high FPG/A1C was 
imputed for BRFSS informants based on relevant variables shared between the BRFSS and 
NHANES rather than measured directly, and as a result the estimates of undiagnosed dia-
betes prevalence, total diabetes prevalence, diabetes awareness, and diabetes control are 
considerably less precise than the estimates of diagnosed diabetes prevalence, as evidenced 
by the much larger uncertainty intervals. Further, county-level estimates of undiagnosed and 
total diabetes, as well as the other measures derived from these, account for the variation 
in diagnosed diabetes, demographic features, BMI, smoking, and health insurance, but not 
for other factors. This is reflected by the relatively low sensitivity of the models for predict-
ing high FPG/A1C—although the variables included in the model are certainly predictive of 
diabetes, they explain only a small portion of the individual-level variation in diabetes risk. As 
such, we are almost certainly underestimating the true variation in these outcomes and may 
be missing important outlier counties with unexpectedly high or low performance in terms 
of diagnosis and treatment. This analysis represents an important step forward in beginning 
to account for undiagnosed diabetes in addition to diagnosed diabetes, and also in exploring 
the variation in awareness and control, but further work on these topics is certainly needed, 
and will likely involve more substantial data collection at the county level.
The NHANES and BRFSS are both subject to nonresponse bias. We address this issue by ex-
plicitly incorporating many of the variables used to develop sample weights for both surveys 
into the small area model and poststratifying the results. Further, the BRFSS is also potentially 
subject to noncoverage bias because individuals without phones cannot be interviewed and 
a cell phone sample was only added in 2011. Previous research, however, suggests that the 
bias due to omission of cell phones is expected to be small for diabetes,19 and we explicitly 
correct for this bias. Nonetheless, it is possible that some bias due to nonresponse or non-
coverage remains.
These limitations notwithstanding, this study also has a number of strengths. Most impor-
tantly, we made efficient use of the available data, capitalizing on the strengths of the BRFSS, 
namely its large sample size and broad geographic coverage, as well as on the strengths of 
the NHANES, in particular the collection of biomarker data. This allowed us to generate a 
significantly more detailed picture of diabetes prevalence at the county level than has previ-
ously been available. Further, we used sophisticated small area models, which simultaneously 
borrow strength spatially, temporally, and from external sources of information, allowing us 
to generate more precise estimates for each county than is possible in a strictly design-based 
setting. Finally, our methods explicitly accounted for uncertainty in all modeling stages, and 
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the results are accompanied by 95% uncertainty intervals to convey the level of precision 
associated with each estimate.
The variation in total diabetes prevalence within the U.S. is staggering, with a threefold 
difference between the counties with the lowest prevalence and those with the highest 
prevalence. Some of this variation can be accounted for by socioeconomic and demographic 
factors, which are explicitly incorporated in our analysis of undiagnosed and total diabetes 
prevalence. However, our estimates of diagnosed diabetes, which are based on data directly 
observed at the county level, suggest that there is more variation in diabetes prevalence 
among counties than can be explained by socioeconomic and demographic differences 
alone. Further, the underlying factors driving differences between socioeconomic and demo-
graphic groups have not been entirely elucidated. Given the significant health and financial 
burden of high diabetes prevalence, this disparity demands further investigation into what 
underlying (and potentially modifiable) factors drive the exceedingly high diagnosed and 
total diabetes rates found in many communities.
Diabetes is both preventable and treatable. The public health system has a roll to play in 
increasing awareness of and screening for diabetes, connecting affected and high-risk 
individuals with appropriate medical care, and promoting community-level interventions 
that address known risk factors such as poor diet or lack of physical activity.4,5 The results of 
this analysis should be considered by state and local health officials aiming to increase early 
detection and improve the health of impacted communities.
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SUPPLeMenTArY DATA
Data
National Health and Nutrition Examination Survey (NHANES) data
We extracted reported age, sex, race/ethnicity, marital status, education status, current 
smoking status, current health insurance status, and diabetes diagnosis as well as measured 
weight, height, fasting plasma glucose (FPG), and A1C for the 17,375 individuals aged 20 
years and older included in the 1999–2012 NHANES sub-sample for FPG measurements. Of 
these respondents, 15,600 (89.8%) had no missing values for any of these variables and were 
subsequently included in this analysis. BMI was calculated directly from measured weight (in 
kilograms) and height (in meters) as weight/height2. Table S1 provides details on the annual 
NHANES sample size as well as missingness by variable.
Table S1. Sample size and missingness in NHANES data.
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1999–2000 100.0 89.3 99.6 100.0 93.4 94.9 98.6 99.9 98.4 81.1 2,188 1,774
2001–2002 100.0 99.9 99.8 100.0 95.0 95.4 94.2 99.8 98.5 89.3 2,508 2,240
2003–2004 100.0 99.9 99.8 100.0 95.3 95.9 98.4 100.0 99.3 93.0 2,247 2,089
2005–2006 100.0 100.0 99.9 99.9 94.8 94.9 98.0 99.9 99.9 92.4 2,289 2,116
2007–2008 100.0 100.0 99.9 99.9 94.5 94.5 98.2 99.9 99.9 92.0 2,776 2,555
2009–2010 100.0 99.9 99.7 99.9 95.1 89.1 99.1 100.0 99.9 87.5 2,740 2,398
2011–2012 100.0 99.9 99.9 99.9 94.1 94.8 98.6 99.8 99.9 92.4 2,627 2,428
All 100.0 98.6 99.8 99.9 94.6 94.1 97.9 99.9 99.4 89.8 17,375 15,600
Behavioral Risk Factor Surveillance System (BRFSS) data
We extracted reported age, sex, race/ethnicity, marital status, education status, current smok-
ing status, current health insurance status, diabetes diagnosis, weight, height, and county of 
residence for the 4,620,693 respondents aged 20 years and older in the 1999–2012 BRFSS. 
4,107,972 (88.9%) of these respondents had no missing values for any of these variables and 
were subsequently included in the analysis. BMI was calculated first directly from reported 
weight (in kilograms) and height (in meters) as weight/height2. We then corrected for self-
report bias by applying the correction factors described by Dwyer-Lindgren et al.1 Table S2 
provides details on the annual BRFSS sample size as well as missingness by variable.
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Table S2. Sample size and missingness in BRFSS data.
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1999 99.0 99.6 99.8 99.8 - 99.9 99.1 96.8 99.7 99.8 94.6 152,557 144,265
2000 98.8 99.5 99.7 99.8 - 99.9 99.2 96.2 99.7 99.8 93.6 175,275 164,107
2001 98.2 99.0 99.7 99.8 - 99.9 98.9 96.0 99.7 99.8 92.3 198,831 183,457
2002 98.6 99.1 99.8 99.8 - 99.9 98.9 96.2 99.7 99.8 92.8 234,589 217,621
2003 98.8 99.2 99.7 99.8 - 99.9 99.0 96.1 99.7 99.8 93.0 251,398 233,898
2004 98.8 99.1 99.7 99.8 - 99.9 98.9 96.2 99.7 99.8 93.0 293,023 272,466
2005 98.7 99.1 99.7 99.8 - 99.9 98.9 96.3 99.6 99.8 93.0 345,653 321,307
2006 95.5 99.0 99.7 99.8 - 99.9 98.8 96.1 99.6 99.8 89.7 342,488 307,339
2007 94.7 99.1 99.7 99.7 - 99.9 98.8 96.4 99.6 99.8 89.4 418,195 373,692
2008 93.0 99.1 99.7 99.7 - 99.9 98.9 96.4 99.6 99.8 87.9 401,258 352,646
2009 91.9 99.0 99.6 99.7 - 99.9 98.9 96.3 99.4 99.8 86.5 419,245 362,696
2010 91.4 98.7 99.6 99.7 - 99.9 98.8 96.1 99.4 99.8 85.7 438,078 375,261
2011 90.6 98.9 99.6 99.7 99.3 99.6 98.8 96.0 99.5 99.7 84.5 489,783 414,108
2012 90.3 98.8 99.5 99.7 99.2 99.8 98.7 96.1 98.0 99.7 83.7 460,320 385,109
All 94.6 99.0 99.7 99.7 99.9 99.9 98.9 96.2 99.4 99.8 88.9 4,620,693 4,107,972
Covariates
Three county-level covariates were included in the small area models: percent rural house-
holds, poverty rate, and doctors per capita. Percent rural households was derived from the 
1990, 2000, and 2010 decennial censuses.2 Linear interpolation was used to estimate this 
variable in intercensal-years and the rate of change from 2000 to 2010 was used to project 
this variable for 2011 and 2012. The poverty rate was obtained from the Small Area Income 
and Poverty Estimates (SAIPE) series.3 Finally, the doctors per capita variable was obtained 
from the Area Health Resource File.4
Population estimates used for post-stratification
Age- and sex-specific county-level population counts by race, by marital status, by education, 
and by phone usage category (i.e., cell phone only, land line only, or dual) were used for post-
stratifying predictions from the small area models. Population counts by race were obtained 
from the National Center for Health Statistics (NCHS) Bridged-Race Files.5–7 Population counts 
by marital status and population counts by education status were obtained from the 19908,9 
and 200010,11 decennial censuses and from the 2004–2014 American Community Survey.12–13 
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Population counts by phone usage category were obtained by applying the proportions 
provided by Blumberg et al.14,15 to the population counts for all races combined from the 
NCHS Bridged-Race Files. Depending on population size, Blumberg et al. provides estimates 
for single counties, groups of counties, or at the state-level. For each county, we used the 
most geographically precise estimate available which included that county.
Additional data sources
We used the county adjacency file16 from the 2010 census to define the neighborhood struc-
ture used for spatial random effects in the small area model. We used the distribution of the 
total population in the 2010 census17 to derive weights used for age-standardizing outcome 
measures. Finally, we used census bureau records of significant county boundary changes18 
to create historically stable county units for analysis.
Model validation
High fasting plasma glucose/A1C model 
We used cross-validation to assess the predictive performance of the high FPG/A1C models. 
First, the NHANES data was randomly split into a training set (80%) and a testing set (20%). 
Second, the model was fit on the training set and predictions were derived from the fitted 
model for respondents in the testing set. Finally, performance was assessed by comparing 
the predictions to the true values for respondents in the testing set. This procedure was 
repeated 100 times and then the concordance (the proportion of individuals correctly clas-
sified), sensitivity (the proportion of true cases that are identified as cases), and specificity 
(the proportion of true negatives that are identified as negative) were calculated across all 
repetitions.
The results of this validation exercise are given in Table S3. The high FPG/A1C models for 
both previously diagnosed and previously undiagnosed respondents had reasonably high 
specificity and overall concordance, but low sensitivity. This suggests that the variables in-
cluded in this model, while predictive, do not explain all variation in risk. This is unsurprising; 
while we are able to capture the effect of a number of demographic characteristics as well as 
some basic health behaviors and resources, there are many other important factors, notably 
familial history and treatment (among those previously diagnosed), which we are not able to 
incorporate.
Small area model
We assessed the performance of the small area models using a validation framework similar 
to that proposed by Srebotnjak et al.19 First, we identified counties with at least 900 male and 
900 female respondents in any given 5-year period. These counties formed our ‘validation set’ 
and we calculated direct (design-based) estimates for these counties using the data pooled 
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over 5-years which we treated as an empirical gold standard. Second, we created testing 
data sets by sampling a set number of respondents from each county in the validation set 
to mimic smaller counties with smaller sample sizes. Specifically, we created ten testing data 
sets each for sample sizes of 1, 10, 50, and 100 respondents of each sex in each year. Next we 
fit the small area model using the testing data sets and generated predictions for all counties 
in the validation set. Finally, we compared the model predictions to the gold standard to 
assess performance. Performance was characterized in terms of the root mean squared error, 
mean error, mean absolute error, and correlation coefficient.
Table S3. High FPG/A1C model validation results.
Population Sex Specificity Sensitivity Concordance
Previously diagnosed
Males 93.3 12.9 87.6
Females 95.7 11.4 91.9
Both 94.6 12.3 89.9
Not previously diagnosed
Males 93.4 13.2 87.8
Females 95.7 11.2 91.8
Both 94.6 12.3 89.9
Table S4 presents the results of this validation analysis alongside the same performance 
metrics calculated in sample (i.e., when models are fit using all respondents). The small area 
models for diagnosed diabetes perform well, with minimal bias (as measured by the mean 
error) and reasonable precision (as measured by the root mean squared error and mean 
absolute error). As expected, performance, particularly in terms of precision, is better the 
larger the sample available.
Table S4. SAE model validation results.
Sample size
root mean squared 
error
Mean error
Mean absolute 
error
Correlation 
coefficient
1 1.39 -0.33 1.04 0.75
10 1.22 -0.34 0.96 0.80
50 1.07 -0.26 0.84 0.85
100 0.99 -0.24 0.77 0.87
In sample 0.85 -0.20 0.65 0.91
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ABSTrACT
Importance
County-level patterns in mortality rates by cause have not been systematically described but 
are potentially useful for public health officials, clinicians, and researchers seeking to improve 
health and reduce geographic disparities.
Objectives
To demonstrate the use of a novel method for county-level estimation and to estimate annual 
mortality rates by US county for 21 mutually exclusive causes of death from 1980 through 
2014.
Design, setting, and participants 
Redistribution methods for garbage codes (implausible or insufficiently specific cause of 
death codes) and small area estimation methods (statistical methods for estimating rates in 
small subpopulations) were applied to death registration data from the National Vital Statis-
tics System to estimate annual county-level mortality rates for 21 causes of death. These esti-
mates were raked (scaled along multiple dimensions) to ensure consistency between causes 
and with existing national-level estimates. Geographic patterns in the age-standardized 
mortality rates in 2014 and in the change in the age-standardized mortality rates between 
1980 and 2014 for the 10 highest-burden causes were determined.
exposure 
County of residence.
Main outcomes and measures 
Cause-specific age-standardized mortality rates.
results 
A total of 80,412,524 deaths were recorded from January 1, 1980, through December 31, 2014, 
in the United States. Of these, 19.4 million deaths were assigned garbage codes. Mortality 
rates were analyzed for 3,110 counties or groups of counties. Large between-county dispari-
ties were evident for every cause, with the gap in age-standardized mortality rates between 
counties in the 90th and 10th percentiles varying from 14.0 deaths per 100,000 population 
(cirrhosis and chronic liver diseases) to 147.0 deaths per 100,000 population (cardiovascu-
lar diseases). Geographic regions with elevated mortality rates differed among causes: for 
example, cardiovascular disease mortality tended to be highest along the southern half of 
the Mississippi River, while mortality rates from self-harm and interpersonal violence were 
elevated in southwestern counties, and mortality rates from chronic respiratory disease were 
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highest in counties in eastern Kentucky and western West Virginia. Counties also varied widely 
in terms of the change in cause-specific mortality rates between 1980 and 2014. For most 
causes (eg, neoplasms, neurological disorders, and self-harm and interpersonal violence), 
both increases and decreases in county-level mortality rates were observed.
Conclusions and relevance 
In this analysis of US cause-specific county-level mortality rates from 1980 through 2014, 
there were large between-county differences for every cause of death, although geographic 
patterns varied substantially by cause of death. The approach to county-level analyses with 
small area models used in this study has the potential to provide novel insights into US 
disease-specific mortality time trends and their differences across geographic regions.
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InTrODUCTIOn
Recent research has highlighted large, long-standing, and increasing geographic inequali-
ties in life expectancy among counties within the United States.1,2 However, relatively little is 
known about geographic patterns and inequalities in mortality by underlying cause of death. 
Information about variation in cause-specific mortality could provide important insights into 
geographic inequalities and divergent trends in life expectancy. Moreover, local information 
about cause-specific mortality rates could be used by policy makers, clinicians, and public 
health professionals to inform more targeted strategies to improve health and survival and 
to decrease geographic inequalities in the United States.
Previous efforts3–8 to generate country-wide county-level estimates of cause-specific mortal-
ity have generally focused on only a single cause or group of closely related causes. The cause 
definitions used by these analyses vary widely (ie, the specific cause of death codes included 
for a given cause varies by analysis) as do the periods considered and the statistical methods 
used. Consequently, it is difficult to compare across causes that were analyzed separately. 
Furthermore, to our knowledge, no previous study of county-level cause-specific mortality 
has attempted to correct for the presence of garbage codes, that is, cause of death codes 
in death registration data that are implausible or insufficiently specific.9 The proportion of 
registered deaths that are assigned garbage codes varies by county, year, and underlying 
true cause, and a failure to appropriately redistribute these deaths may lead to erroneous 
conclusions about geographic patterns, time trends, and the relative burden of different 
causes of death.
This study presents a novel method using garbage code redistribution methods (methods 
for reassigning garbage codes) and small area estimation methods (statistical methods for 
estimating rates among small subpopulations) for estimating county-level cause-specific 
mortality rates.
MeTHODS
Data 
This analysis used deidentified death records from the National Vital Statistics System provid-
ed by the National Center for Health Statistics.10 These records covered deaths that occurred 
within the United States from January 1, 1980, through December 31, 2014, and included 
the age, sex, and county of residence at the time of death for each decedent, as well as the 
registered underlying cause of death, coded according to the International Classification of 
Diseases, Ninth Revision (ICD-9) for deaths prior to 1999 and ICD-10 for deaths that occurred in 
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1999 or later.11,12 Deaths were tabulated by age group (0, 1–4, 5–9, 10–14, …, 75–79, and ≥80 
years), sex, county, year, and cause. This research received institutional review board approval 
from the University of Washington. Informed consent was not required because the study 
used deidentified data and was retrospective.
Annual county-level population counts by age, sex, and race from 1980 to 1989 provided 
by the US Census Bureau and annual county-level population counts by age, sex, and race/
ethnicity from 1990 to 2014 provided by the National Center for Health Statistics were used 
in this analysis.13–16 Population counts in both series were summed across all race/ethnicity 
groups to generate annual county-level population counts by age group and sex. These 2 
sources were then combined to produce a time series covering 1980 through 2014 and scaled 
to match the total population in each year provided by the Human Mortality Database.17
County-level covariates on levels of education, income, race/ethnicity, Native American 
reservations, and population density were used in the small area estimation model. These 
covariates were based on data provided by the US Census Bureau and the National Center 
for Health Statistics. Covariates related to race and ethnicity were derived from self-reported 
responses to the decennial census and American Community Survey and use the categories 
specified by the Office of Management and Budget.18 More details on these data sources are 
provided in eTable 1 in the Supplement.
In a small number of cases, county boundaries shifted between 1980 and the present. To 
account for these changes, several counties were merged to create historically stable units. 
Details on the merged county units are provided in eTable 2 in the Supplement. For simplic-
ity, these units are referred to as counties throughout.
Cause list and garbage code redistribution 
The cause list developed for the Global Burden of Disease Study (GBD)19 was used for this 
analysis; it has been widely used for cause of death analyses.20,21 The GBD cause list is ar-
ranged hierarchically in 4 levels; within each level, the cause list is designed such that all 
deaths are assigned exactly 1 cause. As part of the GBD study, a map has been developed that 
allows ICD-9 and ICD-10 codes to be translated to GBD causes; eTable 3 in the Supplement 
lists all causes in the GBD cause list and the ICD-9 and ICD-10 codes that contributed to each 
cause. This analysis focuses on the 21 causes in the second level of this hierarchy (Box). This 
level was selected because major causes of death (eg, neoplasms, cardiovascular diseases) 
are distinguished but the number of causes is still relatively small, making it possible to 
consider all causes.
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Previous studies9 have documented the high proportion of registered deaths for which the 
underlying cause of death has been assigned a garbage code, that is, a code that refers to 
an intermediate or immediate cause of death rather than an underlying cause of death (eg, 
cardiopulmonary arrest) or a code that is insufficiently specific (eg, malignant neoplasm of 
other and ill-defined sites). Failure to appropriately redistribute garbage codes can lead to 
erroneous geographic and temporal patterns (as the proportion of deaths with garbage 
codes varies over time and place) as well as incorrect relative rankings among causes (as the 
likelihood that a death is assigned a garbage code varies by true underlying cause).
To address this issue, algorithms developed for the GBD study to redistribute deaths assigned 
garbage codes were used.19,21 First, specific garbage codes or groups of related garbage 
codes were assigned biologically plausible target causes. Second, deaths assigned garbage 
codes were redistributed to the target causes according to proportions derived in one of 4 
ways: (1) published literature and/or expert opinion; (2) regression models linking changes 
in the proportion of deaths assigned to a given garbage code and those assigned to a given 
target code; (3) according to the proportions initially observed among the targets; and (4) 
for deaths with certain codes known to be related to human immunodeficiency virus (HIV)/
AIDS, the mortality rate in each 5-year period was compared with that in 1980 and deaths 
beyond a 5% increase were assigned to HIV/AIDS, while the remainder were assigned to a 
different biologically plausible target. More details on each of these methods are provided in 
the eAppendix in the Supplement.
As an example, 62 deaths among men in King County, Washington, were coded to unspeci-
fied heart disease in 2013. Based on the garbage code redistribution algorithms, 48 of these 
deaths were reassigned to ischemic heart disease, 3 to hypertensive heart disease, 2 to atrial 
fibrillation and flutter, 3 to cardiomyopathy and myocarditis, 1 to rheumatic heart disease, 
1 to endocarditis, and 4 to other cardiovascular and circulatory diseases. eFigure 1 in the 
Supplement depicts graphically how garbage code redistribution affects all cardiovascular 
diseases in King County. eFigure 2 and eFigure 3 in the Supplement show the percentage of 
deaths assigned garbage codes in each county and the effect of garbage code redistribution 
on total deaths by cause for the United States as a whole, respectively.
Mapping from ICD-9 and ICD-10 to the GBD cause list and redistribution of garbage codes 
were carried out at the lowest levels of the GBD cause hierarchy. Deaths were then aggre-
gated to the first and second levels of the cause hierarchy.
Statistical analysis 
Bayesian spatially explicit mixed-effects regression models for all-cause mortality and each 
cause in level 1 and level 2 of the GBD cause hierarchy were estimated separately for males 
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and females. The model included the following covariates: the proportion of the adult popu-
lation who has graduated high school; the proportion of the population that is Hispanic; 
the proportion of the population that is black; the proportion of the population that is a 
race other than black or white; the proportion of a county that is contained within a state or 
federal Native American reservation; the median household income; and the population den-
sity. These covariates were chosen because they are well measured at the county level and 
expected to be predictive of county-level mortality rates. Further details about this model are 
provided in the eAppendix in the Supplement.
One thousand draws (ie, simulated values) of each model parameter were sampled from 
the posterior distribution and used to derive draws of the mortality rate for each county, 
year, and age group. To ensure internal consistency between estimates of all-cause mortality 
and cause-specific mortality as well as consistency with national-level estimates from the 
GBD study (which incorporate prevalence data for causes such as atrial fibrillation, as well as 
Alzheimer disease and other dementias, that cannot be used directly at the county level), the 
estimated mortality rates were raked (ie, scaled along multiple dimensions)22 such that the 
sum across all causes equaled the estimated all-cause mortality rate and that the population-
weighted average of the county-level mortality rates equaled the national-level mortality 
rate for each cause (further details are provided in the eAppendix in the Supplement). After 
raking, state- and national-level estimates of the age-specific mortality rates were derived 
by population weighting the county-level estimates, and estimates at the county, state, and 
national levels were age standardized using the US 2010 census population as the standard. 
Similarly, years of life lost (YLLs) were calculated for each age group by multiplying the mor-
tality rate by population by life expectancy at the average age at death from the reference 
life table used in the GBD study19 and then summed across all ages (additional details are 
provided in the eAppendix in the Supplement).
Point estimates for each quantity of interest were derived from the mean of the draws, while 
95% uncertainty intervals (UIs) were derived from the 2.5th and 97.5th percentiles. When 
measuring changes over time, the change was considered statistically significant if the poste-
rior probability of an increase (or decrease) was at least 95%, ie, if the mortality rate increased 
(or declined) in at least 95% of the draws.
The performance of the small area models was evaluated using an established empirical vali-
dation framework designed specifically for the United States.23,24 This validation framework 
was used to compare performance of 4 variants of the model described earlier as well as 2 
previously published models1,24 in terms of bias, precision, and coverage. The selected model 
consistently performed as well as or better than all other models. More details about the 
validation methods and results are included in the eAppendix in the Supplement.
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Box. Level 1 and 2 causes of death in the Global Burden of Disease hierarchy.
Communicable, Maternal, neonatal, and nutritional Diseases (Level 1)
HIV/AIDS and tuberculosis (level 2): tuberculosis; HIV/AIDS
Diarrhea, lower respiratory, and other common infectious diseases (level 2): diarrheal diseases; intestinal 
infectious diseases; lower respiratory tract infections; upper respiratory tract infections; otitis media; meningitis; 
encephalitis; diphtheria; whooping cough; tetanus; measles; varicella-zoster virus infection; herpes zoster
neglected tropical diseases and malaria (level 2): malaria; Chagas disease; leishmaniasis; African trypanoso-
miasis; schistosomiasis; cysticercosis; cystic echinococcosis; dengue; yellow fever; rabies; intestinal nematode in-
fections; other neglected tropical diseases; Ebola
Maternal disorders (level 2): maternal hemorrhage; maternal sepsis and other maternal infections; maternal hy-
pertensive disorders; maternal obstructed labor and uterine rupture; maternal abortion, miscarriage, and ectopic 
pregnancy; indirect maternal deaths; late maternal deaths; other maternal disorders; maternal deaths aggravated 
by HIV/AIDS
neonatal disorders (level 2): neonatal preterm birth complications; neonatal encephalopathy due to birth as-
phyxia and trauma; neonatal sepsis and other neonatal infections; hemolytic disease and other neonatal jaun-
dice; other neonatal disorders
nutritional deficiencies (level 2): protein-energy malnutrition; iodine deficiency; iron deficiency anemia; other 
nutritional deficiencies
Other communicable, maternal, neonatal, and nutritional diseases (level 2): sexually transmitted diseases 
excluding HIV; hepatitis; other infectious diseases
noncommunicable Diseases (Level 1)
neoplasms (level 2): esophageal cancer; stomach cancer; liver cancer; larynx cancer; tracheal, bronchus, and 
lung cancer; breast cancer; cervical cancer; uterine cancer; prostate cancer; colon and rectal cancer; lip and oral 
cavity cancer; nasopharynx cancer; other pharynx cancer; gallbladder and biliary tract cancer; pancreatic cancer; 
malignant skin melanoma; nonmelanoma skin cancer; ovarian cancer; testicular cancer; kidney cancer; bladder 
cancer; brain and nervous system cancer; thyroid cancer; mesothelioma; Hodgkin lymphoma; non-Hodgkin lym-
phoma; multiple myeloma; leukemia; other neoplasms
Cardiovascular diseases (level 2): rheumatic heart disease; ischemic heart disease; cerebrovascular disease; hy-
pertensive heart disease; cardiomyopathy and myocarditis; atrial fibrillation and flutter; aortic aneurysm; periph-
eral vascular disease; endocarditis; other cardiovascular and circulatory diseases
Chronic respiratory diseases (level 2): chronic obstructive pulmonary disease; pneumoconiosis; asthma; inter-
stitial lung disease and pulmonary sarcoidosis; other chronic respiratory diseases
Cirrhosis and other chronic liver diseases (level 2): cirrhosis and other chronic liver diseases
Digestive diseases (level 2): Peptic ulcer disease; gastritis and duodenitis; appendicitis; paralytic ileus and in-
testinal obstruction; inguinal, femoral, and abdominal hernia; inflammatory bowel disease; vascular intestinal 
disorders; gallbladder and biliary diseases; pancreatitis; other digestive diseases
neurological disorders (level 2): Alzheimer disease and other dementias; Parkinson disease; epilepsy; multiple 
sclerosis; motor neuron disease; other neurological disorders
Mental and substance use disorders (level 2): schizophrenia; alcohol use disorders; drug use disorders; eating 
disorders
Diabetes, urogenital, blood, and endocrine diseases (level 2): diabetes mellitus; acute glomerulonephritis; 
chronic kidney disease; urinary diseases and male infertility; gynecological diseases; hemoglobinopathies and 
hemolytic anemias; endocrine, metabolic, blood, and immune disorders
Musculoskeletal disorders (level 2): rheumatoid arthritis; other musculoskeletal disorders
Other noncommunicable diseases (level 2): congenital anomalies; skin and subcutaneous diseases; sudden 
infant death syndrome
Injuries (Level 1)
Transport injuries (level 2): road injuries; other transport injuries
Unintentional injuries (level 2): falls; drowning; fire, heat, and hot substances; poisonings; exposure to me-
chanical forces; adverse effects of medical treatment; animal contact; foreign body; other unintentional injuries; 
environmental heat and cold exposure
Self-harm and interpersonal violence (level 2): self-harm; interpersonal violence
forces of nature, war, and legal intervention (level 2): exposure to forces of nature; collective violence and 
legal intervention
Abbreviation: HIV, human immunodeficiency virus.
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Inequality among counties was quantified by comparing the mortality rate in the 90th 
percentile with the mortality rate in the 10th percentile among all counties in a given year. 
Two types of inequality were considered. Absolute inequality, which represents the absolute 
magnitude of the gap between high- and low-mortality counties, was quantified as the dif-
ference between the mortality rates in the 90th and 10th percentiles. Relative inequality, 
which represents the relative difference between high- and low-mortality counties, was 
quantified as the ratio of the mortality rate in the 90th percentile to the mortality rate in the 
10th percentile.
Garbage code redistribution was carried out in Python version 2.7.3 (Python Software Foun-
dation) and Stata MP version 13.1 (StataCorp LP) statistical software. Small area estimation 
was carried out in R version 3.2.4 statistical software (R Foundation for Statistical Computing). 
Models were fit using the Template Model Builder Package in R.25
reSULTS
A total of 80,412,524 deaths among US residents were recorded from January 1, 1980, through 
December 31, 2014. Of these, 19.4 million deaths were assigned garbage codes. Most of these 
deaths (17.8 million) were assigned codes referring to intermediate or unspecified causes 
presumably within the same ICD-9 or ICD-10 chapter as the true underlying cause (9.1 million 
in the cardiovascular diseases chapter; 2.9 million in the respiratory diseases chapter; 1.7 
million in the cancer chapter; 1.1 million in the injuries chapter; 1.0 million in the infectious 
diseases chapter; and 1.9 million in other chapters), while the remaining 1.7 million deaths 
(2.1% of all deaths) were assigned ill-defined codes. Of the 19.4 million deaths assigned 
garbage codes, 19.1% were reassigned using published literature, 44.7% were reassigned 
using regression methods, 35.6% were reassigned using observed proportions among target 
codes, and 0.6% were reassigned to HIV/AIDS or other targets based on comparison with 
1980. As a result of merging counties to address historical boundary changes, the number of 
areas analyzed was 3,110 (compared with 3,142).
The Table summarizes the results for all 21 causes of death in 2014 at the national and county 
levels. The first section summarizes the burden of each cause at the national level: for ex-
ample, there were 846.3 thousand deaths and 11,735.8 thousand YLLs from cardiovascular 
diseases in 2014, with a mortality rate of 252.7 deaths per 100,000 population. The second 
section summarizes the distribution of counties according to the age-standardized mortal-
ity rate from each cause: for example, the lowest mortality rate from neoplasms was 70.7 
deaths per 100,000 population, compared with 169.5, 204.3, and 246.3 deaths per 100,000 
population in counties in the 10th, 50th, and 90th percentiles, respectively, and 503.1 deaths 
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per 100,000 population in the county with the highest rate. This corresponds to an absolute 
difference of 76.8 deaths per 100,000 population between the mortality rates in counties in 
the 90th and 10th percentiles.
The Figures in the article show the top 10 causes (in terms of YLLs) and eFigures 4–14 in the 
Supplement show the other 11 causes. Estimates for all causes and years are available in an 
online data visualization tool (Interactive).
neoplasms 
Neoplasms (Figure 1) caused 19,511,910 deaths (24.3% of all deaths) from 1980 through 2014 
and were the leading cause of YLLs and the second leading cause of deaths in 2014. The 
mortality rate from neoplasms varied widely among counties: counties in the 90th percentile 
experienced mortality rates 76.8 deaths per 100,000 population higher than those in the 10th 
percentile. Very high mortality rates were observed in counties along the southern half of 
the Mississippi River, in eastern Kentucky and western West Virginia, and in western Alaska. 
At the other extreme, many counties in states stretching from Idaho and Wyoming in the 
north to western Texas in the south had mortality rates from neoplasms much lower than 
average. The mortality rate from neoplasms declined by 20.1% (95% UI, 18.2%–21.4%) overall 
between 1980 and 2014, but the mortality rate increased during the same period in 18.5% of 
counties (statistically significant in 5.1% of counties). Increases in mortality from neoplasms 
were found primarily in south-central counties, with the largest increases observed in eastern 
Kentucky. In contrast, the largest decreases in mortality from neoplasms were found primar-
ily in counties in central Colorado, southern Florida, Alaska, parts of New England, and coastal 
counties in California.
Cardiovascular diseases 
Cardiovascular diseases (Figure 2) caused 31,992,547 deaths (39.8%) from 1980 through 
2014 and were the second leading cause of YLLs and the leading cause of deaths in 2014. 
Cardiovascular diseases were an important contributor to mortality in every county: in 2014, 
cardiovascular diseases were the leading cause of death in 97.1% of counties and the top-
ranked cause in terms of the age-standardized mortality rate in 98.5% of counties. However, 
the rate of death from cardiovascular diseases was far from uniform, with rates among coun-
ties in the 90th percentile 147.0 deaths per 100,000 population higher than rates among 
counties in the 10th percentile. The highest rates in 2014 were observed in counties in a band 
stretching from Oklahoma to Mississippi and in eastern Kentucky. Conversely, the lowest 
rates were observed in counties in central Colorado and near the border of Idaho, Montana, 
and Wyoming. Between 1980 and 2014, cardiovascular disease mortality decreased by 50.2% 
(95% UI, 49.5%–50.8%) overall. However, while nearly every county experienced a decline in 
cardiovascular disease mortality during this period (statistically significant in 99.9% of coun-
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per 100000 population in the county with the highest rate.
This corresponds to an absolute difference of 76.8 deaths per
100000 population between the mortality rates in counties
in the 90th and 10th percentiles.
TheFigures in the article show the top 10 causes (in terms
of YLLs) and eFigures 4-14 in the Supplement show the other
11 causes. Estimates for all causes andyears are available in an
online data visualization tool (Interactive).
Neoplasms
Neoplasms (Figure 1) caused 19 511 910 deaths (24.3% of all
deaths) from 1980 through 2014 and were the leading cause
of YLLs and the second leading cause of deaths in 2014. The
mortality rate from neoplasms varied widely among coun-
ties: counties in the90thpercentileexperiencedmortality rates
76.8 deaths per 100000 population higher than those in the
10th percentile. Very high mortality rates were observed in
counties along the southern half of the Mississippi River, in
eastern Kentucky and western West Virginia, and in western
Alaska. At the other extreme,many counties in states stretch-
ing from Idaho andWyoming in the north towestern Texas in
thesouthhadmortality rates fromneoplasmsmuch lower than
average.Themortality rate fromneoplasmsdeclinedby20.1%
(95%UI, 18.2%-21.4%)overall between 1980and2014, but the
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figure 1. County-level mortality from neoplasms. 
A, Age-standardized mortality rate for both sexes combined in 2014. B, Percent change in the age-standardized mortal-
ity rate for both sexes combined between 1980 and 2014. A and B, The color scale is truncated at approximately the first 
and 99th percentiles as indicated by the range given in the color scale. C, Age-standardized mortality rate in 1980, 1990, 
2000, and 2014. The bottom border, middle line, and top border of the boxes indicate the 25th, 50th, and 75th percentiles, 
respectively, across all counties; whiskers, the full range across counties; and circles, the national-level rate.
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mortality rate increased during the same period in 18.5% of
counties (statistically significant in 5.1% of counties). In-
creases inmortality from neoplasms were found primarily in
south-central counties, with the largest increases observed
in easternKentucky. In contrast, the largest decreases inmor-
tality fromneoplasmswere foundprimarily in counties in cen-
tral Colorado, southernFlorida,Alaska, parts ofNewEngland,
and coastal counties in California.
Cardiovascular Diseases
Cardiovascular diseases (Figure 2) caused 31 992 547 deaths
(39.8%) from 1980 through 2014 andwere the second leading
cause of YLLs and the leading cause of deaths in 2014. Cardio-
vasculardiseaseswerean important contributor tomortality in
every county: in 2014, cardiovascular diseases were the lead-
ingcauseofdeath in97.1%ofcountiesandthetop-rankedcause
in terms of the age-standardized mortality rate in 98.5% of
counties. However, the rate of death from cardiovascular dis-
eases was far from uniform, with rates among counties in the
90thpercentile147.0deathsper100000populationhigherthan
rates among counties in the 10th percentile. The highest rates
in 2014 were observed in counties in a band stretching from
Oklahoma toMississippi and in eastern Kentucky. Conversely,
the lowest rateswere observed in counties in central Colorado
Figure 2. County-Level Mortality From Cardiovascular Diseases
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figure 2. County-level mortality from cardiovascular diseases. 
A, Age-standardized mortality rate for both sexes combined in 2014. The color scale is truncated at approximately the first 
and 99th percentiles as indicated by the range given in the color scale. B, Percent change in the age-standardized mortality 
rate for both sexes combined between 1980 and 2014. The color scale is truncated at the first percentile but not at the 99th 
percentile, to avoid combining counties with decreases in the mortality rate and counties with increases in the mortality 
rate into a single group. C, Age-standardized mortality rate in 1980, 1990, 2000, and 2014. The bottom border, middle line, 
and top border of the boxes indicate the 25th, 50th, and 75th percentiles, respectively, across all counties; whiskers, the full 
r nge acr ss counties; and circles, the national-level rate.
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ties), the rate of decline was highly variable. Particularly slow rates of improvement were 
observed in many of the same counties in the band of south-central states stretching from 
Oklahoma to Alabama and Kentucky that had the highest mortality rates in 2014.
Diabetes, urogenital, blood, and endocrine diseases 
Diabetes, urogenital, blood, and endocrine diseases (Figure 3) caused 4,909,377 deaths 
(6.1%) from 1980 through 2014 and were the third leading cause of YLLs and fourth leading 
cause of deaths in 2014. In 2014, there was a difference of 41.2 deaths per 100,000 population 
in the mortality rates from these diseases between counties in the 90th and 10th percentiles. 
Counties throughout much of the south and mid-Atlantic had mortality rates that were 
higher than average. Mortality rates were particularly high in counties in Arkansas, Louisiana, 
and Mississippi along the Mississippi River and in counties in North Dakota and South Dakota 
with Native American reservations. The mortality rate from this cause increased by 21.0% 
(95% UI, 16.9%–24.9%) overall between 1980 and 2014. Similarly, 91.5% of counties had an 
increase in mortality rates from these diseases (statistically significant in 84.8% of counties). 
However, pockets of counties in Maryland, central Colorado, and north and western Alaska 
as well as individual counties throughout the rest of the country experienced declines in 
mortality from this cause during the same period.
neurological disorders 
Neurological disorders (Figure 4) caused 3,971,426 deaths (4.9%) between 1980 and 2014 
and were the fourth leading cause of YLLs and the third leading cause of deaths in 2014. In 
2014, counties in the 90th percentile had mortality rates 55.7 deaths per 100,000 popula-
tion higher than counties in the 10th percentile. Compared with most of the other causes 
considered, broad regional geographic trends were less prominent and there was more local 
geographic heterogeneity: counties with relatively high and relatively low mortality rates 
from neurological disorders were found throughout the country. Between 1980 and 2014, 
the mortality rate from neurological disorders increased by 18.7% (95% UI, 15.7%–21.9%) 
overall. Most counties (76.2%) experienced an increase during this period (statistically signifi-
cant in 61.8%), and especially large increases were observed in southern counties stretching 
from eastern Texas and Oklahoma to Alabama. Notable declines in mortality were found in 
counties in the west stretching from central Idaho and western Montana to central Colorado.
Self-harm and interpersonal violence 
Self-harm and interpersonal violence (Figure 5) caused 2,049,835 deaths (2.5%) between 
1980 and 2014 and were the fifth leading cause of YLLs and the eighth leading cause of 
deaths in 2014. In 2014, counties in the 90th percentile had mortality rates 15.9 deaths per 
100,000 population higher than counties in the 10th percentile. The highest mortality rates 
were observed in counties in Alaska, in Native American reservations in North Dakota and 
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and near the border of Idaho, Montana, and Wyoming. Be-
tween 1980 and 2014, cardiovascular disease mortality de-
creased by 50.2% (95% UI, 49.5%-50.8%) overall. However,
while nearly every county experienced a decline in cardiovas-
cular disease mortality during this period (statistically signifi-
cant in 99.9% of counties), the rate of decline was highly vari-
able. Particularly slow rates of improvementwere observed in
many of the same counties in the band of south-central states
stretching from Oklahoma to Alabama and Kentucky that had
the highest mortality rates in 2014.
Diabetes, Urogenital, Blood, and Endocrine Diseases
Diabetes, urogenital, blood, andendocrinediseases (Figure 3)
caused 4909377 deaths (6.1%) from 1980 through 2014 and
were the third leading cause of YLLs and fourth leading cause
ofdeaths in2014. In2014, therewasadifferenceof41.2deaths
per 100000 population in themortality rates from these dis-
eases between counties in the 90th and 10th percentiles.
Counties throughoutmuchof the south andmid-Atlantic had
mortality rates that were higher than average.Mortality rates
wereparticularly high in counties inArkansas, Louisiana, and
Figure 3. County-Level Mortality FromDiabetes, Urogenital, Blood, and Endocrine Diseases
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figure 3. County-level mortality from diabetes, urogenital, blood, and endocrine diseases. 
A, Age-standardized mortality rate for both sexes combined in 2014. B, Percent change in the age-standardized mortal-
ity rate for both sexes combined between 1980 and 2014. A and B, The color scale is truncated at approximately the first 
and 99th percentiles as indicated by the range given in the color scale. C, Age-standardized mortality rate in 1980, 1990, 
2000, and 2014. The bottom border, middle line, and top border of the boxes indicate the 25th, 50th, and 75th percentiles, 
respectively, across all counties; whiskers, the full range across counties; and circles, the national-level rate.
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Mississippi along the Mississippi River and in counties in
North Dakota and South Dakota with Native American reser-
vations. Themortality rate fromthis cause increasedby21.0%
(95%UI, 16.9%-24.9%) overall between 1980 and 2014. Simi-
larly, 91.5%of countieshadan increase inmortality rates from
these diseases (statistically significant in 84.8% of counties).
However, pockets of counties in Maryland, central Colorado,
and north and western Alaska as well as individual counties
throughout therestof thecountryexperienceddeclines inmor-
tality from this cause during the same period.
Neurological Disorders
Neurological disorders (Figure 4) caused 3 971 426 deaths
(4.9%) between 1980 and 2014 and were the fourth lead-
ing cause of YLLs and the third leading cause of deaths in
2014. In 2014, counties in the 90th percentile had mortality
rates 55.7 deaths per 100000 population higher than coun-
ties in the 10th percentile. Compared with most of the other
causes considered, broad regional geographic trends were
less prominent and there was more local geographic hetero-
geneity: counties with relatively high and relatively low
Figure 4. County-Level Mortality FromNeurological Disorders
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figure 4. County-level mortality from neurological disorders. 
A, Age-standardized mortality rate for both sexes combined in 2014. B, Percent change in the age-standardized mortal-
ity rate for both sexes combined between 1980 and 2014. A and B, The color scale is truncated at approximately the first 
and 99th percentiles as indicated by the range given in the color scale. C, Age-standardized mortality rate in 1980, 1990, 
2000, and 2014. The bottom border, middle line, and top border of the boxes indicate the 25th, 50th, and 75th percentiles, 
respectively, across all counties; whiskers, the full range across counties; and circles, the national-level rate.
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mortality rates from neurological disorders were found
throughout the country. Between 1980 and 2014, the mortal-
ity rate from neurological disorders increased by 18.7%
(95% UI, 15.7%-21.9%) overall. Most counties (76.2%) experi-
enced an increase during this period (statistically significant
in 61.8%), and especially large increases were observed
in southern counties stretching from eastern Texas and
Oklahoma to Alabama. Notable declines in mortality were
found in counties in the west stretching from central Idaho
and western Montana to central Colorado.
Self-harm and Interpersonal Violence
Self-harm and interpersonal violence (Figure 5) caused
2049835 deaths (2.5%) between 1980 and 2014 andwere the
fifth leading cause of YLLs and the eighth leading cause of
deaths in 2014. In 2014, counties in the 90th percentile had
mortality rates 15.9deathsper 100000populationhigher than
counties in the10thpercentile.Thehighestmortality rateswere
observed in counties in Alaska, in Native American reserva-
tions in North Dakota and South Dakota, and in states in the
southwest,while lower rateswere found in theupperMidwest,
Figure 5. County-Level Mortality From Self-harm and Interpersonal Violence
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figure 5. County-level mortality from self-harm and interpersonal violence. 
A, Age-standardized mortality rate for both sexes combined in 2014. B, Percent change in the age-standardized mortal-
ity rate for both sexes combined between 1980 and 2014. A and B, The color scale is truncated at approximately the first 
and 99th percentiles as indicated by the range given in the color scale. C, Age-standardized mortality rate in 1980, 1990, 
2000, and 2014. The b ttom bord r, middle line, and top border of the boxes indicate the 25th, 50th, and 75th pe centiles, 
respectively, across all counties; whiskers, the full range across counties; and circles, the national-level rate.
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South Dakota, and in states in the southwest, while lower rates were found in the upper 
Midwest, New England, southwestern Texas, and southern California. The mortality rate from 
self-harm and interpersonal violence declined by 22.1% (95% UI, 18.9%–25.3%) overall be-
tween 1980 and 2014, but changes at the county level were highly variable, with substantial 
declines in counties in southern California, Texas, and states along the Atlantic coast from 
Florida to Virginia, while counties in Utah, Oklahoma and Kansas, along the Canadian border 
in North Dakota and Michigan, and parts of the Midwest and New England experienced simi-
larly substantial increases. In total, 48.8% of counties experienced declines in mortality from 
self-harm and interpersonal violence from 1980 to 2014, while 51.2% experienced increases 
(these changes were statistically significant in 29.0% and 25.7% of counties, respectively).
Chronic respiratory diseases 
Chronic respiratory diseases (Figure 6) caused 4,616,711 deaths (5.7%) between 1980 and 
2014 and were the sixth leading cause of YLLs and the fifth leading cause of deaths in 2014. 
As with other causes, there was substantial between-county variation in the mortality rate, 
with a difference of 41.1 deaths per 100,000 population between counties in the 90th and 
10th percentiles. Elevated mortality rates were observed in a prominent cluster in eastern 
Kentucky and West Virginia and in a second cluster in southeastern Colorado, while the lowest 
mortality rates were found in the Washington, DC, area, the upper Midwest, southern Florida, 
southern Texas, and central Colorado. Between 1980 and 2014, mortality rates increased in 
a majority of counties (93.2%; statistically significant in 88.3%), with particularly sizable in-
creases observed among counties in a band through the south from northern Texas to North 
Carolina and South Carolina. During the same period, a smaller number of counties, primarily 
along the Mexico border, in northwestern New Mexico, central Colorado, and southwestern 
Montana, near Washington, DC, and in eastern Pennsylvania, experienced moderate declines.
Transport injuries 
Transport injuries (Figure 7) caused 1,787,070 deaths (2.2%) between 1980 and 2014 and 
were the seventh leading cause of YLLs and the 11th leading cause of deaths in 2014. Coun-
ties in the 90th percentile experienced mortality rates 23.1 deaths per 100,000 population 
higher than counties in the 10th percentile. In general, lower mortality rates were found in 
more urban areas, while higher mortality rates were found in more rural areas. The mortal-
ity rate from transport injuries declined for the United States as a whole by 45.4% (95% UI, 
43.3%–47.5%) between 1980 and 2014. Most counties also experienced a decline during this 
period (98.5%; statistically significant in 93.6%), but to varying degrees. Counties in the cen-
tral United States generally saw smaller improvements, while counties in the west, northern 
Midwest, New England, and southern Florida experienced more substantial declines.
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New England, southwestern Texas, and southern California.
Themortality rate from self-harm and interpersonal violence
declinedby22.1%(95%UI, 18.9%-25.3%)overall between1980
and 2014, but changes at the county level were highly vari-
able, with substantial declines in counties in southern
California, Texas, and states along the Atlantic coast from
Florida to Virginia, while counties in Utah, Oklahoma and
Kansas, along the Canadian border in North Dakota and
Michigan, and parts of theMidwest andNewEngland experi-
enced similarly substantial increases. In total, 48.8%of coun-
ties experienced declines inmortality from self-harm and in-
terpersonal violence from 1980 to 2014, while 51.2%
experienced increases (these changes were statistically sig-
nificant in 29.0% and 25.7% of counties, respectively).
Chronic Respiratory Diseases
Chronic respiratorydiseases (Figure6) caused4616711deaths
(5.7%)between1980and2014andwere thesixth leadingcause
of YLLs and the fifth leading cause of deaths in 2014. As with
other causes, there was substantial between-county varia-
tion in the mortality rate, with a difference of 41.1 deaths per
100000populationbetweencounties in the90thand10thper-
centiles. Elevated mortality rates were observed in a promi-
nent cluster in eastern Kentucky and West Virginia and in a
Figure 6. County-Level Mortality From Chronic Respiratory Diseases
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figure 6. County-level mortality from chronic respiratory diseases. 
A, Age-standardized mortality rate for both sexes combined in 2014. B, Percent change in the age-standardized mortal-
ity rate f  both sexes combined between 1980 a d 2014. A a d B, The color scale s truncated at approximately the first 
and 99th percentiles as indicated by the range given in the color scale. C, Age-standardized mortality rate in 1980, 1990, 
2000, and 2014. The bottom border, middle line, and top border of the boxes indicate the 25th, 50th, and 75th percentiles, 
respectively, across all counties; whiskers, the full range across counties; and circles, the national-level rate.
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secondcluster in southeasternColorado,while the lowestmor-
tality rates were found in the Washington, DC, area, the up-
per Midwest, southern Florida, southern Texas, and central
Colorado. Between 1980 and 2014, mortality rates increased
in a majority of counties (93.2%; statistically significant in
88.3%), with particularly sizable increases observed among
counties in a band through the south from northern Texas to
North Carolina and SouthCarolina. During the sameperiod, a
smaller number of counties, primarily along the Mexico bor-
der, innorthwesternNewMexico, centralColorado, andsouth-
western Montana, near Washington, DC, and in eastern
Pennsylvania, experienced moderate declines.
Transport Injuries
Transport injuries (Figure 7) caused 1 787070 deaths (2.2%)
between 1980 and 2014 and were the seventh leading cause
of YLLs and the 11th leading cause of deaths in 2014. Coun-
ties in the 90th percentile experienced mortality rates 23.1
deaths per 100000 population higher than counties in the
10th percentile. In general, lower mortality rates were found
in more urban areas, while higher mortality rates were found
inmore rural areas. Themortality rate from transport injuries
declined for the United States as a whole by 45.4% (95% UI,
43.3%-47.5%) between 1980 and 2014. Most counties also
experienced a decline during this period (98.5%; statistically
Figure 7. County-Level Mortality From Transport Injuries
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Counties National
A, Age-standardizedmortality rate
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B, Percent change in the
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figure 7. County-level mortality from transport injuries. 
A, Age-standardized mor ality rate for both sexes combined in 2014. B, Pe cent change in the age-standardized mortal-
ity rate for both sexes combined between 1980 and 2014. A and B, T e color scale is truncated at approximately the first 
and 99th percentiles as indicated by the range given in the color scale. C, Age-standardized mortality rate in 1980, 1990, 
2000, and 2014. The bottom border, middle line, and top border of the boxes indicate the 25th, 50th, and 75th percentiles, 
respectively, across all counties; whiskers, the full range across counties; and circles, the national-level rate.
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Mental and substance use disorders 
Mental and substance use disorders (Figure 8) caused 814,391 deaths (1.0%) between 1980 
and 2014 and were ranked eighth in terms of YLLs and 12th in terms of deaths in 2014. Mor-
tality rates among counties in the 90th percentile were 15.0 deaths per 100,000 population 
higher than among counties in the 10th percentile. Exceptionally high mortality rates were 
found in a cluster of counties in eastern Kentucky and southwestern West Virginia; in counties 
in North Dakota, South Dakota, and southwestern states with Native American reservations; 
and in Alaska. Conversely, the lowest rates in 2014 were found primarily in counties in 
Nebraska, Iowa, and eastern South Dakota. The mortality rate due to mental and substance 
use disorders increased by 188% (95% UI, 160%–207%) overall between 1980 and 2014 and 
also increased in nearly every county (99.1%; statistically significant in 96.2%). However, the 
amount of increase varied dramatically across counties. In particular, there were several clus-
ters of counties (in Kentucky, West Virginia, Ohio, Indiana, western Pennsylvania, and east-
central Missouri) where mortality rates increased by more than 1,000% during this period.
Cirrhosis and other chronic liver diseases 
Cirrhosis and other chronic liver diseases (Figure 9) caused 1,506,985 deaths (1.9%) between 
1980 and 2014 and were the ninth-ranked cause of YLLs and deaths in 2014. At the county 
level, mortality rates in the 90th percentile were 14.0 deaths per 100,000 population higher 
than mortality rates in the 10th percentile. Counties in eastern Arizona, New Mexico, and 
south and western Texas and in selected counties in Colorado, Nevada, Wyoming, Montana, 
North Dakota, and South Dakota had the highest mortality rates, while counties in eastern 
South Dakota and Kansas as well as in Iowa and southern Minnesota had the lowest mortality 
rates. Between 1980 and 2014, the mortality rate from this cause declined by 15.6% (95% 
UI, 9.1%–26.9%) overall but increased in 69.6% of counties (statistically significant in 25.9%), 
with particularly large increases in southwestern Oregon and northwestern Texas.
Diarrhea, lower respiratory, and other common infectious diseases 
Diarrhea, lower respiratory, and other common infectious diseases (Figure 10) were responsible 
for 3,234,692 deaths (4.0%) between 1980 and 2014 and were the 10th leading cause of YLLs 
and the sixth leading cause of deaths in 2014. Counties in the 90th percentile experienced 
mortality rates 25.8 deaths per 100,000 population higher than those in the 10th percentile. 
Mortality rates from this cause were highest in counties in southern states from Louisiana and 
Arkansas to Georgia, Tennessee, and Kentucky, while rates were lower than average in southern 
Florida, New England, the upper Midwest, central Colorado, and the Pacific Northwest. Nation-
ally, the mortality rate from this cause declined by 22.1% (95% UI, 18.0%–26.8%) between 1980 
and 2014. However, 28.3% of counties experienced increases in this mortality rate during the 
same period (statistically significant in 13.5%), with especially large increases found in counties 
in Louisiana, Arkansas, Mississippi, Alabama, southern Illinois, and eastern Kentucky.
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significant in 93.6%), but to varying degrees. Counties in the
central United States generally saw smaller improvements,
while counties in the west, northern Midwest, New England,
and southern Florida experienced more substantial declines.
Mental and Substance Use Disorders
Mental and substance use disorders (Figure 8) caused 814391
deaths (1.0%) between 1980 and 2014 and were ranked
eighth in terms of YLLs and 12th in terms of deaths in 2014.
Mortality rates among counties in the 90th percentile were
15.0 deaths per 100000 population higher than among coun-
ties in the 10th percentile. Exceptionally high mortality rates
were found in a cluster of counties in eastern Kentucky and
southwestern West Virginia; in counties in North Dakota,
South Dakota, and southwestern states with Native American
reservations; and in Alaska. Conversely, the lowest rates in
2014 were found primarily in counties in Nebraska, Iowa, and
eastern South Dakota. The mortality rate due to mental and
substance use disorders increased by 188% (95% UI, 160%-
207%) overall between 1980 and 2014 and also increased in
nearly every county (99.1%; statistically significant in
96.2%). However, the amount of increase varied dramatically
Figure 8. County-Level Mortality FromMental and Substance Use Disorders
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figure 8. County-level mortality from mental and substance use disorders. 
A, Age-standardized mortality rate for both sexes combined in 2014. The color scale is truncated at approximately the first 
and 99th percentiles as indicated by the range given in the color scale. B, Percent change in the age-standardized mortality 
rate for both sexes combined between 1980 and 2014. The color scale is truncated at the 99th percentile but not at the first 
percentile, to avoid combining counties with decreases in the mortality rate and counties with increases in the mortality rate 
into a single g oup. C, Age-standa dized mortality rate in 1980, 1990, 2000, and 2014. The bottom border, middle lin , and 
top border of the boxes indicate the 25th, 50th, and 75th percentiles, respectively, across all counties; whiskers, the full range 
across counties; and circles, the national-level rate.
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across counties. In particular, there were several clusters of
counties (in Kentucky, West Virginia, Ohio, Indiana, western
Pennsylvania, and east-central Missouri) where mortality
rates increased by more than 1000% during this period.
Cirrhosis and Other Chronic Liver Diseases
Cirrhosis and other chronic liver diseases (Figure 9) caused
1 506985 deaths (1.9%) between 1980 and 2014 and were the
ninth-ranked cause of YLLs and deaths in 2014. At the county
level, mortality rates in the 90th percentile were 14.0 deaths
per 100000 population higher than mortality rates in the
10th percentile. Counties in eastern Arizona, New Mexico,
and south and western Texas and in selected counties
in Colorado, Nevada, Wyoming, Montana, North Dakota,
and South Dakota had the highest mortality rates, while
counties in eastern South Dakota and Kansas as well as in
Iowa and southern Minnesota had the lowest mortality rates.
Between 1980 and 2014, the mortality rate from this cause
declined by 15.6% (95% UI, 9.1%-26.9%) overall but increased
in 69.6% of counties (statistically significant in 25.9%), with
particularly large increases in southwestern Oregon and
northwestern Texas.
Figure 9. County-Level Mortality From Cirrhosis and Other Chronic Liver Diseases
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figure 9. County-level mortality from cirrhosis and other chronic liver diseases. 
A, Age-standardized mortality rate for both sexes combined in 2014. B, Percent change in the age-standardized mortal-
ity rate for both sexes combined between 1980 and 2014. A and B, The color scale is truncated at approximately the first 
and 99th percentiles as indicated by the range given in the color scale. C, Age-standardized mortality rate in 1980, 1990, 
2000, and 2014. The bottom border, middle line, and top border of the boxes indicate the 25th, 50th, and 75th percentiles, 
respectively, cross all counties; whiskers, the full range across counties; and circles, the national-level rate.
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Diarrhea, Lower Respiratory, and Other Common
Infectious Diseases
Diarrhea, lower respiratory, andother common infectiousdis-
eases (Figure 10)were responsible for 3 234692deaths (4.0%)
between 1980 and 2014 and were the 10th leading cause of
YLLs and the sixth leading cause of deaths in 2014. Counties
in the90thpercentile experiencedmortality rates 25.8deaths
per 100000population higher than those in the 10th percen-
tile. Mortality rates from this cause were highest in counties
in southern states from Louisiana and Arkansas to Georgia,
Tennessee, and Kentucky, while rates were lower than aver-
age in southern Florida, New England, the upper Midwest,
central Colorado, and the Pacific Northwest. Nationally, the
mortality rate from this cause declined by 22.1% (95% UI,
18.0%-26.8%) between 1980 and 2014. However, 28.3% of
counties experienced increases in this mortality rate during
the same period (statistically significant in 13.5%), with
especially large increases found in counties in Louisiana,
Arkansas, Mississippi, Alabama, southern Illinois, and east-
ern Kentucky.
Figure 10. County-Level Mortality FromDiarrhea, Lower Respiratory, and Other Common Infectious Diseases
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figure 10. County-level mortality from diarrhea, lower respiratory, and other common infectious diseases. 
A, Age-standardized mortality rate for both sexes combined in 2014. B, Percent change in the age-standardized mortal-
ity rate for both s xes combined between 1980 and 2014. A and B, The color scale is truncat d t approximately the first 
and 99th percentiles as indicated by the range given in the color scale. C, Age-standardized mortality rate in 1980, 1990, 
2000, and 2014. The bottom border, middle line, and top border of the boxes indicate the 25th, 50th, and 75th percentiles, 
respectively, across all counties; whiskers, the full range across counties; and circles, the national-level rate.
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DISCUSSIOn
Using a novel method, this study estimated county-level mortality rates by cause for 21 major 
causes of death. This analysis improves on previous analyses in 3 ways. First, the scope of this 
analysis was much larger than in previous studies: this is the first study, to our knowledge, 
that considered a comprehensive set of causes over an extended period. Second, this analy-
sis used garbage code redistribution methods to reassign deaths originally classified using 
insufficiently specific or implausible cause of death codes. To our knowledge, garbage code 
redistribution methods have not previously been used at the county level. Third, this analysis 
used new small area estimation methods that generated more precise estimates and more 
accurately quantified uncertainty compared with models previously used. As a consequence 
of these advances, the results of this study represent the most detailed and comprehensive 
accounting of county-level patterns of cause-specific mortality currently available.
Geographic patterns differed significantly across causes, underscoring the importance of 
considering cause-specific mortality in addition to measures of all-cause mortality such as 
life expectancy. For some causes (eg, cardiovascular diseases), counties in the south and Ap-
palachia had elevated mortality, while counties in western states had mortality much lower 
than average, a pattern that, broadly speaking, has also been documented in maps of life ex-
pectancy as well as maps of risk factors such as smoking, physical inactivity, and obesity.1,26,27 
However, other causes had very different geographic patterns. Moreover, for some causes 
(eg, mental and substance use disorders), there were striking clusters of counties with very 
high mortality rates. Geographic patterns in changes over time were similarly variable among 
causes.
Information on cause-specific mortality rates and rankings among causes has long been 
available at the national level19–21,28 and has been widely used for public health planning 
and policy making, but to our knowledge this analysis is the first to consider an exhaustive 
set of causes of death at the county level and to track changes over an extended period at 
this level. There are a number of potential uses for these estimates: state and county health 
departments could use county-level mortality estimates to identify pressing local needs and 
to tailor policies and programs accordingly; physicians could use these estimates to better 
understand the health concerns of the populations they serve; researchers could identify 
counties that have done unexpectedly well or poorly with regard to a particular cause of death 
and that warrant additional study to identify factors driving these trends; and communities 
can use these estimates as evidence when advocating for change. Further, for causes of death 
for which effective treatments are available, variation in mortality rates can highlight where 
access to treatment or quality of care is a pressing problem. Additionally, local-level estimates 
of mortality, and particularly cause-specific mortality, provide a mechanism for evaluating 
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the effect of policies and programs implemented in some, but not all, localities. More detailed 
cause-specific information will further enhance the utility of this type of analysis to all of 
these stakeholders, and in the future we plan to carry out more detailed analyses at the third 
and fourth levels of the GBD cause hierarchy using the framework outlined in this analysis.
This study has several important limitations. First, the death registration data do not include 
deaths of US residents that occurred outside the United States, although these deaths are a 
very small percentage of the total. Second, the population counts were based on intercensal 
interpolations and postcensal projections that may be subject to error. Likewise, the covari-
ates incorporated in the small area models were based on census and other administrative 
data and may also be subject to error.
Third, the garbage code redistribution methods used in this analysis have not been validated 
against a gold standard, such as autopsy, owing to insufficient data. However, several find-
ings support the validity of the redistribution algorithm: redistribution reduces or eliminates 
discontinuities in temporal trends that coincide with revisions to the ICD for some causes 
(eg, ischemic heart disease), resulting in more plausible time trends9; redistribution results in 
more plausible geographic patterns across and within countries based on existing knowledge 
of the distribution of risks (eg, more reasonable patterns of ischemic heart disease mortality 
given knowledge of the distribution of related risk factors)29; and in a small number of cases 
in which hospital linkage studies have been used to examine the cause of death in cases for 
which death certificates list garbage codes, the results are broadly consistent with the effect 
of the redistribution algorithms.
Fourth, although the garbage code redistribution methods used in this analysis may be 
subject to error, this uncertainty is difficult to quantify and has not been accounted for in the 
reported UIs. Fifth, it is possible that the large increases over time observed for some causes 
of deaths are driven by changing registration practices and growing recognition among 
physicians of these particular causes of death. This is particularly true of Alzheimer disease 
and other dementias.30 However, the county-level estimates were raked to national-level 
estimates that incorporated prevalence data not subject to this same limitation, and this may 
have reduced this error. Sixth, small area models were used to more precisely estimate mor-
tality rates, although there may be some situations in which these models were suboptimal. 
In particular, the models used in this analysis smoothed over time, space, and age group. As a 
result, unusually high or low mortality rates may have been attenuated, particularly in small 
counties, leading to an underestimation of geographic inequalities.
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COnCLUSIOnS
In this analysis of US cause-specific county-level mortality rates from 1980 through 2014, 
there were large between-county differences for every cause of death, although geographic 
patterns varied substantially by cause of death. The approach to county-level analyses with 
small area models used in this study has the potential to provide novel insights into US 
disease-specific mortality time trends and their differences across geographic regions.
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eAPPenDIx
Garbage code redistribution
Garbage code redistribution methods developed for the Global Burden of Diseases, Injuries, 
and Risk Factors study (GBD)1 were used in this study in order to reassign deaths to appropri-
ate target causes. This method included four different approaches to determining the frac-
tion of deaths assigned to each group of garbage codes that should be reassigned to a given 
target cause. Deaths assigned each group of garbage codes are addressed using one of these 
four approaches. 
Both the ﬁrst and second approaches used ﬁxed proportions, i.e., the same proportions were 
applied to deaths assigned garbage codes regardless of which county those deaths occurred 
in. In the ﬁrst approach, the ﬁxed proportions were derived from relevant literature and/or 
expert opinion. 
In the second approach, based on work by Ahern et al.,2 the ﬁxed proportions were derived 
from regression models ﬁt to all available deaths registration data. Speciﬁcally, for a particular 
group of related garbage codes, the following model was ﬁt separately for each target code 
and sex:
Tc[r,s],t,a = α +  γ1,s + γ2,r + (β1 +  β2,a +  γ3,s + γ4,r)⋅Gc[r,s],t,a + ϵc[r,s],t,a
where:
·	 c indicates country, s and r indicate the super-region and region where c is located (ac-
cording to the deﬁnition used by the GBD), t indicates the year, and a indicates the age 
group, in this case: <15 years, 15–49 years, 50–59 years, 60–69 years, 70–79 years, or 80+ 
years;
·	 Tc[r,s],t,a is the proportion of deaths coded to the given target cause among all deaths coded 
either to the specified garbage code or any of its target causes, within country c, year t, 
and age group a;
·	 Gc[r,s],t,a is the proportion of deaths coded to the specified garbage code among all deaths 
coded either to the specified garbage code or any of its target causes, within country c, 
year t, and age group a;
·	 α is the intercept;
·	 γ1,s and γ2,r are super-region- and region-level random intercepts;
·	 β1 is the slope on Gc[r,s],t,a;
·	 β2,a is an age-group-specific slope on Gc[r,s],t,a;
·	 and γ3,s and γ4,r are super-region- and region-level random intercepts on Gc[r,s],t,a.
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In general, an inverse relationship between Gc[r,s],t,a and Tc[r,s],t,a is expected: if deaths assigned 
to a garbage code are, in truth, due to a particular target cause, then as the overall proportion 
of deaths assigned garbage codes increases, the deaths assigned to a target cause should 
decline. This relationship may, however, vary by country or age group, so this relationship 
was approximated for each country and age group based on the ﬁtted regression model 
β1 +  β2,a +  γ3,s + γ4,r. Within each country and age group, target causes where the overall effect 
was not negative were dropped and then the effects for the remaining targets were re-scaled 
to sum to 1. These re-scaled effects were used as the proportions for redistributing garbage 
codes to the appropriate target causes. 
The third approach redistributed deaths assigned garbage codes to all relevant targets in 
proportion to the number of deaths observed at the state level in each target group prior to 
redistribution. 
The fourth approach was speciﬁc to garbage codes related to Kaposi sarcoma and certain 
other infectious diseases and immunodeﬁciencies that are known to be frequently used 
when the underlying cause of death is HIV/AIDS. In these cases, the regional rate of change 
compared to 1980–84 was calculated for each set of garbage codes. The proportion of deaths 
assigned to these garbage codes that were due to HIV/AIDS was expected to have increased 
much more rapidly than the proportion due to other target causes as the HIV/AIDS epidemic 
expanded. Consequently, any increase greater than 5% was assumed to have been due to 
deaths that should have been coded as due to HIV/AIDS, while the remainder of deaths were 
assigned to other appropriate target codes. Separate redistribution proportions were derived 
by sex, age group, and 5-year time interval. 
Note that the ﬁrst approach is independent of the US deaths data used elsewhere in this 
analysis, while the third approach uses only this data in order to derive the redistribution 
proportions. In contrast, the second approach uses all available deaths registration data 
globally while the fourth uses data from countries in the same region as deﬁned by the GBD 
(in this case, high income North America, i.e., the US and Canada). Regardless of how the 
redistribution proportions were derived, they were always applied by county such that there 
is no change in the total number of deaths in any county as a result of redistribution. 
Deaths assigned each garbage code (or group of closely related garbage codes) were redis-
tributed using one of the four methods described. Method 4, the HIV/AIDS method, is speciﬁc 
to a subset of garbage codes that are known to be commonly assigned when HIV/AIDS is the 
true underlying cause. Among the remaining garbage codes, the regression method (method 
2), was generally used for garbage codes with a relatively small number of speciﬁed targets; 
this method tends to break down when there are a large number of targets because there is 
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often insufficient data to estimate all of the relevant relationships. For garbage codes where 
the regression method was not appropriate or where the results of the regression method 
were implausible, published literature (method 1) was used as the basis for redistribution if 
available, and otherwise the observed proportions among the targets (method 3) was used. 
Garbage codes that have little information content (e.g., ‘senility’) were typically redistributed 
to all causes using method 3. 
These garbage code redistribution methods were designed to be applied at the most de-
tailed levels of the GBD cause hierarchy (i.e., levels 3 and 4). Although this analysis does not 
consider these more detailed causes, redistribution was carried out at this level and deaths 
were then aggregated to the second level of the GBD cause hierarchy prior to applying the 
small area models.
SAe model
The following model was estimated separately for males and females:
Dj,t,a ~ Poisson(mj,t,a⋅Pj,t,a)
log(mj,t,a) =  β0 +  β1⋅Xj,t +  γ1,a,t +  γ2,j +  γ3,j⋅t +  γ4,j,t + γ5,j⋅a +  γ6,j,a
where
·	 j, t, and a are indices for county, calendar year (1980–2014, renumbered sequentially from 
0 to 34), and age group (0, 1–4, 5–9,… , 75–79, and 80+, recoded sequentially from 0 to 
17), respectively;
·	 Dj,t,a and Pj,t,a are the number of deaths and the population count, respectively, in county 
j, year t, and age group a;
·	 mj,t,a is the underlying mortality rate in county j, year t, and age group a;
·	 β0 is an intercept;
·	 xj,t is a vector of covariates for county j and year t, and β1 is the associated vector of 
regression coefficients;
·	 γ1,a,t is an age group- and year-level random intercept;
·	 γ2,j is a county-level random intercept;
·	 γ3,j is a county-level random slope on year;
·	 γ4,j,t is a county- and year-level random intercept;
·	 γ5,j is a county-level random slope on age group;
·	 and γ6,j,a is a county- and age group-level random intercept.
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γ2, γ3, and γ5 were each assumed to follow a conditional autoregressive distribution3 where 
the full conditional distribution is given by:
γj|γk~j, σ2, ρ ~ Normal
⎛
⎝
ρ ⋅ ∑k~j γk ,
σ2 ⎞
⎠nj ⋅ ρ + 1 − ρ nj ⋅ ρ + 1 − ρ
where
·	 k~j indicates the set of counties k that are adjacent to county j;
·	 nj is the number of counties in k~j;
·	 and σ2 and ρ are variance and correlation parameters, respectively.
These random effects allow for spatial variation beyond what is already explained by the 
covariates in the overall level (γ2), linear deviations from the overall time trend (γ3), and linear 
deviations from the overall age pattern (γ5). The σ2 parameters control the amount of spatial 
variation in each of these dimensions while the ρ parameters, which vary between 0 and 1, 
determine the spatial smoothness. At the limit, as ρ goes to 0 this distribution reduces to a 
fully exchangeable model where the neighborhood configuration is non-informative: γj|σ2 ~ 
Normal(0,  σ2). At the other extreme, as ρ goes to 1, this distribution reduces to an intrinsic 
conditional autoregressive distribution where 
γj|γk~j,  σ2 ~ Normal
⎛
⎝
∑k~jγk ,
σ2 ⎞
⎠nj nj
indicating a high degree of spatial smoothness.
γ1 was also assumed to follow a conditional autoregressive distribution. Speciﬁcally, this was 
speciﬁed as the interaction between two distributions as deﬁned above, but for age and time, 
respectively, rather than county. This was speciﬁed according to the procedure described by 
Clayton4 and Knorr-Held5 (i.e., a ‘Type IV’ interaction). This speciﬁcation allows for smoothing 
over age group and time simultaneously, such that the level for a given age group and year 
is informed both by ﬁrst order neighbors (i.e., adjacent years in the same age group and 
adjacent age groups in the same year) as well as second order neighbors (i.e., adjacent years 
in adjacent age groups). For this distribution there are three hyperparameters: σ2, which 
controls the overall amount of variation, and ρage and ρtime which control the smoothness over 
age and time, respectively.
γ4 and γ6 were assumed to follow identical and independently distributed Normal distribu-
tions. These random effects were included in order to allow for non-linear county-level devia-
tions in the time or age pattern (linear deviations are captured by γ3 and γ5).
Gamma(1, 1000) priors were speciﬁed for the inverse variance (1 / σ2) of each random effect. 
Normal(0, 1.5) priors were speciﬁed for the logit-transform of the correlation parameters (ρ).
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The Template Model Builder (TMB) package6 in R version 3.2.47 was used to ﬁt this model. 
Broadly speaking, there were three steps in this model ﬁtting process. First, TMB was used 
to ﬁnd the Laplace approximation to the marginal log-likelihood of the data and model pa-
rameters with respect to the hyperparameters (i.e., σ2 and ρ terms) integrating over all ﬁxed 
and random parameters (i.e., β and γ terms). Second, non-linear optimization routines in R 
were used to maximize this approximated marginal log-likelihood plus marginal prior for the 
hyperparameters and derive point estimates for all model parameters. Third, a generalized 
delta-method implemented in TMB was used to approximate the joint precision matrix for 
all model parameters. 
After ﬁtting the model, 1,000 draws from the posterior distribution were generated using a 
multivariate-normal approximation. Posterior draws of mj,t,a were derived from each posterior 
draw of the model parameters. Finally, point estimates and 95% uncertainty intervals for mj,t,a 
were derived from the mean and 2.5th and 97.5th percentiles, respectively, of these 1,000 draws.
Model validation 
Methods
The performance of the small area models used in this analysis, several variants on this model, 
and two previously published models, was assessed using a framework similar to that initially 
described by Srebotnjak et al.8 Broadly, there were three steps in this process.
In the ﬁrst step, a ‘validation set’ of counties was identiﬁed. These are counties with large 
populations where the effect of stochastic noise is expected to be small such that the directly 
observed mortality rate is very close to the underlying mortality rate and can therefore be 
treated as a ‘gold standard.’ To maximize the number of counties that were eligible to be in-
cluded in the validation set, populations and deaths for each county were ﬁrst pooled using 
a three-year moving window. The dataset was then subset to only counties with non-zero 
death counts in every age group in each year for both males and females. For each remaining 
county, 1,000 draws of the mortality rate for each age group, sex, and year were simulated 
assuming a Poisson distribution; age groups were combined in order to generate 1,000 draws 
of the age-standardized mortality rate for each sex and year; and the coefficient of varia-
tion of the age-standardized mortality rate and of each age-speciﬁc mortality rate in each 
year and sex was calculated (i.e., the standard deviation of the draws divided by the mean 
of the draws). Finally, counties where the coefficient of variation was less than 1% for the 
age-standardized mortality rates and less than 10% for the age-speciﬁc mortality rates across 
all years and both sexes were selected for the validation set.
In the second step, validation data sets were created and used to ﬁt each model and derive 
predictions. A total of 60 validation data sets were generated: 10 each to examine the perfor-
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mance of the model for counties with a total population of 1,000, 3,000, 5,000, 10,000, 25,000, 
and 100,000, corresponding roughly to the 1st, 5th, 10th, 25th, 50th, and 80th percentile across 
all counties and years. To create each validation data set, a pre-speciﬁed number of individuals 
were sampled in each county in the validation dataset from the observed population age-sex 
distribution. Then, for each age and sex in each county in the validation dataset, deaths were 
sampled from a Poisson distribution with mean equal to the observed mortality rate times the 
sampled population size in that age group and sex. The data for all counties not in the valida-
tion dataset were included without modiﬁcation. After creating the validation data sets, models 
were ﬁt to these data and predictions derived in the same manner as for the observed data.
Finally, the predictions were compared to the directly observed age-standardized mortality 
rates. For each model corresponding to a different validation data set, and for each county-
year in the validation set, the relative error (100⋅ ( mgs - mpred )/ mgs, where mgs is the gold stan-
dard age-standardized mortality rate, and mpred is the predicted age-standardized mortality 
rate) was calculated and whether or not the gold standard was contained by the predicted 
lower and upper uncertainty intervals was recorded. Across all county-years in the validation 
set and across all 10 validation data sets at each population level, performance was sum-
marized in terms of the mean relative error, the mean absolute relative error (i.e., the mean 
of the absolute value of the relative error), and the coverage (i.e., the percent of county-years 
where the gold standard estimate was between the lower and upper uncertainty intervals).
A total of six models were considered.
1. The model described in the previous section.
2. As in (1), but excluding the γ4,j,t and γ6,j,a terms. This simpliﬁes the model in (1) by only 
allowing for linear county-level deviations from the overall age and time trend.
3. As in (2), but also excluding γ3,j⋅t and γ5,j⋅a terms. This further simpliﬁes the model in 
(2) by assuming that the time and age pattern is the same across all counties (beyond 
differences accounted for by the included covariates).
4. As in (3), but replacing γ1,a,t with separate (i.e., not interacted) age and time random 
effects. This simpliﬁes the model in (3) even further by assuming no interaction between 
the age pattern and time pattern, i.e., that the same age pattern applies in all years and, 
equivalently, that the same time pattern applies to all age groups.
5. The model described by Kulkarni et al.9 In this approach, separate mixed effects models 
are speciﬁed for each age group and each year and a two-stage ﬁtting procedure is used 
to estimate and incorporate spatial effects.
6. The model described by Wang et al.10 This model is an extension of the Kulkarni model that 
adds an additional step wherein a non-parametric temporal smoothing model is applied 
to the predictions in larger counties. In both the analysis by Kulkarni and the analysis by 
Wang, smaller counties were merged with their neighbors until all counties were part of 
137
Chapter 5 - US County-Level Trends in Mortality Rates for Major Causes of Death
units with at least 5,000 males and 5,000 females. For this analysis, for comparability with 
models 1–4, no counties were merged beyond what was required to obtain historically 
stable analytic units.
Four variants on the model developed for this analysis were included in order to assess 
whether more complicated versions of this model allowing for more ﬂexible interactions 
between age, time, and space, were appropriate, particularly for smaller populations. The 
previously published models were included to assess whether or not the approach devel-
oped for this analysis improves on methods that were already available. The models by Wang 
and Kulkarni frequently failed to converge when ﬁt to validation sets with population size 
1,000, so results from these models are not reported at this level.
This validation framework was computationally intensive as it required ﬁtting each model and 
generating predictions 120 times (once for males and once for females to each of the 60 valida-
tion data sets). Consequently, applying this validation framework to each cause individually 
was infeasible, so instead performance overall was assessed in terms of all-cause mortality.
Results
The mean relative error for the age-standardized mortality rate is presented in eTable 4. 
The mean relative error is a measure of bias, i.e., whether the rates estimated by the model 
were systematically higher or lower than the true rates. There was no evidence of bias in 
either model 1 or 2, where the mean relative error never exceeded +/- 1%. For models 3 and 
4, the mean relative error was similarly less than 1% at all but the smallest population size 
considered (1,000), where it was approximately -2.5%. The mean relative error for the other 
two models was more substantial: above 1% even for the largest population size, and more 
than 2% and 5% at maximum for the models by Kulkarni and Wang, respectively.
The mean absolute relative error for the age-standardized mortality rate is given in eTable 5. 
This is a measure of the overall error, i.e., how much the model estimates differ from the true 
estimates. As anticipated, all models performed better in this regard for larger populations. 
At the smallest population size, models 1–4 performed roughly equally with around 6.5–7% 
error, although the model used in the ﬁnal analysis (1) did have the lowest error overall. 
For larger population sizes, models 1 and 2 outperformed models 3 and 4 by a substantial 
margin. The models by Kulkarni and Wang performed worse than models 1 and 2 but better 
than models 3 and 4 at the largest population size, however they consistently had the highest 
mean absolute relative error at smaller population sizes. 
eTable 6 shows the coverage for the age-standardized mortality rate. Ideally, coverage should 
be as close as possible to 95% as this indicates that the 95% uncertainty intervals are an 
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appropriate reﬂection of an estimate’s precision. Model 1 had good coverage for counties 
of all population sizes. Coverage for models 2–4 was generally too low, though it was better 
for model 2 as compared to models 3 and 4, and for small counties as compared to large 
counties. Coverage for the models by Kulkarni and Wang was also too low, but was better for 
larger populations than for smaller ones.
In summary, models 1 and 2 slightly outperformed models 3 and 4 in terms of the mean 
relative error and were substantially better when compared in terms of the mean absolute 
relative error. The models by Kulkarni and Wang performed less well in terms of both mean 
relative error and mean absolute relative error than all other models. In terms of coverage, 
model 1 was superior to all of the other models.
raking
After the modeling steps, results were adjusted to ensure consistency across two dimensions: 
cause hierarchy and geography.
Adjustments by cause were needed because SAE models were run independently for all-
cause mortality and each of the 24 causes in the ﬁrst and second level of the GBD cause 
hierarchy. Thus, the cause-speciﬁc model outputs do not necessarily nest as they should; that 
is, summing predicted deaths from the three level 1 causes does not result in precisely the 
predicted all-cause death count, although generally it will be close.
Adjustments were also needed in order to ensure consistency with national-level estimates 
from the GBD. These estimates are based on the same death registration data but also in-
corporated other data sources for certain causes where registration data are known to be 
sub-optimal (e.g., dementias). These data were not available at the county level, so instead 
county-level estimates were raked to the GBD national-level estimates to capitalize on the 
additional information content.
To accomplish these twin goals, an algorithm known as raking, and also called iterative pro-
portional ﬁtting, was utilized. Given an N-dimensional table whose internal entries denote 
uncertain values and whose marginals denote aggregated, more certain values, raking pro-
vides a means of ﬁtting the internal entries to the marginals while preserving some internal 
relationships of the table. This is accomplished simply by proportionately scaling the rows to 
add up to their marginal totals, then scaling the columns the same way, and repeating until 
the entries in the table stabilize (i.e., converge).
Consider a two-dimensional table with r rows and c columns, where ni,j refers to the entry in 
the (i,j)th cell, and Ni and Nj refer to the ﬁxed marginal values along the rows and columns, 
139
Chapter 5 - US County-Level Trends in Mortality Rates for Major Causes of Death
respectively. To illustrate, imagine that the US has only ﬁve counties, named Alpha, Bravo, 
Charlie, Delta, and Echo. The process below shows the raking of (synthetic) county deaths 
for level-1 causes (Communicable Diseases, Noncommunicable Diseases, and Injuries) to 
national deaths for level-1 causes and to county deaths for all-cause mortality.
Start with a table of values.
Cause
Alpha 
County
Bravo 
County
Charlie 
County
Delta 
County
echo 
County
United 
States
Communicable 29 50 7 22 17 119
Noncommunicable 178 202 49 91 45 407
Injuries 53 67 36 26 31 203
All-Cause 200 253 97 103 82 735
In iteration 1, ﬁnd new values ni,j such that:
n1i,j = n0i,j ⋅
Ni
∑ri = 1 n0i,j
Cause
Alpha 
County
Bravo 
County
Charlie 
County
Delta 
County
echo 
County
United 
States
Communicable 27.61 47.60 6.66 20.94 16.18 119.00
Noncommunicable 128.22 145.51 35.30 65.55 32.42 407.00
Injuries 50.51 63.85 34.31 24.78 29.54 203.00
All-Cause 200.00 253.00 97.00 103.00 82.00 735.00
In iteration 2, find new values ni,j such that:
n2i,j = n1i,j ⋅
Nj
∑cj = 1 n1i,j
Cause
Alpha 
County
Bravo 
County
Charlie 
County
Delta 
County
echo 
County
United 
States
Communicable 26.76 46.87 8.48 19.39 16.98 119.00
Noncommunicable 124.28 143.27 44.89 60.68 34.02 407.00
Injuries 48.96 62.87 43.63 22.94 31.00 203.00
All-Cause 200.00 253.00 97.00 103.00 82.00 735.00
In iteration 3, repeat iteration 1 with ni,j2:
Cause
Alpha 
County
Bravo 
County
Charlie 
County
Delta 
County
echo 
County
United 
States
Communicable 26.88 47.08 8.51 19.47 17.06 119.00
Noncommunicable 124.24 143.22 44.88 60.66 34.00 407.00
Injuries 47.46 60.95 42.30 22.24 30.05 203.00
All-Cause 200.00 253.00 97.00 103.00 82.00 735.00
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In iteration 4, repeat iteration 2 with ni,j3:
Cause
Alpha 
County
Bravo 
County
Charlie 
County
Delta 
County
echo 
County
United 
States
Communicable 27.07 47.40 8.63 19.59 17.24 119.00
Noncommunicable 125.13 144.22 45.49 61.03 34.37 407.00
Injuries 47.80 61.37 42.88 22.37 30.38 203.00
All-Cause 200.00 253.00 97.00 103.00 82.00 735.00
Continue until an additional iteration does not meaningfully change ni,j.
Cause
Alpha 
County
Bravo 
County
Charlie 
County
Delta 
County
echo 
County
United 
States
Communicable 27.08 47.42 8.63 19.60 17.25 119.00
Noncommunicable 125.16 144.25 45.51 61.05 34.39 407.00
Injuries 47.77 61.33 42.86 22.36 30.36 203.00
All-Cause 200.00 253.00 97.00 103.00 82.00 735.00
Raking has been shown to converge11 if the sum of the margins are equal (i.e., ∑ri = 1 Ni  =   ∑cj = 1 
Nj) and there are no zeros or negative numbers in the margins. Raking works on tables of 
arbitrary dimensionality, and requires only a single iteration for a one-dimensional table.
It should be noted that this algorithm was applied to mortality rates rather than death counts, 
and as such, an extra population-weighting step was required when raking to national 
estimates. There were two stages in raking. First, one-dimensional raking was applied to ﬁt 
county-level all-cause estimates to national all-cause estimates. Second, two-dimensional 
raking was applied at each level of the cause hierarchy. That is, after raking all-cause county-
level to national estimates, the following groups of causes were raked:
1. The three level 1 causes (Communicable, Noncommunicable, and Injuries) to county-level 
all-cause estimates and national Communicable, Noncommunicable, and Injury results.
2. The seven children of the Communicable cause to county-level Communicable estimates 
and national estimates for those child causes.
3. The ten children of the Noncommunicable cause to county-level Noncommunicable 
estimates and national estimates for those child causes.
4. The four children of the Injuries cause to county-level Injuries estimates and national 
estimates for those child causes.
Calculating years of life lost
Years of life lost (YLLs) were calculated for each cause as in the GBD.1 For each age group, the 
number of deaths was calculated by multiplying the estimated mortality rate by the popula-
tion. YLLs were then calculated for each age group by multiplying the number of deaths by 
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the life expectancy at the average age at death in that age group from a reference life table. 
The reference life table from the GBD was used in this analysis; this life table was constructed 
from the lowest observed mortality rate among all countries in 2013 for each age group and 
corresponds to a life expectancy at birth of 86.6 years.
As an example, the data in the table below show the population (column 2) and the esti-
mated mortality rates from cardiovascular diseases (column 3) in the US in 2014. Deaths 
(column 4) were calculated by multiplying the population by the estimated mortality rate. 
Life expectancy at the average age of death within each age group (column 5) was extracted 
from the GBD reference life table. YLLs in each age group (column 6) were then calculated by 
multiplying deaths by life expectancy. Total YLLS were calculated by summing across all ages.
Age group Population Mortality rate Deaths Life expectancy YLLs
0 3,991,801 8.3 331 86.18 28,551
1–4 16,142,348 1.1 174 84.20 14,629
5–9 21,022,679 0.4 88 79.32 6,981
10–14 20,537,438 0.6 128 73.86 9,455
15–19 21,700,738 1.6 352 69.06 24,336
20–24 22,467,579 3.6 809 64.31 52,029
25–29 21,943,503 6.7 1,471 59.43 87,389
30–34 21,222,396 12.4 2,626 54.48 143,041
35–39 19,345,592 22.0 4,262 49.53 211,091
40–44 20,432,008 40.6 8,286 44.62 369,711
45–49 22,263,758 73.9 16,443 39.80 654,382
50–54 23,899,275 125.6 30,016 35.08 1,052,861
55–59 21,541,555 193.0 41,575 30.48 1,267,073
60–64 20,198,375 279.9 56,540 25.91 1,464,742
65–69 14,333,828 420.9 60,331 21.47 1,295,080
70–74 10,102,967 671.5 67,843 17.23 1,168,681
75–79 7,298,604 1,153.5 84,191 13.28 1,117,654
80+ 12,227,811 3,850.5 470,832 5.88 2,768,105
Total 846,298 11,735,793
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eFigure 1: Example of garbage code redistribution in King County, WA (2013). The left axis
represents ICD codes that were mapped to cardiovascular diseases in the GBD cause hierarchy and the right
axis represents these cardiovascular diseases. The width of each band is proportional to the number of deaths
transferred from a given set of ICD codes to a specific cardiovascular disease. Garbage codes are ICD codes
which are implausible or insufficiently specific for the underlying cause of death. All categories on the left axis
other than "Non-Garbage" refer to sets of garbage codes. The category "Non-Garbage" includes deaths where
the original underlying cause of death code could be mapped directly to a cause in the GBD cause hierarchy.
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efigure 1. Example of garbage code redistribution in King County, WA (2013). 
The left axis repres n s ICD codes that were mapped to cardiovascular diseases in the GBD cause hi rarc y 
and the right axis represents these cardiovascular diseases. The width of each band is proportional to the 
number of deaths transferred from a given set of ICD codes to a speciﬁc cardiovascular disease. Garbage 
codes are ICD codes which are implausible or insufficiently speciﬁc for the underlying cause of death. All 
categor es on the left axis other than “Non-Gar age” refer to sets of garbage cod s. The category “Non-
Garbage” includes deaths where the original underlying cause of death code could be mapped directly to 
a cause in the GBD cause hierarchy.
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eFigure 2: Percent of deaths assigned garbage codes (1980-2014).
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efigure 2. Percent of deaths assigned garbage codes (1980–2014). 
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[A] Distribution of deaths by cause before garbage code redistribution
[B] Distribution of deaths by cause after garbage code redistribution
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eFigure 3: Annual distribution of deaths by cause before [A] and after [B] garbage code
redistribution (1980-2014).
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efigure 3. Annual distribution of deaths by cause before and after garbage code redistribution (1980–
2014). 
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efigure 4. County-level mortality from unintentional injuries. 
A, Age-standardized mortality rate for both sexes combined in 2014. B, Percent change in the age-stan-
dardized mortality rate for both sexes combined between 1980 and 2014. A and B, The color scale is trun-
cated at approximately the first and 99th percentiles as indicated by the range given in the color scale. C, 
Age-standardized mortality rate in 1980, 1990, 2000, and 2014. The bottom border, middle line, and top 
border of the boxes indicate the 25th, 50th, and 75th percentiles, respectively, across all counties; whiskers, 
the full range across counties; and circles, the national-level rate.
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efigure 5. County-level mortality from other non-communicable diseases. 
A, Age-standardized mortality rate for both sexes combined in 2014. The color scale is truncated at ap-
proximately the first and 99th percentiles as indicated by the range given in the color scale. B, Percent 
change in the age-standardized mortality rate for both sexes combined between 1980 and 2014. The color 
scale is truncated at the first percentile but not at the 99th percentile, to avoid combining counties with 
decreases in the mortality rate and counties with increases in the mortality rate into a single group. C, Age-
standardized mortality rate in 1980, 1990, 2000, and 2014. The bottom border, middle line, and top border 
of the boxes indicate the 25th, 50th, and 75th percentiles, respectively, across all counties; whiskers, the full 
range across counties; and circles, the national-level rate.
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efigure 6. County-level mortality from neonatal disorders. 
A, Age-standardized mortality rate for both sexes combined in 2014. B, Percent change in the age-stan-
dardized mortality rate for both sexes combined between 1980 and 2014. A and B, The color scale is trun-
cated at approximately the first and 99th percentiles as indicated by the range given in the color scale. C, 
Age-standardized mortality rate in 1980, 1990, 2000, and 2014. The bottom border, middle line, and top 
border of the boxes indicate the 25th, 50th, and 75th percentiles, respectively, across all counties; whiskers, 
the full range across counties; and circles, the national-level rate.
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efigure 7. County-level mortality from digestive diseases. 
A, Age-standardized mortality rate for both sexes combined in 2014. B, Percent change in the age-stan-
dardized mortality rate for both sexes combined between 1980 and 2014. A and B, The color scale is trun-
cated at approximately the first and 99th percentiles as indicated by the range given in the color scale. C, 
Age-standardized mortality rate in 1980, 1990, 2000, and 2014. The bottom border, middle line, and top 
border of the boxes indicate the 25th, 50th, and 75th percentiles, respectively, across all counties; whiskers, 
the full range across counties; and circles, the national-level rate.
150
0.2 1.8 3.4 5 6.6 8.2 to 65.7
Age−standardized mortality rate (deaths per 100,000 population):
[A]
−74 to
−50% 0% 50% 150% 249% 349%
449 to
1516%
Change in age−standardized mortality rate (%):
[B]
●
●
●
●0
16
32
48
64
80
96
112
1980 1990 2000 2014
Year
A
ge
−S
ta
nd
ar
di
ze
d 
M
or
ta
lit
y 
R
at
e
(d
ea
th
s 
pe
r 1
00
,0
00
 p
op
ul
at
io
n) Counties National
[C]
efigure 8. County-level mortality from HIV/AIDS and tuberculosis. 
A, Age-standardized mortality rate for both sexes combined in 2014. B, Percent change in the age-stan-
dardized mortality rate for both sexes combined between 1980 and 2014. A and B, The color scale is trun-
cated at approximately the first and 99th percentiles as indicated by the range given in the color scale. C, 
Age-standardized mortality rate in 1980, 1990, 2000, and 2014. The bottom border, middle line, and top 
border of the boxes indicate the 25th, 50th, and 75th percentiles, respectively, across all counties; whiskers, 
the full range across counties; and circles, the national-level rate.
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efigure 9. County-level mortality from musculoskeletal disorders. 
A, Age-standardized mortality rate for both sexes combined in 2014. B, Percent change in the age-stan-
dardized mortality rate for both sexes combined between 1980 and 2014. A and B, The color scale is trun-
cated at approximately the first and 99th percentiles as indicated by the range given in the color scale. C, 
Age-standardized mortality rate in 1980, 1990, 2000, and 2014. The bottom border, middle line, and top 
border of the boxes indicate the 25th, 50th, and 75th percentiles, respectively, across all counties; whiskers, 
the full range across counties; and circles, the national-level rate.
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efigure 10. County-level mortality from other communicable, maternal, neonatal, and nutritional dis-
eases. 
A, Age-standardized mortality rate for both sexes combined in 2014. B, Percent change in the age-stan-
dardized mortality rate for both sexes combined between 1980 and 2014. A and B, The color scale is trun-
cated at approximately the first and 99th percentiles as indicated by the range given in the color scale. C, 
Age-standardized mortality rate in 1980, 1990, 2000, and 2014. The bottom border, middle line, and top 
border of the boxes indicate the 25th, 50th, and 75th percentiles, respectively, across all counties; whiskers, 
the full range across counties; and circles, the national-level rate.
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efigure 11. County-level mortality from maternal disorders. 
A, Age-standardized mortality rate for both sexes combined in 2014. B, Percent change in the age-stan-
dardized mortality rate for both sexes combined between 1980 and 2014. A and B, The color scale is trun-
cated at approximately the first and 99th percentiles as indicated by the range given in the color scale. C, 
Age-standardized mortality rate in 1980, 1990, 2000, and 2014. The bottom border, middle line, and top 
border of the boxes indicate the 25th, 50th, and 75th percentiles, respectively, across all counties; whiskers, 
the full range across counties; and circles, the national-level rate.
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efigure 12. County-level mortality from nutritional deficiencies. 
A, Age-standardized mortality rate for both sexes combined in 2014. B, Percent change in the age-stan-
dardized mortality rate for both sexes combined between 1980 and 2014. A and B, The color scale is trun-
cated at approximately the first and 99th percentiles as indicated by the range given in the color scale. C, 
Age-standardized mortality rate in 1980, 1990, 2000, and 2014. The bottom border, middle line, and top 
border of the boxes indicate the 25th, 50th, and 75th percentiles, respectively, across all counties; whiskers, 
the full range across counties; and circles, the national-level rate.
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efigure 13. County-level mortality from forces of nature, war, and legal intervention. 
A, Age-standardized mortality rate for both sexes combined in 2014. The color scale is truncated at ap-
proximately the first and 99th percentiles as indicated by the range given in the color scale. B, Percent 
change in the age-standardized mortality rate for both sexes combined between 1980 and 2014. The color 
scale is truncated at the first percentile but not at the 99th percentile, to avoid combining counties with 
decreases in the mortality rate and counties with increases in the mortality rate into a single group. C, Age-
standardized mortality rate in 1980, 1990, 2000, and 2014. The bottom border, middle line, and top border 
of the boxes indicate the 25th, 50th, and 75th percentiles, respectively, across all counties; whiskers, the full 
range across counties; and circles, the national-level rate.
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efigure 14. County-level mortality from neglected tropical diseases and malaria.
A, Age-standardized mortality rate for both sexes combined in 2014. B, Percent change in the age-stan-
dardized mortality rate for both sexes combined between 1980 and 2014. A and B, The color scale is trun-
cated at approximately the first and 99th percentiles as indicated by the range given in the color scale. C, 
Age-standardized mortality rate in 1980, 1990, 2000, and 2014. The bottom border, middle line, and top 
border of the boxes indicate the 25th, 50th, and 75th percentiles, respectively, across all counties; whiskers, 
the full range across counties; and circles, the national-level rate.
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eTABLeS
eTable 1. Data sources used for covariates.
Covariate Data sources Data processing
Percent of the population 
age 25 and older who 
have completed high 
school
1980 census;a 1990 census;b 2000 
census;c 2009–2014 ACS.d
Linear interpolation was used ﬁll in 
intermediate years between data sources. 
The rate of change calculated between 2007 
and 2012 was applied to ﬁll in estimates for 
2013 and 2014.
Percent of the population 
who are Hispanic
1980 census;e 1990–2014 NCHS 
Bridged Race Files.f,g,h
Linear interpolation was used to ﬁll in 
intermediate years between data sources.
Percent of the population 
who are Black and some 
other race
1980–1989 Census Bureau 
Intercensal County Estimates by 
Age, Sex, and Race;i 1990–2014 
NCHS Bridged Race Files.f,g,h
Linear interpolation was used to ﬁll in 
intermediate years between data sources.
Percent of land area 
in a Native American 
reservation
2013 Cartographic Boundary File, 
State-County for United States;j 
AIANNH Areas National Shapeﬁle.k
Geographic boundaries of AIANNH Areas 
were intersected with county boundaries 
using ArcGIS. The area of the intersection 
and the area of the county were calculated 
using an Albers Equal Area Conic projection. 
The proportion of the land area that is in a 
reservation was generated by dividing the 
area of the reservation by the total area in 
each county.
Household median 
income
1980 census;l 1989, 1993, 
1995–2014 Small Area Income and 
Poverty Estimates;m 1980–2014 
Bureau of Labor Statistics, 
Consumer Price Index.n
Data were adjusted for inﬂation using 
the consumer price index, and linear 
interpolation was used to generate values 
between observed data points. Income was 
then log-transformed.
Population density 1980–1989 Census Bureau 
Intercensal County Estimates by 
Age, Sex, and Race;i 1990–2014 
NCHS Bridged Race Files;f,g,h 2013 
Cartographic Boundary File, State-
County for United States.j
The area of each county was calculated 
using an Albers Equal Area Conic projection. 
The total population of each county was 
divided by the total area of the county, and 
was then log-transformed.
aMissouri Census Data Center. 1980 Census Summary Tape File 3, Table NT48A. MCDC Data Archive (Uex-
plore/Dexter). http://mcdc2.missouri.edu/applications/uexplore.shtml. Accessed April 22, 2013.
bMinnesota Population Center. 1990 Census Summary Tape File 3, Table P057. National Historical Geo-
graphic Information System: Version 2.0. Minneapolis, MN: University of Minnesota 2011. http://www.nhgis.
org. Accessed July 18, 2013.
cU.S. Census Bureau. 2000 Census Summary Tape File 3, Table DP2; using American FactFinder; http://
factﬁnder2.census.gov. Accessed April 18, 2013.
dU.S. Census Bureau. American Community Survey, 2009–2014 American Community Survey 5-Year Esti-
mates, Table S1501; using American FactFinder; http://factﬁnder2.census.gov. Accessed December 8, 2015.
eMinnesota Population Center. 1980 Census Summary Tape File 1, Table NT8. National Historical Geographic 
Information System: Version 2.0. Minneapolis, MN: University of Minnesota 2011. http://www.nhgis.org. Ac-
cessed January 13, 2016.
fNational Center for Health Statistics, Centers for Disease Control and Prevention, US Census Bureau. United 
States Bridged-Race Intercensal Population Estimates 1990–1999. Hyattsville, United States: National Cen-
ter for Health Statistics, Centers for Disease Control and Prevention, 2004. Accessed November 21, 2011.
158
gNational Center for Health Statistics, Centers for Disease Control and Prevention, US Census Bureau. United 
States Bridged-Race Intercensal Population Estimates 2000–2009. Hyattsville, United States: National Cen-
ter for Health Statistics, Centers for Disease Control and Prevention, 2012. Accessed October 30, 2012.
hNational Center for Health Statistics, Centers for Disease Control and Prevention, United States Census 
Bureau. United States Vintage 2014 Bridged-Race Postcensal Population Estimates 2010–2014. Hyattsville, 
United States: National Center for Health Statistics, Centers for Disease Control and Prevention, 2015. Ac-
cessed December 18, 2015.
iU.S. Census Bureau. Intercensal County Estimates by Age, Sex, Race: 1980–1989. http://www.census.gov/
popest/data/counties/asrh/1980s/PE-02.html. Accessed January 8, 2015.
jU.S. Census Bureau. TIGER/Line Shapeﬁle, 2013 Cartographic Boundary File, State-County for United States, 
1:20,000,000. https://catalog.data.gov/dataset/2013-cartographic-boundary-ﬁle-state-county-for-united-
states-1-20000000. Accessed February 2, 2015.
kU.S. Census Bureau. TIGER/Line Shapeﬁle, 2012, Series Information File for the Nation, Current American 
Indian/Alaska Native/Native Hawaiian Areas (AIANNH) National Shapeﬁle. http://catalog.data.gov/dataset/
tiger-line-shapeﬁle-2012-series-information-ﬁle-for-the-nation-current-american-indian-alaska. Accessed 
February 10, 2015.
lMinnesota Population Center. 1980 Census Summary Tape File 3, Table NT69. National Historical Geograph-
ic Information System: Version 2.0. Minneapolis, MN: University of Minnesota 2011. http://www.nhgis.org. 
Accessed November 12, 2015.
mU.S. Census Bureau. Small Area Income and Poverty Estimates. https://www.census.gov/did/www/saipe/
data/statecounty/data/index.html. Accessed December 28, 2015.
nU.S Bureau of Labor Statistics. Consumer Price Index: All Urban Consumers History, All Items 1913–2015. 
http://www.bls.gov/data/. Accessed March 24, 2015.
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eTable 2. Counties combined to ensure historically stable units of analysis. 
State Group Areas
Alaska 1 Kusilvak Census Area (2158), Wade Hampton Census Area (2270)a
2 Kobuk Census Area (2140),a Northwest Arctic Borough (2188)
3 Aleutian Islands Census Area (2010),a Aleutians East Borough (2013), Aleutians West 
Census Area (2016)
4 Dillingham Census Area (2070), Lake and Peninsula Borough (2164)
5 Denali Borough (2068), Yukon-Koyukuk Census Area (2290)
6 Hoonah-Angoon Census Area (2105), Skagway Municipality (2230), Skagway-Yakutat-
Angoon Census Area (2231),a Skagway-Hoonah-Angoon Census Area (2232),a Yakutat 
City and Borough (2282)
7 Ketchikan Gateway Borough (2130), Petersburg Borough (2195), Prince of Wales-Hyder 
Census Area (2198), Prince of Wales-Outer Ketchikan Census Area (2201),a Wrangell City 
and Borough (2275), Wrangell-Petersburg Census Area (2280)a
Arizona 1 La Paz County (4012), Yuma County (4027)
Colorado 1 Adams County (8001), Arapahoe County (8005), Boulder County (8013), Broomfield 
County (8014), Denver County (8031), Jefferson County (8059), Weld County (8123)
Florida 1 Dade County (12025),a Miami-Dade County (12086)
Hawaii 1 Kalawao County (15005), Maui County (15009)
Maryland 1 Montgomery County (24031), Prince George’s County (24033)
Montana 1 Park County (30067), Yellowstone National Park (30113)a
New 
Mexico
1 Cibola County (35006), Valencia County (35061)
South 
Dakota
1 Oglala Lakota County (46102), Shannon County (46113)a
2 Jackson County (46071), Washabaugh County (46131)a
Virginia 1 Fairfax County (51059), Fairfax City (51600)
2 Rockingham County (51165), Harrisonburg City (51660)
3 James City County (51095), Williamsburg City (51830)
4 Prince William County (51153), Manassas City (51683), Manassas Park City (51685)
5 Rockbridge County (51163), Buena Vista City (51530)
6 Spotsylvania County (51177), Fredericksburg City (51630)
7 Augusta County (51015), Staunton City (51790), Waynesboro City (51820)
8 Pittsylvania County (51143), Danville City (51590)
9 Greensville County (51081), Emporia City (51595)
10 Albemarle County (51003), Charlottesville City (51540)
11 Bedford County (51019), Bedford City (51515)a
12 Halifax County (51083), South Boston City (51780)a
13 Southampton County (51175), Franklin City (51620)
14 Alleghany County (51005), Clifton Forge City (51560)a
15 York County (51199), Newport News City (51700)
aCounty no longer exists due to boundary or name change. 
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eTable 3. GBD cause list and associated ICD9 and ICD10 codes.
Cause Level ICD9 ICD10
Communi-
cable, maternal, 
neonatal, and 
nutritional 
diseases
1 001–001.9, 002.0–030.9, 032–034.9, 036–036.40, 036.5, 036.8–037.9, 039–039.4, 
039.8–040, 040.1–041.09, 042–066.9, 070–070.21, 070.3–070.31, 070.4–070.43, 
070.49–070.53, 070.59–074.1, 074.20, 074.3–075.9, 078.4–078.7, 079–079.7, 080–
083.9, 084.0–084.5, 084.7–084.9, 085.0, 086–088.9, 090–101.6, 104–104.9, 120–124.9, 
125.4–125.9, 127–127.1, 128–129.0, 136–136.29, 137–139.0, 244.2, 260–263.9, 265–
269.9, 280.1–280.8, 281.0–281.9, 320.0–320.89, 321–323.9, 381–383.9, 390–390.9, 
392, 392.9, 461–461.9, 464.0, 464.01, 464.11–464.2, 464.21, 464.31–464.4, 464.8–
464.9, 466–469, 470.0, 475–475.9, 476.9, 480–482.89, 483.0–483.9, 484.0–484.7, 487–
489, 613–614.9, 630–636.92, 638–638.92, 640–679.14, 716.0–716.09, 730.4–730.6, 
760–760.64, 760.8–768, 768.2–770, 770.1–775, 775.4–779.34, 779.6–779.89, 787.91
A00–A00.9, A01.0–A14, A15–A28.9, A30–A30.9, A32–A39.4, A39.8–A39.9, A48.1–A48.2, A48.4–A48.52, A49.1, 
A50–A58, A60–A60.9, A63–A63.8, A65–A65.0, A68–A70, A74, A74.8–A75.9, A77–A96.9, A98–A98.8, B00–B06.9, 
B10–B10.89, B15–B17.9, B19–B27.99, B29.4, B33–B33.1, B33.3–B33.8, B47–B48.8, B50–B53.8, B55.0, B56–B57.5, 
B60–B60.8, B63, B65–B67.99, B69–B72.0, B74.3–B75, B77–B77.9, B83–B83.8, B90–B92, B94.1–B94.2, B95–B95.5, 
D50.1–D50.8, D51–D52.0, D52.8–D53.9, D64.3, D86.81, E00–E02, E40–E46.9, E51–E61.9, E63–E64.0, E64.2–E64.9, 
F07.1, G00.0–G00.8, G03–G03.8, G04–G05.8, G14–G14.6, H70–H70.93, I00, I02, I02.9, I98.0–I98.1, J01–J01.91, 
J02.0, J03.0–J03.01, J04.0, J05–J05.0, J05.11, J09–J15.8, J16–J16.9, J20–J21.9, J36–J36.0, K67.0–K67.8, K74.7–
K74.8, K93.0, M03.1, M12.1–M12.19, M49.0–M49.1, M73.0–M73.1, M89.6–M89.69, N70–N71.9, N73–N74.8, N96, 
N98–N98.9, O00–O07.9, O09–O16.9, O20–O26.93, O28–O36.93, O40–O48.1, O60–O77.9, O80–O92.79, O96–
P04.2, P04.5–P05.9, P07–P15.9, P19–P22.9, P23.0–P23.4, P24–P29.9, P35–P37.2, P37.5–P39.9, P50–P61.9, P70, 
P70.3–P72.9, P74–P78.9, P80–P81.9, P83–P84, P90–P94.9, P96, P96.3–P96.4, P96.8–P96.89, R19.7
HIV/AIDS and 
tuberculosis
2 010–019.9, 042–044.9, 137–137.9, 138.0–138.9, 730.4–730.6 A10–A14, A15–A19.9, B20–B24.9, B90–B90.9, K67.3, K93.0, M49.0, P37.0
Tuberculosis 3–4 010–019.9, 137–137.9, 138.0–138.9, 730.4–730.6 A10–A14, A15–A19.9, B90–B90.9, K67.3, K93.0, M49.0, P37.0
HIV/AIDS 3 042–044.9 B20–B24.9
HIV/AIDS - 
Tuberculosis
4 B20.0
HIV/AIDS result-
ing in other 
diseases
4 042.0–042.9, 043.0–043.9, 044.1–044.9 B20.1–B23.9, B24.0
Diarrhea, lower 
respiratory, and 
other common 
infectious 
diseases
2 001–001.9, 002.0–009.9, 032–033.9, 036–036.40, 036.5, 036.8–037.9, 047–049.9, 
052–053.9, 055–055.9, 062–064.9, 073.0–073.6, 139.0, 320.0–320.89, 321–323, 323.1, 
323.4–323.9, 381–383.9, 461–461.9, 464.0, 464.01, 464.11–464.2, 464.21, 464.31–
464.4, 464.8–464.9, 466–469, 470.0, 475–475.9, 476.9, 480–482.89, 483.0–483.9, 
484.0–484.4, 484.6–484.7, 487–489, 771.3, 787.91
A00–A00.9, A01.0–A09.9, A33–A37.91, A39–A39.4, A39.8–A39.9, A48.1, A70, A83–A87.9, B01–B02.9, B05–B05.9, 
B94.1, D86.81, F07.1, G00.0–G00.8, G03–G03.8, G04–G05.8, H70–H70.93, J01–J01.91, J04.0, J05–J05.0, J05.11, 
J09–J15.8, J16–J16.9, J20–J21.9, J36–J36.0, P23.0–P23.4, P35.8, R19.7
Diarrheal 
diseases
3–4 001–001.9, 003–006.9, 007.4–007.8, 008.01–008.02, 008.04, 008.2–009.9, 787.91 A00–A00.9, A02–A04.1, A04.3, A04.5–A07, A07.2–A07.4, A08–A09.9, R19.7
Intestinal infec-
tious diseases
3 002.0–002.9, 007–007.3, 007.9–008.00, 008.03, 008.09–008.1 A01.0–A01.4, A04.2, A04.4, A07.0–A07.1, A07.8–A07.9
Typhoid fever 4 2 A01.0–A01.09
Paratyphoid 
fever
4 002.1–002.9 A01.1–A01.4
Other intestinal 
infectious 
diseases
4 007–007.3, 007.9–008.00, 008.03, 008.09–008.1 A04.2, A04.4, A07.0–A07.1, A07.8–A07.9
Lower respira-
tory infections
3–4 073.0–073.6, 466–469, 470.0, 480–482.89, 483.0–483.9, 484.1–484.2, 484.6–484.7, 
487–489
A48.1, A70, J09–J15.8, J16–J16.9, J20–J21.9, P23.0–P23.4
Upper respira-
tory infections
3–4 461–461.9, 464.0, 464.01, 464.11–464.2, 464.21, 464.31–464.4, 464.8–464.9, 
475–475.9, 476.9
J01–J01.91, J04.0, J05–J05.0, J05.11, J36–J36.0
Otitis media 3–4 381–383.9 H70–H70.93
Meningitis 3 036–036.40, 036.5, 036.8–036.9, 047–049.9, 320.0–320.89, 321–322.9 A39–A39.4, A39.8–A39.9, A87–A87.9, D86.81, G00.0–G00.8, G03–G03.8
Pneumococcal 
meningitis
4 320.1 G00.1
H influenzae 
type B menin-
gitis
4 320 G00.0
161
Chapter 5 - US County-Level Trends in Mortality Rates for Major Causes of Death
eTable 3. GBD cause list and associated ICD9 and ICD10 codes.
Cause Level ICD9 ICD10
Communi-
cable, maternal, 
neonatal, and 
nutritional 
diseases
1 001–001.9, 002.0–030.9, 032–034.9, 036–036.40, 036.5, 036.8–037.9, 039–039.4, 
039.8–040, 040.1–041.09, 042–066.9, 070–070.21, 070.3–070.31, 070.4–070.43, 
070.49–070.53, 070.59–074.1, 074.20, 074.3–075.9, 078.4–078.7, 079–079.7, 080–
083.9, 084.0–084.5, 084.7–084.9, 085.0, 086–088.9, 090–101.6, 104–104.9, 120–124.9, 
125.4–125.9, 127–127.1, 128–129.0, 136–136.29, 137–139.0, 244.2, 260–263.9, 265–
269.9, 280.1–280.8, 281.0–281.9, 320.0–320.89, 321–323.9, 381–383.9, 390–390.9, 
392, 392.9, 461–461.9, 464.0, 464.01, 464.11–464.2, 464.21, 464.31–464.4, 464.8–
464.9, 466–469, 470.0, 475–475.9, 476.9, 480–482.89, 483.0–483.9, 484.0–484.7, 487–
489, 613–614.9, 630–636.92, 638–638.92, 640–679.14, 716.0–716.09, 730.4–730.6, 
760–760.64, 760.8–768, 768.2–770, 770.1–775, 775.4–779.34, 779.6–779.89, 787.91
A00–A00.9, A01.0–A14, A15–A28.9, A30–A30.9, A32–A39.4, A39.8–A39.9, A48.1–A48.2, A48.4–A48.52, A49.1, 
A50–A58, A60–A60.9, A63–A63.8, A65–A65.0, A68–A70, A74, A74.8–A75.9, A77–A96.9, A98–A98.8, B00–B06.9, 
B10–B10.89, B15–B17.9, B19–B27.99, B29.4, B33–B33.1, B33.3–B33.8, B47–B48.8, B50–B53.8, B55.0, B56–B57.5, 
B60–B60.8, B63, B65–B67.99, B69–B72.0, B74.3–B75, B77–B77.9, B83–B83.8, B90–B92, B94.1–B94.2, B95–B95.5, 
D50.1–D50.8, D51–D52.0, D52.8–D53.9, D64.3, D86.81, E00–E02, E40–E46.9, E51–E61.9, E63–E64.0, E64.2–E64.9, 
F07.1, G00.0–G00.8, G03–G03.8, G04–G05.8, G14–G14.6, H70–H70.93, I00, I02, I02.9, I98.0–I98.1, J01–J01.91, 
J02.0, J03.0–J03.01, J04.0, J05–J05.0, J05.11, J09–J15.8, J16–J16.9, J20–J21.9, J36–J36.0, K67.0–K67.8, K74.7–
K74.8, K93.0, M03.1, M12.1–M12.19, M49.0–M49.1, M73.0–M73.1, M89.6–M89.69, N70–N71.9, N73–N74.8, N96, 
N98–N98.9, O00–O07.9, O09–O16.9, O20–O26.93, O28–O36.93, O40–O48.1, O60–O77.9, O80–O92.79, O96–
P04.2, P04.5–P05.9, P07–P15.9, P19–P22.9, P23.0–P23.4, P24–P29.9, P35–P37.2, P37.5–P39.9, P50–P61.9, P70, 
P70.3–P72.9, P74–P78.9, P80–P81.9, P83–P84, P90–P94.9, P96, P96.3–P96.4, P96.8–P96.89, R19.7
HIV/AIDS and 
tuberculosis
2 010–019.9, 042–044.9, 137–137.9, 138.0–138.9, 730.4–730.6 A10–A14, A15–A19.9, B20–B24.9, B90–B90.9, K67.3, K93.0, M49.0, P37.0
Tuberculosis 3–4 010–019.9, 137–137.9, 138.0–138.9, 730.4–730.6 A10–A14, A15–A19.9, B90–B90.9, K67.3, K93.0, M49.0, P37.0
HIV/AIDS 3 042–044.9 B20–B24.9
HIV/AIDS - 
Tuberculosis
4 B20.0
HIV/AIDS result-
ing in other 
diseases
4 042.0–042.9, 043.0–043.9, 044.1–044.9 B20.1–B23.9, B24.0
Diarrhea, lower 
respiratory, and 
other common 
infectious 
diseases
2 001–001.9, 002.0–009.9, 032–033.9, 036–036.40, 036.5, 036.8–037.9, 047–049.9, 
052–053.9, 055–055.9, 062–064.9, 073.0–073.6, 139.0, 320.0–320.89, 321–323, 323.1, 
323.4–323.9, 381–383.9, 461–461.9, 464.0, 464.01, 464.11–464.2, 464.21, 464.31–
464.4, 464.8–464.9, 466–469, 470.0, 475–475.9, 476.9, 480–482.89, 483.0–483.9, 
484.0–484.4, 484.6–484.7, 487–489, 771.3, 787.91
A00–A00.9, A01.0–A09.9, A33–A37.91, A39–A39.4, A39.8–A39.9, A48.1, A70, A83–A87.9, B01–B02.9, B05–B05.9, 
B94.1, D86.81, F07.1, G00.0–G00.8, G03–G03.8, G04–G05.8, H70–H70.93, J01–J01.91, J04.0, J05–J05.0, J05.11, 
J09–J15.8, J16–J16.9, J20–J21.9, J36–J36.0, P23.0–P23.4, P35.8, R19.7
Diarrheal 
diseases
3–4 001–001.9, 003–006.9, 007.4–007.8, 008.01–008.02, 008.04, 008.2–009.9, 787.91 A00–A00.9, A02–A04.1, A04.3, A04.5–A07, A07.2–A07.4, A08–A09.9, R19.7
Intestinal infec-
tious diseases
3 002.0–002.9, 007–007.3, 007.9–008.00, 008.03, 008.09–008.1 A01.0–A01.4, A04.2, A04.4, A07.0–A07.1, A07.8–A07.9
Typhoid fever 4 2 A01.0–A01.09
Paratyphoid 
fever
4 002.1–002.9 A01.1–A01.4
Other intestinal 
infectious 
diseases
4 007–007.3, 007.9–008.00, 008.03, 008.09–008.1 A04.2, A04.4, A07.0–A07.1, A07.8–A07.9
Lower respira-
tory infections
3–4 073.0–073.6, 466–469, 470.0, 480–482.89, 483.0–483.9, 484.1–484.2, 484.6–484.7, 
487–489
A48.1, A70, J09–J15.8, J16–J16.9, J20–J21.9, P23.0–P23.4
Upper respira-
tory infections
3–4 461–461.9, 464.0, 464.01, 464.11–464.2, 464.21, 464.31–464.4, 464.8–464.9, 
475–475.9, 476.9
J01–J01.91, J04.0, J05–J05.0, J05.11, J36–J36.0
Otitis media 3–4 381–383.9 H70–H70.93
Meningitis 3 036–036.40, 036.5, 036.8–036.9, 047–049.9, 320.0–320.89, 321–322.9 A39–A39.4, A39.8–A39.9, A87–A87.9, D86.81, G00.0–G00.8, G03–G03.8
Pneumococcal 
meningitis
4 320.1 G00.1
H influenzae 
type B menin-
gitis
4 320 G00.0
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Cause Level ICD9 ICD10
Meningococcal 
meningitis
4 036–036.40, 036.5, 036.8–036.9 A39–A39.4, A39.8–A39.9
Other menin-
gitis
4 047–049.9, 320.2–320.89, 321–322.9 A87–A87.9, D86.81, G00.2–G00.8, G03–G03.8
Encephalitis 3–4 062–064.9, 139.0, 323, 323.4–323.9 A83–A86.4, B94.1, F07.1, G04–G05.8
Diphtheria 3–4 032–032.9 A36–A36.9
Whooping 
cough
3–4 033–033.9, 484.3–484.4 A37–A37.91
Tetanus 3–4 037–037.9, 771.3 A33–A35.0
Measles 3–4 055–055.9, 323.1, 484.0 B05–B05.9
Varicella and 
herpes zoster
3–4 052–053.9 B01–B02.9, P35.8
Neglected tropi-
cal diseases and 
malaria
2 030–030.9, 060–061.8, 065–066.9, 071–071.9, 080, 080.2–083.9, 084.0–084.5, 
084.7–084.9, 085.0, 086–088.9, 120–124.9, 125.4–125.9, 127–127.1, 128–129.0
A30–A30.9, A68–A68.9, A69.2–A69.9, A75–A75.9, A77–A79.9, A82–A82.9, A90–A96.9, A98–A98.8, B33.0–B33.1, 
B50–B53.8, B55.0, B56–B57.5, B60–B60.8, B65–B67.99, B69–B72.0, B74.3–B75, B77–B77.9, B83–B83.8, B92, P37.1
Malaria 3–4 084.0–084.5, 084.7–084.9 B50–B53.8
Chagas disease 3–4 086–086.2, 086.9 B57–B57.5
Leishmaniasis 3 85 B55.0
Visceral leish-
maniasis
4 85 B55.0
African trypano-
somiasis
3–4 086.3–086.5 B56–B56.9
Schistosomiasis 3–4 120–120.9 B65–B65.9
Cysticercosis 3–4 123.1 B69–B69.9
Cystic echino-
coccosis
3–4 122–122.4, 122.8–122.9 B67–B67.4, B67.8–B67.99
Dengue 3–4 061–061.8 A90–A91.9
Yellow fever 3–4 060–060.9 A95–A95.9
Rabies 3–4 071–071.9 A82–A82.9
Intestinal nema-
tode infections
3 127 B77–B77.9
Ascariasis 4 127 B77–B77.9
Ebola 3–4 A98.4
Other ne-
glected tropical 
diseases
3–4 065–066.9, 080, 080.2–083.9, 087–088.9, 122.5–122.7, 123–123.0, 123.2–124.9, 
125.4–125.9, 127, 127.1, 128–129.0
A68–A68.9, A69.2–A69.9, A75–A75.9, A77–A79.9, A92–A94.0, A96–A96.9, A98–A98.3, A98.5–A98.8, B33.0–B33.1, 
B60–B60.8, B67.5–B67.7, B70–B72.0, B74.3–B75, B83–B83.8, P37.1
Maternal dis-
orders
2 630–636.92, 638–638.92, 640–679.14 N96, N98–N98.9, O00–O07.9, O09–O16.9, O20–O26.93, O28–O36.93, O40–O48.1, O60–O77.9, O80–O92.79, 
O96–O99.91
Maternal hem-
orrhage
3–4 640–641.93, 661–661.93, 665, 666–666.9 O20–O20.9, O43.2–O43.239, O44–O46.93, O62–O62.9, O67–O67.9, O70, O72–O72.3
Maternal sepsis 
and other ma-
ternal infections
3–4 659.3–659.33, 670–670.9 O23–O23.93, O85–O86.89, O91–O91.23
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Cause Level ICD9 ICD10
Meningococcal 
meningitis
4 036–036.40, 036.5, 036.8–036.9 A39–A39.4, A39.8–A39.9
Other menin-
gitis
4 047–049.9, 320.2–320.89, 321–322.9 A87–A87.9, D86.81, G00.2–G00.8, G03–G03.8
Encephalitis 3–4 062–064.9, 139.0, 323, 323.4–323.9 A83–A86.4, B94.1, F07.1, G04–G05.8
Diphtheria 3–4 032–032.9 A36–A36.9
Whooping 
cough
3–4 033–033.9, 484.3–484.4 A37–A37.91
Tetanus 3–4 037–037.9, 771.3 A33–A35.0
Measles 3–4 055–055.9, 323.1, 484.0 B05–B05.9
Varicella and 
herpes zoster
3–4 052–053.9 B01–B02.9, P35.8
Neglected tropi-
cal diseases and 
malaria
2 030–030.9, 060–061.8, 065–066.9, 071–071.9, 080, 080.2–083.9, 084.0–084.5, 
084.7–084.9, 085.0, 086–088.9, 120–124.9, 125.4–125.9, 127–127.1, 128–129.0
A30–A30.9, A68–A68.9, A69.2–A69.9, A75–A75.9, A77–A79.9, A82–A82.9, A90–A96.9, A98–A98.8, B33.0–B33.1, 
B50–B53.8, B55.0, B56–B57.5, B60–B60.8, B65–B67.99, B69–B72.0, B74.3–B75, B77–B77.9, B83–B83.8, B92, P37.1
Malaria 3–4 084.0–084.5, 084.7–084.9 B50–B53.8
Chagas disease 3–4 086–086.2, 086.9 B57–B57.5
Leishmaniasis 3 85 B55.0
Visceral leish-
maniasis
4 85 B55.0
African trypano-
somiasis
3–4 086.3–086.5 B56–B56.9
Schistosomiasis 3–4 120–120.9 B65–B65.9
Cysticercosis 3–4 123.1 B69–B69.9
Cystic echino-
coccosis
3–4 122–122.4, 122.8–122.9 B67–B67.4, B67.8–B67.99
Dengue 3–4 061–061.8 A90–A91.9
Yellow fever 3–4 060–060.9 A95–A95.9
Rabies 3–4 071–071.9 A82–A82.9
Intestinal nema-
tode infections
3 127 B77–B77.9
Ascariasis 4 127 B77–B77.9
Ebola 3–4 A98.4
Other ne-
glected tropical 
diseases
3–4 065–066.9, 080, 080.2–083.9, 087–088.9, 122.5–122.7, 123–123.0, 123.2–124.9, 
125.4–125.9, 127, 127.1, 128–129.0
A68–A68.9, A69.2–A69.9, A75–A75.9, A77–A79.9, A92–A94.0, A96–A96.9, A98–A98.3, A98.5–A98.8, B33.0–B33.1, 
B60–B60.8, B67.5–B67.7, B70–B72.0, B74.3–B75, B83–B83.8, P37.1
Maternal dis-
orders
2 630–636.92, 638–638.92, 640–679.14 N96, N98–N98.9, O00–O07.9, O09–O16.9, O20–O26.93, O28–O36.93, O40–O48.1, O60–O77.9, O80–O92.79, 
O96–O99.91
Maternal hem-
orrhage
3–4 640–641.93, 661–661.93, 665, 666–666.9 O20–O20.9, O43.2–O43.239, O44–O46.93, O62–O62.9, O67–O67.9, O70, O72–O72.3
Maternal sepsis 
and other ma-
ternal infections
3–4 659.3–659.33, 670–670.9 O23–O23.93, O85–O86.89, O91–O91.23
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Cause Level ICD9 ICD10
Maternal 
hypertensive 
disorders
3–4 642–642.94 O10–O16.9
Maternal ob-
structed labor 
and uterine 
rupture
3–4 652–653.93, 660–660.93, 665.0–665.34 O32–O33.9, O64–O66.9, O71–O71.9
Maternal 
abortion, 
miscarriage, 
and ectopic 
pregnancy
3–4 630–636.92, 638–638.92, 646.3–646.33 N96, O00–O07.9
Indirect mater-
nal deaths
3–4 646–646.24, 646.4–649.9, 674–674.94 O24–O25.3, O98–O99.91
Late maternal 
deaths
3–4 O96–O97.9
Other maternal 
disorders
3–4 643–645.23, 650–651.93, 654–659.23, 659.4–659.93, 662–664.94, 665.4–665.94, 
667–669.94, 671–673.9, 675–679.14
N98–N98.9, O09–O09.93, O21–O22.93, O26–O26.93, O28–O31.8, O34–O36.93, O40–O43.199, O43.8–O43.93, 
O47–O48.1, O60–O61.9, O63–O63.9, O68–O69.9, O70.0–O70.9, O73–O77.9, O80–O84.9, O87–O90.9, O92–
O92.79
Neonatal dis-
orders
2 760–760.64, 760.8–768, 768.2–770, 770.1–771, 771.4–775, 775.4–779.34, 779.6–
779.89
P00–P04.2, P04.5–P05.9, P07–P15.9, P19–P22.9, P24–P29.9, P36–P36.9, P38–P39.9, P50–P61.9, P70, P70.3–P72.9, 
P74–P78.9, P80–P81.9, P83–P84, P90–P94.9, P96, P96.3–P96.4, P96.8–P96.89
Neonatal 
preterm birth 
complications
3–4 761.0–761.1, 765–765.9, 769–769.9, 770.2–770.9, 776.6, 777.5–777.6 P01.0–P01.1, P07–P07.39, P22–P22.9, P25–P28.9, P61.2, P77–P77.9
Neonatal 
encephalopathy 
due to birth 
asphyxia and 
trauma
3–4 761.7–763.9, 767–768, 768.2–768.9, 770.1–770.18, 772.1–772.9, 779.0–779.2 P01.7, P02–P03.9, P10–P15.9, P20–P21.9, P24–P24.9, P90–P91.9
Neonatal sepsis 
and other neo-
natal infections
3–4 771.4–771.9 P36–P36.9, P38–P39.9
Hemolytic 
disease and 
other neonatal 
jaundice
3–4 773–774.9 P55–P59.9
Other neonatal 
disorders
3–4 760–760.64, 760.8–761, 761.2–761.6, 764–764.99, 766–766.9, 770, 771, 772–772.0, 
775, 775.4–776.5, 776.7–777.4, 777.7–779, 779.3–779.34, 779.6–779.89
P00–P01, P01.2–P01.6, P01.8–P01.9, P04–P04.2, P04.5–P05.9, P08–P09, P19–P19.9, P29–P29.9, P50–P54.9, P60–
P61.1, P61.3–P61.9, P70, P70.3–P72.9, P74–P76.9, P78–P78.9, P80–P81.9, P83–P84, P92–P94.9, P96, P96.3–P96.4, 
P96.8–P96.89
Nutritional 
deficiencies
2 244.2, 260–263.9, 265–269.9, 280.1–280.8, 281.0–281.9, 716.0–716.09 D50.1–D50.8, D51–D52.0, D52.8–D53.9, D64.3, E00–E02, E40–E46.9, E51–E61.9, E63–E64.0, E64.2–E64.9, M12.1–
M12.19
Protein-energy 
malnutrition
3–4 260–263.9 E40–E46.9, E64.0
Iodine defi-
ciency
3–4 244.2 E00–E02
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Cause Level ICD9 ICD10
Maternal 
hypertensive 
disorders
3–4 642–642.94 O10–O16.9
Maternal ob-
structed labor 
and uterine 
rupture
3–4 652–653.93, 660–660.93, 665.0–665.34 O32–O33.9, O64–O66.9, O71–O71.9
Maternal 
abortion, 
miscarriage, 
and ectopic 
pregnancy
3–4 630–636.92, 638–638.92, 646.3–646.33 N96, O00–O07.9
Indirect mater-
nal deaths
3–4 646–646.24, 646.4–649.9, 674–674.94 O24–O25.3, O98–O99.91
Late maternal 
deaths
3–4 O96–O97.9
Other maternal 
disorders
3–4 643–645.23, 650–651.93, 654–659.23, 659.4–659.93, 662–664.94, 665.4–665.94, 
667–669.94, 671–673.9, 675–679.14
N98–N98.9, O09–O09.93, O21–O22.93, O26–O26.93, O28–O31.8, O34–O36.93, O40–O43.199, O43.8–O43.93, 
O47–O48.1, O60–O61.9, O63–O63.9, O68–O69.9, O70.0–O70.9, O73–O77.9, O80–O84.9, O87–O90.9, O92–
O92.79
Neonatal dis-
orders
2 760–760.64, 760.8–768, 768.2–770, 770.1–771, 771.4–775, 775.4–779.34, 779.6–
779.89
P00–P04.2, P04.5–P05.9, P07–P15.9, P19–P22.9, P24–P29.9, P36–P36.9, P38–P39.9, P50–P61.9, P70, P70.3–P72.9, 
P74–P78.9, P80–P81.9, P83–P84, P90–P94.9, P96, P96.3–P96.4, P96.8–P96.89
Neonatal 
preterm birth 
complications
3–4 761.0–761.1, 765–765.9, 769–769.9, 770.2–770.9, 776.6, 777.5–777.6 P01.0–P01.1, P07–P07.39, P22–P22.9, P25–P28.9, P61.2, P77–P77.9
Neonatal 
encephalopathy 
due to birth 
asphyxia and 
trauma
3–4 761.7–763.9, 767–768, 768.2–768.9, 770.1–770.18, 772.1–772.9, 779.0–779.2 P01.7, P02–P03.9, P10–P15.9, P20–P21.9, P24–P24.9, P90–P91.9
Neonatal sepsis 
and other neo-
natal infections
3–4 771.4–771.9 P36–P36.9, P38–P39.9
Hemolytic 
disease and 
other neonatal 
jaundice
3–4 773–774.9 P55–P59.9
Other neonatal 
disorders
3–4 760–760.64, 760.8–761, 761.2–761.6, 764–764.99, 766–766.9, 770, 771, 772–772.0, 
775, 775.4–776.5, 776.7–777.4, 777.7–779, 779.3–779.34, 779.6–779.89
P00–P01, P01.2–P01.6, P01.8–P01.9, P04–P04.2, P04.5–P05.9, P08–P09, P19–P19.9, P29–P29.9, P50–P54.9, P60–
P61.1, P61.3–P61.9, P70, P70.3–P72.9, P74–P76.9, P78–P78.9, P80–P81.9, P83–P84, P92–P94.9, P96, P96.3–P96.4, 
P96.8–P96.89
Nutritional 
deficiencies
2 244.2, 260–263.9, 265–269.9, 280.1–280.8, 281.0–281.9, 716.0–716.09 D50.1–D50.8, D51–D52.0, D52.8–D53.9, D64.3, E00–E02, E40–E46.9, E51–E61.9, E63–E64.0, E64.2–E64.9, M12.1–
M12.19
Protein-energy 
malnutrition
3–4 260–263.9 E40–E46.9, E64.0
Iodine defi-
ciency
3–4 244.2 E00–E02
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Cause Level ICD9 ICD10
Iron-deficiency 
anemia
3–4 280.1–280.8 D50.1–D50.8, D64.3
Other nutrition-
al deficiencies
3–4 265–269.9, 281.0–281.9, 716.0–716.09 D51–D52.0, D52.8–D53.9, E51–E61.9, E63–E64, E64.2–E64.3, M12.1–M12.19
Other com-
municable, ma-
ternal, neonatal, 
and nutritional 
diseases
2 020–029, 034–034.9, 039–039.4, 039.8–040, 040.1–041.09, 045–046.9, 050–051.9, 
054–054.9, 056–059.9, 070–070.21, 070.3–070.31, 070.4–070.43, 070.49–070.53, 
070.59–070.9, 072–073, 073.7–074.1, 074.20, 074.3–075.9, 078.4–078.7, 079–079.7, 
080.0, 090–101.6, 104–104.9, 136–136.29, 138, 139, 323.0–323.02, 323.2–323.3, 
390–390.9, 392, 392.9, 484.5, 613–614.9, 771.0–771.2
A20–A28.9, A32–A32.9, A38–A38.9, A48.2, A48.4–A48.52, A49.1, A50–A58, A60–A60.9, A63–A63.8, A65–A65.0, 
A69–A69.1, A74, A74.8–A74.9, A80–A81.9, A88–A89.9, B00–B00.9, B03–B04, B06–B06.9, B10–B10.89, B15–B17.9, 
B19–B19.9, B25–B27.99, B29.4, B33, B33.3–B33.8, B47–B48.8, B63, B91, B94.2, B95–B95.5, G14–G14.6, I00, I02, 
I02.9, I98.0–I98.1, J02.0, J03.0–J03.01, K67.0–K67.2, K67.8, K74.7–K74.8, M03.1, M49.1, M73.0–M73.1, M89.6–
M89.69, N70–N71.9, N73–N74.8, P35–P35.3, P35.9, P37, P37.2, P37.5–P37.9
Sexually trans-
mitted diseases 
excluding HIV
3 054.1, 090–099.9, 613–614.9 A50–A58, A60–A60.9, A63–A63.8, B63, I98.0, K67.0–K67.2, M03.1, M73.0–M73.1, N70–N71.9, N73–N74.8
Syphilis 4 090–097.9 A50–A53.9, I98.0, K67.2, M03.1, M73.1
Chlamydial 
infection
4 099, 099.1–099.6 A55–A56.8, K67.0
Gonococcal 
infection
4 098–098.9 A54–A54.9, K67.1, M73.0
Other sexu-
ally transmitted 
diseases
4 099.0, 099.8–099.9 A57–A58, A63–A63.8
Hepatitis 3–4 070–070.21, 070.3–070.31, 070.4–070.43, 070.49–070.53, 070.59–070.9 B15–B17.9, B19–B19.9, B94.2, P35.3
Other infectious 
diseases
3–4 020–029, 034–034.9, 039–039.4, 039.8–040, 040.1–041.09, 045–046.9, 050–051.9, 
054–054.0, 054.10–054.9, 056–059.9, 072–073, 073.7–074.1, 074.20, 074.3–075.9, 
078.4–078.7, 079–079.7, 080.0, 100–101.6, 104–104.9, 136–136.29, 138, 139, 
323.0–323.02, 323.2–323.3, 390–390.9, 392, 392.9, 484.5, 771.0–771.2
A20–A28.9, A32–A32.9, A38–A38.9, A48.2, A48.4–A48.52, A49.1, A65–A65.0, A69–A69.1, A74, A74.8–A74.9, 
A80–A81.9, A88–A89.9, B00–B00.9, B03–B04, B06–B06.9, B10–B10.89, B25–B27.99, B29.4, B33, B33.3–B33.8, 
B47–B48.8, B91, B95–B95.5, G14–G14.6, I00, I02, I02.9, I98.1, J02.0, J03.0–J03.01, K67.8, K74.7–K74.8, M49.1, 
M89.6–M89.69, P35–P35.2, P35.9, P37, P37.2, P37.5–P37.9
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Cause Level ICD9 ICD10
Iron-deficiency 
anemia
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al deficiencies
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054–054.9, 056–059.9, 070–070.21, 070.3–070.31, 070.4–070.43, 070.49–070.53, 
070.59–070.9, 072–073, 073.7–074.1, 074.20, 074.3–075.9, 078.4–078.7, 079–079.7, 
080.0, 090–101.6, 104–104.9, 136–136.29, 138, 139, 323.0–323.02, 323.2–323.3, 
390–390.9, 392, 392.9, 484.5, 613–614.9, 771.0–771.2
A20–A28.9, A32–A32.9, A38–A38.9, A48.2, A48.4–A48.52, A49.1, A50–A58, A60–A60.9, A63–A63.8, A65–A65.0, 
A69–A69.1, A74, A74.8–A74.9, A80–A81.9, A88–A89.9, B00–B00.9, B03–B04, B06–B06.9, B10–B10.89, B15–B17.9, 
B19–B19.9, B25–B27.99, B29.4, B33, B33.3–B33.8, B47–B48.8, B63, B91, B94.2, B95–B95.5, G14–G14.6, I00, I02, 
I02.9, I98.0–I98.1, J02.0, J03.0–J03.01, K67.0–K67.2, K67.8, K74.7–K74.8, M03.1, M49.1, M73.0–M73.1, M89.6–
M89.69, N70–N71.9, N73–N74.8, P35–P35.3, P35.9, P37, P37.2, P37.5–P37.9
Sexually trans-
mitted diseases 
excluding HIV
3 054.1, 090–099.9, 613–614.9 A50–A58, A60–A60.9, A63–A63.8, B63, I98.0, K67.0–K67.2, M03.1, M73.0–M73.1, N70–N71.9, N73–N74.8
Syphilis 4 090–097.9 A50–A53.9, I98.0, K67.2, M03.1, M73.1
Chlamydial 
infection
4 099, 099.1–099.6 A55–A56.8, K67.0
Gonococcal 
infection
4 098–098.9 A54–A54.9, K67.1, M73.0
Other sexu-
ally transmitted 
diseases
4 099.0, 099.8–099.9 A57–A58, A63–A63.8
Hepatitis 3–4 070–070.21, 070.3–070.31, 070.4–070.43, 070.49–070.53, 070.59–070.9 B15–B17.9, B19–B19.9, B94.2, P35.3
Other infectious 
diseases
3–4 020–029, 034–034.9, 039–039.4, 039.8–040, 040.1–041.09, 045–046.9, 050–051.9, 
054–054.0, 054.10–054.9, 056–059.9, 072–073, 073.7–074.1, 074.20, 074.3–075.9, 
078.4–078.7, 079–079.7, 080.0, 100–101.6, 104–104.9, 136–136.29, 138, 139, 
323.0–323.02, 323.2–323.3, 390–390.9, 392, 392.9, 484.5, 771.0–771.2
A20–A28.9, A32–A32.9, A38–A38.9, A48.2, A48.4–A48.52, A49.1, A65–A65.0, A69–A69.1, A74, A74.8–A74.9, 
A80–A81.9, A88–A89.9, B00–B00.9, B03–B04, B06–B06.9, B10–B10.89, B25–B27.99, B29.4, B33, B33.3–B33.8, 
B47–B48.8, B91, B95–B95.5, G14–G14.6, I00, I02, I02.9, I98.1, J02.0, J03.0–J03.01, K67.8, K74.7–K74.8, M49.1, 
M89.6–M89.69, P35–P35.2, P35.9, P37, P37.2, P37.5–P37.9
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Cause Level ICD9 ICD10
Non-communi-
cable diseases
1 035–035.9, 036.41–036.43, 036.6, 070.22–070.23, 070.32–070.33, 070.44, 070.54, 
074.2, 074.21–074.23, 102–103.9, 133–133.6, 135–135.9, 136.6, 140–148.9, 150–
158.9, 160–164.9, 170–175.9, 180–183.8, 184.0–184.4, 184.8, 185–186.9, 187.1–187.8, 
188–188.9, 189.0–189.8, 190–194.8, 200–208.92, 209.0–209.17, 209.21–209.27, 
209.31–209.57, 209.61, 209.63–209.67, 210.0–210.9, 211.0–211.8, 212.0–212.8, 
213–213.9, 217–220.9, 221.0–221.8, 222.0–222.8, 223.0–223.89, 224–228.9, 229.0, 
229.8, 230.1–230.8, 231.0–231.2, 232–232.9, 233.0–233.2, 233.31–233.32, 233.4–
233.5, 233.7, 234.0–234.8, 235.0, 235.4, 235.6–235.8, 236.0–236.2, 236.4–236.5, 236.7, 
236.91–237.3, 237.5–237.9, 238.0–238.5, 239.2–239.4, 239.6, 240–243.9, 244.0–244.1, 
244.3–244.8, 245–246.9, 250–259.9, 270–273.9, 275–276, 277–277.2, 277.4–277.9, 
278.0–278.8, 282–284.9, 286–286.5, 286.7–289.7, 290–292.9, 294.1–295.95, 303–
303.93, 304.0–304.83, 305–305.93, 307.1, 307.51, 307.54, 327.2–327.8, 330–331.2, 
331.5–337.9, 340–341.9, 345–345.91, 349–349.8, 353.6–353.9, 356–356.9, 357.0–
357.7, 358–359.9, 376.0–376.1, 391–391.9, 392.0, 393–398.99, 402–404.93, 410–414.9, 
416.1, 417–417.9, 420–423, 423.1–425.9, 427–427.32, 427.6–427.89, 429.0–429.1, 
430–435.9, 437.0–437.2, 437.4–437.8, 441–443.9, 446–457.9, 459, 459.1–459.39, 470, 
470.9–474.9, 476–476.1, 477–479, 490–504.9, 506–506.9, 508–509, 515, 516–517.8, 
518.6–518.7, 518.9, 519.0–519.4, 530–536.1, 536.4–536.49, 537–537.6, 537.8–537.84, 
538–543.9, 550–553.6, 555–558.9, 560–560.39, 560.8–560.9, 562–562.13, 564–564.7, 
565–566.9, 569.0–569.44, 569.5–569.71, 569.84–569.85, 571–571.9, 572.3–572.9, 
573.0–573.4, 573.8–577.9, 579–583.9, 585–585.9, 588–590.9, 592–593.89, 594–
599.69, 599.8–599.89, 601–602.9, 604–604.99, 608.2–608.24, 610–610.9, 617–618.9, 
620–620.9, 621.4–621.9, 622.3–622.7, 629–629.81, 680–689, 694–695.59, 707–707.9, 
710–711.99, 714–714.33, 714.8–714.9, 728.86, 728.88, 730.1–730.19, 732–732.9, 
733.0–733.19, 740–749.04, 749.2–758.9, 759.0–759.89, 760.7–760.79, 775.0–775.3, 
779.4–779.5, 780.57, 780.59, 780.62–780.63, 786.03, 787.1, 788.0, 790.2–790.22, 
790.3, 798–798.0, E850–E850.29, E850.9–E854.39, E860–E860.19
A39.5–A39.53, A46–A46.0, A66–A67.9, B18–B18.9, B33.2–B33.24, B86, C0–C13.9, C15–C25.9, C3–C34.92, 
C37–C38.8, C4–C41.9, C43–C45.9, C47–C54.9, C56–C57.8, C58–C58.0, C60–C63.8, C64–C67.9, C68.0–C68.8, 
C69–C75.8, C81–C86.6, C88–C96.9, D00.00–D00.2, D01.0–D01.3, D02.0–D02.3, D03–D06.9, D07.0–D07.2, 
D07.4–D07.5, D09.0, D09.2–D09.3, D09.8, D10.0–D10.7, D11–D12.9, D13.0–D13.7, D14.0–D14.32, D15–D16.9, 
D22–D27.9, D28.0–D28.7, D29.0–D29.8, D30.0–D30.8, D31–D36, D36.1–D36.7, D37.01–D37.5, D38.0–D38.5, 
D39.1–D39.2, D39.8, D40.0–D40.8, D41.0–D41.8, D42–D43.9, D44.0–D44.8, D45–D45.9, D47–D47.0, D47.2–
D47.9, D48.0–D48.62, D49.2–D49.4, D49.6, D49.81, D52.1, D55–D58.9, D59.0–D59.3, D59.5–D59.6, D60–D61.9, 
D63.1, D64.0, D64.4, D66–D67, D68.0–D69.8, D70–D75.89, D76–D78.89, D86–D86.8, D86.82–D86.9, D89–D89.3, 
E03–E07.1, E09–E14.9, E15.0, E16.0–E16.9, E20–E34.8, E36–E36.8, E65–E68, E70–E85.29, E87.71, E88–E89.9, F00–
F03.91, F06.2, F10–F16.99, F18–F29.9, F50.0–F50.5, G10–G13.8, G20–G26.0, G30–G31.9, G35–G37.9, G40–G41.9, 
G45–G46.8, G47.3–G47.39, G61–G61.9, G70–G73.7, G90–G90.9, G93.7, G95–G95.9, G97–G97.9, H05.0–H05.119, 
I01–I01.9, I02.0, I05–I09.9, I11–I13.9, I20–I25.9, I27.1, I28–I28.8, I30–I31.1, I31.8–I43.9, I47–I48.92, I51.0–I51.5, 
I60–I61.9, I62.0–I62.03, I63–I63.9, I65–I66.9, I67.0–I67.3, I67.5–I67.7, I68.0–I68.2, I69.0–I69.398, I70.2–I70.799, 
I71–I73.9, I77–I89.9, I91.9, I95.2–I95.3, I97–I98, I98.2, I98.9, J30–J35.9, J37–J47.9, J60–J63.8, J65–J68.9, J70–J70.9, 
J82, J84–J84.9, J91–J92.9, J95–J95.9, K20–K29.91, K31–K31.89, K35–K38.9, K40–K46.9, K50–K52.9, K55–K62.9, 
K63.5, K64–K64.9, K66.8, K67, K68–K68.9, K70–K70.9, K71.3–K71.51, K71.7, K72.1–K74.69, K74.9, K75.2–K77.8, 
K80–K83.9, K85–K86.9, K90–K91.9, K92.8–K92.89, K94–K95.89, L00–L05.92, L08–L08.9, L10–L14.0, L51–L51.9, 
L88–L89.95, L93–L93.2, L97–L98.499, M00–M03.0, M03.2–M03.6, M05–M09.8, M30–M36.8, M40–M43.19, M65–
M65.08, M71.0–M71.19, M80–M82.8, M86.3–M86.49, M87–M87.19, M88–M89.09, M89.5–M89.59, M89.7–M89.9, 
N00–N08.8, N10–N12.9, N14–N16.8, N18–N18.9, N20–N23.0, N25–N32.0, N32.3–N32.4, N34–N34.3, N36–N36.9, 
N39–N39.2, N41–N41.9, N44–N44.04, N45–N45.9, N49–N49.9, N60–N60.99, N65–N65.1, N72–N72.0, N75–N77.8, 
N80–N81.9, N83–N83.9, N84.0–N84.1, N87–N87.9, N99–N99.9, P04.3–P04.49, P70.0–P70.2, P96.0–P96.2, P96.5, 
Q00–Q07.9, Q10.4–Q18.9, Q20–Q28.9, Q30–Q36, Q37–Q45.9, Q50–Q87.89, Q89–Q89.8, Q90–Q93.9, Q95–Q99.8, 
R50.2, R50.82–R50.83, R73–R73.9, R78.0–R78.5, R95, X45–X45.9 
Neoplasms 2 140–148.9, 150–158.9, 160–164.9, 170–175.9, 180–183.8, 184.0–184.4, 184.8, 185–
186.9, 187.1–187.8, 188–188.9, 189.0–189.8, 190–194.8, 200–208.92, 209.0–209.17, 
209.21–209.27, 209.31–209.57, 209.61, 209.63–209.67, 210.0–210.9, 211.0–211.8, 
212.0–212.8, 213–213.9, 217–217.8, 219.0, 220–220.9, 221.0–221.8, 222.0–222.8, 
223.0–223.89, 224–228.9, 229.0, 229.8, 230.1–230.8, 231.0–231.2, 232–232.9, 233.0–
233.2, 233.31–233.32, 233.4–233.5, 233.7, 234.0–234.8, 235.0, 235.4, 235.6–235.8, 
236.1–236.2, 236.4–236.5, 236.7, 236.91–237.3, 237.5–237.9, 238.0–238.5, 239.2–
239.4, 239.6, 569.0, 569.43–569.44, 569.84–569.85, 610–610.9
C0–C13.9, C15–C25.9, C3–C34.92, C37–C38.8, C4–C41.9, C43–C45.9, C47–C54.9, C56–C57.8, C58–C58.0, C60–
C63.8, C64–C67.9, C68.0–C68.8, C69–C75.8, C81–C86.6, C88–C96.9, D00.00–D00.2, D01.0–D01.3, D02.0–D02.3, 
D03–D06.9, D07.0–D07.2, D07.4–D07.5, D09.0, D09.2–D09.3, D09.8, D10.0–D10.7, D11–D12.9, D13.0–D13.7, 
D14.0–D14.32, D15–D16.9, D22–D24.9, D26.0, D27–D27.9, D28.0–D28.1, D28.7, D29.0–D29.8, D30.0–D30.8, 
D31–D36, D36.1–D36.7, D37.01–D37.5, D38.0–D38.5, D39.1–D39.2, D39.8, D40.0–D40.8, D41.0–D41.8, D42–
D43.9, D44.0–D44.8, D45–D45.9, D47–D47.0, D47.2–D47.9, D48.0–D48.62, D49.2–D49.4, D49.6, D49.81, K31.7, 
K62.0–K62.1, K63.5, N60–N60.99, N84.0–N84.1, N87–N87.9
Lip and oral cav-
ity cancer
3–4 140–145.9, 210.0–210.6, 235.0 C0–C08.9, D00.00–D00.07, D10.0–D10.5, D11–D11.9, D37.01–D37.04, D37.09
Nasopharynx 
cancer
3–4 147–147.9, 210.7–210.9 C11–C11.9, D00.08, D10.6, D37.05
Other pharynx 
cancer
3–4 146–146.9, 148–148.9 C09–C10.9, C12–C13.9, D10.7
Esophageal 
cancer
3–4 150–150.9, 211.0, 230.1 C15–C15.9, D00.1, D13.0
Stomach cancer 3–4 151–151.9, 209.23, 209.63, 211.1, 230.2 C16–C16.9, D00.2, D13.1, D37.1
Colon and rec-
tum cancer
3–4 153–154.9, 209.1–209.17, 209.5–209.57, 211.3–211.4, 230.3–230.6 C18–C21.9, D01.0–D01.3, D12–D12.9, D37.3–D37.5
Liver cancer 3–4 155–155.9, 211.5 C22–C22.9, D13.4
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Cause Level ICD9 ICD10
Non-communi-
cable diseases
1 035–035.9, 036.41–036.43, 036.6, 070.22–070.23, 070.32–070.33, 070.44, 070.54, 
074.2, 074.21–074.23, 102–103.9, 133–133.6, 135–135.9, 136.6, 140–148.9, 150–
158.9, 160–164.9, 170–175.9, 180–183.8, 184.0–184.4, 184.8, 185–186.9, 187.1–187.8, 
188–188.9, 189.0–189.8, 190–194.8, 200–208.92, 209.0–209.17, 209.21–209.27, 
209.31–209.57, 209.61, 209.63–209.67, 210.0–210.9, 211.0–211.8, 212.0–212.8, 
213–213.9, 217–220.9, 221.0–221.8, 222.0–222.8, 223.0–223.89, 224–228.9, 229.0, 
229.8, 230.1–230.8, 231.0–231.2, 232–232.9, 233.0–233.2, 233.31–233.32, 233.4–
233.5, 233.7, 234.0–234.8, 235.0, 235.4, 235.6–235.8, 236.0–236.2, 236.4–236.5, 236.7, 
236.91–237.3, 237.5–237.9, 238.0–238.5, 239.2–239.4, 239.6, 240–243.9, 244.0–244.1, 
244.3–244.8, 245–246.9, 250–259.9, 270–273.9, 275–276, 277–277.2, 277.4–277.9, 
278.0–278.8, 282–284.9, 286–286.5, 286.7–289.7, 290–292.9, 294.1–295.95, 303–
303.93, 304.0–304.83, 305–305.93, 307.1, 307.51, 307.54, 327.2–327.8, 330–331.2, 
331.5–337.9, 340–341.9, 345–345.91, 349–349.8, 353.6–353.9, 356–356.9, 357.0–
357.7, 358–359.9, 376.0–376.1, 391–391.9, 392.0, 393–398.99, 402–404.93, 410–414.9, 
416.1, 417–417.9, 420–423, 423.1–425.9, 427–427.32, 427.6–427.89, 429.0–429.1, 
430–435.9, 437.0–437.2, 437.4–437.8, 441–443.9, 446–457.9, 459, 459.1–459.39, 470, 
470.9–474.9, 476–476.1, 477–479, 490–504.9, 506–506.9, 508–509, 515, 516–517.8, 
518.6–518.7, 518.9, 519.0–519.4, 530–536.1, 536.4–536.49, 537–537.6, 537.8–537.84, 
538–543.9, 550–553.6, 555–558.9, 560–560.39, 560.8–560.9, 562–562.13, 564–564.7, 
565–566.9, 569.0–569.44, 569.5–569.71, 569.84–569.85, 571–571.9, 572.3–572.9, 
573.0–573.4, 573.8–577.9, 579–583.9, 585–585.9, 588–590.9, 592–593.89, 594–
599.69, 599.8–599.89, 601–602.9, 604–604.99, 608.2–608.24, 610–610.9, 617–618.9, 
620–620.9, 621.4–621.9, 622.3–622.7, 629–629.81, 680–689, 694–695.59, 707–707.9, 
710–711.99, 714–714.33, 714.8–714.9, 728.86, 728.88, 730.1–730.19, 732–732.9, 
733.0–733.19, 740–749.04, 749.2–758.9, 759.0–759.89, 760.7–760.79, 775.0–775.3, 
779.4–779.5, 780.57, 780.59, 780.62–780.63, 786.03, 787.1, 788.0, 790.2–790.22, 
790.3, 798–798.0, E850–E850.29, E850.9–E854.39, E860–E860.19
A39.5–A39.53, A46–A46.0, A66–A67.9, B18–B18.9, B33.2–B33.24, B86, C0–C13.9, C15–C25.9, C3–C34.92, 
C37–C38.8, C4–C41.9, C43–C45.9, C47–C54.9, C56–C57.8, C58–C58.0, C60–C63.8, C64–C67.9, C68.0–C68.8, 
C69–C75.8, C81–C86.6, C88–C96.9, D00.00–D00.2, D01.0–D01.3, D02.0–D02.3, D03–D06.9, D07.0–D07.2, 
D07.4–D07.5, D09.0, D09.2–D09.3, D09.8, D10.0–D10.7, D11–D12.9, D13.0–D13.7, D14.0–D14.32, D15–D16.9, 
D22–D27.9, D28.0–D28.7, D29.0–D29.8, D30.0–D30.8, D31–D36, D36.1–D36.7, D37.01–D37.5, D38.0–D38.5, 
D39.1–D39.2, D39.8, D40.0–D40.8, D41.0–D41.8, D42–D43.9, D44.0–D44.8, D45–D45.9, D47–D47.0, D47.2–
D47.9, D48.0–D48.62, D49.2–D49.4, D49.6, D49.81, D52.1, D55–D58.9, D59.0–D59.3, D59.5–D59.6, D60–D61.9, 
D63.1, D64.0, D64.4, D66–D67, D68.0–D69.8, D70–D75.89, D76–D78.89, D86–D86.8, D86.82–D86.9, D89–D89.3, 
E03–E07.1, E09–E14.9, E15.0, E16.0–E16.9, E20–E34.8, E36–E36.8, E65–E68, E70–E85.29, E87.71, E88–E89.9, F00–
F03.91, F06.2, F10–F16.99, F18–F29.9, F50.0–F50.5, G10–G13.8, G20–G26.0, G30–G31.9, G35–G37.9, G40–G41.9, 
G45–G46.8, G47.3–G47.39, G61–G61.9, G70–G73.7, G90–G90.9, G93.7, G95–G95.9, G97–G97.9, H05.0–H05.119, 
I01–I01.9, I02.0, I05–I09.9, I11–I13.9, I20–I25.9, I27.1, I28–I28.8, I30–I31.1, I31.8–I43.9, I47–I48.92, I51.0–I51.5, 
I60–I61.9, I62.0–I62.03, I63–I63.9, I65–I66.9, I67.0–I67.3, I67.5–I67.7, I68.0–I68.2, I69.0–I69.398, I70.2–I70.799, 
I71–I73.9, I77–I89.9, I91.9, I95.2–I95.3, I97–I98, I98.2, I98.9, J30–J35.9, J37–J47.9, J60–J63.8, J65–J68.9, J70–J70.9, 
J82, J84–J84.9, J91–J92.9, J95–J95.9, K20–K29.91, K31–K31.89, K35–K38.9, K40–K46.9, K50–K52.9, K55–K62.9, 
K63.5, K64–K64.9, K66.8, K67, K68–K68.9, K70–K70.9, K71.3–K71.51, K71.7, K72.1–K74.69, K74.9, K75.2–K77.8, 
K80–K83.9, K85–K86.9, K90–K91.9, K92.8–K92.89, K94–K95.89, L00–L05.92, L08–L08.9, L10–L14.0, L51–L51.9, 
L88–L89.95, L93–L93.2, L97–L98.499, M00–M03.0, M03.2–M03.6, M05–M09.8, M30–M36.8, M40–M43.19, M65–
M65.08, M71.0–M71.19, M80–M82.8, M86.3–M86.49, M87–M87.19, M88–M89.09, M89.5–M89.59, M89.7–M89.9, 
N00–N08.8, N10–N12.9, N14–N16.8, N18–N18.9, N20–N23.0, N25–N32.0, N32.3–N32.4, N34–N34.3, N36–N36.9, 
N39–N39.2, N41–N41.9, N44–N44.04, N45–N45.9, N49–N49.9, N60–N60.99, N65–N65.1, N72–N72.0, N75–N77.8, 
N80–N81.9, N83–N83.9, N84.0–N84.1, N87–N87.9, N99–N99.9, P04.3–P04.49, P70.0–P70.2, P96.0–P96.2, P96.5, 
Q00–Q07.9, Q10.4–Q18.9, Q20–Q28.9, Q30–Q36, Q37–Q45.9, Q50–Q87.89, Q89–Q89.8, Q90–Q93.9, Q95–Q99.8, 
R50.2, R50.82–R50.83, R73–R73.9, R78.0–R78.5, R95, X45–X45.9 
Neoplasms 2 140–148.9, 150–158.9, 160–164.9, 170–175.9, 180–183.8, 184.0–184.4, 184.8, 185–
186.9, 187.1–187.8, 188–188.9, 189.0–189.8, 190–194.8, 200–208.92, 209.0–209.17, 
209.21–209.27, 209.31–209.57, 209.61, 209.63–209.67, 210.0–210.9, 211.0–211.8, 
212.0–212.8, 213–213.9, 217–217.8, 219.0, 220–220.9, 221.0–221.8, 222.0–222.8, 
223.0–223.89, 224–228.9, 229.0, 229.8, 230.1–230.8, 231.0–231.2, 232–232.9, 233.0–
233.2, 233.31–233.32, 233.4–233.5, 233.7, 234.0–234.8, 235.0, 235.4, 235.6–235.8, 
236.1–236.2, 236.4–236.5, 236.7, 236.91–237.3, 237.5–237.9, 238.0–238.5, 239.2–
239.4, 239.6, 569.0, 569.43–569.44, 569.84–569.85, 610–610.9
C0–C13.9, C15–C25.9, C3–C34.92, C37–C38.8, C4–C41.9, C43–C45.9, C47–C54.9, C56–C57.8, C58–C58.0, C60–
C63.8, C64–C67.9, C68.0–C68.8, C69–C75.8, C81–C86.6, C88–C96.9, D00.00–D00.2, D01.0–D01.3, D02.0–D02.3, 
D03–D06.9, D07.0–D07.2, D07.4–D07.5, D09.0, D09.2–D09.3, D09.8, D10.0–D10.7, D11–D12.9, D13.0–D13.7, 
D14.0–D14.32, D15–D16.9, D22–D24.9, D26.0, D27–D27.9, D28.0–D28.1, D28.7, D29.0–D29.8, D30.0–D30.8, 
D31–D36, D36.1–D36.7, D37.01–D37.5, D38.0–D38.5, D39.1–D39.2, D39.8, D40.0–D40.8, D41.0–D41.8, D42–
D43.9, D44.0–D44.8, D45–D45.9, D47–D47.0, D47.2–D47.9, D48.0–D48.62, D49.2–D49.4, D49.6, D49.81, K31.7, 
K62.0–K62.1, K63.5, N60–N60.99, N84.0–N84.1, N87–N87.9
Lip and oral cav-
ity cancer
3–4 140–145.9, 210.0–210.6, 235.0 C0–C08.9, D00.00–D00.07, D10.0–D10.5, D11–D11.9, D37.01–D37.04, D37.09
Nasopharynx 
cancer
3–4 147–147.9, 210.7–210.9 C11–C11.9, D00.08, D10.6, D37.05
Other pharynx 
cancer
3–4 146–146.9, 148–148.9 C09–C10.9, C12–C13.9, D10.7
Esophageal 
cancer
3–4 150–150.9, 211.0, 230.1 C15–C15.9, D00.1, D13.0
Stomach cancer 3–4 151–151.9, 209.23, 209.63, 211.1, 230.2 C16–C16.9, D00.2, D13.1, D37.1
Colon and rec-
tum cancer
3–4 153–154.9, 209.1–209.17, 209.5–209.57, 211.3–211.4, 230.3–230.6 C18–C21.9, D01.0–D01.3, D12–D12.9, D37.3–D37.5
Liver cancer 3–4 155–155.9, 211.5 C22–C22.9, D13.4
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eTable 3. GBD cause list and associated ICD9 and ICD10 codes. (continued)
Cause Level ICD9 ICD10
Gallbladder 
and biliary tract 
cancer
3–4 156–156.9, 209.25–209.27, 209.65–209.67 C23–C24.9, D13.5
Pancreatic 
cancer
3–4 157–157.9, 211.6–211.7 C25–C25.9, D13.6–D13.7
Larynx cancer 3–4 161–161.9, 212.1, 231.0, 235.6 C32–C32.9, D02.0, D14.1, D38.0
Tracheal, bron-
chus, and lung 
cancer
3–4 162–162.9, 209.21, 209.61, 212.2–212.3, 231.1–231.2, 235.7 C33–C34.92, D02.1–D02.3, D14.2–D14.32, D38.1
Malignant skin 
melanoma
3–4 172–172.9 C43–C43.9, D03–D03.9, D22–D23.9, D48.5
Non-melanoma 
skin cancer
3–4 173–173.99, 222.4, 232–232.9, 238.2 C44–C44.99, D04–D04.9, D49.2
Breast cancer 3–4 174–175.9, 217–217.8, 233.0, 238.3, 239.3, 610–610.9 C50–C50.929, D05–D05.92, D24–D24.9, D48.6–D48.62, D49.3, N60–N60.99
Cervical cancer 3–4 180–180.9, 219.0, 233.1 C53–C53.9, D06–D06.9, D26.0
Uterine cancer 3–4 182–182.8, 233.2 C54–C54.9, D07.0–D07.2, N87–N87.9
Ovarian cancer 3–4 183–183.0, 220–220.9, 236.2 C56–C56.9, D27–D27.9, D39.1–D39.12
Prostate cancer 3–4 185–185.9, 222.2, 236.5 C61–C61.9, D07.5, D29.1, D40.0
Testicular 
cancer
3–4 186–186.9, 222.0, 222.3, 236.4 C62–C62.92, D29.2–D29.8, D40.1–D40.8
Kidney cancer 3–4 189.0–189.1, 209.24, 209.64, 223.0–223.1, 236.91 C64–C65.9, D30.0–D30.12, D41.0–D41.12
Bladder cancer 3–4 188–188.9, 223.3, 233.7, 236.7, 239.4 C67–C67.9, D09.0, D30.3, D41.4–D41.8, D49.4
Brain and 
nervous system 
cancer
3–4 191–192.9 C70–C72.9
Thyroid cancer 3–4 193–193.9, 226–226.9 C73–C73.9, D09.3, D09.8, D34–D34.9, D44.0
Mesothelioma 3–4 158.9, 163–163.9, 212.4 C45–C45.9
Hodgkin lym-
phoma
3–4 201–201.98 C81–C81.99
Non-Hodgkin 
lymphoma
3–4 200–200.9, 202–202.98 C82–C86.6, C96–C96.9
Multiple my-
eloma
3–4 203–203.9 C88–C90.9
Leukemia 3 204–208.92 C91–C95.92
Acute lymphoid 
leukemia
4 204.0–204.02 C91.0–C91.02
Chronic lym-
phoid leukemia
4 204.1–204.12 C91.1–C91.12
Acute myeloid 
leukemia
4 205.0–205.02, 205.3–205.32, 206.0–206.02, 207.0 C92.0–C92.02, C92.3–C92.62, C93.0–C93.02, C94.0–C94.02, C94.2–C94.22, C94.4–C94.5
Chronic myeloid 
leukemia
4 205.1–205.12, 206.1–206.12, 207.1 C92.1–C92.12
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Cause Level ICD9 ICD10
Gallbladder 
and biliary tract 
cancer
3–4 156–156.9, 209.25–209.27, 209.65–209.67 C23–C24.9, D13.5
Pancreatic 
cancer
3–4 157–157.9, 211.6–211.7 C25–C25.9, D13.6–D13.7
Larynx cancer 3–4 161–161.9, 212.1, 231.0, 235.6 C32–C32.9, D02.0, D14.1, D38.0
Tracheal, bron-
chus, and lung 
cancer
3–4 162–162.9, 209.21, 209.61, 212.2–212.3, 231.1–231.2, 235.7 C33–C34.92, D02.1–D02.3, D14.2–D14.32, D38.1
Malignant skin 
melanoma
3–4 172–172.9 C43–C43.9, D03–D03.9, D22–D23.9, D48.5
Non-melanoma 
skin cancer
3–4 173–173.99, 222.4, 232–232.9, 238.2 C44–C44.99, D04–D04.9, D49.2
Breast cancer 3–4 174–175.9, 217–217.8, 233.0, 238.3, 239.3, 610–610.9 C50–C50.929, D05–D05.92, D24–D24.9, D48.6–D48.62, D49.3, N60–N60.99
Cervical cancer 3–4 180–180.9, 219.0, 233.1 C53–C53.9, D06–D06.9, D26.0
Uterine cancer 3–4 182–182.8, 233.2 C54–C54.9, D07.0–D07.2, N87–N87.9
Ovarian cancer 3–4 183–183.0, 220–220.9, 236.2 C56–C56.9, D27–D27.9, D39.1–D39.12
Prostate cancer 3–4 185–185.9, 222.2, 236.5 C61–C61.9, D07.5, D29.1, D40.0
Testicular 
cancer
3–4 186–186.9, 222.0, 222.3, 236.4 C62–C62.92, D29.2–D29.8, D40.1–D40.8
Kidney cancer 3–4 189.0–189.1, 209.24, 209.64, 223.0–223.1, 236.91 C64–C65.9, D30.0–D30.12, D41.0–D41.12
Bladder cancer 3–4 188–188.9, 223.3, 233.7, 236.7, 239.4 C67–C67.9, D09.0, D30.3, D41.4–D41.8, D49.4
Brain and 
nervous system 
cancer
3–4 191–192.9 C70–C72.9
Thyroid cancer 3–4 193–193.9, 226–226.9 C73–C73.9, D09.3, D09.8, D34–D34.9, D44.0
Mesothelioma 3–4 158.9, 163–163.9, 212.4 C45–C45.9
Hodgkin lym-
phoma
3–4 201–201.98 C81–C81.99
Non-Hodgkin 
lymphoma
3–4 200–200.9, 202–202.98 C82–C86.6, C96–C96.9
Multiple my-
eloma
3–4 203–203.9 C88–C90.9
Leukemia 3 204–208.92 C91–C95.92
Acute lymphoid 
leukemia
4 204.0–204.02 C91.0–C91.02
Chronic lym-
phoid leukemia
4 204.1–204.12 C91.1–C91.12
Acute myeloid 
leukemia
4 205.0–205.02, 205.3–205.32, 206.0–206.02, 207.0 C92.0–C92.02, C92.3–C92.62, C93.0–C93.02, C94.0–C94.02, C94.2–C94.22, C94.4–C94.5
Chronic myeloid 
leukemia
4 205.1–205.12, 206.1–206.12, 207.1 C92.1–C92.12
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Cause Level ICD9 ICD10
Other neo-
plasms
3–4 152–152.9, 158–158.8, 160–160.9, 164–164.9, 170–171.9, 181–181.9, 182.9, 
183.2–183.8, 184.0–184.4, 184.8, 187.1–187.8, 189.2–189.8, 190–190.9, 194–194.8, 
209.0–209.03, 209.22, 209.31–209.43, 211.2, 211.8, 212.0, 212.5–212.8, 213–213.9, 
221.0–221.8, 222.1, 222.8, 223.2, 223.8–223.89, 224–225.9, 227–228.9, 229.0, 229.8, 
230.7–230.8, 233.31–233.32, 233.4–233.5, 234.0–234.8, 235.4, 235.8, 236.1, 236.99–
237.3, 237.5–237.9, 238.0–238.1, 238.4–238.5, 239.2, 239.6, 569.0, 569.43–569.44, 
569.84–569.85
C17–C17.9, C3–C31.9, C37–C38.8, C4–C41.9, C47–C5, C51–C52.9, C57–C57.8, C58–C58.0, C60–C60.9, C63–
C63.8, C66–C66.9, C68.0–C68.8, C69–C7, C74–C75.8, D07.4, D09.2–D09.22, D13.2–D13.39, D14.0, D15–D16.9, 
D28.0–D28.1, D28.7, D29.0, D30.2–D30.22, D30.4–D30.8, D31–D33.9, D35–D36, D36.1–D36.7, D37.2, D38.2–
D38.5, D39.2, D39.8, D41.2–D41.3, D42–D43.9, D44.1–D44.8, D45–D45.9, D47–D47.0, D47.2–D47.9, D48.0–
D48.4, D49.6, D49.81, K31.7, K62.0–K62.1, K63.5, N84.0–N84.1
Cardiovascular 
diseases
2 036.41–036.43, 036.6, 074.2, 074.21–074.23, 391–391.9, 392.0, 393–398.99, 
402–402.91, 410–414.9, 417–417.9, 420–423, 423.1–425.9, 427–427.32, 427.6–427.89, 
429.0–429.1, 430–435.9, 437.0–437.2, 437.5–437.8, 441–443.9, 447–454.9, 456, 
456.3–457.9, 459, 459.1–459.39
A39.5–A39.53, B33.2–B33.24, D86.85, G45–G46.8, I01–I01.9, I02.0, I05–I09.9, I11–I11.9, I20–I25.9, I28–I28.8, 
I30–I31.1, I31.8–I43.9, I47–I48.92, I51.0–I51.5, I60–I61.9, I62.0–I62.03, I63–I63.9, I65–I66.9, I67.0–I67.3, I67.5–I67.6, 
I68.0–I68.2, I69.0–I69.398, I70.2–I70.799, I71–I73.9, I77–I83.93, I86–I89.9, I91.9, I98
Rheumatic 
heart disease
3–4 391–391.9, 392.0, 393–398.99 I01–I01.9, I02.0, I05–I09.9
Ischemic heart 
disease
3–4 410–414.9 I20–I25.9
Cerebrovascular 
disease
3 430–435.9, 437.0–437.2, 437.5–437.8 G45–G46.8, I60–I61.9, I62.0–I62.03, I63–I63.9, I65–I66.9, I67.0–I67.3, I67.5–I67.6, I68.1–I68.2, I69.0–I69.398
Ischemic stroke 4 433–435.9, 437.0–437.1, 437.5–437.8 G45–G46.8, I63–I63.9, I65–I66.9, I67.2–I67.3, I67.5–I67.6, I69.3–I69.398
Hemorrhagic 
stroke
4 430–432.9, 437.2 I60–I61.9, I62.0–I62.03, I67.0–I67.1, I68.1–I68.2, I69.0–I69.298
Hypertensive 
heart disease
3–4 402–402.91 I11–I11.9
Cardiomy-
opathy and 
myocarditis
3–4 036.43, 036.6, 074.23, 422–422.99, 425–425.9, 429.0–429.1 A39.52, B33.2–B33.24, D86.85, I40–I43.9, I51.4–I51.5
Atrial fibrillation 
and flutter
3–4 427.3–427.32 I48–I48.92
Aortic aneu-
rysm
3–4 441–441.9 I71–I71.9
Peripheral vas-
cular disease
3–4 443.0–443.9 I70.2–I70.799, I73–I73.9
Endocarditis 3–4 036.42, 074.22, 421–421.9, 424.9–424.91 A39.51, I33–I33.9, I38–I39.9
Other cardio-
vascular and 
circulatory 
diseases
3–4 036.41, 074.2, 074.21, 417–417.9, 420–420.99, 423, 423.1–424.8, 424.99, 427–427.2, 
427.6–427.89, 442–443, 447–454.9, 456, 456.3–457.9, 459, 459.1–459.39
A39.5–A39.50, A39.53, I28–I28.8, I30–I31.1, I31.8–I32.8, I34–I37.9, I47–I47.9, I51.0–I51.3, I68.0, I72–I72.9, I77–
I83.93, I86–I89.9, I91.9, I98
Chronic respira-
tory diseases
2 135–135.9, 136.6, 327.2–327.8, 470, 470.9–474.9, 476–476.1, 477–479, 490–504.9, 
506–506.9, 508–509, 515, 516–517.8, 518.6, 518.9, 519.1–519.4, 780.57, 786.03
D86–D86.2, D86.89–D86.9, G47.3–G47.39, J30–J35.9, J37–J47.9, J60–J63.8, J65–J68.9, J70–J70.1, J70.8–J70.9, 
J82, J84–J84.9, J91–J92.9
Chronic 
obstructive 
pulmonary 
disease
3–4 490–492.9, 494–494.9, 496–499 J40–J44.9, J47–J47.9
Pneumoco-
niosis
3 500–504.9 J60–J63.8, J65–J65.0, J92.0
Silicosis 4 502–502.9, 503.0, 503.9 J62–J62.9
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Cause Level ICD9 ICD10
Other neo-
plasms
3–4 152–152.9, 158–158.8, 160–160.9, 164–164.9, 170–171.9, 181–181.9, 182.9, 
183.2–183.8, 184.0–184.4, 184.8, 187.1–187.8, 189.2–189.8, 190–190.9, 194–194.8, 
209.0–209.03, 209.22, 209.31–209.43, 211.2, 211.8, 212.0, 212.5–212.8, 213–213.9, 
221.0–221.8, 222.1, 222.8, 223.2, 223.8–223.89, 224–225.9, 227–228.9, 229.0, 229.8, 
230.7–230.8, 233.31–233.32, 233.4–233.5, 234.0–234.8, 235.4, 235.8, 236.1, 236.99–
237.3, 237.5–237.9, 238.0–238.1, 238.4–238.5, 239.2, 239.6, 569.0, 569.43–569.44, 
569.84–569.85
C17–C17.9, C3–C31.9, C37–C38.8, C4–C41.9, C47–C5, C51–C52.9, C57–C57.8, C58–C58.0, C60–C60.9, C63–
C63.8, C66–C66.9, C68.0–C68.8, C69–C7, C74–C75.8, D07.4, D09.2–D09.22, D13.2–D13.39, D14.0, D15–D16.9, 
D28.0–D28.1, D28.7, D29.0, D30.2–D30.22, D30.4–D30.8, D31–D33.9, D35–D36, D36.1–D36.7, D37.2, D38.2–
D38.5, D39.2, D39.8, D41.2–D41.3, D42–D43.9, D44.1–D44.8, D45–D45.9, D47–D47.0, D47.2–D47.9, D48.0–
D48.4, D49.6, D49.81, K31.7, K62.0–K62.1, K63.5, N84.0–N84.1
Cardiovascular 
diseases
2 036.41–036.43, 036.6, 074.2, 074.21–074.23, 391–391.9, 392.0, 393–398.99, 
402–402.91, 410–414.9, 417–417.9, 420–423, 423.1–425.9, 427–427.32, 427.6–427.89, 
429.0–429.1, 430–435.9, 437.0–437.2, 437.5–437.8, 441–443.9, 447–454.9, 456, 
456.3–457.9, 459, 459.1–459.39
A39.5–A39.53, B33.2–B33.24, D86.85, G45–G46.8, I01–I01.9, I02.0, I05–I09.9, I11–I11.9, I20–I25.9, I28–I28.8, 
I30–I31.1, I31.8–I43.9, I47–I48.92, I51.0–I51.5, I60–I61.9, I62.0–I62.03, I63–I63.9, I65–I66.9, I67.0–I67.3, I67.5–I67.6, 
I68.0–I68.2, I69.0–I69.398, I70.2–I70.799, I71–I73.9, I77–I83.93, I86–I89.9, I91.9, I98
Rheumatic 
heart disease
3–4 391–391.9, 392.0, 393–398.99 I01–I01.9, I02.0, I05–I09.9
Ischemic heart 
disease
3–4 410–414.9 I20–I25.9
Cerebrovascular 
disease
3 430–435.9, 437.0–437.2, 437.5–437.8 G45–G46.8, I60–I61.9, I62.0–I62.03, I63–I63.9, I65–I66.9, I67.0–I67.3, I67.5–I67.6, I68.1–I68.2, I69.0–I69.398
Ischemic stroke 4 433–435.9, 437.0–437.1, 437.5–437.8 G45–G46.8, I63–I63.9, I65–I66.9, I67.2–I67.3, I67.5–I67.6, I69.3–I69.398
Hemorrhagic 
stroke
4 430–432.9, 437.2 I60–I61.9, I62.0–I62.03, I67.0–I67.1, I68.1–I68.2, I69.0–I69.298
Hypertensive 
heart disease
3–4 402–402.91 I11–I11.9
Cardiomy-
opathy and 
myocarditis
3–4 036.43, 036.6, 074.23, 422–422.99, 425–425.9, 429.0–429.1 A39.52, B33.2–B33.24, D86.85, I40–I43.9, I51.4–I51.5
Atrial fibrillation 
and flutter
3–4 427.3–427.32 I48–I48.92
Aortic aneu-
rysm
3–4 441–441.9 I71–I71.9
Peripheral vas-
cular disease
3–4 443.0–443.9 I70.2–I70.799, I73–I73.9
Endocarditis 3–4 036.42, 074.22, 421–421.9, 424.9–424.91 A39.51, I33–I33.9, I38–I39.9
Other cardio-
vascular and 
circulatory 
diseases
3–4 036.41, 074.2, 074.21, 417–417.9, 420–420.99, 423, 423.1–424.8, 424.99, 427–427.2, 
427.6–427.89, 442–443, 447–454.9, 456, 456.3–457.9, 459, 459.1–459.39
A39.5–A39.50, A39.53, I28–I28.8, I30–I31.1, I31.8–I32.8, I34–I37.9, I47–I47.9, I51.0–I51.3, I68.0, I72–I72.9, I77–
I83.93, I86–I89.9, I91.9, I98
Chronic respira-
tory diseases
2 135–135.9, 136.6, 327.2–327.8, 470, 470.9–474.9, 476–476.1, 477–479, 490–504.9, 
506–506.9, 508–509, 515, 516–517.8, 518.6, 518.9, 519.1–519.4, 780.57, 786.03
D86–D86.2, D86.89–D86.9, G47.3–G47.39, J30–J35.9, J37–J47.9, J60–J63.8, J65–J68.9, J70–J70.1, J70.8–J70.9, 
J82, J84–J84.9, J91–J92.9
Chronic 
obstructive 
pulmonary 
disease
3–4 490–492.9, 494–494.9, 496–499 J40–J44.9, J47–J47.9
Pneumoco-
niosis
3 500–504.9 J60–J63.8, J65–J65.0, J92.0
Silicosis 4 502–502.9, 503.0, 503.9 J62–J62.9
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Asbestosis 4 501 J61–J61.0, J92.0
Coal workers 
pneumoco-
niosis
4 500–500.9, 501.0–501.9 J60–J60.0
Other pneumo-
coniosis
4 503, 503.1, 504–504.9 J63–J63.8, J65–J65.0
Asthma 3–4 493–493.92 J45–J46.9
Interstitial lung 
disease and 
pulmonary 
sarcoidosis
3–4 135–135.9, 136.6, 515, 516–516.9 D86–D86.2, D86.89–D86.9, J84–J84.9
Other chronic 
respiratory 
diseases
3–4 327.2–327.8, 470, 470.9–474.9, 476–476.1, 477–479, 495–495.9, 506–506.9, 508–509, 
517–517.8, 518.6, 518.9, 519.1–519.4, 780.57, 786.03
G47.3–G47.39, J30–J35.9, J37–J39.9, J66–J68.9, J70–J70.1, J70.8–J70.9, J82, J91–J92, J92.9
Cirrhosis and 
other chronic 
liver diseases
2–4 070.22–070.23, 070.32–070.33, 070.44, 070.54, 456.0–456.21, 571–571.9, 572.3–
572.9, 573.0–573.3, 573.8–573.9
B18–B18.9, I85–I85.9, I98.2, K70–K70.9, K71.3–K71.51, K71.7, K72.1–K74.69, K74.9, K75.8–K76.0, K76.6–K76.7, 
K76.9
Digestive 
diseases
2 455–455.9, 530–536.1, 537–537.6, 537.8–537.84, 538, 540–543.9, 550–551.1, 551.3–
552.1, 552.3–553.6, 555–558.9, 560–560.39, 560.8–560.9, 562–562.13, 564–564.1, 
564.5–564.7, 565–566.9, 569.1–569.42, 569.5, 569.7–569.71, 573.4, 574–577.9, 
579–579.2, 579.4–579.9, 787.1
I84–I84.9, K20–K29.91, K31–K31.6, K31.8–K31.89, K35–K38.9, K40–K42.9, K44–K46.9, K50–K52.9, K55–K62, 
K62.2–K62.6, K62.8–K62.9, K64–K64.9, K66.8, K67, K68–K68.9, K75.2–K75.4, K76.1–K76.5, K76.8–K76.89, K77–
K77.8, K80–K83.9, K85–K86.9, K90–K90.9, K92.8–K92.89, M09.1
Peptic ulcer 
disease
3–4 531–534.91 K25–K28.9, K31, K31.1–K31.6, K31.8, K31.82–K31.89
Gastritis and 
duodenitis
3–4 535–535.9 K29–K29.91
Appendicitis 3–4 540–542.9 K35–K37.9, K38.3–K38.9
Paralytic ileus 
and intestinal 
obstruction
3–4 560–560.39, 560.8–560.9 K56–K56.9
Inguinal, 
femoral, and 
abdominal 
hernia
3–4 550–551.1, 551.3–552.1, 552.3–553.03, 553.6 K40–K42.9, K44–K46.9
Inflammatory 
bowel disease
3–4 555–556.9, 558–558.9, 569.5 K50–K52.9, M09.1
Vascular intesti-
nal disorders
3–4 557–557.9 K55–K55.9
Gallbladder and 
biliary diseases
3–4 574–576.9 K80–K83.9
Pancreatitis 3–4 577–577.9, 579.4 K85–K86.9
Other digestive 
diseases
3–4 455–455.9, 530–530.9, 536–536.1, 537–537.6, 537.8–537.84, 538, 543–543.9, 553.1–
553.3, 562–562.13, 564–564.1, 564.5–564.7, 565–566.9, 569.1–569.42, 569.7–569.71, 
573.4, 579–579.2, 579.8–579.9, 787.1
I84–I84.9, K20–K24, K31.0, K31.81–K31.819, K38–K38.2, K57–K62, K62.2–K62.6, K62.8–K62.9, K64–K64.9, K66.8, 
K67, K68–K68.9, K75.2–K75.4, K76.1–K76.5, K76.8–K76.89, K77–K77.8, K90–K90.9, K92.8–K92.89
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eTable 3. GBD cause list and associated ICD9 and ICD10 codes. (continued)
Cause Level ICD9 ICD10
Asbestosis 4 501 J61–J61.0, J92.0
Coal workers 
pneumoco-
niosis
4 500–500.9, 501.0–501.9 J60–J60.0
Other pneumo-
coniosis
4 503, 503.1, 504–504.9 J63–J63.8, J65–J65.0
Asthma 3–4 493–493.92 J45–J46.9
Interstitial lung 
disease and 
pulmonary 
sarcoidosis
3–4 135–135.9, 136.6, 515, 516–516.9 D86–D86.2, D86.89–D86.9, J84–J84.9
Other chronic 
respiratory 
diseases
3–4 327.2–327.8, 470, 470.9–474.9, 476–476.1, 477–479, 495–495.9, 506–506.9, 508–509, 
517–517.8, 518.6, 518.9, 519.1–519.4, 780.57, 786.03
G47.3–G47.39, J30–J35.9, J37–J39.9, J66–J68.9, J70–J70.1, J70.8–J70.9, J82, J91–J92, J92.9
Cirrhosis and 
other chronic 
liver diseases
2–4 070.22–070.23, 070.32–070.33, 070.44, 070.54, 456.0–456.21, 571–571.9, 572.3–
572.9, 573.0–573.3, 573.8–573.9
B18–B18.9, I85–I85.9, I98.2, K70–K70.9, K71.3–K71.51, K71.7, K72.1–K74.69, K74.9, K75.8–K76.0, K76.6–K76.7, 
K76.9
Digestive 
diseases
2 455–455.9, 530–536.1, 537–537.6, 537.8–537.84, 538, 540–543.9, 550–551.1, 551.3–
552.1, 552.3–553.6, 555–558.9, 560–560.39, 560.8–560.9, 562–562.13, 564–564.1, 
564.5–564.7, 565–566.9, 569.1–569.42, 569.5, 569.7–569.71, 573.4, 574–577.9, 
579–579.2, 579.4–579.9, 787.1
I84–I84.9, K20–K29.91, K31–K31.6, K31.8–K31.89, K35–K38.9, K40–K42.9, K44–K46.9, K50–K52.9, K55–K62, 
K62.2–K62.6, K62.8–K62.9, K64–K64.9, K66.8, K67, K68–K68.9, K75.2–K75.4, K76.1–K76.5, K76.8–K76.89, K77–
K77.8, K80–K83.9, K85–K86.9, K90–K90.9, K92.8–K92.89, M09.1
Peptic ulcer 
disease
3–4 531–534.91 K25–K28.9, K31, K31.1–K31.6, K31.8, K31.82–K31.89
Gastritis and 
duodenitis
3–4 535–535.9 K29–K29.91
Appendicitis 3–4 540–542.9 K35–K37.9, K38.3–K38.9
Paralytic ileus 
and intestinal 
obstruction
3–4 560–560.39, 560.8–560.9 K56–K56.9
Inguinal, 
femoral, and 
abdominal 
hernia
3–4 550–551.1, 551.3–552.1, 552.3–553.03, 553.6 K40–K42.9, K44–K46.9
Inflammatory 
bowel disease
3–4 555–556.9, 558–558.9, 569.5 K50–K52.9, M09.1
Vascular intesti-
nal disorders
3–4 557–557.9 K55–K55.9
Gallbladder and 
biliary diseases
3–4 574–576.9 K80–K83.9
Pancreatitis 3–4 577–577.9, 579.4 K85–K86.9
Other digestive 
diseases
3–4 455–455.9, 530–530.9, 536–536.1, 537–537.6, 537.8–537.84, 538, 543–543.9, 553.1–
553.3, 562–562.13, 564–564.1, 564.5–564.7, 565–566.9, 569.1–569.42, 569.7–569.71, 
573.4, 579–579.2, 579.8–579.9, 787.1
I84–I84.9, K20–K24, K31.0, K31.81–K31.819, K38–K38.2, K57–K62, K62.2–K62.6, K62.8–K62.9, K64–K64.9, K66.8, 
K67, K68–K68.9, K75.2–K75.4, K76.1–K76.5, K76.8–K76.89, K77–K77.8, K90–K90.9, K92.8–K92.89
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Cause Level ICD9 ICD10
Neurological 
disorders
2 290–290.9, 294.1–294.9, 330–331.2, 331.5–337.9, 340–341.9, 345–345.91, 349, 
349.2–349.8, 353.6–353.9, 356–356.9, 357.0–357.1, 357.3–357.4, 357.7, 358–359.9, 
728.86, 728.88, 775.2
F00–F03.91, G10–G13.8, G20–G21.0, G21.2–G24, G24.1–G25.0, G25.2–G25.3, G25.5, G25.8–G26.0, G30–G31.1, 
G31.8–G31.9, G35–G37.9, G40–G41.9, G61–G61.9, G70–G72, G72.2–G73.7, G90–G90.9, G95–G95.9, M33–M33.99
Alzheimer dis-
ease and other 
dementias
3–4 290–290.9, 294.1–294.9, 331–331.2 F00–F03.91, G30–G31.1, G31.8–G31.9
Parkinson 
disease
3–4 332–332.9 G20–G21.0, G21.2–G22.0
Epilepsy 3–4 345–345.91 G40–G41.9
Multiple scle-
rosis
3–4 340–340.9 G35–G35.9
Motor neuron 
disease
3–4 335–335.29, 335.8–335.9 G12.2–G12.9
Other neuro-
logical disorders
3–4 330–330.9, 331.5–331.9, 333–334.9, 335.3, 336–337.9, 341–341.9, 349, 349.2–349.8, 
353.6–353.9, 356–356.9, 357.0–357.1, 357.3–357.4, 357.7, 358–359.9, 728.86, 728.88, 
775.2
G10–G12.1, G13–G13.8, G23–G24, G24.1–G25.0, G25.2–G25.3, G25.5, G25.8–G26.0, G36–G37.9, G61–G61.9, 
G70–G72, G72.2–G73.7, G90–G90.9, G95–G95.9, M33–M33.99
Mental and 
substance use 
disorders
2 291–292.9, 295–295.95, 303–303.93, 304.0–304.83, 305–305.93, 307.1, 307.51, 
307.54, 357.5, 760.7–760.79, 780.59, 790.3, E850–E850.29, E850.9–E854.39, E860–
E860.19
F06.2, F10–F16.99, F18–F29.9, F50.0–F50.5, G31.2, G72.1, P04.3–P04.49, P96.1, Q86.0, R78.0–R78.5, X45–X45.9
Schizophrenia 3–4 295–295.95 F06.2, F20–F23.9, F25–F29.9
Alcohol use 
disorders
3–4 291–291.9, 303–303.93, 305.0–305.03, 357.5, 790.3, E860–E860.19 F10–F10.99, G31.2, G72.1, P04.3, Q86.0, R78.0, X45–X45.9
Drug use dis-
orders
3 292–292.9, 304.0–304.83, 305, 305.1–305.93, 760.7–760.79, E850–E850.29, E850.9–
E854.39
F11–F16.99, F18–F19.99, P04.4–P04.49, P96.1, R78.1–R78.5
Opioid use 
disorders
4 304.0–304.03, 305.5–305.53, E850.0–E850.29 F11–F11.99, P96.1, R78.1
Cocaine use 
disorders
4 304.2–304.23, 305.6–305.63 F14–F14.99, R78.2
Amphetamine 
use disorders
4 304.4–304.43, 305.7–305.73 F15–F15.99
Other drug use 
disorders
4 292–292.9, 304.1–304.13, 304.5–304.83, 305, 305.1–305.13, 305.3–305.43, 305.8–
305.93
F13–F13.99, F16–F16.99, F18–F19.99, R78.3–R78.5
Eating disorders 3 307.1, 307.51, 307.54 F50.0–F50.5
Anorexia 
nervosa
4 307.1, 307.54 F50.0–F50.1
Bulimia nervosa 4 307.51 F50.2–F50.5
Diabetes, uro-
genital, blood, 
and endocrine 
diseases
2 218–219, 219.1–219.9, 236.0, 240–243.9, 244.0–244.1, 244.3–244.8, 245–246.9, 
250–259.9, 270–273.9, 275–276, 277–277.2, 277.4–277.9, 278.0–278.8, 282–284.9, 
286–286.5, 286.7–289.7, 349.0–349.1, 357.2, 357.6, 403–404.93, 518.7, 519.0–519.09, 
536.4–536.49, 539–539.9, 551.2–551.29, 552.2–552.29, 564.2–564.4, 569.6–569.69, 
579.3, 580–583.9, 585–585.9, 588–590.9, 592–593.89, 594–599.69, 599.8–599.89, 
601–602.9, 604–604.99, 608.2–608.24, 617–618.9, 620–620.9, 621.4–621.9, 
622.3–622.7, 629–629.81, 775.0–775.1, 775.3, 779.4–779.5, 780.62–780.63, 788.0, 
790.2–790.22
D25–D26, D26.1–D26.9, D28.2, D52.1, D55–D58.9, D59.0–D59.3, D59.5–D59.6, D60–D61.9, D63.1, D64.0, D64.4, 
D66–D67, D68.0–D69.8, D70–D75.89, D76–D78.89, D86.8, D86.82–D86.84, D86.86–D86.87, D89–D89.3, E03–
E07.1, E09–E14.9, E15.0, E16.0–E16.9, E20–E34.8, E36–E36.8, E65–E68, E70–E85.29, E87.71, E88–E89.9, G21.1–
G21.19, G24.0–G24.09, G25.1, G25.4, G25.6–G25.79, G72.0, G93.7, G97–G97.9, I12–I13.9, I95.2–I95.3, I97–I97.9, 
I98.9, J70.2–J70.5, J95–J95.9, K43–K43.9, K62.7, K91–K91.9, K94–K95.89, M87.1–M87.19, N00–N08.8, N10–N12.9, 
N14–N16.8, N18–N18.9, N20–N23.0, N25–N32.0, N32.3–N32.4, N34–N34.3, N36–N36.9, N39–N39.2, N41–N41.9, 
N44–N44.04, N45–N45.9, N49–N49.9, N65–N65.1, N72–N72.0, N75–N77.8, N80–N81.9, N83–N83.9, N99–N99.9, 
P70.0–P70.2, P96.2, P96.5, R50.2, R50.82–R50.83, R73–R73.9
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eTable 3. GBD cause list and associated ICD9 and ICD10 codes. (continued)
Cause Level ICD9 ICD10
Neurological 
disorders
2 290–290.9, 294.1–294.9, 330–331.2, 331.5–337.9, 340–341.9, 345–345.91, 349, 
349.2–349.8, 353.6–353.9, 356–356.9, 357.0–357.1, 357.3–357.4, 357.7, 358–359.9, 
728.86, 728.88, 775.2
F00–F03.91, G10–G13.8, G20–G21.0, G21.2–G24, G24.1–G25.0, G25.2–G25.3, G25.5, G25.8–G26.0, G30–G31.1, 
G31.8–G31.9, G35–G37.9, G40–G41.9, G61–G61.9, G70–G72, G72.2–G73.7, G90–G90.9, G95–G95.9, M33–M33.99
Alzheimer dis-
ease and other 
dementias
3–4 290–290.9, 294.1–294.9, 331–331.2 F00–F03.91, G30–G31.1, G31.8–G31.9
Parkinson 
disease
3–4 332–332.9 G20–G21.0, G21.2–G22.0
Epilepsy 3–4 345–345.91 G40–G41.9
Multiple scle-
rosis
3–4 340–340.9 G35–G35.9
Motor neuron 
disease
3–4 335–335.29, 335.8–335.9 G12.2–G12.9
Other neuro-
logical disorders
3–4 330–330.9, 331.5–331.9, 333–334.9, 335.3, 336–337.9, 341–341.9, 349, 349.2–349.8, 
353.6–353.9, 356–356.9, 357.0–357.1, 357.3–357.4, 357.7, 358–359.9, 728.86, 728.88, 
775.2
G10–G12.1, G13–G13.8, G23–G24, G24.1–G25.0, G25.2–G25.3, G25.5, G25.8–G26.0, G36–G37.9, G61–G61.9, 
G70–G72, G72.2–G73.7, G90–G90.9, G95–G95.9, M33–M33.99
Mental and 
substance use 
disorders
2 291–292.9, 295–295.95, 303–303.93, 304.0–304.83, 305–305.93, 307.1, 307.51, 
307.54, 357.5, 760.7–760.79, 780.59, 790.3, E850–E850.29, E850.9–E854.39, E860–
E860.19
F06.2, F10–F16.99, F18–F29.9, F50.0–F50.5, G31.2, G72.1, P04.3–P04.49, P96.1, Q86.0, R78.0–R78.5, X45–X45.9
Schizophrenia 3–4 295–295.95 F06.2, F20–F23.9, F25–F29.9
Alcohol use 
disorders
3–4 291–291.9, 303–303.93, 305.0–305.03, 357.5, 790.3, E860–E860.19 F10–F10.99, G31.2, G72.1, P04.3, Q86.0, R78.0, X45–X45.9
Drug use dis-
orders
3 292–292.9, 304.0–304.83, 305, 305.1–305.93, 760.7–760.79, E850–E850.29, E850.9–
E854.39
F11–F16.99, F18–F19.99, P04.4–P04.49, P96.1, R78.1–R78.5
Opioid use 
disorders
4 304.0–304.03, 305.5–305.53, E850.0–E850.29 F11–F11.99, P96.1, R78.1
Cocaine use 
disorders
4 304.2–304.23, 305.6–305.63 F14–F14.99, R78.2
Amphetamine 
use disorders
4 304.4–304.43, 305.7–305.73 F15–F15.99
Other drug use 
disorders
4 292–292.9, 304.1–304.13, 304.5–304.83, 305, 305.1–305.13, 305.3–305.43, 305.8–
305.93
F13–F13.99, F16–F16.99, F18–F19.99, R78.3–R78.5
Eating disorders 3 307.1, 307.51, 307.54 F50.0–F50.5
Anorexia 
nervosa
4 307.1, 307.54 F50.0–F50.1
Bulimia nervosa 4 307.51 F50.2–F50.5
Diabetes, uro-
genital, blood, 
and endocrine 
diseases
2 218–219, 219.1–219.9, 236.0, 240–243.9, 244.0–244.1, 244.3–244.8, 245–246.9, 
250–259.9, 270–273.9, 275–276, 277–277.2, 277.4–277.9, 278.0–278.8, 282–284.9, 
286–286.5, 286.7–289.7, 349.0–349.1, 357.2, 357.6, 403–404.93, 518.7, 519.0–519.09, 
536.4–536.49, 539–539.9, 551.2–551.29, 552.2–552.29, 564.2–564.4, 569.6–569.69, 
579.3, 580–583.9, 585–585.9, 588–590.9, 592–593.89, 594–599.69, 599.8–599.89, 
601–602.9, 604–604.99, 608.2–608.24, 617–618.9, 620–620.9, 621.4–621.9, 
622.3–622.7, 629–629.81, 775.0–775.1, 775.3, 779.4–779.5, 780.62–780.63, 788.0, 
790.2–790.22
D25–D26, D26.1–D26.9, D28.2, D52.1, D55–D58.9, D59.0–D59.3, D59.5–D59.6, D60–D61.9, D63.1, D64.0, D64.4, 
D66–D67, D68.0–D69.8, D70–D75.89, D76–D78.89, D86.8, D86.82–D86.84, D86.86–D86.87, D89–D89.3, E03–
E07.1, E09–E14.9, E15.0, E16.0–E16.9, E20–E34.8, E36–E36.8, E65–E68, E70–E85.29, E87.71, E88–E89.9, G21.1–
G21.19, G24.0–G24.09, G25.1, G25.4, G25.6–G25.79, G72.0, G93.7, G97–G97.9, I12–I13.9, I95.2–I95.3, I97–I97.9, 
I98.9, J70.2–J70.5, J95–J95.9, K43–K43.9, K62.7, K91–K91.9, K94–K95.89, M87.1–M87.19, N00–N08.8, N10–N12.9, 
N14–N16.8, N18–N18.9, N20–N23.0, N25–N32.0, N32.3–N32.4, N34–N34.3, N36–N36.9, N39–N39.2, N41–N41.9, 
N44–N44.04, N45–N45.9, N49–N49.9, N65–N65.1, N72–N72.0, N75–N77.8, N80–N81.9, N83–N83.9, N99–N99.9, 
P70.0–P70.2, P96.2, P96.5, R50.2, R50.82–R50.83, R73–R73.9
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Cause Level ICD9 ICD10
Diabetes mel-
litus
3–4 250–250.39, 250.5–250.99, 357.2, 775.0–775.1, 790.2–790.22 E10–E10.11, E10.3–E11.1, E11.3–E12.1, E12.3–E13.11, E13.3–E14.1, E14.3–E14.9, P70.0–P70.2, R73–R73.9
Acute glomeru-
lonephritis
3–4 580–580.9 N00–N01.9
Chronic kidney 
disease
3 250.4–250.49, 403–404.93, 581–583.9, 585–585.9, 589–589.9 D63.1, E10.2–E10.29, E11.2–E11.29, E12.2, E13.2–E13.29, E14.2, I12–I13.9, N02–N08.8, N15.0, N18–N18.9
Chronic kidney 
disease due to 
diabetes mel-
litus
4 250.4–250.49 E10.2–E10.29, E11.2–E11.29, E12.2, E13.2–E13.29, E14.2
Chronic kidney 
disease due to 
hypertension
4 403–404.93 I12–I13.9
Chronic kidney 
disease due to 
glomerulone-
phritis
4 581–583.9 N03–N06.9
Chronic kidney 
disease due to 
other causes
4 589–589.9 N02–N02.9, N07–N08.8, N15.0
Urinary diseases 
and male infer-
tility
3 588–588.9, 590–590.9, 592–593.89, 594–596.81, 596.89–598.1, 598.8–599.69, 
599.8–599.89, 601–602.9, 604–604.99, 608.2–608.24, 788.0
N10–N12.9, N15, N15.1–N16.8, N20–N23.0, N25–N32.0, N32.3–N32.4, N34–N34.3, N36–N36.9, N39–N39.2, N41–
N41.9, N44–N44.04, N45–N45.9, N49–N49.9
Interstitial 
nephritis and 
urinary tract 
infections
4 590–590.9, 595–595.9, 597–597.9, 599.0 N10–N12.9, N15, N15.1–N16.8, N30–N30.91, N34–N34.3, N39.0–N39.2
Urolithiasis 4 592–592.9, 594–594.9, 788.0 N20–N23.0
Other urinary 
diseases
4 588–588.9, 593–593.89, 596–596.81, 596.89–596.9, 598–598.1, 598.8–599, 599.1–
599.69, 599.8–599.89, 601–602.9, 604–604.99, 608.2–608.24
N25–N29.8, N31–N32.0, N32.3–N32.4, N36–N36.9, N39, N41–N41.9, N44–N44.04, N45–N45.9, N49–N49.9
Gynecological 
diseases
3 218–219, 219.1–219.9, 236.0, 256.4, 617–618.9, 620–620.9, 621.4–621.9, 622.3–622.7, 
629–629.81
D25–D26, D26.1–D26.9, D28.2, E28.2, N72–N72.0, N75–N77.8, N80–N81.9, N83–N83.9
Uterine fibroids 4 218–219, 219.1–219.9, 236.0 D25–D26, D26.1–D26.9, D28.2
Polycystic ovar-
ian syndrome
4 256.4 E28.2
Endometriosis 4 617–617.9 N80–N80.9
Genital prolapse 4 618–618.9 N81–N81.9
Other gyneco-
logical diseases
4 620–620.9, 621.4–621.9, 622.3–622.7, 629–629.81 N72–N72.0, N75–N77.8, N83–N83.9
Hemoglobin-
opathies and 
hemolytic 
anemias
3 282–284.9 D55–D58.9, D59.1, D59.3, D59.5, D60–D61.9, D64.0, D64.4
Thalassemias 4 282.4–282.49 D56–D56.9
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Cause Level ICD9 ICD10
Diabetes mel-
litus
3–4 250–250.39, 250.5–250.99, 357.2, 775.0–775.1, 790.2–790.22 E10–E10.11, E10.3–E11.1, E11.3–E12.1, E12.3–E13.11, E13.3–E14.1, E14.3–E14.9, P70.0–P70.2, R73–R73.9
Acute glomeru-
lonephritis
3–4 580–580.9 N00–N01.9
Chronic kidney 
disease
3 250.4–250.49, 403–404.93, 581–583.9, 585–585.9, 589–589.9 D63.1, E10.2–E10.29, E11.2–E11.29, E12.2, E13.2–E13.29, E14.2, I12–I13.9, N02–N08.8, N15.0, N18–N18.9
Chronic kidney 
disease due to 
diabetes mel-
litus
4 250.4–250.49 E10.2–E10.29, E11.2–E11.29, E12.2, E13.2–E13.29, E14.2
Chronic kidney 
disease due to 
hypertension
4 403–404.93 I12–I13.9
Chronic kidney 
disease due to 
glomerulone-
phritis
4 581–583.9 N03–N06.9
Chronic kidney 
disease due to 
other causes
4 589–589.9 N02–N02.9, N07–N08.8, N15.0
Urinary diseases 
and male infer-
tility
3 588–588.9, 590–590.9, 592–593.89, 594–596.81, 596.89–598.1, 598.8–599.69, 
599.8–599.89, 601–602.9, 604–604.99, 608.2–608.24, 788.0
N10–N12.9, N15, N15.1–N16.8, N20–N23.0, N25–N32.0, N32.3–N32.4, N34–N34.3, N36–N36.9, N39–N39.2, N41–
N41.9, N44–N44.04, N45–N45.9, N49–N49.9
Interstitial 
nephritis and 
urinary tract 
infections
4 590–590.9, 595–595.9, 597–597.9, 599.0 N10–N12.9, N15, N15.1–N16.8, N30–N30.91, N34–N34.3, N39.0–N39.2
Urolithiasis 4 592–592.9, 594–594.9, 788.0 N20–N23.0
Other urinary 
diseases
4 588–588.9, 593–593.89, 596–596.81, 596.89–596.9, 598–598.1, 598.8–599, 599.1–
599.69, 599.8–599.89, 601–602.9, 604–604.99, 608.2–608.24
N25–N29.8, N31–N32.0, N32.3–N32.4, N36–N36.9, N39, N41–N41.9, N44–N44.04, N45–N45.9, N49–N49.9
Gynecological 
diseases
3 218–219, 219.1–219.9, 236.0, 256.4, 617–618.9, 620–620.9, 621.4–621.9, 622.3–622.7, 
629–629.81
D25–D26, D26.1–D26.9, D28.2, E28.2, N72–N72.0, N75–N77.8, N80–N81.9, N83–N83.9
Uterine fibroids 4 218–219, 219.1–219.9, 236.0 D25–D26, D26.1–D26.9, D28.2
Polycystic ovar-
ian syndrome
4 256.4 E28.2
Endometriosis 4 617–617.9 N80–N80.9
Genital prolapse 4 618–618.9 N81–N81.9
Other gyneco-
logical diseases
4 620–620.9, 621.4–621.9, 622.3–622.7, 629–629.81 N72–N72.0, N75–N77.8, N83–N83.9
Hemoglobin-
opathies and 
hemolytic 
anemias
3 282–284.9 D55–D58.9, D59.1, D59.3, D59.5, D60–D61.9, D64.0, D64.4
Thalassemias 4 282.4–282.49 D56–D56.9
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eTable 3. GBD cause list and associated ICD9 and ICD10 codes. (continued)
Cause Level ICD9 ICD10
Sickle cell 
disorders
4 282.6–282.68 D57–D57.219, D57.4–D57.819
G6PD deficiency 4 282.2–282.3 D55–D55.2
Other hemo-
globinopathies 
and hemolytic 
anemias
4 282–282.1, 282.69–284.9 D55.3–D55.9, D58–D58.9, D59.1, D59.3, D59.5, D60–D61.9, D64.0, D64.4
Endocrine, 
metabolic, 
blood, and im-
mune disorders
3–4 240–243.9, 244.0–244.1, 244.3–244.8, 245–246.9, 251–256.39, 256.8–259.9, 
270–273.9, 275–276, 277–277.2, 277.4–277.9, 278.0–278.8, 286–286.5, 286.7–289.7, 
349.0–349.1, 357.6, 518.7, 519.0–519.09, 536.4–536.49, 539–539.9, 551.2–551.29, 
552.2–552.29, 564.2–564.4, 569.6–569.69, 579.3, 596.82–596.83, 598.2, 775.3, 
779.4–779.5, 780.62–780.63
D52.1, D59.0, D59.2, D59.6, D66–D67, D68.0–D69.8, D70–D75.89, D76–D78.89, D86.8, D86.82–D86.84, D86.86–
D86.87, D89–D89.3, E03–E07.1, E09–E09.9, E15.0, E16.0–E16.9, E20–E28.1, E28.3–E34.8, E36–E36.8, E65–E68, 
E70–E85.29, E87.71, E88–E89.9, G21.1–G21.19, G24.0–G24.09, G25.1, G25.4, G25.6–G25.79, G72.0, G93.7, G97–
G97.9, I95.2–I95.3, I97–I97.9, I98.9, J70.2–J70.5, J95–J95.9, K43–K43.9, K62.7, K91–K91.9, K94–K95.89, M87.1–
M87.19, N14–N14.4, N65–N65.1, N99–N99.9, P96.2, P96.5, R50.2, R50.82–R50.83
Musculoskeletal 
disorders
2 416.1, 437.4, 446–446.9, 695.4–695.59, 710–711.99, 714–714.33, 714.8–714.9, 
730.1–730.19, 732–732.9, 733.0–733.19
I27.1, I67.7, L93–L93.2, M00–M03.0, M03.2–M03.6, M05–M09.0, M09.2–M09.8, M30–M32.9, M34–M36.8, M40–
M43.19, M65–M65.08, M71.0–M71.19, M80–M82.8, M86.3–M86.49, M87–M87.09, M88–M89.09, M89.5–M89.59, 
M89.7–M89.9
Rheumatoid 
arthritis
3–4 714–714.33, 714.8–714.9 M05–M06.9, M08.0–M08.89
Other mus-
culoskeletal 
disorders
3–4 416.1, 437.4, 446–446.9, 695.4–695.59, 710–711.99, 730.1–730.19, 732–732.9, 
733.0–733.19
I27.1, I67.7, L93–L93.2, M00–M03.0, M03.2–M03.6, M07–M08, M08.9–M09.0, M09.2–M09.8, M30–M32.9, M34–
M36.8, M40–M43.19, M65–M65.08, M71.0–M71.19, M80–M82.8, M86.3–M86.49, M87–M87.09, M88–M89.09, 
M89.5–M89.59, M89.7–M89.9
Other non-
communicable 
diseases
2 035–035.9, 102–103.9, 133–133.6, 376.0–376.1, 680–689, 694–695.3, 707–707.9, 
740–749.04, 749.2–758.9, 759.0–759.89, 798–798.0
A46–A46.0, A66–A67.9, B86, D86.3, H05.0–H05.119, L00–L05.92, L08–L08.9, L10–L14.0, L51–L51.9, L88–L89.95, 
L97–L98.499, P96.0, Q00–Q07.9, Q10.4–Q18.9, Q20–Q28.9, Q30–Q36, Q37–Q45.9, Q50–Q86, Q86.1–Q87.89, 
Q89–Q89.8, Q90–Q93.9, Q95–Q99.8, R95
Congenital 
anomalies
3 740–749.04, 749.2–758.9, 759.0–759.89 P96.0, Q00–Q07.9, Q10.4–Q18.9, Q20–Q28.9, Q30–Q36, Q37–Q45.9, Q50–Q86, Q86.1–Q87.89, Q89–Q89.8, Q90–
Q93.9, Q95–Q99.8
Neural tube 
defects
4 740–741.93, 742.0 Q00–Q01.9, Q05–Q05.9
Congenital 
heart anomalies
4 745–747.9 Q20–Q28.9
Cleft lip and 
cleft palate
4 749–749.04, 749.2–749.25 Q35–Q36, Q37–Q37.9
Down syn-
drome
4 758 Q90–Q90.9
Other chromo-
somal abnor-
malities
4 758, 758.1–758.6, 758.8–758.9 Q91–Q93.9, Q95–Q95.9, Q97–Q97.9, Q99–Q99.8
Other congeni-
tal anomalies
4 742, 742.1–744.9, 748–748.9, 749.6–757.9, 759.0–759.89 P96.0, Q02–Q04.9, Q06–Q07.9, Q10.4–Q18.9, Q30–Q34.9, Q38–Q45.9, Q50–Q86, Q86.1–Q87.89, Q89–Q89.8
Skin and 
subcutaneous 
diseases
3 035–035.9, 102–103.9, 133–133.6, 680–689, 694–695.3, 707–707.9 A46–A46.0, A66–A67.9, B86, D86.3, L00–L05.92, L08–L08.9, L10–L14.0, L51–L51.9, L88–L89.95, L97–L98.499
Cellulitis 4 681–682.9 L03–L03.91
Pyoderma 4 035–035.9, 102–103.9, 680–680.9, 683–689 A46–A46.0, A66–A67.9, L00–L02.93, L04–L05.92, L08–L08.9, L88, L97–L98.499
Decubitus ulcer 4 707–707.9 L89–L89.95
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eTable 3. GBD cause list and associated ICD9 and ICD10 codes. (continued)
Cause Level ICD9 ICD10
Sickle cell 
disorders
4 282.6–282.68 D57–D57.219, D57.4–D57.819
G6PD deficiency 4 282.2–282.3 D55–D55.2
Other hemo-
globinopathies 
and hemolytic 
anemias
4 282–282.1, 282.69–284.9 D55.3–D55.9, D58–D58.9, D59.1, D59.3, D59.5, D60–D61.9, D64.0, D64.4
Endocrine, 
metabolic, 
blood, and im-
mune disorders
3–4 240–243.9, 244.0–244.1, 244.3–244.8, 245–246.9, 251–256.39, 256.8–259.9, 
270–273.9, 275–276, 277–277.2, 277.4–277.9, 278.0–278.8, 286–286.5, 286.7–289.7, 
349.0–349.1, 357.6, 518.7, 519.0–519.09, 536.4–536.49, 539–539.9, 551.2–551.29, 
552.2–552.29, 564.2–564.4, 569.6–569.69, 579.3, 596.82–596.83, 598.2, 775.3, 
779.4–779.5, 780.62–780.63
D52.1, D59.0, D59.2, D59.6, D66–D67, D68.0–D69.8, D70–D75.89, D76–D78.89, D86.8, D86.82–D86.84, D86.86–
D86.87, D89–D89.3, E03–E07.1, E09–E09.9, E15.0, E16.0–E16.9, E20–E28.1, E28.3–E34.8, E36–E36.8, E65–E68, 
E70–E85.29, E87.71, E88–E89.9, G21.1–G21.19, G24.0–G24.09, G25.1, G25.4, G25.6–G25.79, G72.0, G93.7, G97–
G97.9, I95.2–I95.3, I97–I97.9, I98.9, J70.2–J70.5, J95–J95.9, K43–K43.9, K62.7, K91–K91.9, K94–K95.89, M87.1–
M87.19, N14–N14.4, N65–N65.1, N99–N99.9, P96.2, P96.5, R50.2, R50.82–R50.83
Musculoskeletal 
disorders
2 416.1, 437.4, 446–446.9, 695.4–695.59, 710–711.99, 714–714.33, 714.8–714.9, 
730.1–730.19, 732–732.9, 733.0–733.19
I27.1, I67.7, L93–L93.2, M00–M03.0, M03.2–M03.6, M05–M09.0, M09.2–M09.8, M30–M32.9, M34–M36.8, M40–
M43.19, M65–M65.08, M71.0–M71.19, M80–M82.8, M86.3–M86.49, M87–M87.09, M88–M89.09, M89.5–M89.59, 
M89.7–M89.9
Rheumatoid 
arthritis
3–4 714–714.33, 714.8–714.9 M05–M06.9, M08.0–M08.89
Other mus-
culoskeletal 
disorders
3–4 416.1, 437.4, 446–446.9, 695.4–695.59, 710–711.99, 730.1–730.19, 732–732.9, 
733.0–733.19
I27.1, I67.7, L93–L93.2, M00–M03.0, M03.2–M03.6, M07–M08, M08.9–M09.0, M09.2–M09.8, M30–M32.9, M34–
M36.8, M40–M43.19, M65–M65.08, M71.0–M71.19, M80–M82.8, M86.3–M86.49, M87–M87.09, M88–M89.09, 
M89.5–M89.59, M89.7–M89.9
Other non-
communicable 
diseases
2 035–035.9, 102–103.9, 133–133.6, 376.0–376.1, 680–689, 694–695.3, 707–707.9, 
740–749.04, 749.2–758.9, 759.0–759.89, 798–798.0
A46–A46.0, A66–A67.9, B86, D86.3, H05.0–H05.119, L00–L05.92, L08–L08.9, L10–L14.0, L51–L51.9, L88–L89.95, 
L97–L98.499, P96.0, Q00–Q07.9, Q10.4–Q18.9, Q20–Q28.9, Q30–Q36, Q37–Q45.9, Q50–Q86, Q86.1–Q87.89, 
Q89–Q89.8, Q90–Q93.9, Q95–Q99.8, R95
Congenital 
anomalies
3 740–749.04, 749.2–758.9, 759.0–759.89 P96.0, Q00–Q07.9, Q10.4–Q18.9, Q20–Q28.9, Q30–Q36, Q37–Q45.9, Q50–Q86, Q86.1–Q87.89, Q89–Q89.8, Q90–
Q93.9, Q95–Q99.8
Neural tube 
defects
4 740–741.93, 742.0 Q00–Q01.9, Q05–Q05.9
Congenital 
heart anomalies
4 745–747.9 Q20–Q28.9
Cleft lip and 
cleft palate
4 749–749.04, 749.2–749.25 Q35–Q36, Q37–Q37.9
Down syn-
drome
4 758 Q90–Q90.9
Other chromo-
somal abnor-
malities
4 758, 758.1–758.6, 758.8–758.9 Q91–Q93.9, Q95–Q95.9, Q97–Q97.9, Q99–Q99.8
Other congeni-
tal anomalies
4 742, 742.1–744.9, 748–748.9, 749.6–757.9, 759.0–759.89 P96.0, Q02–Q04.9, Q06–Q07.9, Q10.4–Q18.9, Q30–Q34.9, Q38–Q45.9, Q50–Q86, Q86.1–Q87.89, Q89–Q89.8
Skin and 
subcutaneous 
diseases
3 035–035.9, 102–103.9, 133–133.6, 680–689, 694–695.3, 707–707.9 A46–A46.0, A66–A67.9, B86, D86.3, L00–L05.92, L08–L08.9, L10–L14.0, L51–L51.9, L88–L89.95, L97–L98.499
Cellulitis 4 681–682.9 L03–L03.91
Pyoderma 4 035–035.9, 102–103.9, 680–680.9, 683–689 A46–A46.0, A66–A67.9, L00–L02.93, L04–L05.92, L08–L08.9, L88, L97–L98.499
Decubitus ulcer 4 707–707.9 L89–L89.95
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Cause Level ICD9 ICD10
Other skin and 
subcutaneous 
diseases
4 694–695.3 D86.3, L10–L14.0, L51–L51.9
Sudden infant 
death syndrome
3–4 798–798.0 R95
Injuries 1 E800–E800.3, E801–E801.3, E802–E802.3, E803–E803.3, E804–E804.3, E805–E805.3, 
E806–E806.3, E807–E807.3, E810.0–E810.7, E811.0–E811.7, E812.0–E812.7, E813.0–
E813.7, E814.0–E814.7, E815.0–E815.7, E816.0–E816.7, E817.0–E817.7, E818.0–E818.7, 
E819.0–E819.7, E820.0–E820.7, E821.0–E821.7, E822.0–E822.7, E823.0–E823.7, 
E824.0–E824.7, E825.0–E825.7, E826.0–E826.4, E827.0–E827.4, E828.0– E828.4, 
E829.0–E829.4, E830–E838.9, E840–E849.9, E850.3–E850.89, E854.8, E856–E857.09, 
E860.2–E869.99, E870–E876.9, E878–E879.9, E880–E886.99, E888–E928.89, E929.1–
E929.5, E930–E979.9, E990–E999.1
V00–V86.99, V87.2–V87.3, V88.2–V88.3, V90–V98.8, W00–W46.2, W49–W62.9, W64–W70.9, W73–W75.9, W77–
W81.9, W83–W94.9, W97.9, W99–X06.9, X08–X39.9, X46–X47, X47.1–X47.8, X48–X48.9, X50–X54.9, X57–X58.9, 
X60–Y08.9, Y35–Y84.9, Y87.0–Y87.1, Y88–Y88.3, Y89.0–Y89.1
Transport 
injuries
2 E800–E800.3, E801–E801.3, E802–E802.3, E803–E803.3, E804–E804.3, E805–E805.3, 
E806–E806.3, E807–E807.3, E810.0–E810.7, E811.0–E811.7, E812.0–E812.7, E813.0–
E813.7, E814.0–E814.7, E815.0–E815.7, E816.0–E816.7, E817.0–E817.7, E818.0–E818.7, 
E819.0–E819.7, E820.0–E820.7, E821.0–E821.7, E822.0–E822.7, E823.0–E823.7, 
E824.0–E824.7, E825.0–E825.7, E826.0–E826.4, E827.0–E827.4, E828.0–E828.4, 
E829.0–E829.4, E830–E838.9, E840–E849.9, E929.1
V00–V86.99, V87.2–V87.3, V88.2–V88.3, V90–V98.8
Road injuries 3 E800.3, E801.3, E802.3, E803.3, E804.3, E805.3, E806.3, E807.3, E810.0–E810.6, E811.0–
E811.7, E812.0–E812.7, E813.0–E813.7, E814.0–E814.7, E815.0–E815.7, E816.0–E816.7, 
E817.0–E817.7, E818.0–E818.7, E819.0–E819.7, E820.0–E820.6, E821.0–E821.6, 
E822.0–E822.7, E823.0–E823.7, E824.0–E824.7, E825.0–E825.7, E826.0–E826.1, 
E826.3–E826.4, E827.0, E827.3–E827.4, E828.0, E828.4, E829.0–E829.4
V01–V04.99, V06–V80.929, V82–V82.9, V87.2–V87.3
Pedestrian road 
injuries
4 E811.7, E812.7, E813.7, E814.7, E815.7, E816.7, E817.7, E818.7, E819.7, E822.7, E823.7, 
E824.7, E825.7, E826.0, E827.0, E828.0, E829.0
V01–V04.99, V06–V09.9
Cyclist road 
injuries
4 E800.3, E801.3, E802.3, E803.3, E804.3, E805.3, E806.3, E807.3, E810.6, E811.6, E812.6, 
E813.6, E814.6, E815.6, E816.6, E817.6, E818.6, E819.6, E820.6, E821.6, E822.6, E823.6, 
E824.6, E825.6, E826.1
V10–V19.9
Motorcyclist 
road injuries
4 E810.2–E810.3, E811.2–E811.3, E812.2–E812.3, E813.2–E813.3, E814.2–E814.3, 
E815.2–E815.3, E816.2–E816.3, E817.2–E817.3, E818.2–E818.3, E819.2–E819.3, 
E820.2–E820.3, E821.2–E821.3, E822.2–E822.3, E823.2–E823.3, E824.2–E824.3, 
E825.2–E825.3
V20–V29.9
Motor vehicle 
road injuries
4 E810.0–E810.1, E811.0–E811.1, E812.0–E812.1, E813.0–E813.1, E814.0–E814.1, 
E815.0–E815.1, E816.0–E816.1, E817.0–E817.1, E818.0–E818.1, E819.0–E819.1, 
E820.0–E820.1, E821.0–E821.1, E822.0–E822.1, E823.0–E823.1, E824.0–E824.1, 
E825.0–E825.1
V30–V79.9, V87.2–V87.3
Other road 
injuries
4 E810.4–E810.5, E811.4–E811.5, E812.4–E812.5, E813.4–E813.5, E814.4–E814.5, 
E815.4–E815.5, E816.4–E816.5, E817.4–E817.5, E818.4–E818.5, E819.4–E819.5, 
E820.4–E820.5, E821.4–E821.5, E822.4–E822.5, E823.4–E823.5, E824.4–E824.5, 
E825.4–E825.5, E826.3–E826.4, E827.3–E827.4, E828.4, E829.4
V80–V80.929, V82–V82.9
Other transport 
injuries
 3–4 E800–E800.2, E801–E801.2, E802–E802.2, E803–E803.2, E804–E804.2, E805–E805.2, 
E806–E806.2, E807–E807.2, E810.7, E820.7, E821.7, E826.2, E827.2, E828.2, E830–
E838.9, E840–E849.9, E929.1
V00–V00.898, V05–V05.99, V81–V81.9, V83–V86.99, V88.2–V88.3, V90–V98.8
Unintentional 
injuries
2 E850.3–E850.89, E854.8, E856–E857.09, E860.2–E869.99, E870–E876.9, E878–E879.9, 
E880–E886.99, E888–E906.99, E910–E928.89, E929.2–E929.5, E930–E949.9
W00–W46.2, W49–W62.9, W64–W70.9, W73–W75.9, W77–W81.9, W83–W94.9, W97.9, W99–X06.9, X08–X32.9, 
X39–X39.9, X46–X47, X47.1–X47.8, X48–X48.9, X50–X54.9, X57–X58.9, Y38.9–Y84.9, Y88–Y88.3
Falls 3–4 E880–E886.99, E888–E888.9, E929.3 W00–W19.9
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eTable 3. GBD cause list and associated ICD9 and ICD10 codes. (continued)
Cause Level ICD9 ICD10
Other skin and 
subcutaneous 
diseases
4 694–695.3 D86.3, L10–L14.0, L51–L51.9
Sudden infant 
death syndrome
3–4 798–798.0 R95
Injuries 1 E800–E800.3, E801–E801.3, E802–E802.3, E803–E803.3, E804–E804.3, E805–E805.3, 
E806–E806.3, E807–E807.3, E810.0–E810.7, E811.0–E811.7, E812.0–E812.7, E813.0–
E813.7, E814.0–E814.7, E815.0–E815.7, E816.0–E816.7, E817.0–E817.7, E818.0–E818.7, 
E819.0–E819.7, E820.0–E820.7, E821.0–E821.7, E822.0–E822.7, E823.0–E823.7, 
E824.0–E824.7, E825.0–E825.7, E826.0–E826.4, E827.0–E827.4, E828.0– E828.4, 
E829.0–E829.4, E830–E838.9, E840–E849.9, E850.3–E850.89, E854.8, E856–E857.09, 
E860.2–E869.99, E870–E876.9, E878–E879.9, E880–E886.99, E888–E928.89, E929.1–
E929.5, E930–E979.9, E990–E999.1
V00–V86.99, V87.2–V87.3, V88.2–V88.3, V90–V98.8, W00–W46.2, W49–W62.9, W64–W70.9, W73–W75.9, W77–
W81.9, W83–W94.9, W97.9, W99–X06.9, X08–X39.9, X46–X47, X47.1–X47.8, X48–X48.9, X50–X54.9, X57–X58.9, 
X60–Y08.9, Y35–Y84.9, Y87.0–Y87.1, Y88–Y88.3, Y89.0–Y89.1
Transport 
injuries
2 E800–E800.3, E801–E801.3, E802–E802.3, E803–E803.3, E804–E804.3, E805–E805.3, 
E806–E806.3, E807–E807.3, E810.0–E810.7, E811.0–E811.7, E812.0–E812.7, E813.0–
E813.7, E814.0–E814.7, E815.0–E815.7, E816.0–E816.7, E817.0–E817.7, E818.0–E818.7, 
E819.0–E819.7, E820.0–E820.7, E821.0–E821.7, E822.0–E822.7, E823.0–E823.7, 
E824.0–E824.7, E825.0–E825.7, E826.0–E826.4, E827.0–E827.4, E828.0–E828.4, 
E829.0–E829.4, E830–E838.9, E840–E849.9, E929.1
V00–V86.99, V87.2–V87.3, V88.2–V88.3, V90–V98.8
Road injuries 3 E800.3, E801.3, E802.3, E803.3, E804.3, E805.3, E806.3, E807.3, E810.0–E810.6, E811.0–
E811.7, E812.0–E812.7, E813.0–E813.7, E814.0–E814.7, E815.0–E815.7, E816.0–E816.7, 
E817.0–E817.7, E818.0–E818.7, E819.0–E819.7, E820.0–E820.6, E821.0–E821.6, 
E822.0–E822.7, E823.0–E823.7, E824.0–E824.7, E825.0–E825.7, E826.0–E826.1, 
E826.3–E826.4, E827.0, E827.3–E827.4, E828.0, E828.4, E829.0–E829.4
V01–V04.99, V06–V80.929, V82–V82.9, V87.2–V87.3
Pedestrian road 
injuries
4 E811.7, E812.7, E813.7, E814.7, E815.7, E816.7, E817.7, E818.7, E819.7, E822.7, E823.7, 
E824.7, E825.7, E826.0, E827.0, E828.0, E829.0
V01–V04.99, V06–V09.9
Cyclist road 
injuries
4 E800.3, E801.3, E802.3, E803.3, E804.3, E805.3, E806.3, E807.3, E810.6, E811.6, E812.6, 
E813.6, E814.6, E815.6, E816.6, E817.6, E818.6, E819.6, E820.6, E821.6, E822.6, E823.6, 
E824.6, E825.6, E826.1
V10–V19.9
Motorcyclist 
road injuries
4 E810.2–E810.3, E811.2–E811.3, E812.2–E812.3, E813.2–E813.3, E814.2–E814.3, 
E815.2–E815.3, E816.2–E816.3, E817.2–E817.3, E818.2–E818.3, E819.2–E819.3, 
E820.2–E820.3, E821.2–E821.3, E822.2–E822.3, E823.2–E823.3, E824.2–E824.3, 
E825.2–E825.3
V20–V29.9
Motor vehicle 
road injuries
4 E810.0–E810.1, E811.0–E811.1, E812.0–E812.1, E813.0–E813.1, E814.0–E814.1, 
E815.0–E815.1, E816.0–E816.1, E817.0–E817.1, E818.0–E818.1, E819.0–E819.1, 
E820.0–E820.1, E821.0–E821.1, E822.0–E822.1, E823.0–E823.1, E824.0–E824.1, 
E825.0–E825.1
V30–V79.9, V87.2–V87.3
Other road 
injuries
4 E810.4–E810.5, E811.4–E811.5, E812.4–E812.5, E813.4–E813.5, E814.4–E814.5, 
E815.4–E815.5, E816.4–E816.5, E817.4–E817.5, E818.4–E818.5, E819.4–E819.5, 
E820.4–E820.5, E821.4–E821.5, E822.4–E822.5, E823.4–E823.5, E824.4–E824.5, 
E825.4–E825.5, E826.3–E826.4, E827.3–E827.4, E828.4, E829.4
V80–V80.929, V82–V82.9
Other transport 
injuries
 3–4 E800–E800.2, E801–E801.2, E802–E802.2, E803–E803.2, E804–E804.2, E805–E805.2, 
E806–E806.2, E807–E807.2, E810.7, E820.7, E821.7, E826.2, E827.2, E828.2, E830–
E838.9, E840–E849.9, E929.1
V00–V00.898, V05–V05.99, V81–V81.9, V83–V86.99, V88.2–V88.3, V90–V98.8
Unintentional 
injuries
2 E850.3–E850.89, E854.8, E856–E857.09, E860.2–E869.99, E870–E876.9, E878–E879.9, 
E880–E886.99, E888–E906.99, E910–E928.89, E929.2–E929.5, E930–E949.9
W00–W46.2, W49–W62.9, W64–W70.9, W73–W75.9, W77–W81.9, W83–W94.9, W97.9, W99–X06.9, X08–X32.9, 
X39–X39.9, X46–X47, X47.1–X47.8, X48–X48.9, X50–X54.9, X57–X58.9, Y38.9–Y84.9, Y88–Y88.3
Falls 3–4 E880–E886.99, E888–E888.9, E929.3 W00–W19.9
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eTable 3. GBD cause list and associated ICD9 and ICD10 codes. (continued)
Cause Level ICD9 ICD10
Drowning 3–4 E910–E910.99 W65–W70.9, W73–W74.9
Fire, heat, and 
hot substances
3–4 E890–E899.09, E924–E924.99, E929.4 X00–X06.9, X08–X19.9
Poisonings 3–4 E850.3–E850.89, E854.8, E856–E857.09, E860.2–E869.99, E929.2 X46–X47, X47.1–X47.8, X48–X48.9
Exposure to 
mechanical 
forces
3 E913–E913.19, E916–E922.99, E928.1–E928.7 W20–W38.9, W40–W43.9, W45.0–W45.2, W46–W46.2, W49–W52, W75–W75.9
Unintentional 
firearm injuries
4 E922–E922.99, E928.7 W32–W34.9
Unintentional 
suffocation
4 E913–E913.19 W75–W75.9
Other exposure 
to mechanical 
forces
4 E916–E921.99, E928.1–E928.6 W20–W31.9, W35–W38.9, W40–W43.9, W45.0–W45.2, W46–W46.2, W49–W52
Adverse effects 
of medical 
treatment
3–4 E870–E876.9, E878–E879.9, E930–E949.9 Y38.9–Y84.9, Y88–Y88.3
Animal contact 3 E905–E906.99 W52.0–W62.9, W64–W64.9, X20–X29.9
Venomous ani-
mal contact
4 E905–E905.99 X20–X29.9
Non-venomous 
animal contact
4 E906–E906.99 W52.0–W62.9, W64–W64.9
Foreign body 3 E911–E912.09, E913.8–E915.09 W44–W45, W45.3–W45.9, W78–W80.9, W83–W84.9
Pulmonary 
aspiration and 
foreign body in 
airway
4 E911–E912.09, E913.8–E913.99 W78–W80.9, W83–W84.9
Foreign body in 
other body part
4 E914–E915.09 W44–W45, W45.3–W45.9
Environmental 
heat and cold 
exposure
3–4 E900–E902.99, E926–E926.99, E929.5 W88–W94.9, W97.9, W99–W99.9, X30–X32.9, X39–X39.9
Other uninten-
tional injuries
3–4 E903–E904.99, E913.2–E913.39, E923–E923.99, E925–E925.99, E927–E928.09, E928.8–
E928.89
W39–W39.9, W77–W77.9, W81–W81.9, W85–W87.9, X50–X54.9, X57–X58.9
Self-harm and 
interpersonal 
violence
2 E950–E969 X60–Y08.9, Y87.0–Y87.1
Self-harm 3–4 E950–E959 X60–X84.9, Y87.0
Interpersonal 
violence
3 E960–E969 X85–Y08.9, Y87.1
Assault by 
firearm
4 E965–E965.4 X93–X94.0, X94.3–X94.7, X94.9–X95.9, X96.5
Assault by sharp 
object
4 E966 X99–X99.9
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eTable 3. GBD cause list and associated ICD9 and ICD10 codes. (continued)
Cause Level ICD9 ICD10
Drowning 3–4 E910–E910.99 W65–W70.9, W73–W74.9
Fire, heat, and 
hot substances
3–4 E890–E899.09, E924–E924.99, E929.4 X00–X06.9, X08–X19.9
Poisonings 3–4 E850.3–E850.89, E854.8, E856–E857.09, E860.2–E869.99, E929.2 X46–X47, X47.1–X47.8, X48–X48.9
Exposure to 
mechanical 
forces
3 E913–E913.19, E916–E922.99, E928.1–E928.7 W20–W38.9, W40–W43.9, W45.0–W45.2, W46–W46.2, W49–W52, W75–W75.9
Unintentional 
firearm injuries
4 E922–E922.99, E928.7 W32–W34.9
Unintentional 
suffocation
4 E913–E913.19 W75–W75.9
Other exposure 
to mechanical 
forces
4 E916–E921.99, E928.1–E928.6 W20–W31.9, W35–W38.9, W40–W43.9, W45.0–W45.2, W46–W46.2, W49–W52
Adverse effects 
of medical 
treatment
3–4 E870–E876.9, E878–E879.9, E930–E949.9 Y38.9–Y84.9, Y88–Y88.3
Animal contact 3 E905–E906.99 W52.0–W62.9, W64–W64.9, X20–X29.9
Venomous ani-
mal contact
4 E905–E905.99 X20–X29.9
Non-venomous 
animal contact
4 E906–E906.99 W52.0–W62.9, W64–W64.9
Foreign body 3 E911–E912.09, E913.8–E915.09 W44–W45, W45.3–W45.9, W78–W80.9, W83–W84.9
Pulmonary 
aspiration and 
foreign body in 
airway
4 E911–E912.09, E913.8–E913.99 W78–W80.9, W83–W84.9
Foreign body in 
other body part
4 E914–E915.09 W44–W45, W45.3–W45.9
Environmental 
heat and cold 
exposure
3–4 E900–E902.99, E926–E926.99, E929.5 W88–W94.9, W97.9, W99–W99.9, X30–X32.9, X39–X39.9
Other uninten-
tional injuries
3–4 E903–E904.99, E913.2–E913.39, E923–E923.99, E925–E925.99, E927–E928.09, E928.8–
E928.89
W39–W39.9, W77–W77.9, W81–W81.9, W85–W87.9, X50–X54.9, X57–X58.9
Self-harm and 
interpersonal 
violence
2 E950–E969 X60–Y08.9, Y87.0–Y87.1
Self-harm 3–4 E950–E959 X60–X84.9, Y87.0
Interpersonal 
violence
3 E960–E969 X85–Y08.9, Y87.1
Assault by 
firearm
4 E965–E965.4 X93–X94.0, X94.3–X94.7, X94.9–X95.9, X96.5
Assault by sharp 
object
4 E966 X99–X99.9
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eTable 3. GBD cause list and associated ICD9 and ICD10 codes. (continued)
Cause Level ICD9 ICD10
Assault by other 
means
4 E960–E964, E965.5–E965.9, E967–E969 X85–X92.9, X94.1–X94.2, X94.8, X96–X96.4, X96.6–X98.9, Y00–Y08.9, Y87.1
Forces of 
nature, war, and 
legal interven-
tion
2 E907–E909.9, E970–E979.9, E990–E999.1 X33–X38.9, Y35–Y38.893, Y89.0–Y89.1
Exposure to 
forces of nature
3–4 E907–E909.9 X33–X38.9
Collective vio-
lence and legal 
intervention
3–4 E970–E979.9, E990–E999.1 Y35–Y38.893, Y89.0–Y89.1
Garbage codes - 000–000.9, 002, 031–031.9, 038–038.9, 039.6, 040.0, 041.1–041.9, 067–069, 
076–078.3, 078.8–078.9, 079.8–079.99, 084, 084.6, 085, 085.1–085.9, 089–089.9, 
105–119, 125–125.3, 126–126.9, 127.2–127.9, 130–132.9, 133.8–134.9, 136.3–136.5, 
136.8–136.9, 139.1–139.9, 149–149.9, 159–159.9, 165–169, 176–179.9, 183.9–184, 
184.5, 184.9, 187, 187.9, 189, 189.9, 194.9–199.9, 209, 209.2–209.20, 209.29–209.30, 
209.6–209.60, 209.62, 209.69–210, 211, 211.9–212, 212.9, 214–216.9, 221, 
221.9–222, 222.9–223, 223.9, 229, 229.1, 229.9–230.0, 230.9–231, 231.8–231.9, 233, 
233.3–233.30, 233.39, 233.6, 233.9–234, 234.9–235, 235.1–235.3, 235.5, 235.9–236, 
236.3, 236.6, 236.9–236.90, 237.4, 238, 238.6–239.1, 239.5, 239.7–239.9, 244, 244.9, 
247–249.91, 264–264.9, 274–274.9, 276.0–276.9, 277.3–277.39, 278, 279–280.0, 
280.9–281, 285–285.9, 286.6, 289.8–289.9, 293–294.0, 296–302.9, 304, 304.9–304.93, 
306–307.0, 307.2–307.50, 307.52–307.53, 307.59–320, 320.9, 324–327.19, 328–329, 
331.3–331.4, 338–339.89, 342–344.9, 346–348.9, 349.81–353.5, 354–355.9, 357, 
357.8–357.9, 360–376, 376.10–380.9, 384–389.9, 399–401.9, 405–409.4, 415–416.0, 
416.2–416.9, 418–419.9, 423.0, 426–426.9, 427.4–427.5, 427.9–429, 429.2–429.9, 
436–437, 437.3, 437.9–440.9, 444–445.89, 458–458.9, 459.0, 459.5–460.9, 462–464, 
464.00, 464.1–464.10, 464.20, 464.3–464.30, 464.5–464.51, 465–465.9, 482.9–483, 
484, 484.8–486.9, 505–505.9, 507–507.9, 510–514.9, 515.0–515.9, 518–518.53, 
518.8–518.89, 519, 519.8–529.9, 536.2–536.3, 536.8–536.9, 537.7, 537.89–537.9, 
544–549, 553.8–553.9, 559–559.0, 560.4–560.7, 561, 562.2–563, 564.8–564.9, 
567–569, 569.49, 569.79–569.83, 569.86–570.9, 572–572.2, 573, 573.5, 578–578.9, 
584–584.9, 586–587.9, 591–591.9, 593.9, 599.7–599.72, 599.9–600.91, 603–603.9, 
605–608.1, 608.3–609, 611–612.1, 615–616.9, 619–619.9, 621–621.35, 622–622.2, 
622.8–628.9, 629.89–629.9, 637–637.92, 639–639.9, 690–693.9, 695.8–706.9, 
708–709.9, 712–713.8, 714.4, 715–716, 716.1–728.85, 728.87, 728.89–730.09, 730.2–
730.39, 730.7–731.9, 733, 733.2–739.9, 749.1–749.14, 759, 759.9, 770.0, 779.9–780.56, 
780.58, 780.6–780.61, 780.64–786.02, 786.04–787.04, 787.2–787.9, 787.99–788, 
788.1–790.1, 790.29, 790.4–797.9, 798.1–E80, E800.8–E800.9, E801.8–E801.9, E802.8–
E802.9, E803.8–E803.9, E804.8–E804.9, E805.8–E805.9, E806.8–E806.9, E807.8–E810, 
E810.8–E811, E811.8–E812, E812.8–E813, E813.8–E814, E814.8–E815, E815.8–E816, 
E816.8–E817, E817.8–E818, E818.8–E819, E819.8–E820, E820.8–E821, E821.8–E822, 
E822.8–E823, E823.8–E824, E824.8–E825, E825.8–E826, E826.8–E827, E827.8–E828, 
E828.8–E829, E829.8–E83, E839, E85, E855–E855.99, E858–E859, E87, E877, E88, 
E887–E887.09, E928.9–E929.0, E929.8–E929.9, E980–E989
A01, A14.9, A29, A31–A31.9, A40–A45.9, A47–A48.0, A48.3, A48.8–A49.02, A49.2–A49.9, A59–A59.9, A61–
A62, A64–A64.0, A71–A73, A74.0, A76, A97, A99–A99.0, B07–B09, B11–B14, B28–B29, B30–B32.4, B34–B46.9, 
B49–B49.9, B54–B55, B55.1–B55.9, B58–B59.9, B61–B62, B64, B68–B68.9, B73–B74.2, B76–B76.9, B78–B82.9, 
B83.9–B85.4, B87–B89, B93–B94.0, B94.8–B94.9, B95.6–B99.9, C14–C14.9, C26–C29, C35–C36, C39–C39.9, 
C42, C46–C46.9, C55–C55.9, C57.9, C59–C6, C63.9, C68, C68.9, C75.9–C80.9, C87, C97–D00.0, D01, D01.4–D02, 
D02.4–D02.9, D07, D07.3–D07.39, D07.6–D09, D09.1–D09.19, D09.7, D09.9–D10, D10.9, D13, D13.9–D14, D14.4, 
D17–D21.9, D28, D28.9–D29, D29.9–D30, D30.9, D36.0, D36.9–D37.0, D37.6–D38, D38.6–D39.0, D39.7, D39.9–
D40, D40.9–D41, D41.9, D44, D44.9, D46–D46.9, D47.1, D48, D48.7–D49.1, D49.5, D49.7–D49.8, D49.89–D50.0, 
D50.9, D54, D59, D59.4, D59.8–D59.9, D62–D63.0, D63.8–D64, D64.1–D64.2, D64.8–D65.9, D68, D69.9, D75.9, 
D79–D85, D87–D88, D89.8–D99, E07.8–E08.9, E15, E16, E17–E19, E34.9–E35.8, E37–E39, E47–E50.9, E62, E64.1, 
E69, E85.3–E87.70, E87.79–E87.99, E90–E998, F04–F06.1, F06.3–F07.0, F07.2–F09.9, F17–F17.9, F30–F50, F50.8–
G00, G00.9–G02.8, G03.9, G06–G09.9, G15–G19, G27–G29, G32–G34, G38–G39, G42–G44.89, G47–G47.29, 
G47.4–G60.9, G62–G69, G74–G89.4, G91–G93.6, G93.8–G94.8, G96–G96.9, G98–H05, H05.12–H69.93, H71–H99, 
I00.0, I03–I04, I10–I10.9, I14–I19, I26–I27.0, I27.2–I27.9, I28.9–I29.9, I31.2–I31.4, I44–I46.9, I49–I51, I51.6–I59, I62, 
I62.1–I62.9, I64–I64.9, I67, I67.4, I67.8–I68, I68.8–I69, I69.4–I70.1, I70.8–I70.92, I74–I76, I90, I92–I95.1, I95.8–I96.9, 
I98.4–I98.8, I99–J00.0, J02, J02.8–J03, J03.8–J04, J04.1–J04.31, J05.1–J05.10, J06–J08, J15.9, J17–J19.6, J22–J29, 
J48–J59, J64–J64.9, J69–J69.9, J71–J81.9, J83, J85–J90.9, J93–J94.9, J96–K19, K30, K31.9–K34, K39, K47–K49, 
K53–K54, K63–K63.4, K63.8–K63.9, K65–K66.1, K66.9, K69, K71–K71.2, K71.6, K71.8–K72.01, K75–K75.1, K78–K79, 
K84, K87–K89, K92–K92.2, K92.9–K93, K93.1–K93.8, K96–K99, L06–L07, L09, L15–L50.9, L52–L87.9, L90–L92.9, 
L94–L96, L98.5–L99.8, M04, M10–M12.09, M12.2–M29, M37–M39, M43.2–M49, M49.2–M64, M65.1–M71, 
M71.2–M73, M73.8–M79.9, M83–M86.29, M86.5–M86.9, M87.2–M87.9, M89.1–M89.49, M90–M99.9, N09, 
N13–N13.9, N17–N17.9, N19–N19.9, N24, N32.1–N32.2, N32.8–N33.8, N35–N35.9, N37–N38, N39.3–N40.9, 
N42–N43.42, N44.1–N44.8, N46–N48.9, N50–N59, N61–N64.9, N66–N69, N78–N79, N82–N82.9, N84, N84.2–N86, 
N88–N95.9, N97–N97.9, O08–O08.9, O17–O19, O27, O37–O39, O49–O59, O78–O79, O93–O95.9, P06, P16–P18, 
P23, P23.5–P23.9, P30–P34.2, P37.3–P37.4, P40–P49, P62–P69, P73, P79, P82, P85–P89, P96.9–P99.9, Q08–Q10.3, 
Q19, Q29, Q36.0–Q36.9, Q46–Q49, Q88, Q89.9, Q94, Q99.9–R19.6, R19.8–R50.1, R50.8–R50.81, R50.84–R72.9, 
R74–R78, R78.6–R94.8, R95.0–T71.161, T71.163–U03, U05–U99, V87–V87.1, V87.4–V88.1, V88.4–V89.9, V99–
V99.0, W47–W48, W63, W71–W72, W76–W76.9, W82, W95–W97, W98, X07, X40–X44.9, X47.0, X47.9, X49–X49.9, 
X55–X56, X59–X59.9, Y09–Y34.9, Y85–Y87, Y87.2, Y89, Y89.9
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eTable 3. GBD cause list and associated ICD9 and ICD10 codes. (continued)
Cause Level ICD9 ICD10
Assault by other 
means
4 E960–E964, E965.5–E965.9, E967–E969 X85–X92.9, X94.1–X94.2, X94.8, X96–X96.4, X96.6–X98.9, Y00–Y08.9, Y87.1
Forces of 
nature, war, and 
legal interven-
tion
2 E907–E909.9, E970–E979.9, E990–E999.1 X33–X38.9, Y35–Y38.893, Y89.0–Y89.1
Exposure to 
forces of nature
3–4 E907–E909.9 X33–X38.9
Collective vio-
lence and legal 
intervention
3–4 E970–E979.9, E990–E999.1 Y35–Y38.893, Y89.0–Y89.1
Garbage codes - 000–000.9, 002, 031–031.9, 038–038.9, 039.6, 040.0, 041.1–041.9, 067–069, 
076–078.3, 078.8–078.9, 079.8–079.99, 084, 084.6, 085, 085.1–085.9, 089–089.9, 
105–119, 125–125.3, 126–126.9, 127.2–127.9, 130–132.9, 133.8–134.9, 136.3–136.5, 
136.8–136.9, 139.1–139.9, 149–149.9, 159–159.9, 165–169, 176–179.9, 183.9–184, 
184.5, 184.9, 187, 187.9, 189, 189.9, 194.9–199.9, 209, 209.2–209.20, 209.29–209.30, 
209.6–209.60, 209.62, 209.69–210, 211, 211.9–212, 212.9, 214–216.9, 221, 
221.9–222, 222.9–223, 223.9, 229, 229.1, 229.9–230.0, 230.9–231, 231.8–231.9, 233, 
233.3–233.30, 233.39, 233.6, 233.9–234, 234.9–235, 235.1–235.3, 235.5, 235.9–236, 
236.3, 236.6, 236.9–236.90, 237.4, 238, 238.6–239.1, 239.5, 239.7–239.9, 244, 244.9, 
247–249.91, 264–264.9, 274–274.9, 276.0–276.9, 277.3–277.39, 278, 279–280.0, 
280.9–281, 285–285.9, 286.6, 289.8–289.9, 293–294.0, 296–302.9, 304, 304.9–304.93, 
306–307.0, 307.2–307.50, 307.52–307.53, 307.59–320, 320.9, 324–327.19, 328–329, 
331.3–331.4, 338–339.89, 342–344.9, 346–348.9, 349.81–353.5, 354–355.9, 357, 
357.8–357.9, 360–376, 376.10–380.9, 384–389.9, 399–401.9, 405–409.4, 415–416.0, 
416.2–416.9, 418–419.9, 423.0, 426–426.9, 427.4–427.5, 427.9–429, 429.2–429.9, 
436–437, 437.3, 437.9–440.9, 444–445.89, 458–458.9, 459.0, 459.5–460.9, 462–464, 
464.00, 464.1–464.10, 464.20, 464.3–464.30, 464.5–464.51, 465–465.9, 482.9–483, 
484, 484.8–486.9, 505–505.9, 507–507.9, 510–514.9, 515.0–515.9, 518–518.53, 
518.8–518.89, 519, 519.8–529.9, 536.2–536.3, 536.8–536.9, 537.7, 537.89–537.9, 
544–549, 553.8–553.9, 559–559.0, 560.4–560.7, 561, 562.2–563, 564.8–564.9, 
567–569, 569.49, 569.79–569.83, 569.86–570.9, 572–572.2, 573, 573.5, 578–578.9, 
584–584.9, 586–587.9, 591–591.9, 593.9, 599.7–599.72, 599.9–600.91, 603–603.9, 
605–608.1, 608.3–609, 611–612.1, 615–616.9, 619–619.9, 621–621.35, 622–622.2, 
622.8–628.9, 629.89–629.9, 637–637.92, 639–639.9, 690–693.9, 695.8–706.9, 
708–709.9, 712–713.8, 714.4, 715–716, 716.1–728.85, 728.87, 728.89–730.09, 730.2–
730.39, 730.7–731.9, 733, 733.2–739.9, 749.1–749.14, 759, 759.9, 770.0, 779.9–780.56, 
780.58, 780.6–780.61, 780.64–786.02, 786.04–787.04, 787.2–787.9, 787.99–788, 
788.1–790.1, 790.29, 790.4–797.9, 798.1–E80, E800.8–E800.9, E801.8–E801.9, E802.8–
E802.9, E803.8–E803.9, E804.8–E804.9, E805.8–E805.9, E806.8–E806.9, E807.8–E810, 
E810.8–E811, E811.8–E812, E812.8–E813, E813.8–E814, E814.8–E815, E815.8–E816, 
E816.8–E817, E817.8–E818, E818.8–E819, E819.8–E820, E820.8–E821, E821.8–E822, 
E822.8–E823, E823.8–E824, E824.8–E825, E825.8–E826, E826.8–E827, E827.8–E828, 
E828.8–E829, E829.8–E83, E839, E85, E855–E855.99, E858–E859, E87, E877, E88, 
E887–E887.09, E928.9–E929.0, E929.8–E929.9, E980–E989
A01, A14.9, A29, A31–A31.9, A40–A45.9, A47–A48.0, A48.3, A48.8–A49.02, A49.2–A49.9, A59–A59.9, A61–
A62, A64–A64.0, A71–A73, A74.0, A76, A97, A99–A99.0, B07–B09, B11–B14, B28–B29, B30–B32.4, B34–B46.9, 
B49–B49.9, B54–B55, B55.1–B55.9, B58–B59.9, B61–B62, B64, B68–B68.9, B73–B74.2, B76–B76.9, B78–B82.9, 
B83.9–B85.4, B87–B89, B93–B94.0, B94.8–B94.9, B95.6–B99.9, C14–C14.9, C26–C29, C35–C36, C39–C39.9, 
C42, C46–C46.9, C55–C55.9, C57.9, C59–C6, C63.9, C68, C68.9, C75.9–C80.9, C87, C97–D00.0, D01, D01.4–D02, 
D02.4–D02.9, D07, D07.3–D07.39, D07.6–D09, D09.1–D09.19, D09.7, D09.9–D10, D10.9, D13, D13.9–D14, D14.4, 
D17–D21.9, D28, D28.9–D29, D29.9–D30, D30.9, D36.0, D36.9–D37.0, D37.6–D38, D38.6–D39.0, D39.7, D39.9–
D40, D40.9–D41, D41.9, D44, D44.9, D46–D46.9, D47.1, D48, D48.7–D49.1, D49.5, D49.7–D49.8, D49.89–D50.0, 
D50.9, D54, D59, D59.4, D59.8–D59.9, D62–D63.0, D63.8–D64, D64.1–D64.2, D64.8–D65.9, D68, D69.9, D75.9, 
D79–D85, D87–D88, D89.8–D99, E07.8–E08.9, E15, E16, E17–E19, E34.9–E35.8, E37–E39, E47–E50.9, E62, E64.1, 
E69, E85.3–E87.70, E87.79–E87.99, E90–E998, F04–F06.1, F06.3–F07.0, F07.2–F09.9, F17–F17.9, F30–F50, F50.8–
G00, G00.9–G02.8, G03.9, G06–G09.9, G15–G19, G27–G29, G32–G34, G38–G39, G42–G44.89, G47–G47.29, 
G47.4–G60.9, G62–G69, G74–G89.4, G91–G93.6, G93.8–G94.8, G96–G96.9, G98–H05, H05.12–H69.93, H71–H99, 
I00.0, I03–I04, I10–I10.9, I14–I19, I26–I27.0, I27.2–I27.9, I28.9–I29.9, I31.2–I31.4, I44–I46.9, I49–I51, I51.6–I59, I62, 
I62.1–I62.9, I64–I64.9, I67, I67.4, I67.8–I68, I68.8–I69, I69.4–I70.1, I70.8–I70.92, I74–I76, I90, I92–I95.1, I95.8–I96.9, 
I98.4–I98.8, I99–J00.0, J02, J02.8–J03, J03.8–J04, J04.1–J04.31, J05.1–J05.10, J06–J08, J15.9, J17–J19.6, J22–J29, 
J48–J59, J64–J64.9, J69–J69.9, J71–J81.9, J83, J85–J90.9, J93–J94.9, J96–K19, K30, K31.9–K34, K39, K47–K49, 
K53–K54, K63–K63.4, K63.8–K63.9, K65–K66.1, K66.9, K69, K71–K71.2, K71.6, K71.8–K72.01, K75–K75.1, K78–K79, 
K84, K87–K89, K92–K92.2, K92.9–K93, K93.1–K93.8, K96–K99, L06–L07, L09, L15–L50.9, L52–L87.9, L90–L92.9, 
L94–L96, L98.5–L99.8, M04, M10–M12.09, M12.2–M29, M37–M39, M43.2–M49, M49.2–M64, M65.1–M71, 
M71.2–M73, M73.8–M79.9, M83–M86.29, M86.5–M86.9, M87.2–M87.9, M89.1–M89.49, M90–M99.9, N09, 
N13–N13.9, N17–N17.9, N19–N19.9, N24, N32.1–N32.2, N32.8–N33.8, N35–N35.9, N37–N38, N39.3–N40.9, 
N42–N43.42, N44.1–N44.8, N46–N48.9, N50–N59, N61–N64.9, N66–N69, N78–N79, N82–N82.9, N84, N84.2–N86, 
N88–N95.9, N97–N97.9, O08–O08.9, O17–O19, O27, O37–O39, O49–O59, O78–O79, O93–O95.9, P06, P16–P18, 
P23, P23.5–P23.9, P30–P34.2, P37.3–P37.4, P40–P49, P62–P69, P73, P79, P82, P85–P89, P96.9–P99.9, Q08–Q10.3, 
Q19, Q29, Q36.0–Q36.9, Q46–Q49, Q88, Q89.9, Q94, Q99.9–R19.6, R19.8–R50.1, R50.8–R50.81, R50.84–R72.9, 
R74–R78, R78.6–R94.8, R95.0–T71.161, T71.163–U03, U05–U99, V87–V87.1, V87.4–V88.1, V88.4–V89.9, V99–
V99.0, W47–W48, W63, W71–W72, W76–W76.9, W82, W95–W97, W98, X07, X40–X44.9, X47.0, X47.9, X49–X49.9, 
X55–X56, X59–X59.9, Y09–Y34.9, Y85–Y87, Y87.2, Y89, Y89.9
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eTable 4. Mean relative error (%) for age-standardized mortality rates derived from the SAE model.
Model
Population size
1,000 3,000 5,000 10,000 25,000 100,000
1 -0.63 -0.03 -0.04 0.15 0.09 0.13
2 -0.33 0.01 -0.05 0.08 -0.04 -0.02
3 -2.45 -0.85 -0.48 -0.00 0.14 0.28
4 -2.55 -0.69 -0.25 0.30 0.49 0.66
Kulkarni et al. - 2.18 2.05 1.84 1.54 1.35
Wang et al. - 3.28 4.31 5.79 4.39 1.86
eTable 5. Mean absolute relative error (%) for age-standardized mortality rates derived from the SAE mod-
el.
Model
Population size
1,000 3,000 5,000 10,000 25,000 100,000
1 6.53 4.71 4.00 3.23 2.50 1.83
2 7.17 4.86 4.05 3.27 2.54 1.94
3 6.73 5.22 4.75 4.28 3.99 3.77
4 6.81 5.19 4.70 4.24 3.95 3.75
Kulkarni et al. - 5.97 5.72 5.21 4.33 2.86
Wang et al. - 6.82 6.98 7.01 5.09 2.43
eTable 6. Coverage (%) for age-standardized mortality rates derived from the SAE model.
Model
Population size
1,000 3,000 5,000 10,000 25,000 100,000
1 95.43 95.15 94.75 95.20 95.63 96.68
2 93.58 92.00 90.29 87.56 80.72 64.08
3 86.30 81.10 76.24 67.61 52.20 30.91
4 85.96 81.53 76.91 68.22 52.53 30.99
Kulkarni et al. - 63.37 64.02 65.30 68.26 73.31
Wang et al. - 66.66 72.89 78.21 80.15 81.45
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ABSTrACT 
Importance 
Examining life expectancy by county allows for tracking geographic disparities over time and 
assessing factors related to these disparities. This information is potentially useful for policy 
makers, clinicians, and researchers seeking to reduce disparities and increase longevity.
Objective 
To estimate annual life tables by county from 1980 to 2014; describe trends in geographic 
inequalities in life expectancy and age-specific risk of death; and assess the proportion of 
variation in life expectancy explained by variation in socioeconomic and race/ethnicity fac-
tors, behavioral and metabolic risk factors, and health care factors.
Design, setting, and participants 
Annual county-level life tables were constructed using small area estimation methods from 
deidentified death records from the National Center for Health Statistics (NCHS), and popula-
tion counts from the US Census Bureau, NCHS, and the Human Mortality Database. Measures 
of geographic inequality in life expectancy and age-specific mortality risk were calculated. 
Principal component analysis and ordinary least squares regression were used to examine 
the county-level association between life expectancy and socioeconomic and race/ethnicity 
factors, behavioral and metabolic risk factors, and health care factors.
exposures 
County of residence.
Main outcomes and measures 
Life expectancy at birth and age-specific mortality risk.
results 
Counties were combined as needed to create stable units of analysis over the period 1980 
to 2014, reducing the number of areas analyzed from 3,142 to 3,110. In 2014, life expec-
tancy at birth for both sexes combined was 79.1 (95% uncertainty interval [UI], 79.0–79.1) 
years overall, but differed by 20.1 (95% UI, 19.1–21.3) years between the counties with 
the lowest and highest life expectancy. Absolute geographic inequality in life expectancy 
increased between 1980 and 2014. Over the same period, absolute geographic inequality 
in the risk of death decreased among children and adolescents, but increased among older 
adults. Socioeconomic and race/ethnicity factors, behavioral and metabolic risk factors, and 
health care factors explained 60%, 74%, and 27% of county-level variation in life expectancy, 
respectively. Combined, these factors explained 74% of this variation. Most of the associa-
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tion between socioeconomic and race/ethnicity factors and life expectancy was mediated 
through behavioral and metabolic risk factors.
Conclusions and relevance 
Geographic disparities in life expectancy among US counties are large and increasing. Much 
of the variation in life expectancy among counties can be explained by a combination of 
socioeconomic and race/ethnicity factors, behavioral and metabolic risk factors, and health 
care factors. Policy action targeting socioeconomic factors and behavioral and metabolic risk 
factors may help reverse the trend of increasing disparities in life expectancy in the United 
States.
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InTrODUCTIOn 
Studies have routinely shown that life expectancy in the United States varies geographically, 
in some cases dramatically.1–3 Counties are the smallest administrative unit routinely available 
in death registration data and represent an opportunity to explore the extent of geographic 
inequalities in the United States. In particular, tracking inequality at the county level over 
time is an important means of assessing progress toward the goal of more equitable health 
outcomes, as enshrined in the Healthy People 2020 objective: “Achieve health equity, elimi-
nate disparities, and improve the health of all groups.”4 Moreover, county-level information 
on basic health outcomes is essential for appropriately targeting resources and designing 
and implementing health and social welfare policy at both the federal and state level.
Previous analyses of life expectancy at the county level have found large2,5 and increasing3 
geographic disparities. However, these analyses either excluded or combined a large number 
of smaller counties, likely leading to an underestimation of geographic inequality. Moreover, 
recent research has highlighted the need to consider age-specific metrics of survival in ad-
dition to life expectancy overall. Case and Deaton6 identified differential trends in mortality 
rates among age groups, with middle age mortality rates stagnating or even increasing for 
certain populations, while mortality rates among older individuals continued to decline. 
Similarly, Currie and Schwandt7 identified differential trends in income-based inequalities by 
age, with inequalities generally declining among children and adolescents and increasing for 
older ages. To our knowledge, age-specific trends in geographic inequalities have not been 
previously described at the county level in the United States.
Beyond describing geographic variation in life expectancy, exploring what factors explain 
this variation might provide import insights into how to reduce inequalities and achieve more 
equitable health outcomes. Several previous analyses5,8,9 have used local data on all-cause 
mortality to explore this question and have identified a large number of socioeconomic and 
race/ethnicity factors, behavioral and metabolic risk factors, and health care factors that are 
correlated with survival. However, these analyses have not systematically explored the extent 
to which county-level variation in life expectancy can be explained by the larger social and 
economic context of a county, the behavioral and metabolic risk profile of county residents, 
or the availability and quality of health care.
This analysis has 3 specific aims. First, to generate annual estimates of life expectancy and 
age-specific mortality risk for each county from 1980 to 2014. Second, to quantify geographic 
inequalities in life expectancy and age-specific mortality risks and to examine trends in geo-
graphic inequality over time. Third, to assess the extent to which variation in life expectancy is 
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explained by variation in socioeconomic and race/ethnicity factors, behavioral and metabolic 
risk factors, and health care access and quality.
MeTHODS 
Small area models for estimating life expectancy and age-specific mortality 
risks 
Unit of analysis 
All analyses were carried out at the county level. Counties were combined as needed to create 
stable units of analysis over the period 1980 to 2014, reducing the number of areas analyzed 
from 3,142 to 3,110 (eTable 1 in the Supplement). For simplicity, these units are referred to as 
“counties” throughout.
Data 
Deidentified death records from the National Center for Health Statistics (NCHS)10 and 
population counts from the census bureau,11 NCHS,12–14 and the Human Mortality Database15 
were used in this analysis. Deaths and population were tabulated by county, age group (0, 
1–4, 5–9, …, 80–84, and ≥85), sex, and year. County-level information on levels of education, 
income, race/ethnicity, Native American reservations, and population density derived from 
data provided by the census bureau and NCHS was also incorporated (eTable 2 in the Supple-
ment).
Small area model 
Previously described and validated Bayesian small area models for estimating age-specific 
mortality rates by county were used in this analysis.16 These models incorporated 7 covariates 
(the proportion of the adult population who graduated high school; the proportion of the 
population that is Hispanic; the proportion of the population that is black; the proportion 
of the population that is a race other than black or white; the proportion of a county that 
is contained within a state or federal Native American reservation; the median household 
income; and the population density) and smooth mortality rates over space, time, and age 
to produce more stable estimates of the mortality rate in each county, year, and age group. 
Models were fit using the Template Model Builder Package17 in R version 3.2.4 (R Founda-
tion).18 County-level estimates were scaled to ensure consistency with existing national-level 
estimates from the Global Burden of Disease study.19
Life table construction and metrics 
The method described by Wang et al20 was used to extrapolate mortality rates to older ages 
(5-year age groups up to age 110 years). Standard demographic methods were used to 
196
construct period life tables for each county and year from the age-specific mortality rates 
estimated by the small area model.21 Life expectancy at birth (e0) and the probability of death 
for 5 age groups—0 to 5 (5q0); 5 to 25 (20q5), 25 to 45 (20q25), 45 to 65 (20q45), and 65 to 85 
(20q65)—were extracted from these life tables.
For each measure, absolute geographic inequality was quantified as the difference between 
the 99th and 1st percentile level, and relative geographic inequality was quantified as the 
ratio of the 99th to 1st percentile level. The corresponding measures using the 90th and 10th 
percentile were calculated as well.
Analysis of county-level variation in life expectancy 
Data 
A cross-sectional data set was constructed of variables correlated with life expectancy at the 
county level. To maximize the number of variables included, 2009, the year with the best 
data coverage, was used. Three groups of variables were considered. For the first group, 
variables related to the broader social, economic, and demographic context of a county were 
identified. Specifically: the poverty rate, median household income, proportion of the adult 
population who graduated high school, proportion of the adult population who graduated 
college, the unemployment rate, proportion of the population that are black, proportion of 
the population that are native American, and proportion of the population that are Hispanic. 
For the second group, behavioral and metabolic risk factors with high attributable burden 
in the United States22 for which reliable estimates were available at the county level were 
identified. The prevalence of obesity, leisure–time physical inactivity, cigarette smoking, 
hypertension, and diabetes were included. For the third group, variables related to access to 
health care and health care quality were identified. Three variables were ultimately included: 
the percentage of the population younger than 65 years who are insured, a quality index that 
is a composite of variables related to primary care access and quality based on Medicare data 
analyzed by the Dartmouth Atlas project,23 and the number of physicians per capita. eTable 3 
in the Supplement provides details about the data sources for each of these variables.
Regression models 
A series of bivariate ordinary least squares regression models were fitted with life expectancy 
at birth in 2009 as the dependent variable and each of the variables listed above as indepen-
dent variables to assess the independent relationship between each of these variables and 
life expectancy.
Many of the variables considered were highly correlated (eFigure 1 in the Supplement), 
making multivariate models including all of these factors challenging to interpret due 
to collinearity. Therefore, a principal component analysis24 was conducted on each group 
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of variables and the first principal component from each (rescaled to run from 0 to 1) was 
used as a composite index representing the socioeconomic and race/ethnicity, behavioral 
and metabolic risk, and health care characteristics, respectively, of each county. A series of 
ordinary least squares regression models were fitted with life expectancy at birth as the 
dependent variable and each of these indices separately, and then in combination, as the 
independent variable(s). For all models, the estimated model coefficients and the adjusted 
and unadjusted R2 were extracted. As a sensitivity analysis, the full multivariate regression 
models using all of the factors separately were also fitted.
reSULTS 
Inequalities in life expectancy and age-specific mortality risk 
There was considerable variation in mortality risk and life expectancy at the county level in 
all years. In 2014, life expectancy at birth for both sexes combined at the national level was 
79.1 (95% uncertainty interval [UI], 79.0–79.1) years (76.7 [95% UI, 76.7–76.8] years for men, 
Copyright 2017 American Medical Association. All rights reserved.
1st and99thpercentile increasingby2.4 (95%UI, 2.1-2.7) years
(Figure 3). However, formortality risks, this pattern varied by
age: the difference between the 1st and 99th among counties
declinedby42.9%(95%UI,40.4%-45.1%)amongchildren(ages
0 to 5 years), by 18.9% (95%UI, 15.2%-22.7%) for adolescents
(ages 5 to 25years), and increased by 10.1% (95% UI, 6.4%-
14.1%), 15.0% (95% UI, 11.6%-18.4%), and 48.2% (95% UI,
42.7%-53.7%) for age groups25 to45years, 45 to65years, and
65 to85years, respectively. Relative inequality rose for all age
groups, likelydue to theoverall decrease inmortality riskover
this period. Similar trendswereobservedwhencomparing the
10th and 90th percentiles (eFigure 8 in the Supplement).
Factors Related to Variation in Life Expectancy
Table 1 provides summary statistics for each of the variables
included in the analysis of factors related to variation in life
expectancy as well as the bivariate regression results. Statis-
ticallysignificant relationshipswith lifeexpectancywere found
for each variable. Detailed results of the principal component
analysis are given in eTables 4 through 6 and eFigure 9 in the
Supplement. The first principal component explained 42%,
79%,and56%of the total variation in socioeconomicand race/
ethnicity factors, behavioral and metabolic risk factors, and
health care factors, respectively.Table2 lists the regression re-
sults based on these three indices. Socioeconomic and race/
ethnicity factors, behavioral and metabolic risk factors, and
health care factors, when considered independently, ex-
plained 60%, 74%, and 27%, respectively, of the county-level
variation in life expectancy. In combination, these3 factors ex-
plained 74% of the variation. The effect size for the behav-
ioral and metabolic risk factors index is similar in the com-
bined model (Model 4) as in the model with just risk factors
as a predictor (Model 2). In contrast, the effect size for socio-
economic and race/ethnicity factors is much reduced in the
combinedmodel (Model4) comparedwith themodelwith just
socioeconomic and race/ethnicity factors (Model 1), and is no
longer statistically significant. The effect size for health care
factors is also reduced in the combinedmodel (Model 4) com-
pared with the model with just health care factors (Model 3),
but the effect is still statistically significant.
The corresponding results from the regressions using all
variables separately are presented in eTable 7 in the Supple-
ment. The overall amount of variation explained by each
group of factors, both separately and in combination, is
Figure 1. Life Expectancy at Birth by County, 2014
66 69 72 75 78 81 84 87
Life expectancy at birth (years):
Counties in South Dakota and North Dakota had the lowest life expectancy, and
counties along the lower half of the Mississippi, in eastern Kentucky, and
southwesternWest Virginia also had very low life expectancy compared with
the rest of the country. Counties in central Colorado had the highest life
expectancies.
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figure 1. Life expectancy at birth by county, 2014. 
Counties in South Dakota and North Dakota had the lowest life expectancy, and counties along the lower 
half of the Mississippi, in eastern Kentucky, and southwestern West Virginia also had very low life expec-
tancy compa ed with the rest of the country. Counties in central Colorado had the highest life expe tancies. 
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and 81.5 [95% UI, 81.4–81.5] years for women), but there was a 6.2-year gap (95% UI, 6.1–6.2) 
between the 10th and 90th percentile, a 10.7-year gap (95% UI, 10.5–11.0) between the 1st 
and 99th percentile, and a 20.1-year gap (95% UI, 19.1–21.3) between the lowest and highest 
life expectancy among all counties. Several counties in South and North Dakota (typically 
those with Native American reservations) had the lowest life expectancy, and counties along 
the lower half of the Mississippi and in eastern Kentucky and southwestern West Virginia also 
had very low life expectancy compared with the rest of the country. In contrast, counties in 
central Colorado had the highest life expectancies (Figure 1). Geographical patterns in mor-
tality risk for each age group were similar, but not identical (eFigures 2–6 in the Supplement). 
Results by sex and for all counties and years are available in an online visualization tool.
Between 1980 and 2014, life expectancy at birth for both sexes combined in the United 
States increased by 5.3 (95% UI, 5.3–5.4) years, from 73.8 (95% UI, 73.7–73.8) to 79.1 (95% 
UI, 79.0–79.1) years (6.7 [95% UI, 6.7–6.8] years, from 70.0 [95% UI, 70.0–70.0] to 76.7 [95% 
UI, 76.7–76.8] for men; 3.9 [95% UI, 3.9–4.0] years, from 77.5 [95% UI, 77.5–77.6] to 81.5 
[95% UI, 81.4–81.5] for women). This masks massive variation at the county level; counties 
Copyright 2017 American Medical Association. All rights reserved.
somewhat higher, but with the same ordering among the dif-
ferent groups of factors: 69% for socioeconomic and race/
ethnicity factors, 77% for behavioral and metabolic risk fac-
tors, 31% for health care factors, and 82% for all factors
combined.
Discussion
This study found large—and increasing—geographic dispari-
ties among counties in life expectancy over the past 35 years.
The magnitude of these disparities demands action, all the
more urgently because inequalities will only increase further
if recent trends are allowed to continue uncontested.
The finding thatcounty-levelgeographic inequalities in life
expectancy are large and increasing is consistent with earlier
studies. Kulkarni et al2 reported a 15.2-year and 12.5-year gap
between counties with the lowest and highest life expec-
tancy in 2007 for men and women, respectively, while Wang
et al3 reported a 17.8-year and 12.3-year gap in 2010 for men
and women, respectively. This study estimates noticeably
larger disparities: in recent years, the gap in life expectancy
among counties for both sexes combined was more than 20
years. The smaller estimates inKulkarni et al2 andWang et al3
are likelydueto theiraggregationof smaller counties into larger
merged county units (they analyze 2356units comparedwith
3110 in this study). Chetty et al5 also estimated county-level
life expectancy for a subset of counties, with a focus on how
life expectancy varies among counties for low-income com-
pared with high-income individuals. As in this analysis, they
found substantial variation in life expectancy among coun-
ties. There are several important differences in their estima-
tionstrategyascomparedwith theoneused in this study,how-
ever. Inparticular, to estimate life expectancyby income level,
they use death records from the social security administra-
tion rather than fromNCHS. This restricts their analysis to in-
dividuals aged 40 to 76 years who reported at least some in-
come, and introduces some uncertainty in the county of
residence for decedents who relocated after reaching retire-
ment age (62 years). Likely as a consequence of the differ-
ences in the underlying data, as well as differences in analy-
sismethods, thecorrelationbetweentheestimates fromChetty
et al5 and this analysis was lower thanmight be expected: be-
tween 0.38 and 0.65, depending on sex and income quartile.
Figure 2. Change in Life Expectancy at Birth by County, 1980 to 2014
−2.3 to −1 0 1 2 3 4 5 6 7 8 to 13
Change in life expectancy at birth (years):
Compared with the national average, counties in central Colorado, Alaska, and
along both coasts experienced larger increases in life expectancy between 1980
and 2014, while some southern counties in states stretching fromOklahoma to
West Virginia saw little, if any, improvement over this same period.
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figur  2. Change in lif  exp cta cy at birth by county, 1980 to 2014. 
Compared with the national average, counties in central Colorado, Alaska, and along both coasts experi-
enced larger increases in life expectancy between 1980 and 2014, while some southern counties in states 
tretching from Oklahoma to West V r inia saw little, if ny, improv ment over this same period. 
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in central Colorado, Alaska, and along both coasts experienced much larger increases, while 
some southern counties in states stretching from Oklahoma to West Virginia saw little, if any, 
improvement over this same period (Figure 2). Similarly, there was considerable variation 
among counties in the percent decline in the mortality risk within each age group (eFigure 
7 in the Supplement). While all counties experienced declines in mortality risk for children 
(ages 0 to 5 years) and nearly all counties (>98%) experienced declines in the mortality risk 
for adolescents (ages 5 to 25 years) and older adults (ages 45 to 65 and 65 to 85 years), a 
significant minority of counties (11.5%) experienced increases in the risk of death between 
ages 25 and 45 years.
Absolute geographic inequality in life expectancy at birth increased between 1980 and 2014, 
with the gap between the 1st and 99th percentile increasing by 2.4 (95% UI, 2.1–2.7) years 
(Figure 3). However, for mortality risks, this pattern varied by age: the difference between 
the 1st and 99th among counties declined by 42.9% (95% UI, 40.4%–45.1%) among children 
(ages 0 to 5 years), by 18.9% (95% UI, 15.2%–22.7%) for adolescents (ages 5 to 25 years), and 
increased by 10.1% (95% UI, 6.4%–14.1%), 15.0% (95% UI, 11.6%–18.4%), and 48.2% (95% UI, 
Copyright 2017 American Medical Association. All rights reserved.
This study expanded upon earlier analyses of county-
level variation in longevity by examiningmortality risk by age
in addition to life expectancy. There were substantial geo-
graphic inequalities in the risk of death in each age group con-
sidered; however, the trajectory of inequalities over time dif-
fered by age: absolute geographic inequalities in the risk of
death declined over the study period for children and adoles-
cents, and increased for adults, especially those aged 65 to 85
years. This is broadly consistentwith recent findingsbyCurrie
and Schwandt7 who analyzed age-specific mortality rates
among counties grouped by income and found that inequal-
ity among income groups decreased for children and adoles-
cents and increased for older adults from 1990 to 2010. Fur-
ther research should focus on the drivers of these divergent
trends. It seems likely that increases in geographic inequality
in life expectancy over the past 3 decades have been driven
largelyby increases ingeographic inequality in the riskofdeath
in older ages. Consequently, these age groups are an espe-
cially important target for further research and intervention.
A large body of previous research documents a relation-
ship between socioeconomic and race/ethnicity factors and
various measures of survival.25-28 Consistent with this re-
search, this study found that socioeconomic and race/
ethnicity factors alone explained 60% of the variation in life
expectancy. At the same time, 74% of the variation was ex-
plained by behavioral andmetabolic risk factors alone, while
only marginally more variation was explained by socioeco-
nomicandrace/ethnicity factors,behavioral andmetabolic risk
factors, andhealth care factors combined. Furthermore, there
was very little additional effect of socioeconomic and race/
ethnicity factors when accounting for all 3 sets of factors si-
multaneously, suggesting that theassociationbetween life ex-
pectancy and socioeconomic and race/ethnicity factors at the
county level is largelymediated throughbehavioral andmeta-
bolic risk factors.
Previousstudies8,9examining therelationshipbetweenso-
cioeconomic and race/ethnicity factors, behavioral andmeta-
bolic risk factors, and/or health care factors and some mea-
sure of survival at a substate level in the United States are not
directly analogousbecause theyusedifferentmeasuresof sur-
vival, different explanatory factors, andmore aggregatedgeo-
graphic units or a subset of larger counties, but certain find-
ings can still be compared. Cullen et al8 examined the
relationship between 22 socioeconomic and environmental
variables and the sex-specific and race-specific probability of
survival to age 70 years in 510 groups of counties. Consistent
with the results of this study, they found that a large propor-
tion of the variation in survival among counties could be ex-
Figure 3. Absolute and Relative Inequality Among Counties in Life Expectancy and Age-Specific Mortality Risks, 1980–2014
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99th and first percentile level, and relative geographic inequality was quantified
as the ratio of the 99th to the first percentile level.
Research Original Investigation Inequalities in Life Expectancy Among US Counties
E6 JAMA Internal Medicine Published onlineMay 8, 2017 (Reprinted) jamainternalmedicine.com
Downloaded From: http://archinte.jamanetwork.com/pdfaccess.ashx?url=/data/journals/intemed/0/ by a University of Washington Libraries User  on 05/08/2017
figure 3. Absolute and relative inequality among counties in life expectancy and age-specific mortality 
risks, 1980–2014. 
Shaded areas along the plotted data represent 95% uncertainty intervals. Absolute geographic inequal-
ity was qua tified as the differe ce between the 99th nd first percentile lev l, and relative ge graphic 
inequality was quantified as the ratio of the 99th to the first percentile level. 
200
42.7%–53.7%) for age groups 25 to 45 years, 45 to 65 years, and 65 to 85 years, respectively. 
Relative inequality rose for all age groups, likely due to the overall decrease in mortality risk 
over this period. Similar trends were observed when comparing the 10th and 90th percentiles 
(eFigure 8 in the Supplement).
factors related to variation in life expectancy 
Table 1 provides summary statistics for each of the variables included in the analysis of factors 
related to variation in life expectancy as well as the bivariate regression results. Statistically 
significant relationships with life expectancy were found for each variable. Detailed results of 
the principal component analysis are given in eTables 4 through 6 and eFigure 9 in the Sup-
plement. The first principal component explained 42%, 79%, and 56% of the total variation in 
Table 1. Variables included in the regression analysis with summary statistics and bivariate regression re-
sults. 
Variable
Summary statistics, mean 
(SD) [range]
Bivariate regression results
Coefficient (Se) r2
Socioeconomic and race/ethnicity factors
Population below the poverty line, % 16.3 (6.4) [3.1–62.0] -0.24 (0.005) 0.47
Median household income, log $ 10.6 (0.2) [9.8–11.6] 6.06 (0.130) 0.41
Graduates, age ≥25 y, %
 High school 83.7 (7.2) [46.3–98.6] 0.20 (0.004) 0.42
 College 19.2 (8.6) [4.2–72.0] 0.15 (0.004) 0.34
Unemployment rate, age ≥16 y, % 9.1 (3.2) [2.1–27.4] -0.29 (0.011) 0.18
Black population, % 9.4 (14.7) [0.0–85.8] -0.07 (0.002) 0.24
American Indian, Native Alaskan, and Native 
Hawaiian population, %
2.3 (7.9) [0.0–97.2] -0.06 (0.005) 0.04
Hispanic population, % 8.1 (13.1) [0.0–95.9] 0.02 (0.003) 0.01
Behavioral and metabolic risk factors, %
Obesity prevalence, age ≥20 y 37.0 (4.3) [18.0–52.0] -0.39 (0.006) 0.54
No leisure-time physical activity prevalence, 
age ≥20 y
27.0 (5.2) [11.7–47.2] -0.34 (0.005) 0.62
Cigarette smoking prevalence, age ≥18 y 24.7 (4.1) [7.7–42.1] -0.40 (0.007) 0.54
Hypertension prevalence, age ≥30 y 39.5 (3.6) [27.9–56.4] -0.49 (0.007) 0.62
Diabetes prevalence, age ≥20 y 14.0 (2.4) [8.1–25.5] -0.72 (0.011) 0.59
Health care factors
Insured population, age <65 y, % 81.7 (5.7) [57.3–96.7] 0.15 (0.007) 0.14
Quality index 70.1 (11.5) [0.0–100.0] 0.10 (0.003) 0.28
Physicians per 1,000 population, No. 1.1 (1.0) [0.0–4.4] 0.53 (0.039) 0.06
Abbreviations: SE, standard error.
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socioeconomic and race/ethnicity factors, behavioral and metabolic risk factors, and health 
care factors, respectively. Table 2 lists the regression results based on these three indices. 
Socioeconomic and race/ethnicity factors, behavioral and metabolic risk factors, and health 
care factors, when considered independently, explained 60%, 74%, and 27%, respectively, of 
the county-level variation in life expectancy. In combination, these 3 factors explained 74% 
of the variation. The effect size for the behavioral and metabolic risk factors index is similar in 
the combined model (Model 4) as in the model with just risk factors as a predictor (Model 2). 
In contrast, the effect size for socioeconomic and race/ethnicity factors is much reduced in 
the combined model (Model 4) compared with the model with just socioeconomic and race/
ethnicity factors (Model 1), and is no longer statistically significant. The effect size for health 
care factors is also reduced in the combined model (Model 4) compared with the model with 
just health care factors (Model 3), but the effect is still statistically significant.
The corresponding results from the regressions using all variables separately are presented 
in eTable 7 in the Supplement. The overall amount of variation explained by each group of 
factors, both separately and in combination, is somewhat higher, but with the same ordering 
among the different groups of factors: 69% for socioeconomic and race/ethnicity factors, 
77% for behavioral and metabolic risk factors, 31% for health care factors, and 82% for all 
factors combined.
Table 2. Multivariate regression results. 
Variable Model 1a Model 2a Model 3a Model 4a
Intercept, coefficient (SE) 70.60 (0.10)b 70.40 (0.08)b 73.21 (0.13)b 70.07 (0.09)b
Socioeconomic and race/ethnicity factors, 
coefficient (SE)
13.13 (0.19)b NA NA -0.10 (0.37)
Behavioral and metabolic risk factors, coefficient (SE) NA 13.73 (0.15)b NA 13.04 (0.33)b
Health care factors, coefficient (SE) NA NA 7.88 (0.23)b 1.37 (0.17)b
R2 0.60 0.74 0.27 0.74
Adjusted R2 0.60 0.74 0.27 0.74
Abbreviations: NA, not applicable or no data available; SE, standard error. 
aModel 1 includes adjustments for socioeconomic and race/ethnicity factors (ie, poverty; income; educa-
tion level; unemployment; black population; American Indian, Native Alaskan, and Native Hawaiian popula-
tion; and Hispanic population); Model 2, behavioral and metabolic risk factors (ie, obesity, inactivity, smok-
ing status, hypertension, and diabetes); Model 3, health care factors (ie, insurance, quality index, number of 
physicians per 1,000 people); and Model 4, combined (ie, all factors from all models).
bP < .05. 
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DISCUSSIOn 
This study found large—and increasing—geographic disparities among counties in life 
expectancy over the past 35 years. The magnitude of these disparities demands action, all 
the more urgently because inequalities will only increase further if recent trends are allowed 
to continue uncontested.
The finding that county-level geographic inequalities in life expectancy are large and increas-
ing is consistent with earlier studies. Kulkarni et al2 reported a 15.2-year and 12.5-year gap 
between counties with the lowest and highest life expectancy in 2007 for men and women, 
respectively, while Wang et al3 reported a 17.8-year and 12.3-year gap in 2010 for men and 
women, respectively. This study estimates noticeably larger disparities: in recent years, the 
gap in life expectancy among counties for both sexes combined was more than 20 years. 
The smaller estimates in Kulkarni et al2 and Wang et al3 are likely due to their aggregation of 
smaller counties into larger merged county units (they analyze 2,356 units compared with 
3,110 in this study). Chetty et al5 also estimated county-level life expectancy for a subset of 
counties, with a focus on how life expectancy varies among counties for low-income com-
pared with high-income individuals. As in this analysis, they found substantial variation in 
life expectancy among counties. There are several important differences in their estimation 
strategy as compared with the one used in this study, however. In particular, to estimate life 
expectancy by income level, they use death records from the social security administration 
rather than from NCHS. This restricts their analysis to individuals aged 40 to 76 years who re-
ported at least some income, and introduces some uncertainty in the county of residence for 
decedents who relocated after reaching retirement age (62 years). Likely as a consequence 
of the differences in the underlying data, as well as differences in analysis methods, the cor-
relation between the estimates from Chetty et al5 and this analysis was lower than might be 
expected: between 0.38 and 0.65, depending on sex and income quartile.
This study expanded upon earlier analyses of county-level variation in longevity by examin-
ing mortality risk by age in addition to life expectancy. There were substantial geographic 
inequalities in the risk of death in each age group considered; however, the trajectory of 
inequalities over time differed by age: absolute geographic inequalities in the risk of death 
declined over the study period for children and adolescents, and increased for adults, espe-
cially those aged 65 to 85 years. This is broadly consistent with recent findings by Currie and 
Schwandt7 who analyzed age-specific mortality rates among counties grouped by income 
and found that inequality among income groups decreased for children and adolescents and 
increased for older adults from 1990 to 2010. Further research should focus on the drivers of 
these divergent trends. It seems likely that increases in geographic inequality in life expec-
tancy over the past 3 decades have been driven largely by increases in geographic inequality 
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in the risk of death in older ages. Consequently, these age groups are an especially important 
target for further research and intervention.
A large body of previous research documents a relationship between socioeconomic and 
race/ethnicity factors and various measures of survival.25–28 Consistent with this research, 
this study found that socioeconomic and race/ethnicity factors alone explained 60% of the 
variation in life expectancy. At the same time, 74% of the variation was explained by behav-
ioral and metabolic risk factors alone, while only marginally more variation was explained by 
socioeconomic and race/ethnicity factors, behavioral and metabolic risk factors, and health 
care factors combined. Furthermore, there was very little additional effect of socioeconomic 
and race/ethnicity factors when accounting for all 3 sets of factors simultaneously, suggest-
ing that the association between life expectancy and socioeconomic and race/ethnicity 
factors at the county level is largely mediated through behavioral and metabolic risk factors.
Previous studies8,9 examining the relationship between socioeconomic and race/ethnicity 
factors, behavioral and metabolic risk factors, and/or health care factors and some measure 
of survival at a substate level in the United States are not directly analogous because they 
use different measures of survival, different explanatory factors, and more aggregated geo-
graphic units or a subset of larger counties, but certain findings can still be compared. Cullen 
et al8 examined the relationship between 22 socioeconomic and environmental variables 
and the sex-specific and race-specific probability of survival to age 70 years in 510 groups 
of counties. Consistent with the results of this study, they found that a large proportion of 
the variation in survival among counties could be explained by these variables (72%–86%, 
depending on the sex and race). Furthermore, in a small subset of larger counties, they found 
that additionally considering 8 risk and health care factors increased the amount of variation 
explained to 86% to 90%. Davids and Jones9 assessed the relationship between county-level 
life expectancy and a small set of socioeconomic and race factors (poverty, no high school 
diploma, black race) and metabolic risk factors (diabetes and hypertension prevalence). As 
in this study, Davids and Jones9 found an inverse relationship between life expectancy and 
markers of low socioeconomic status and metabolic risk factors. Their findings differ from 
ours, however, in that the effect of the socioeconomic and race factors was only slightly at-
tenuated when considering risk factors concurrently, although this may be due to the much 
smaller number of factors considered.
The findings on factors related to variation in life expectancy have important policy implica-
tions. In particular, policies and programs that target behavioral and metabolic risk factors 
have the potential to improve health in all locations but especially those that are currently 
most at a disadvantage, consequently reducing geographic disparities. This is not to say 
that policies that target socioeconomic drivers of disparities would not also be effective, but 
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rather that there are multiple potential routes to more equitable health outcomes for fed-
eral, state, and local policy makers to consider. Furthermore, researchers now recognize that 
the relationship between socioeconomic status and health likely reflects causal pathways 
running in both directions (ie, from better health to higher socioeconomic status as well as 
from higher socioeconomic status to better health).29 Thus, policies that target inequalities 
in health may also in the long run be effective mechanisms for addressing inequalities in 
socioeconomic status as well.
This study has a number of strengths. First, this analysis used recently developed and 
validated small area models that have been shown to generate more precise estimates than 
previous methodologies.16 Second, this study did not exclude small counties or aggregate 
them beyond what was necessary to address historical boundary changes, allowing for a 
more complete accounting of geographic inequalities at the county level than previously 
available. Third, in addition to life expectancy, this study considered geographic inequalities 
in age-specific mortality risks that have not been previously explored. Fourth, this study is 
the first to systematically consider to what extent geographic inequalities in life expectancy 
at the county level can be explained by socioeconomic and race/ethnicity factors, behavioral 
and metabolic risk factors, and health care factors, both independently and in combination.
Limitations 
This analysis also has a number of limitations. The deaths, population, and covariates data 
used as the basis for estimating life expectancy by county are all subject to error. The small 
area models are designed to smooth across counties, years, and age groups and may in some 
cases over-smooth, resulting in an underestimation of geographic inequalities. This study 
documented increasing geographic inequality in life expectancy among counties but did 
not assess the extent to which these trends are a reflection of increasing inequality among 
individuals as opposed to changes in the geographic distribution of low-risk and high-risk 
individuals as a result of differential migration (eg, increasing segregation of low and high 
risk populations).30 In the regression analysis of factors related to county-level variation in life 
expectancy, the outcome variable (life expectancy) as well as the socioeconomic and race/
ethnicity variables, behavioral and metabolic risk variables, and health care variables, are 
subject to measurement error. Moreover, all of the risk factor variables are themselves based 
on models that incorporated some socioeconomic factors as covariates, which may induce 
additional correlation between risk and socioeconomic factors in the regression analysis—
this is unlikely to have a substantial effect however, because the relationship between risk 
factors and socioeconomic factors in the risk factor small area models is not imposed, but 
rather estimated from the data. A relatively small number of variables were used to represent 
the overall socioeconomic and race/ethnicity, behavioral and metabolic risk, and health care 
characteristics of a county, and consequently have likely not captured all relevant factors 
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within each of these groups. There are also likely factors outside of these 3 categories that 
are related to geographic inequality but that were not considered in this analysis. The regres-
sion analysis is cross-sectional and can be used to draw conclusions about associations but 
not whether these associations are causal. Similarly, it cannot be used to assess the extent 
to which increasing geographic inequality in life expectancy among counties is due to 
change in the factors considered in the regression analysis. Furthermore, if socioeconomic 
and race/ethnicity factors, behavioral and metabolic risk factors, and health care factors are 
causally related to life expectancy, this effect almost certainly plays out over the life course. 
However, the regression analysis only incorporates contemporaneous information about life 
expectancy, and these other factors and a county’s current status in terms of socioeconomic 
and race/ethnicity, behavioral and metabolic risk, and health care factors may not perfectly 
represent the lifetime experience of individuals currently living and dying in that county.
COnCLUSIOnS 
Geographic disparities in life expectancy among counties are large and increasing. Much 
of the variation in life expectancy among counties can be explained by a combination of 
socioeconomic and race/ethnicity factors, behavioral and metabolic risk factors, and health 
care factors. Policy action targeting socioeconomic factors and behavioral and metabolic risk 
factors may help reverse the trend of increasing disparities in life expectancy in the United 
States.
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SUPPLeMenT
eFigure 1: Correlation matrix for variables included in the regression analysis of variation in
life expectancy.
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efigure 1. Correlation matrix for variables included in the regression analysis of variation in life expec-
tancy. 
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eFigure 2: Probability of death between age 0 and 5 (5q0) by county, 2014.
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efigure 2. Probability of death between age 0 and 5 (5q0) by county, 2014. 
eFigure 3: Probability of death between age 5 and 25 (20q5) by county, 2014.
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efigure 3. Probability of death between age 5 and 25 (20q5) by county, 2014. 
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efigure 4. Probability of death between age 25 and 45 (20q25) by county, 2014. 
eFigure 5: Probability of death between age 45 and 65 (20q45) by county, 2014.
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efigure 5. Probability of death between age 45 and 65 (20q45) by county, 2014. 
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eFigure 6: Probability of death between age 65 and 85 (20q65) by county, 2014.
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efigure 6. Probability of death between age 65 and 85 (20q65) by county, 2014. eFigure 7: Distribution of county-level declines in age-specific mortality risks, 1980-2014.
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efigure 7. Distribution of county-level declines in age-specific mortality risks, 1980–2014. 
Density plot (smoot ed histogram) of the perce t decline in age-specific mortality risks between 1980 and 
2014 for 3,110 counties. Colors indicate age group, as described in the plot key. 
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eFigure 8: Absolute and relative inequality among counties in life expectancy and age-specific
mortality risks, 1980-2014.
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eFigure 9: Index of socioeconomic and race/ethnicity factors, behavioral and metabolic risk
factors, and health care factors by county, 2009.
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Index:
[A] Socioeconomic and race/ethnicity factors index; [B] Behavioral and metabolic risk factors index; [C]
Health care factors index.
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efigure 9. Index of socioeconomic and race/ethnicity factors, behavioral and metabolic risk factors, and 
health care factors by county, 2009. 
A, Socioeconomic and race/ethnicity factors index. B, Behavioral and metabolic risk factors index. C, Health 
care factors index. 
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eTable 1. Counties combined to ensure historically stable units of analysis.
State Group Areas
Alaska 1 Kusilvak Census Area (2158), Wade Hampton Census Area (2270)a
2 Kobuk Census Area (2140),a Northwest Arctic Borough (2188)
3 Aleutian Islands Census Area (2010),a Aleutians East Borough (2013), Aleutians West 
Census Area (2016)
4 Dillingham Census Area (2070), Lake and Peninsula Borough (2164)
5 Denali Borough (2068), Yukon-Koyukuk Census Area (2290)
6 Hoonah-Angoon Census Area (2105), Skagway Municipality (2230), Skagway-Yakutat-
Angoon Census Area (2231),a Skagway-Hoonah-Angoon Census Area (2232),a Yakutat 
City and Borough (2282)
7 Ketchikan Gateway Borough (2130), Petersburg Borough (2195), Prince of Wales-Hyder 
Census Area (2198), Prince of Wales-Outer Ketchikan Census Area (2201),a Wrangell City 
and Borough (2275), Wrangell-Petersburg Census Area (2280)a
Arizona 1 La Paz County (4012), Yuma County (4027)
Colorado 1 Adams County (8001), Arapahoe County (8005), Boulder County (8013), Broomfield 
County (8014), Denver County (8031), Jefferson County (8059), Weld County (8123)
Florida 1 Dade County (12025),a Miami-Dade County (12086)
Hawaii 1 Kalawao County (15005), Maui County (15009)
Maryland 1 Montgomery County (24031), Prince George’s County (24033)
Montana 1 Park County (30067), Yellowstone National Park (30113)a
New Mexico 1 Cibola County (35006), Valencia County (35061)
South 
Dakota
1 Oglala Lakota County (46102), Shannon County (46113)a
2 Jackson County (46071), Washabaugh County (46131)a
Virginia 1 Fairfax County (51059), Fairfax City (51600)
2 Rockingham County (51165), Harrisonburg City (51660)
3 James City County (51095), Williamsburg City (51830)
4 Prince William County (51153), Manassas City (51683), Manassas Park City (51685)
5 Rockbridge County (51163), Buena Vista City (51530)
6 Spotsylvania County (51177), Fredericksburg City (51630)
7 Augusta County (51015), Staunton City (51790), Waynesboro City (51820)
8 Pittsylvania County (51143), Danville City (51590)
9 Greensville County (51081), Emporia City (51595)
10 Albemarle County (51003), Charlottesville City (51540)
11 Bedford County (51019), Bedford City (51515)a
12 Halifax County (51083), South Boston City (51780)a
13 Southampton County (51175), Franklin City (51620)
14 Alleghany County (51005), Clifton Forge City (51560)a
15 York County (51199), Newport News City (51700)
aCounty no longer exists due to boundary or name change. 
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eTable 2. Data sources used for covariates in the small area models.
Variable Data sources Data processing
Percent of the 
population age 25 
and older who have 
completed high 
school
1980 census;a 1990 census;b 2000 
census;c 2009–2014 ACSd
Linear interpolation was used fill in intermediate 
years between data sources. The rate of change 
calculated between 2007 and 2012 was applied to fill 
in estimates for 2013 and 2014.
Percent of the 
population who are 
Hispanic
1980 census;e 1990–2014 NCHS 
Bridged Race Filesf,g,h
Linear interpolation was used to fill in intermediate 
years between data sources.
Percent of the 
population who 
are Black and some 
other race
1980–1989 Census Bureau 
Intercensal County Estimates by 
Age, Sex, and Race;i 1990–2014 
NCHS Bridged Race Filesf,g,h
Linear interpolation was used to fill in intermediate 
years between data sources.
Percent of land 
area in a Native 
American 
reservation
2013 Cartographic Boundary File, 
State-County for United States;j 
AIANNH Areas National Shapefilek
Geographic boundaries of AIANNH Areas were 
intersected with county boundaries using ArcGIS. 
The area of the intersection and the area of the 
county were calculated using an Albers Equal Area 
Conic projection. The proportion of the land area 
that is in a reservation was generated by dividing 
the area of the reservation by the total area in each 
county.
Household median 
income
1980 census;l 1989, 1993, 1995–
2014 Small Area Income and 
Poverty Estimates;m 1980–2014 
Bureau of Labor Statistics, 
Consumer Price Indexn
Data were adjusted for inflation using the consumer 
price index, and linear interpolation was used to 
generate values between observed data points. 
Income was then log-transformed.
Population density 1980–1989 Census Bureau 
Intercensal County Estimates by 
Age, Sex, and Race;i 1990–2014 
NCHS Bridged Race Files;f,g,h 2013 
Cartographic Boundary File, 
State-County for United Statesj
The area of each county was calculated using 
an Albers Equal Area Conic projection. The total 
population of each county was divided by the total 
area of the county, and was then log-transformed.
aMissouri Census Data Center. 1980 Census Summary Tape File 3, Table NT48A. MCDC Data Archive (Uex-
plore/Dexter). http://mcdc2.missouri.edu/applications/uexplore.shtml. Accessed April 22, 2013.
bMinnesota Population Center. 1990 Census Summary Tape File 3, Table P057. National Historical Geo-
graphic Information System: Version 2.0. Minneapolis, MN: University of Minnesota 2011. http://www.nhgis.
org. Accessed July 18, 2013.
cUS Census Bureau. 2000 Census Summary Tape File 3, Table DP2; using American FactFinder; http://fact-
finder2.census.gov. Accessed April 18, 2013.
dUS Census Bureau. American Community Survey, 2009–2014 American Community Survey 5-Year Esti-
mates, Table S1501; using American FactFinder; http://factfinder2.census.gov. Accessed December 8, 2015.
eMinnesota Population Center. 1980 Census Summary Tape File 1, Table NT8. National Historical Geographic 
Information System: Version 2.0. Minneapolis, MN: University of Minnesota 2011. http://www.nhgis.org. Ac-
cessed January 13, 2016.
fNational Center for Health Statistics, Centers for Disease Control and Prevention, US Census Bureau. United 
States Bridged-Race Intercensal Population Estimates 1990–1999. Hyattsville, United States: National Cen-
ter for Health Statistics, Centers for Disease Control and Prevention, 2004. Accessed November 21, 2011.
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gNational Center for Health Statistics, Centers for Disease Control and Prevention, US Census Bureau. United 
States Bridged-Race Intercensal Population Estimates 2000–2009. Hyattsville, United States: National Cen-
ter for Health Statistics, Centers for Disease Control and Prevention, 2012. Accessed October 30, 2012.
hNational Center for Health Statistics, Centers for Disease Control and Prevention, United States Census 
Bureau. United States Vintage 2014 Bridged-Race Postcensal Population Estimates 2010–2014. Hyattsville, 
United States: National Center for Health Statistics, Centers for Disease Control and Prevention, 2015. Ac-
cessed December 18, 2015.
iUS Census Bureau. Intercensal County Estimates by Age, Sex, Race: 1980–1989. http://www.census.gov/
popest/data/counties/asrh/1980s/PE-02.html. Accessed January 8, 2015.
jUS Census Bureau. TIGER/Line Shapefile, 2013 Cartographic Boundary File, State-County for United States, 
1:20,000,000. https://catalog.data.gov/dataset/2013-cartographic-boundary-file-state-county-for-united-
states-1-20000000. Accessed February 2, 2015.
kUS Census Bureau. TIGER/Line Shapefile, 2012, Series Information File for the Nation, Current American 
Indian/Alaska Native/Native Hawaiian Areas (AIANNH) National Shapefile. http://catalog.data.gov/dataset/
tiger-line-shapefile-2012-series-information-file-for-the-nation-current-american-indian-alaska. Accessed 
February 10, 2015.
lMinnesota Population Center. 1980 Census Summary Tape File 3, Table NT69. National Historical Geograph-
ic Information System: Version 2.0. Minneapolis, MN: University of Minnesota 2011. http://www.nhgis.org. 
Accessed November 12, 2015.
mUS Census Bureau. Small Area Income and Poverty Estimates. https://www.census.gov/did/www/saipe/
data/statecounty/data/index.html. Accessed December 28, 2015.
nUS Bureau of Labor Statistics. Consumer Price Index: All Urban Consumers History, All Items 1913–2015. 
http://www.bls.gov/data/. Accessed March 24, 2015. 
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eTable 3. Data sources used for the regression analysis of variation in life expectancy.
Variable Data sources
Population living in households 
below the federal poverty line based 
on household income and size (%)
Small Area Income and Poverty Estimates.a
Median household income ($) Small Area Income and Poverty Estimates.a
High school graduates, age 25+ (%) American Community Survey.b
College graduates, age 25+ (%) American Community Survey.b
Unemployment rate, age 16+ (%) BLS Local Area Unemployment Statistics.c
Black population (%) NCHS Bridged Race File.d
American Indian, Native Alaskan, and 
Native Hawaiian population (%)
NCHS Bridged Race File.d
Hispanic population (%) NCHS Bridged Race File.d
Obesity prevalence, ages 20+ (%) Dwyer-Lindgren et al.,e based on the Behavioral Risk Factor Surveillance 
System.f
No leisure-time physical activity 
prevalence, age 20+ (%)
Dwyer-Lindgren et al.,e based on the Behavioral Risk Factor Surveillance 
System.f
Cigarette smoking prevalence, age 
18+ (%)
Dwyer-Lindgren et al.,g based on the Behavioral Risk Factor Surveillance 
System.f
Hypertension prevalence, age 30+ 
(%)
Olives et al.,h based on the Behavioral Risk Factor Surveillance Systemf 
and National Health and Nutrition Examination Survey.i
Diabetes prevalence, age 20+ (%) Dwyer-Lindgren et al.,j based on the Behavioral Risk Factor Surveillance 
Systemf and National Health and Nutrition Examination Survey.i
Insured population, age <65 (%) Small Area Health Insurance Estimates.k
Quality index Dartmouth Atlas Project.l Following Chetty et al.,m the quality index 
was constructed by taking the mean of the z-scores for six variables 
related to primary care access and quality among Medicare enrollees: 
the percent of enrollees who had an ambulatory care visit to a 
primary care clinician; the percent of diabetic enrollees who had an 
A1C test; the percent of diabetic enrollees who had an eye exam; the 
percent of diabetic enrollees who had an LDL-C test; the percent of 
female enrollees who had a mammogram; and the discharge rate for 
ambulatory care sensitive conditions.
Doctors per 1,000 population Area Health Resource File.n
aUS Census Bureau. 2009 Small Area Income and Poverty Estimates. https://www.census.gov/did/www/
saipe/data/statecounty/data/index.html. Accessed October 31, 2012.
bUS Census Bureau. American Community Survey, 2011 American Community Survey 5-Year Estimates, 
Table S1501; using American FactFinder; http://factfinder2.census.gov. Accessed April 17, 2013.
cUS Bureau of Labor Statistics. Local Area Unemployment Statistics: Labor Force Data by County, 2009 An-
nual Averages. http://download.bls.gov/pub/time.series/la/. Accessed December 14, 2015.
dNational Center for Health Statistics, Centers for Disease Control and Prevention, US Census Bureau. United 
States Bridged-Race Intercensal Population Estimates 2000–2009. Hyattsville, United States: National Cen-
ter for Health Statistics, Centers for Disease Control and Prevention, 2012. Accessed October 30, 2012.
eDwyer-Lindgren L, Freedman G, Engell RE, et al. Prevalence of physical activity and obesity in US counties, 
2001–2011: A road map for action. Population Health Metrics. 2013;11(1):7.
fCenters for Disease Control and Prevention. Behavioral Risk Factor Surveillance System. http://www.cdc.
gov/brfss/. Accessed July 24, 2013.
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gDwyer-Lindgren L, Mokdad AH, Srebotnjak T, Flaxman AD, Hansen GM, Murray CJ. Cigarette smoking prev-
alence in US counties: 1996–2012. Population Health Metrics. 2014;12(1):5.
hOlives C, Myerson R, Mokdad AH, Murray CJL, Lim SS. Prevalence, awareness, treatment, and control of 
hypertension in United States counties, 2001–2009. PLoS ONE. 2013;8(4):e60308.
iCenters for Disease Control and Prevention. National Health and Nutrition Examination Survey. http://
www.cdc.gov/nchs/nhanes.htm. Accessed September 30, 2013.
jDwyer-Lindgren L, Mackenbach JP, van Lenthe FJ, Flaxman AD, Mokdad AH. Diagnosed and undiagnosed 
diabetes prevalence by county in the U.S., 1999–2012. Diabetes Care. 2016;39(9):1556–62.
kUS Census Bureau. 2009 Small Area Health Insurance Estimates. https://www.census.gov/did/www/sahie/
data/20082014/index.html. Accessed June 8, 2016.
lThe Dartmouth Atlas of Health Care. 2009 Selected measures of primary care access and quality. http://
www.dartmouthatlas.org/tools/downloads.aspx#primary. Accessed June 16, 2016.
mChetty R, Stepner M, Abraham S, et al. The association between income and life expectancy in the United 
States, 2001–2014. JAMA. 2016;315(16).
nHealth Resources and Services Administration. 2014–2015 Area Health Resource Files: Total active non-
federal MDs. http://ahrf.hrsa.gov/download.htm. Accessed October 12, 2015.
eTable 4. Principal component analysis of socioeconomic and race/ethnicity factors.a
Component
1 2 3 4 5 6 7 8
Poverty -0.485 0.041 -0.080 0.256 -0.179 0.434 0.078 -0.681
Income 0.475 -0.028 0.174 0.146 0.311 -0.419 0.237 -0.627
High school 0.464 -0.207 -0.238 0.024 -0.026 0.298 -0.746 -0.195
College 0.397 -0.072 0.161 0.561 0.024 0.529 0.372 0.278
Unemployment -0.298 -0.345 0.036 -0.044 0.862 0.193 -0.072 0.060
Black -0.260 -0.476 0.295 0.568 -0.204 -0.404 -0.286 0.099
Native -0.064 0.322 -0.731 0.485 0.209 -0.255 -0.019 0.114
Hispanic -0.068 0.707 0.507 0.195 0.205 0.038 -0.394 0.030
Standard deviation 1.837 1.096 1.052 0.945 0.850 0.641 0.462 0.278
Proportion of variance 0.422 0.150 0.138 0.112 0.090 0.051 0.027 0.010
aA principal component analysis was carried out on the following socioeconomic and race/ethnicity fac-
tors: the percent of the population below the poverty line (Poverty); the logged median household income 
(Income); the percent of the population that has graduated high school (High school); the percent of the 
population that has graduated college (College); the unemployment rate (Unemployment); the percent of 
the population that is black (Black); the percent of the population that is American Indian, Native Alaska, or 
Native Hawaiian (Native); and the percent of the population that is Hispanic (Hispanic). The top portion of 
the table shows the variable loadings for each component while the bottom portion shows the standard 
deviation and the proportion of variance explained by each component. 
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eTable 5. Principal component analysis of behavioral and metabolic risk factors.a
Component
1 2 3 4 5
Obesity -0.468 0.141 0.321 -0.756 -0.293
Inactivity -0.468 -0.085 0.586 0.295 0.586
Smoking -0.385 -0.850 -0.202 0.102 -0.280
Hypertension -0.459 0.208 -0.715 -0.157 0.458
Diabetes -0.451 0.455 -0.040 0.553 -0.532
Standard deviation 1.987 0.740 0.468 0.397 0.359
Proportion of variance 0.789 0.109 0.044 0.032 0.026
aA principal component analysis was carried out on the following behavioral and metabolic risk factors: 
obesity prevalence (Obesity); no leisure-time physical activity prevalence (Inactivity); cigarette smoking 
prevalence (Smoking); hypertension prevalence (Hypertension); and diabetes prevalence (Diabetes). The 
top portion of the table shows the variable loadings for each component while the bottom portion shows 
the standard deviation and the proportion of variance explained by each component. 
eTable 6. Principal component analysis of health care factors.a
Component
1 2 3
Insurance 0.627 -0.262 0.734
Quality 0.606 -0.429 -0.670
MDs 0.491 0.864 -0.110
Standard deviation 1.291 0.890 0.735
Proportion of variance 0.556 0.264 0.180
aA principal component analysis was carried out on the following health care factors: insurance prevalence 
under age 65 (Insured); health care quality index (Quality); doctors per 1,000 population (MDs). The top 
portion of the table shows the variable loadings for each component while the bottom portion shows the 
standard deviation and the proportion of variance explained by each component. 
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eTable 7. Multivariate regression models.a
Variable Model 1 Model 2 Model 3 Model 4
Intercept 69.264 (2.613)b 92.546 (0.258)b 66.167 (0.497)b 85.935 (2.164)b
Poverty -0.077 (0.009)b 0.022 (0.008)b
Income 0.006 (0.231) 0.489 (0.185)b
High school 0.104 (0.006)b -0.027 (0.007)b
College 0.061 (0.004)b -0.011 (0.005)b
Unemployment -0.037 (0.008)b -0.031 (0.006)b
Black -0.036 (0.002)b 0.002 (0.003)
Native -0.049 (0.003)b -0.017 (0.003)b
Hispanic 0.038 (0.002)b 0.011 (0.003)b
Obesity 0.065 (0.010)b -0.002 (0.010)
Inactivity -0.070 (0.008)b -0.092 (0.011)b
Smoking -0.206 (0.007)b -0.154 (0.009)b
Hypertension -0.148 (0.011)b -0.174 (0.019)b
Diabetes -0.334 (0.017)b -0.235 (0.028)b
Insurance 0.062 (0.007)b 0.037 (0.005)b
Quality 0.086 (0.003)b 0.034 (0.002)b
MDs 0.199 (0.035)b -0.301 (0.026)b
R2 0.69 0.77 0.31 0.82
Adjusted R2 0.69 0.77 0.31 0.82
aRegression results from multivariate ordinary least squares regressions with life expectancy at birth as 
the outcome variable. Three sets of variables were considered: socioeconomic and race/ethnicity factors 
(the percent of the population below the poverty line [Poverty]; the logged median household income 
[Income]; the percent of the population that has graduated high school [High school]; the percent of the 
population that has graduated college [College]; the unemployment rate [Unemployment]; the percent of 
the population that is black [Black]; the percent of the population that is American Indian, Native Alaska, 
or Native Hawaiian [Native]; and the percent of the population that is Hispanic [Hispanic]), behavioral and 
metabolic risk factors (obesity prevalence [Obesity]; no leisure-time physical activity prevalence [Inactivity]; 
cigarette smoking prevalence [Smoking]; hypertension prevalence [Hypertension]; and diabetes preva-
lence [Diabetes]), and health care factors (insurance prevalence under age 65 [Insured]; health care quality 
index [Quality]; doctors per 1,000 population [MDs]). The numbers in parentheses are the standard errors 
for the estimated coefficients. 
bP < 0.05
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ABSTrACT
Background
Metrics based on self-reports of health status have been proposed for tracking population 
health and making comparisons among different populations. While these metrics have been 
used in the US to explore disparities by sex, race/ethnicity, and socioeconomic position, less 
is known about how self-reported health varies geographically. This study aimed to describe 
county-level trends in the prevalence of poor self-reported health and to assess the face 
validity of these estimates.
Methods
We applied validated small area estimation methods to Behavioral Risk Factor Surveillance 
System data to estimate annual county-level prevalence of four measures of poor self-
reported health (low general health, frequent physical distress, frequent mental distress, 
and frequent activity limitation) from 1995 and 2012. We compared these measures of poor 
self-reported health to other population health indicators, including risk factor prevalence 
(smoking, physical inactivity, and obesity), chronic condition prevalence (hypertension and 
diabetes), and life expectancy.
results
We found substantial geographic disparities in poor self-reported health. Counties in parts 
of South Dakota, eastern Kentucky and western West Virginia, along the Texas-Mexico 
border, along the southern half of the Mississippi river, and in southern Alabama generally 
experienced the highest levels of poor self-reported health. At the county level, there was 
a strong positive correlation among the four measures of poor self-reported health and 
between the prevalence of poor self-reported health and the prevalence of risk factors and 
chronic conditions. There was a strong negative correlation between prevalence of poor 
self-reported health and life expectancy. Nonetheless, counties with similar levels of poor 
self-reported health experienced life expectancies that varied by several years. Changes over 
time in life expectancy were only weakly correlated with changes in the prevalence of poor 
self-reported health.
Conclusions
This analysis adds to the growing body of literature documenting large geographic dispari-
ties in health outcomes in the United States. Health metrics based on self-reports of health 
status can and should be used to complement other measures of population health, such 
as life expectancy, to identify high need areas, efficiently allocate resources, and monitor 
geographic disparities.
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BACkGrOUnD
Measures of survival, such as life expectancy, have long been used to compare the health 
status of different populations and to track changes in health status over time.1,2 While objec-
tive, and relatively easily measured, these metrics fail to capture differences in health due to 
non-fatal (or not yet fatal) conditions.3 Moreover, they fail to take into account individuals’ 
own assessment of and satisfaction with their health and functioning. In response to these 
limitations, metrics based on self-reported health status have been proposed as a comple-
ment to objective measures for use in tracking levels of population health over time and for 
evaluating disparities in health.4,5 
The Behavioral Risk Factor Surveillance System (BRFSS) is an annual telephone survey con-
ducted in all states and supported by the Centers for Disease Control and Prevention.6,7 Since 
1993, the BRFSS has included four core “Healthy Days” questions in which respondents are 
asked to rate their overall health and to report the number of days in the past month that 
they experienced poor physical health, poor mental and emotional health, or were unable 
to participate in their usual activities. These questions are designed to elicit respondents’ 
self-assessment of and satisfaction with their health generally and with their recent physical 
health, mental and emotional health, and functional limitations.4 Health metrics based on 
these and similar questions have been shown to be highly correlated with metrics based on 
lengthier survey instruments8,9 health behaviors and risk factors,10–12 chronic health condi-
tions,13 health care utilization,14 and mortality risk.15 
Healthy days questions from the BRFSS have been used to track national- and state-level 
trends in poor self-reported health16 and to explore disparities by gender,17 race/ethnicity,18 
socioeconomic status,16 and employment status.19 However, these data have only been used 
in a limited way to explore local-level variations in poor self-reported health. Jia et al.20 and 
others21 considered county-level measures of poor self-reported health based on the healthy 
days questions, but focused on county-level correlates of poor self-reported health rather 
than on spatial patterns and disparities. The County Health Rankings & Roadmaps Program 
includes three county-level measures of poor self-reported health based on BRFSS healthy 
days questions, but recent methodological changes make it difficult to track trends over 
time.22
In this analysis, we used validated small area estimation methods to estimate the prevalence 
of four measures of poor self-reported health—low general health, frequent physical distress, 
frequent mental distress, and frequent activity limitation—by county from 1995 to 2012. We 
used these estimates to explore spatial patterns in poor self-reported health and to quantify 
county-level geographic disparities.
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We performed two additional analyses combining these estimates of poor self-reported 
health with other estimates of health risk factors and outcomes at the county level. First, we 
compared the prevalence of poor self-reported health to the prevalence of behavioral and 
metabolic risk factors (i.e., obesity, smoking, and physical inactivity) and chronic conditions 
(i.e., hypertension and diabetes) to assess the face validity of self-reported health as a proxy 
for a county’s population health. We expected the prevalence of poor self-reported health to 
be higher in places with higher prevalence of risk factors and chronic conditions known to 
result in considerable health burden.
Second, we compared the prevalence of poor self-reported health to estimates of life expec-
tancy at the county-level, in order to assess whether geographic county-level disparities in life 
expectancy and self-reported health follow the same pattern. We expected the prevalence 
of poor self-reported health to be strongly and negatively correlated with life expectancy, 
albeit not perfectly as life expectancy and self-reported health may reflect somewhat differ-
ent aspects of a county’s health burden.
MeTHODS
Data
We analyzed data from the BRFSS surveys conducted from 1995, the first year in which all 50 
states participated in the BRFSS, through 2012, the most recent year in which county identi-
fiers were publicly available. The BRFSS included four “healthy days” questions:
1. Would you say in general that your health is—excellent, very good, good, fair, or poor?
2. Now thinking about your physical health, which includes physical illness and injury, for 
how many days during the past 30 days was your physical health not good?
3. Now thinking about your mental health, which includes stress, depression, and problems 
with emotions, for how many days during the past 30 days was your mental health not good?
4. During the past 30 days, for about how many days did poor physical or mental health 
keep you from doing your usual activities, such as self-care, work, or recreation?
Only the first question was asked by all states in 2002; consequently we excluded data on the 
remaining questions for this year only.
We created four binary variables from these questions: low general health (responding “fair” 
or “poor” to question 1); frequent physical distress (reporting 14 or more days in response to 
question 2); frequent mental distress (reporting 14 or more days in response to question 3); 
and frequent activity limitation (reporting 14 or more days in response to question 4). The 
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14 day cut-off used for frequent physical distress, mental distress, and activity limitation is in 
line with previous research utilizing these questions, and is intended to identify individuals 
who experienced significant health burden in the previous month.10–12, 17–19 In addition, we 
extracted county of residence, age, gender, race/ethnicity (white non-Hispanic, black non-
Hispanic, native non-Hispanic, or Hispanic), education status (less than high school, high 
school graduate, some college, or college graduate), marital status (never married, currently 
married, or formerly married), and, starting in 2011, phone type (landline only, cell phone 
only, or dual) from the survey. Respondents with missing values on any of these variables 
were excluded from the analysis. There were 5,239,833 respondents in the study period. Of 
these, 2.2% were missing some demographic information, 3.8% were missing one or more 
outcome variables, and 5.1% were missing the county variable, primarily due to CDC data 
suppression rules. In total, 4,698,203 (89.7%) had no missing values and were included in 
the analysis. The survey response rate in the BRFSS varied by year and by state; in 2012, the 
response rate ranged from 27.7 to 60.4% among states.23
Small area estimation model
We used previously described and validated small area models to estimate county-level 
prevalence of low general health, frequent physical distress, frequent mental distress, and 
frequent activity limitation.24 These models are designed to “borrow strength” across time, 
space, and from external data sources (i.e., covariates) in order to increase the effective 
amount of information available for each county. Briefly, these models were specified as:
Yj,t,a,r,m,e ~ Binomial(pj,t,a,r,m,e,  Nj,t,a,r,m,e)
logit(pj,t,a,r,m,e) =  β0 + β1,a + β2,r + β3,m +  β4,e + β5⋅Xj,t + uj + wt + dj,t
where Nj,t,a,r,m,e, Yj,t,a,r,m,e, and  pj,t,a,r,m,e are the total number of respondents; the number of re-
spondents with low general health, frequent physical distress, frequent mental distress, or 
frequent activity limitation, depending on the model; and true prevalence, respectively, in 
county j, year t, age group a, race/ethnicity group r, marital status group m, and education 
group e. The β terms are fixed effects: β0 is the intercept; β1,a are age group effects and are 
included to account for differences in self-reported health among age groups; β2,r, β3,m, and 
β4,e are race/ethnicity, marital status, and education effects, respectively, and are included to 
account for differences in self-reported health among each of these groups; β5 is a vector of 
coefficients on three county-level covariates that are expected to be predictive of poor self-
reported health (percent of the population living in poverty, the unemployment rate, and the 
percent of households which are rural). The remaining terms are random effects. uj and wt are 
county- and year-level random effects, respectively, each of which is assumed to follow a con-
ditional autoregressive distribution that allows for spatial (uj) and temporal (wt) smoothing 
(specifically, the distribution described by Leroux et al.25). dj,t is a county-year-level random 
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effect with a non-separable “Type IV” interaction between space and time as described by 
Knorr-Held,26 but using the conditional autoregressive distribution described by Leroux et 
al.25 for both the spatial and temporal dimensions. Gamma(1, 1,000) priors were assigned for 
the precision parameters of each random effect. Normal(0, 1.5) priors were assigned for the 
logit-transformed autocorrelation parameter of each random effect.
Models were fit using the TMB package27 in R version 3.2.428 and 1,000 draws of pj,t,a,r,m,e were 
simulated from the posterior distribution. These draws were post-stratified by race, marital 
status, and education using population counts from the census and American Community 
Survey to ensure that prevalence estimates represent the demographic composition of a 
county even where response rates vary among different demographic groups. Draws were 
then age-standardized using the 2010 census population as the standard. Point estimates 
were calculated from the mean of the 1,000 draws and 95% uncertainty intervals (UIs) were 
calculated from the 2.5th and 97.5th percentiles. State- and national-level estimates were 
generated by population-weighting the county-level estimates.
Separate models were fit for males and females for each of the four measures, for eight total 
models. Prior to 2011, the BRFSS sample did not include cell phones, raising the possibility of 
non-coverage bias; the correction method described by Dwyer-Lindgren et al. was applied 
to address this issue.29
Comparison to risk factors, chronic conditions, and life expectancy
After modeling county-level prevalence of low general health, frequent physical distress, 
frequent mental distress, and frequent activity limitation, we compared these measures to 
existing estimates of county-level prevalence of behavioral and metabolic risk factors (smok-
ing, obesity, and physical inactivity), and chronic conditions (hypertension and diabetes), 
also derived from BRFSS data.24, 29–31 For each of these variables, we calculated the Pearson 
correlation coefficient with each of the four measures of poor self-reported health in the 
most recent year of data available (ranging from 2009 for hypertension to 2012 for diabetes).
We also compared the prevalence of low general health, frequent physical distress, frequent men-
tal distress, and frequent activity limitation with life expectancy in 2012 (Laura Dwyer-Lindgren, 
Amelia Bertozzi-Villa, Rebecca W Stubbs, Chloe Morozoff, Johan P Mackenbach, Frank J van Len-
the, Ali H Mokdad, and Christopher JL Murray: Inequalities in life expectancy among US counties, 
1980 to 2014: Temporal trends and key drivers., forthcoming). We used loess regression—a non-
parametric smoothing technique32—to characterize the relationship between each of these four 
variables and life expectancy. We also examined the correlation between change in prevalence 
of low general health, frequent physical distress, frequent mental distress, and frequent activity 
limitation, and change in life expectancy between 1995 and 2012.
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reSULTS
Nationally, the prevalence of all four measures of poor self-reported health increased 
between 1995 and 2012: from 15.5% (95% UI: 15.2–15.8%) to 17.5% (17.4–17.7%) for low 
general health; from 10.1% (9.9–10.4%) to 12.3% (12.2–12.5%) for frequent physical distress; 
from 9.5% (9.3–9.7%) to 12.5% (12.3–12.7%) for frequent mental distress; and from 6.0% 
(5.8–6.2%) to 8.4% (8.3–8.5%) for frequent activity limitation (Figure 1). The prevalence was 
higher among women than among men in all years. In 2012, the prevalence among women 
exceeded that among men by 7.6% (18.2% [18.0–18.4%] vs. 16.9% [16.6–17.1%]) for low gen-
eral health; 23.2% (13.6% [13.4–13.8%] vs. 11.0% [10.9–11.2%]) for frequent physical distress; 
38.6% (14.5% [14.3–14.6%] vs. 10.4% [10.2–10.7%]) for frequent mental distress; and 20.8% 
(9.2% [9.0–9.3%] vs. 7.6% [7.4–7.8%]) for frequent activity limitation.
There was significant variation in all four outcomes at the county level in all years. The 
standard deviation of county-level prevalence of low general health decreased somewhat 
between 1995 (5.4 percentage points) and 2012 (5.1 percentage points). The standard 
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figure 1. National trends in low general health, frequent physical distress, frequent mental distress, and 
frequent activity limitation, 1995–2012.
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figure 2. Low general health prevalence, 2012.
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figure 3. Frequent physical distress prevalence, 2012.
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figure 4. Frequent mental distress prevalence, 2012.
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figure 5. Frequent activity limitation prevalence, 2012.
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deviation of county-level prevalence of frequent physical distress, frequent mental distress, 
and frequent activity limitation increased over this same period (from 2.2 to 2.7, 2.0 to 2.4, 
and 1.9 to 2.2 percentage points, respectively). Counties with the lowest prevalence of low 
general health (Figure 2) were located primarily in New England and north-western states 
stretching from Utah to Wisconsin. In contrast, counties with the highest prevalence of low 
general health were found in parts of South Dakota, eastern Kentucky and western West 
Virginia, along the Texas-Mexico border, along the southern half of the Mississippi river, and 
in southern Alabama. Spatial patterns were similar for frequent physical distress, frequent 
mental distress, and frequent activity limitation (Figures 3, 4 and 5). Results for all counties 
and all years are reported in Additional file 1.
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figure 6. Comparison among self-reported health measures, 2012.
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Pairwise correlation coefficients between all four measures in 2012 were very high (Figure 6), 
ranging from 0.88 (low general health and frequent mental distress) to 0.99 (frequent physical 
distress and frequent activity limitation). At the national level, the prevalence of low general 
health (17.5% [17.4–17.7%]) was highest and the prevalence of frequent activity limitation 
(8.4% [8.3–8.5%]) was lowest among the four measures, while prevalence of frequent mental 
distress (12.5% [12.3–12.7%]) and frequent physical distress (12.3% [12.2–12.5%]) were in-
termediate. This pattern was also observed at the county level, where the prevalence of low 
general health was nearly always the highest among the four measures, while the prevalence 
of frequent activity limitation was always the lowest. Levels of frequent physical and mental 
distress were generally similar within counties, except at the high end of the distribution: 
counties with very high prevalence of both typically had a slightly higher prevalence of 
frequent physical distress than frequent mental distress.
Low general health prevalence was positively correlated with the prevalence of behavioral 
and metabolic risk factors—0.63 for smoking, 0.76 for obesity, and 0.85 for physical inactiv-
ity—and with the prevalence of diabetes (0.90) and hypertension (0.78) (Figure 7). Gener-
ally similar correlations were found between these variables and frequent physical distress, 
frequent mental distress, and frequent activity limitation (data not shown).
Life expectancy was negatively correlated with all four measures (Figure 8). The relationship 
between life expectancy and low general health was somewhat curvilinear, with a steeper 
decline in life expectancy as low general health prevalence moved from very low values to 
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figure 7. Relationship between low general health prevalence and prevalence of smoking, obesity, physi-
cal inactivity, diabetes, and hypertension.
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more moderate values, and a more moderate decline in life expectancy as low general health 
prevalence increased from moderate to high values. The relationship between life expec-
tancy and the other three measures was closer to linear, but flattened somewhat among 
counties with very high prevalence of frequent physical distress, frequent mental distress, 
and frequent activity limitation.
Figure 9 shows the difference between observed life expectancy and life expectancy predicted 
based on low general health prevalence, frequent physical distress, frequent mental distress, 
and frequent activity limitation. The spatial patterns are generally similar across these four 
measures. Counties in Western and Southwestern states (excluding Nevada) and in southern 
Florida tended to have higher life expectancy than average given their prevalence of poor 
self-reported health. In contrast, counties in Alaska, the Deep South (excluding Florida) and 
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figure 8. Relationship between life expectancy and self-reported health measures, 2012.
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parts of Nevada and the upper Midwest and Great Plains regions tended to have lower life 
expectancy then average, given their prevalence of poor self-reported health.
Between 1995 and 2012, life expectancy increased in most counties (99.7%), while the preva-
lence of low general health, frequent physical distress, frequent mental distress, and frequent 
activity limitation also increased in most counties (88.1, 99.3, 98.3, and 99.2% of counties, 
respectively). There was a small negative correlation between change in life expectancy and 
change in the prevalence of frequent physical distress, frequent mental distress, and frequent 
activity limitation (Pearson correlation coefficients: −0.27, −0.23, and −0.22, respectively). 
When examined separately by sex, the correlations were again negative, but were generally 
larger among women (−0.25 to −0.35) than among men (−0.08 to −0.15). There was a weak 
positive correlation between changes in low general health prevalence and changes in life 
expectancy (0.09 overall; 0.12 for men and 0.06 for women).
Frequent mental distress Frequent activity limitation
Low general health Frequent physical distress
Expected − observed life expectancy (years):
<−3 −3 to −2 −2 to −1 −1 to 1 1 to 2 2 to 3 >3
figure 9. Gap between observed life expectancy and predicted life expectancy based on poor self-report-
ed health prevalence, 2012.
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DISCUSSIOn
This analysis found increasing rates and considerable geographic disparities in poor self-
reported health within the US. These findings underscore the utility of local measurements 
of population health status and highlight the need for closer attention paid to geographic 
disparities in health outcomes.
The four measures considered—low general health, frequent physical distress, frequent 
mental distress, and frequent activity limitation—were highly correlated, though with 
important differences in some counties. Each of these measures were intended to capture 
a distinct facet of health: general health status (low general health), recent physical health 
(frequent physical distress), recent mental and emotional health (frequent mental distress), 
and recent day-to-day functioning (frequent activity limitation). The high correlations among 
these measures is likely a reflection of the close connections between different domains of 
health, though it may also indicate some overlap in the way each of the four healthy days 
questions were understood by respondents. Moreover, the close relationship between these 
four measures may also reflect shared determinants among different health domains, for 
example, socioeconomic factors.
Consistent with previous research at the individual level,10–12 we found that population-level 
prevalence of poor self-reported health (all four measures) was positively correlated with the 
prevalence of behavioral and metabolic risk factors. This may reflect a direct pathway from 
these risk factors to poorer health outcomes (e.g., smoking causing respiratory disease), but 
may also reflect individuals’ expectation of future health based on what they know about their 
own behaviors.5 We also found a positive population-level relationship between poor self-
reported health and chronic conditions such as diabetes and hypertension. These findings 
serve as an important external check on the validity of the self-reported health measures: all 
else equal, we expect poorer overall health when the prevalence of behavioral and metabolic 
risk factors or chronic conditions is high. However, the correlation among these variables may 
also reflect some common underlying determinants.
All four measures of poor self-reported health were strongly and negatively correlated with 
life expectancy at the county level. Nonetheless, life expectancy among counties with compa-
rable levels of poor self-reported health often varied by multiple years, while the prevalence 
of poor self-reported health varied considerably among counties with similar life expectancy. 
This may reflect differences in non-fatal health outcomes: life expectancy captures only dif-
ferences in survival, but not differences in health due to disabling but non-fatal conditions. 
However, this may also reflect differences in how respondents understand and respond to 
the healthy days questions, e.g., different understanding of what constitutes “good” health or 
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a “healthy” day.33, 34 Further research is required in the US to disentangle the extent to which 
geographic (or other) disparities in self-rated health reflect true disparities in health status.
Consistent with other studies utilizing BRFSS data, our analysis found that rates of poor self-
reported health have increased at the national level as well as in most counties between 
1995 and 2012.16 Over this same period, however, life expectancy has also increased nation-
ally and in most counties (Laura Dwyer-Lindgren, Amelia Bertozzi-Villa, Rebecca W Stubbs, 
Chloe Morozoff, Johan P Mackenbach, Frank J van Lenthe, Ali H Mokdad, and Christopher JL 
Murray: Inequalities in life expectancy among US counties, 1980 to 2014: Temporal trends 
and key drivers., forthcoming). While changes in life expectancy were negatively correlated 
with changes in most of the self-reported health measures considered (i.e., the counties with 
smaller increases in life expectancy tended to have larger increases in poor self-reported 
health), this relationship is relatively weak. Additionally, comparative studies have high-
lighted differential trends in poor self-reported health among various US surveys.35 Further 
research is needed to identify what is driving changes in poor self-reported health in the US 
and to identify to what extent these trends reflect true changes in underlying health status.
This study has a number of limitations. Survey response rates to the BRFSS are low and item 
non-response is also a concern. In both cases, missingness is not at random. Although we 
use post-stratification to explicitly account for factors such as education that are known to 
be related to both the likelihood of responding and the likelihood of reporting poor self-
reported health, it is still possible that differential non-response biases our results. Moreover, 
the BRFSS, a telephone survey, excludes individuals with no phone and, prior to 2011, ex-
cluded individuals with only a cell phone. We have attempted to correct the latter issue, but 
some non-coverage bias may remain. The data sources we used for populations counts for 
post-stratification and for covariates for the small area models may also be subject to error. 
The small area model smooths both spatially and temporally; while this allows us to produce 
more precise estimates than otherwise possible, the model may in some cases over-smooth 
and thus underestimate variation in self-reported health. Finally, the BRFSS data used in this 
analysis were also used for generating the estimates of smoking, obesity, physical inactivity, 
diabetes, and hypertension prevalence and the correlation between the self-reported health 
measures and these risk factors may be somewhat higher in this analysis than they would be 
if these measures were based on independent data sources.
COnCLUSIOnS
Our findings revealed large disparities in the prevalence of poor self-reported health among 
counties in the US. Poor self-reported health was positively correlated with risk factor 
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prevalence and prevalence of chronic health conditions and negatively correlated with life 
expectancy at the county level. Local information on health outcomes should be used by 
policymakers and health professionals to identify communities that are lagging behind, to 
evaluate the impact of policies and programs, and to monitor geographic inequalities.
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This thesis has described the development of a methodology for estimating risk factor 
prevalence and health outcomes at the county level in the United States (US). Using this 
methodology, estimates of smoking prevalence, alcohol use prevalence, diabetes preva-
lence, cause-specific mortality rates, life expectancy, and self-reported health status were 
constructed for each county. These estimates were then used to describe spatial patterns, 
quantify geographic disparities and track changes in disparities over time, and explore driv-
ers of disparities in life expectancy among counties. This final chapter summarizes the main 
findings of this thesis, discusses relevant methodological limitations, considers the findings 
of this thesis in the context of previous research, and discusses the implications of these 
findings for policy and for future research. 
SUMMArY Of fInDInGS
first research question
Can methods be developed that both address small numbers issues and also account for known 
biases in available data, allowing for sufficiently precise estimates of health-related risk factors 
and mortality for US counties? 
In chapters 2–5, this thesis employed an empirical validation strategy based on simulating 
data for small areas from observed data in relatively large areas to assess the performance 
of the proposed small area models. With respect to the models for risk factor prevalence 
based on survey data, the validation results demonstrate that the typical error associated 
with the modeled county-level prevalence estimates is small compared to both typical levels 
of prevalence and the magnitude of variation among counties (Table 1). With respect to the 
models used to estimate mortality rates, the validation points to minimal bias and a mean 
absolute relative error around 6.5% for populations of at least 1,000 (which includes more 
than 99% of all county-years). In both cases, estimates are considerably more precise when 
Table 1. Validation results compared to county-level estimates for smoking, alcohol use, and diagnosed 
diabetes. 
risk factor
rMSe
(percentage points)a
estimated county prevalence, all years (%)
Minimum Median Maximum
Smoking – males 2.7 8.9 28.2 50.5
Smoking – females 2.8 5.4 23.7 42.8
Alcohol use – males 3.3 11.4 59.1 84.4
Alcohol use – females 3.4 6.2 41.5 79.4
Diagnosed diabetes 1.2 2.7 8.6 20.4
aRoot mean squared error for a county with ten respondents per year.
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larger sample sizes or larger populations (still well within the range observed at the county 
level) are available. Moreover, chapter 5 compared the final small area model for mortality 
rates to two previously published models and found substantial gains in model performance 
not only in terms of precision, but also in terms of bias and uncertainty interval coverage. 
Chapters 2–5 also described methods for correcting various biases in the underlying data 
used to generate county-level estimates, specifically: non-coverage bias due to omission 
of cell phones from the BRFSS sample frame prior to 2011 (chapter 2); discontinuities due 
to changes in item wording between survey rounds (chapter 3); self-report bias related to 
undiagnosed health conditions (chapter 4); and bias introduced by the presence of garbage 
codes in death registration data (chapter 5). These methodological developments are 
considerably more difficult to formerly validate as appropriate ‘gold standard’ data are not 
available. Nonetheless, chapters 2–5 demonstrate that corrections for these biases can be 
operationalized in the context of small area analyses. Furthermore, while formal validation 
is impractical, implementing these corrections improves the face-validity of the resulting 
estimates, particularly with regards to temporal trends and comparisons with alternate data 
sources at the national level. 
Second research question
To what extent does the prevalence of health-related risk factors and health outcomes vary 
among counties in the US, and are inequalities increasing or decreasing over time? 
This thesis considered three sets of risk factors—smoking, alcohol use, and diabetes—as well 
as three sets of health outcomes—cause-specific mortality rates, life expectancy, and self-
reported health status. In all cases, there was considerable inequality among counties in all 
years examined. This was true both when considering absolute measures of inequality as well 
as when considering relative measures. Furthermore, there were large disparities in terms of 
temporal trends; for most risk factors and health outcomes, both counties with increases and 
counties with decreases were identified. 
Figure 1 depicts the change in geographic inequality between 2002 and 2012 for many of 
the risk factors and health outcomes measured in this thesis, considering two measures of 
absolute inequality (the standard deviation and the difference between the 90th and 10th 
percentile) and two corresponding measures of relative inequality (the coefficient of variation 
and the ratio of the 90th to the 10th percentile). For all three risk factors, absolute geographic 
inequality increased, while relative geographic inequality increased for smoking, declined for 
binge drinking, and was relatively unchanged for diabetes. Absolute geographic inequality 
increased for all health outcomes except self-reported low general health and mortality from 
cardiovascular diseases and transport injuries, while relative geographic inequality increased 
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for most health outcomes apart from self-reported health status. The magnitude of the 
changes in geographic inequality varied widely among the different risk factors and health 
outcomes, and in some cases among different inequality measures. 
Third research question
What proportion of the variation observed in life expectancy at the county level can be explained 
by variation in socioeconomic factors, behavioral and metabolic risk factors, and access to and 
quality of health care? 
Chapter 6 explored the extent to which variation in socioeconomic factors, behavioral and 
metabolic risk factors, and health care factors can explain variation in life expectancy at the 
county level. Taken separately, socioeconomic factors (poverty, income, unemployment, edu-
cation, and race/ethnicity) explained 60% of the variation in life expectancy while behavioral 
and metabolic risk factors (obesity, physical inactivity, smoking, hypertension, and diabetes) 
and health care factors (insurance rates, quality of care, and medical doctors per capita) 
explained 74% and 27%, respectively. 
When considered simultaneously, all three sets of variables explained 74% of the variation, 
but the effect of socioeconomic factors was non-significant and the effect of health care 
factors was substantially reduced. This indicates that a substantial portion of the variation 
in life expectancy at the county level can be explained by variation in risk factors, and that 
much of the relationship between socioeconomic factors and risk factors at the county level 
is mediated via risk factors. 
MeTHODOLOGICAL LIMITATIOnS
Validation of the small area methodology 
The first research question in this thesis focused on developing methods for generating 
county-level estimates of risk factors and health outcomes. Validating this methodology was 
essential to answering the first research question, nonetheless there are several important 
limitations related to this validation. First, although considerable emphasis was placed on 
validation of the methodology, it was only possible to rigorously validate the small area 
models. Methods related to bias corrections—e.g., garbage code redistribution when exam-
ining cause-specific mortality rates—were not validated beyond examining the face-validity 
of the resulting spatial and temporal trends. Second, the strategy employed to validate the 
small area models assumes that the counties included in the validation set differ from other 
counties in ways that are relevant for small area estimation only in terms of population size. 
This is a difficult assumption to validate and it’s easy to imagine violations of this assump-
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tion: for example, the degree of spatial relatedness among counties may differ between the 
often more densely population counties included in the validation set and more sparsely 
populated counties not included in the validation set. Third, the validation framework uti-
lized is computationally expensive, so in some cases, the fact that the model performed well 
in one setting was taken as evidence of sufficient performance in other, similar settings: for 
example, with respect to mortality rates, the model was only validated for all-cause mortality, 
not for each individual cause considered. While this is likely often the case, there is always the 
possibility that the models will perform sub-optimally due to an idiosyncrasy in the data or 
the particular outcome considered. 
Quantification of geographic inequalities 
The second research question focused on quantifying geographic inequalities and evaluat-
ing whether geographic inequalities are increasing or decreasing with time. The most impor-
tant limitation relevant to this portion of the analysis is related to those just discussed with 
respect to the first research question: the quality of an estimate of geographic inequalities is 
constrained by the quality of the underlying county-level estimates of risk factors and health 
outcomes. Moreover, small area models such as those employed in this thesis are ‘shrinkage’ 
models which work by smoothing observed data. This allows for more precise estimates over-
all but likely results in some under-estimation of the true variance. The extent to which this 
expected under-estimation may vary among different estimated quantities or over time is 
not clear, but to the extent that it does vary this may compromise comparisons made across 
indicators or conclusions drawn about temporal trends. 
An additional limitation is inherent in any attempt to summarize geographic inequalities 
using a single metric: conclusions drawn about the relative rankings of different risk factors 
or health outcomes in terms of magnitude of geographic inequalities or about temporal 
trends in geographic inequalities are sensitive to how inequality is operationalized. Earlier in 
this chapter, four different inequality metrics, including two absolute and two relative mea-
sures, were used to compare temporal changes in geographic inequality among different 
risk factors and health outcomes. Displaying results in terms of multiple measures partially 
addresses this challenge, however it precludes unqualified answers to questions such as 
“are inequalities increasing or decreasing over time?” Moreover, it will never be feasible to 
consider all possible formulations of geographic inequality.
Finally, interpretation of temporal trends in geographic disparities is potentially complicated 
by migration. This thesis did not formerly consider the extent to which changes in the mag-
nitude of geographic disparities are due to changes in the health of otherwise stable popula-
tions as compared to selective migration resulting in greater (or less) segregation of healthy 
and unhealthy individuals. Individual-level migration data linkable to the data sources used 
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in this thesis would be ideal for assessing the extent to which selective migration of healthier 
or less healthy individuals is driving changes in geographic differences in health, however 
these type of data are unavailable. Counts of migrants to and from each pairing of counties 
are available, however, and could be used to simulate the potential impact of migration under 
varying assumptions of the relative health status of migrants compared to non-migrants.1,2
Analysis of drivers of county-level inequalities in life expectancy
The third research question in this thesis focused on drivers of county-level inequalities in life 
expectancy. A major limitation with respect to this research question (as with the second), 
is the quality of the inputs to this analysis, particularly life expectancy and the risk factors 
included as potential drivers, all of which were estimated using a similar methodology. 
Moreover, the small area models used to generate estimates of both risk factors and life 
expectancy included several of the same or very similar covariates (e.g., education, poverty), 
which were in turn also used as socioeconomic variables in the analysis of drivers of county-
level inequalities in life expectancy. The strength of the relationship between these socioeco-
nomic variables and the outcome variables in the small area models (i.e., life expectancy or 
risk factor prevalence) was estimated as part of the model fitting process, so it’s unlikely that 
this process itself induces correlations that do not otherwise exist. Nonetheless, there is still 
some possibility that the reuse of these socioeconomic variables at multiple stages of this 
analysis lead to an overestimation of the strength of the relationship between life expectancy 
and these socioeconomic variables as well as life expectancy and risk factor prevalence. 
In addition to limitations related to the inputs to this part of the analysis, there are also 
limitations related to the model utilized to assess the contribution of different drivers to 
inequalities in life expectancy. A relatively small number of variables were used to represent 
the socioeconomic characteristics, mix of behavioral and metabolic risk factors, and health 
care access and quality within each county, and it is likely that not all relevant factors in 
each of these domains were captured. Similarly, other potentially influential domains like 
environmental risk factors3,4 were not included. Furthermore, a cross-sectional design was 
used in order to maximize the number of factors which could be included in the analysis. This 
design does not allow for parsing the extent to which changes in variation in life expectancy 
are related to changes in variation in socioeconomic factors, behavioral and metabolic risk 
factors, and health care factors. Additionally, assuming these factors are causally related to 
life expectancy, a cross-sectional model does not allow for potential lags between ‘exposure’ 
and ‘outcome’, nor does it account for potential migration in the interim. Finally, the nature of 
this model makes it difficult to assess the extent to which the relationship between the vari-
ous ‘drivers’ and life expectancy is due to contextual effects as compared to the composition 
of the individuals in a given county. 
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InTerPreTATIOn Of fInDInGS
Small area methodology 
A large number of potential small area models have been proposed for estimating health-
related indicators for small areas such as counties in the US and similar administrative areas 
in other countries.5–11 Performance of these models has generally been assessed in one of 
three ways: internal validity checks, such as comparing aggregated small area estimates to 
direct estimates from the same data source for larger geographies (e.g., states in the US), or 
comparing small area estimates to direct estimates only in areas with a large sample size or 
population;5–8 external validity checks comparing small area estimates to direct estimates 
from an alternate data source (typically a census or much larger survey);6,9 and using simu-
lated data so that small area estimates can be compared to a known true value.10,11 These 
studies have consistently found that small area models outperform direct estimates and 
earlier approaches such as synthetic estimation. However, while these approaches to assess-
ing model performance are useful, there are important limitations. Internal validity checks 
only assess performance at more aggregate geographies or for larger areas and provide little 
information about the reliability of the estimates for smaller areas. External validity checks are 
only possible in the limited circumstance where data for the indicator of interest are available 
in a census or similar data source—it is not clear that results for these indicators generalize 
to other risks or health outcomes. Similarly, results based on simulated data are potentially 
sensitive to the assumptions underlying how the simulated data were constructed and it is 
not clear that model performance will be the same in ‘real world’ applications. 
This thesis used an empirical validation approach pioneered by Srebotnjak et al.12 and previ-
ously applied to evaluating the performance of county-level small area models for diagnosed 
diabetes prevalence,12 hypertension prevalence,13 and life expectancy14 in the US. This method 
avoids the limitations inherent in the previously described approaches by simulating based 
on the observed county-level data to be modeled, ensuring that results are applicable to the 
case at hand while allowing for assessment of performance for areas (in this case, counties) 
across a wide range of population sizes. Previous studies using this assessment methodology 
have reported that the small area models tested produced sufficiently precise estimates even 
for relatively small sample sizes (when considering survey data) or small populations (when 
considering life expectancy). This thesis confirms this finding for small area models applied 
to diabetes and life expectancy and demonstrates that this finding also holds for small area 
models applied to smoking, alcohol use, cause-specific mortality rates, and self-reported 
health. These consistent findings across a fairly wide range of outcomes and using multiple 
validation strategies strongly suggests that small area estimation methods are likely to be 
useful for many different estimation problems at the county level in the US and equivalent 
sub-national divisions in other countries. 
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In addition to confirming these earlier findings, this thesis expands upon existing knowl-
edge in two important ways. First, chapter 5 demonstrates that there is utility in continued 
development of small area estimation methodologies. The model developed in this thesis 
for estimating mortality rates takes advantage of recent technological improvements that 
make fitting more complex models possible. Compared to previously described models, 
these developments resulted in substantially more precise, less biased estimates and more 
accurate quantification of uncertainty. Second, chapters 2–5 demonstrate the potential for 
incorporating various bias corrections into the overall estimation strategy alongside the 
small area models. ‘Perfect’ data sources are rarely available, particularly at the county level, 
so the ability to correct for known biases as part of an overall small area estimation strategy 
dramatically expands the scope of potential data sources, and therefore outcomes, that 
could potentially be examined. 
Spatial patterns of risk factor prevalence and health outcomes in the US 
Numerous previous studies have considered county-level spatial patterns in some risk fac-
tor or health outcome in the US using an assortment of methodologies.2,5,7,12–21 Where these 
studies overlap with the risks and outcomes considered in this thesis, the spatial patterns 
described are broadly similar. For example, chapter 5 identifies areas in central Appalachia, 
Oklahoma, and the Southwest with elevated mortality rates from mental and substance use 
disorders that are comparable to the areas identified by Rossen et al.17 as having elevated 
mortality rates from drug poisoning. Similarly, the results for cardiovascular disease mortality 
from chapter 5 are consistent with earlier reports18 of elevated mortality from heart disease 
in the southeastern US. 
These similarities notwithstanding, this thesis expands upon previous research on spatial 
patterns in risk factor prevalence and health outcomes in the US in two significant ways. 
First, in contrast to many earlier analyses, this thesis considered annual estimates over an 
extended period of time, which is the basis for two insights: in most cases, spatial patterns 
evolve significantly over time, and counties vary not only in their current level but also in 
their trajectory. Second, with respect to previous analyses of mortality, most studies have 
focused on a single cause of death, whereas this thesis considered a comprehensive set of 21 
causes of death. Considering all causes simultaneously improves comparability and prevents 
double counting. Furthermore, previous analyses of mortality rates at the county level have 
focused on a relatively small set of causes of death (e.g., heart disease,18,22 stroke,21,23 breast 
cancer,20 and drug use17,24) but little attention has been paid to other causes that account for 
substantial burden such as neurological disorders, infectious diseases including diarrhea and 
lower respiratory infections, and transport injuries. This thesis finds that spatial patterns in 
both the level and rate of change in mortality vary substantially by cause, highlighting the 
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need to consider not just spatial patterns in all-cause mortality or selected causes, but spatial 
patterns across a range of high-burden causes. 
Increasing geographic disparities in life expectancy in the US
Studies by Ezzati et al.2 and Wang et al.15 both found evidence of increasing geographic 
disparities in life expectancy among counties in the US in recent decades. Other researchers, 
also using county-level data, have identified increasing disparities in life expectancy with 
reference to county urbanicity25 and socioeconomic status.26,27 Chapter 6 of this thesis con-
firms the earlier finding of increasing geographic disparities in life expectancy in the US over 
the past few decades and adds evidence that inequality has continued to increase in recent 
years. Moreover, the magnitude of this increase is large: the absolute gap in life expectancy 
between the 90th and 10th percentiles increased by 39% (1.7 years) between 1980 and 2014, 
with more than half the increase occurring from 2000 onwards. 
Recently, Currie and Schwandt28 used county-level data to analyze trends in all-cause mortal-
ity by poverty status, revealing different trends by age group, with inequality (with reference 
to county poverty) increasing among older age groups but declining among children and 
young adults. Chapter 6 reveals similar patterns with respect to absolute geographic dis-
parities in risk of death from all causes, with disparities declining substantially under age 25, 
increasing moderately between ages 25 and 45, and increasing substantially above age 45. 
Taken together, this research strongly suggests that disparities in longevity, particularly but 
not exclusively with reference to location, have been increasing in the US for decades primar-
ily due to increasing disparities in mortality for middle and older ages. While this thesis did 
not formerly consider the extent to which these changes may be driven by selective migration 
(e.g., exodus of healthier individuals from less healthy locations), simulations carried out by 
Ezzati et al.2 suggest that increases in county-level geographic inequality in life expectancy 
are unlikely to be due solely to migration patterns. 
A small number of studies have considered trends in geographic disparities in life expectancy 
or some measure of all-cause mortality in other countries, though generally at a less granular 
level as compared to counties in the US. Consistent with the findings in this thesis regarding 
increasing geographic disparities in life expectancy at the county level in the US from 1980 to 
2014, increasing geographic disparities have also been described in Canada at the provincial 
level from 1986 to 1997 (after earlier periods of decline),29 in the United Kingdom at the local 
authority level from the 1969 to 2007 (also after earlier periods of decline),30 and in Eastern 
Europe (for men only) at the region level from 1991 to 2008.31 At the same time, decreases 
in geographic disparities have been identified in Austria at the commune level from 1969 
to 2004,32 in Spain at the provincial level from 1981 to 1995,33 and in the Netherlands (for 
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men only) at the region level from 1988 to 2009,34 and relatively stable levels of geographic 
disparities have been found at the region level in Western Europe from 1991 to 2008.31 This 
variation in experience across countries highlights that increasing geographic disparities in 
mortality and life expectancy are neither inevitable nor irreversible. 
The increase in geographic inequalities in life expectancy in the US observed between 1980 
and 2014 was accompanied by an increase in geographic inequality in cause-specific mortal-
ity rates for a number of causes, particularly: mental and substance use disorders; cirrhosis 
and other common liver diseases; chronic respiratory diseases; self-harm and interpersonal 
violence; and neoplasms. This thesis did not explicitly consider the driving forces behind 
the observed increases in geographic inequality for these specific causes of death or for life 
expectancy more generally, but there are likely multiple factors at play, and these factors 
may have evolved over the time period considered. Describing these mechanisms will be 
an important area for future research and could help inform efforts to reverse these trends. 
Drivers of geographic disparities in life expectancy in the US
Correlations between longevity and summary measures of socioeconomic status, racial and 
ethnic composition, risk factor prevalence, and health care quality and availability have previ-
ously been documented at the county level.35–38 Cullen et al.35 and Davids et al.37 considered 
a number of these different factors simultaneously at the county level and found that collec-
tively they can explain much of the variation in longevity among counties. This thesis again 
confirms these earlier outcomes, finding both that these relationships exist independently at 
the county level and that collectively these factors can explain the majority of the variation in 
life expectancy among counties in the US. 
This thesis goes beyond earlier research at the county level and considers the potential for 
mediation of the relationship between socioeconomic factors, behavioral and metabolic 
risk factors, health care access and quality factors, and life expectancy. The results of this 
analysis suggest that essentially all of the relationship between socioeconomic factors and 
life expectancy at the county-level is mediated via differences in the prevalence of behavioral 
and metabolic risk factors. 
Individual-level analysis of prospective cohort studies in both the US39–42 and other high 
income countries42–45 have consistently found that differences in behavioral and metabolic 
risk factors mediate the relationship between socioeconomic factors and risk of death to 
a substantial degree. Results vary depending on study design, socioeconomic factors 
considered, behavioral and metabolic risks considered, and setting, but the proportion of 
the relationship between socioeconomic factors and mortality risk mediated by behavioral 
and metabolic risk factor is typically found to be between one- and three-quarters in these 
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studies. Findings from individual-level analyses are thus partially consistent with the findings 
of this thesis: both identify a role for behavioral and metabolic risk factors in mediating the 
relationship between socioeconomic factors and mortality, however the magnitude of this 
effect is smaller in the analyses of individual-level data compared to county-level data. There 
are a number of potential causes for this discrepancy. The relationship between socioeco-
nomic factors, behavioral and metabolic risk factors, and mortality may be different at the 
ecological level as compared to the individual level. The choice of outcome—life expectancy, 
accounting for deaths at all ages, compared to mortality risk, typically among middle aged 
or older adults only—may also matter. Furthermore, both types of analyses are potentially 
sensitive to unmeasured confounding. 
There are important limitations to the analysis in this thesis, as previously discussed, so it is 
not possible to definitely characterize these county-level relationships as causal or, conse-
quently, to assert that modifying one or more of these factors would change inequalities in 
life expectancy among counties. Nonetheless, the findings regarding the importance of both 
socioeconomic factors and behavioral and metabolic risk factors in explaining county-level 
variation in longevity are suggestive, and are supported by a large body of literature docu-
menting socio-economic gradients in mortality risk among individuals and demonstrating 
the importance of behavioral and metabolic risk factors in explaining these socio-economic 
gradients. 
POLICY IMPLICATIOnS AnD reCOMMenDATIOnS
County-level estimates of risk factor prevalence and health outcomes should 
be used for policy development and public health practice in the US
This thesis demonstrated the practicality of reliably estimating risk factor prevalence and 
health outcomes at the county level using existing national data sources. There are a number 
of different ways that these types of data can and should be used to inform policy and public 
health practice, particularly regarding program development and resource allocation. First, 
with respect to national- and state-level policies and programs designed to target particular 
risk factors or health outcomes, county-level estimates should be used to identify areas most 
in need of intervention and with the greatest potential to benefit. As illustrated in earlier 
chapters, these areas vary somewhat depending on the particular outcome considered: e.g., 
nationally, the counties most impacted by cardiovascular diseases are located primarily in 
the South, while counties most impacted by cirrhosis and other chronic liver diseases are 
located primarily in the Western US. Second, with respect to local health departments, most 
of which serve a single county or small group of counties,46 county-level estimates of risk 
factor prevalence and health outcomes should be used to identify the most pressing local 
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needs and guide resource allocation. Moreover, local estimates can be used by local health 
departments as evidence when advocating for additional funds from local taxpayers or state, 
federal, and private sources for particular programs. In both cases, using local estimates to 
more efficiently deploy resources is particularly important given increasingly constrained 
public health budgets in the US.46 
County-level estimates of risk factor prevalence and health outcomes should 
be used for monitoring disparities as part of tracking progress towards 
national health targets
In the US, overarching national health objectives are established and tracked in decennial 
cycles as part of the Healthy People Program. The most recent iteration, Healthy People 2020, 
includes “achieve health equity, eliminate disparities, and improve the health of all groups” 
among its four overarching goals, and specifically identifies disparities by race, ethnicity, 
gender, sexual identity and orientation, disability status, and geographic location.47 None-
theless, tracking geographic disparities in the indicators identified in Healthy People targets 
remains largely limited to comparing the census regions (Northeast, Midwest, South, and 
West), metropolitan and non-metropolitan areas, or, less commonly, states. The results of this 
thesis clearly demonstrate important differences in both exposure to risk factors and health 
outcomes among counties within states and regions and in similarly urban (or rural) loca-
tions. County-level estimates of risk factor prevalence and health outcomes should be used 
in place of or in addition to these more aggregate measures for tracking trends in geographic 
disparities. 
Behavioral and metabolic risk factors are an important target for improving 
health outcomes overall and reducing inequalities
The relationship between behavioral and metabolic risk factors such as smoking, obesity, 
physical inactivity, hypertension, and diabetes and increased risk of mortality is well-estab-
lished at the individual level.48 This thesis additionally provided evidence that variation in the 
prevalence of behavioral and metabolic risk factors at the county level is related to disparities 
in county-level life expectancy. 
A wide range of evidence-based and cost-effective intervention strategies targeting these 
risk factors are available.49 For example, increasing tobacco prices through taxes and imple-
menting indoor smoking bans have both been shown to reduce smoking prevalence,50,51 
but many counties and states have not fully implemented these policies.52 Mixed-use de-
velopment, improved connectivity, and access to green space have been shown to increase 
physical activity and can be promoted through zoning regulations but are similarly variable 
across counties.53–55 
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Addressing behavioral and metabolic risk factors, including smoking, obesity, physical in-
activity, hypertension, and diabetes, should be a priority not just for improving population 
health overall in the US, but also for attempting to reduce geographic disparities in longevity 
and other health outcomes. County-level estimates of these risk factors can be used by local 
and state health officials and policymakers to pinpoint targets for future interventions in 
particular counties or regions. National action aimed at reducing the impact of these risk 
factors is also warranted. 
DIreCTIOnS fOr fUTUre reSeArCH
There are at least five avenues for future research building on this thesis: further development 
and improvement of the underlying methods for estimating county-level trends; expansion 
beyond fatal to non-fatal health outcomes; analysis at even more local levels; analyses in 
other countries; and further explanatory work focused on drivers of geographic inequalities. 
Methodological improvements
Among the large number of opportunities for improving the methodologies described in this 
thesis, there are two areas with particular potential. First: joint modeling of outcomes. Each 
risk factor and health outcome considered in this thesis was modeled independently and 
for each indicator separate models were fit for men and women. Risk factor exposures and 
health outcomes are often similar among men and women living in the same county; like-
wise, spatial and temporal patterns in health outcomes with similar underlying risk factors 
(e.g., lung cancer and chronic obstructive pulmonary disease, both of which are closely linked 
with smoking) are also likely to be similar. Thus joint modeling of related indicators and/or 
joint modeling for males and females may improve the precision of the resulting predictions 
by introducing another dimension for “borrowing strength.” Second: more fully accounting 
for uncertainty from all stages of analysis. This thesis used simulation methods to account 
for parameter uncertainty from the small area models, however there are other sources of 
uncertainty that were not fully accounted for, most importantly the uncertainty introduced 
by the garbage redistribution algorithms utilized for cause-specific mortality rates, which 
is likely non-negligible. Developing methods to more accurately reflect uncertainty at each 
stage of analysis and propagate this uncertainty through to the final estimates would allow 
for more accurate assessments of the precision of county-level estimates. 
non-fatal health outcomes
This thesis considered primarily fatal health outcomes, examining county-level trends in 
cause-specific mortality rates as well as overall longevity as measured by life expectancy at 
birth. Self-reported health status is intended to capture information on morbidity and be 
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sensitive to non-fatal health problems, but is relatively non-specific. The methods developed 
in this thesis could be adapted for measuring non-fatal health outcomes. This will require 
identifying additional data sources with county-level resolution and appropriate information 
about non-fatal health outcomes: cancer registries, disease surveillance systems, hospital 
and pharmacy records, and insurance claims data are all potential data sources, though each 
with its own set of strengths and limitations. 
More local levels of analysis 
Most public health activities and many other government functions are organized by county 
in the US.46 County is also the finest geographic level typically available in national data 
sources for health-related indicators. Consequently, counties are an important level of analy-
sis in the US, but even more local level analyses may be useful in some settings, particularly 
in large and diverse counties where there is likely to be significant within-county variation in 
risk factor exposure and health outcomes. Where data with the necessary geographic resolu-
tion are available (possibly for a particular region, state, or county), it should be possible to 
adapt the methods presented in this thesis for analyses by census tract, ZIP (postal) code, or 
other smaller geographies. 
Analyses in other countries
This thesis has focused exclusively on describing trends at the county-level in the US. The 
methods developed in this thesis are likely to be more broadly useful, however. Many coun-
tries have similar survey and deaths registration data with appropriate geographic identi-
fiers for subnational analyses and the small area models described in this thesis could be 
applied to these type of data in other countries with minimal modification. In many cases, the 
validation framework used in this thesis to assess the performance of the small area models 
with reference to county-level trends in the US could also be repurposed in order to assess 
performance for various subnational units in other countries. 
further explanatory analysis 
This thesis explored potential drivers of variation in life expectancy among counties, however 
there are at least two directions in which this analysis should be further developed. First, 
there is room for improvement methodologically. Ordinary least squares regression on a 
cross-sectional dataset was used for exploring drivers of variation in life expectancy in this 
thesis. More sophisticated methods would allow for a more detailed and nuanced accounting 
of geographic variation. In particular, using time-series methods and data would allow for 
exploration of what is driving changes in geographic inequalities over time. Similarly, multi-
level analyses would allow for exploration of compositional versus contextual effects of the 
different factors considered in this thesis. Future research could also explore the sensitivity 
of the findings of such analyses to the inclusion of certain variables (e.g., education) in both 
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the small area models used to generate life expectancy and risk factor prevalence as well the 
final analysis of drivers of variation in life expectancy. Second, this thesis considered a rela-
tively small set of potential drivers of inequalities in life expectancy, but a much larger pool 
of potential explanatory factors could be explored within a similar framework. This could 
include additional factors not considered here—for example, differences in features of the 
natural and built environment, or differences in policy or in program implementation—or 
could further delve into the root causes of variation in some of the factors identified in this 
thesis (e.g., root causes of variation in physical activity). 
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SUMMArY
Risk exposures, health outcomes, and longevity are known to vary regionally within the 
United States of America (US). Relatively little, however, is known about how these health 
indicators vary on a smaller geographic scale. Below the state level, the US is administratively 
divided into approximately 3,100 counties. County-level measurements of risk exposures, 
health outcomes, and longevity are important for at least three reasons: local information is 
valuable to public health practitioners and policy-makers; geographic differences in health 
outcomes can facilitate identifying and addressing avoidable health differences; and under-
standing how health outcomes vary on a fine-scale geographically can lead to new or deeper 
insights into the underlying drivers of ill health. 
This thesis addresses three related questions. First, can methods be developed that both ad-
dress small numbers issues and also account for known biases in available data, allowing for 
sufficiently precise estimates of health-related risk factors and mortality for US counties? Sec-
ond, to what extent does the prevalence of health-related risk factors and health outcomes 
vary among counties in the US, and are inequalities increasing or decreasing over time? And 
third, what proportion of the variation observed in life expectancy at the county level can be 
explained by variation in socioeconomic factors, behavioral and metabolic risk factors, and 
access to and quality of health care? 
In this thesis, small area models are proposed for estimating smoking prevalence, excessive 
alcohol use prevalence, diabetes prevalence, the prevalence of poor self-reported health, 
cause-specific mortality rates, and life expectancy at the county level. Data from the Behav-
ioral Risk Factor Surveillance System (BRFSS), an annual telephone survey conducted by the 
Centers for Disease Control and Prevention, are used for estimating county-level prevalence of 
smoking, alcohol use, diabetes, and poor self-reported health. For estimating cause-specific 
mortality rates for 21 mutually exclusive and exhaustive causes of death and life expectancy 
at the county level, death registration data from the National Vital Statistics System (NVSS) 
are used. In addition, corrections for various known biases in these data sources are imple-
mented alongside these small area models. Finally, the estimates derived from these models 
are used to explore spatial patterns, quantify geographic disparities, describe changes in the 
magnitude of geographic disparities over time, and explore the drivers of variation in health 
outcomes among counties. 
Chapters 2–5 describe the proposed small area models for estimating risk factor and low self-
reported health prevalence based on BRFSS data and mortality rates based on NVSS data. An 
empirical validation strategy, based on simulating data for small areas from observed data in 
relatively large areas is employed to assess the performance of these models in counties of 
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varying population sizes. For models based on BRFSS data, this validation strategy demon-
strates that the expected error associated with modeled county-level prevalence estimates 
is small compared to both typical levels of prevalence and the magnitude of variation 
among counties. For models based on NVSS data, this validation strategy demonstrates that 
estimates have minimal bias, relatively high precision, and well-calibrated 95% uncertainty 
intervals. In both cases, the models produce more precise results for counties with larger 
sample sizes or populations, but perform well even for very small counties. Similar small area 
modeling strategies are likely to be useful for estimating a wide variety of health indicators at 
the county level in the US and for equivalent subnational areas in other countries. 
These chapters also describe methods for correcting various biases in the underlying data 
used to generate county-level estimates, specifically non-coverage bias due to omission 
of cell phones prior to 2011 in the BRFSS, discontinuities due to changes in item wording 
between BRFSS survey rounds, self-report bias related to undiagnosed health conditions, 
and bias introduced by the presence of ‘garbage codes’ (implausible or imprecise underlying 
cause of death codes) in death registration data. These corrections are difficult to formerly 
validate as appropriate ‘gold standard’ data sources do not exist, particularly at the county 
level. However, this thesis demonstrates that these bias corrections can be operationalized in 
the context of small area analyses, and noticeably improve the face-validity of the resulting 
estimates, particularly with regards to temporal trends and comparisons with alternate data 
sources at the national level. 
Chapters 2–7 use the generated county-level estimates of smoking prevalence, excessive 
alcohol use prevalence, diabetes prevalence, cause-specific mortality rates, life expec-
tancy, and self-reported health status to describe spatial patterns and quantify county-level 
geographic disparities in levels and trends. For all health indicators considered, there was 
considerable inequality among counties in all years examined. This was true both when con-
sidering absolute and relative measures of inequality. Moreover, there were large disparities 
in temporal trends in addition to levels: for most indicators, both counties with increases and 
counties with decreases were identified. For cause-specific mortality rates specifically, spatial 
patterns differed by cause, in some cases substantially, underscoring the utility of examining 
individual causes in addition to summary measures of health such as life expectancy. 
Chapter 6 specifically focused on trends in geographic disparities in life expectancy. Between 
1980 and 2014, absolute geographic inequalities in mortality risk declined for children (ages 
0 to 5) and adolescents (ages 5 to 25), but increased for adults, particularly adults over age 65. 
This resulted in an increase in geographic inequalities in life expectancy over this period, such 
that by 2014 life expectancy ranged by two decades among counties. Chapter 8 compared 
changes in geographic inequalities for all health indicators considered in this thesis over the 
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decade from 2002 to 2012. Absolute geographic inequalities increased for all health indica-
tors considered except self-reported low general health, mortality from cardiovascular dis-
eases, and mortality from transport injuries. Relative geographic inequalities also increased 
for most health indicators considered, but declined for self-reported measures of poor health 
and binge drinking. These increasing trends in geographic inequalities across a wide range 
of health indicators are cause for concern as they may indicate increasing individual-level 
health disparities. 
Finally, chapter 6 considered the extent to which variation in socioeconomic factors, behav-
ioral and metabolic risk factors, and health care factors can explain variation in life expectancy 
at the county level. Taken separately, socioeconomic factors (poverty, income, unemploy-
ment, education, and race/ethnicity) explained 60% of the variation in life expectancy while 
behavioral and metabolic risk factors (obesity, physical inactivity, smoking, hypertension, 
and diabetes) and health care factors (insurance rates, quality of care, and medical doctors 
per capita) explained 74% and 27%, respectively. When considered simultaneously, all three 
sets of variables explained 74% of the variation, but the effect of socioeconomic factors was 
non-significant and the effect of health care factors was substantially reduced. This indicates 
that a substantial portion of the variation in life expectancy at the county level can be ex-
plained by variation in risk factors, and that much of the relationship between socioeconomic 
factors and risk factors at the county level is mediated via risk factors. Policy action to reduce 
geographic disparities in socioeconomic factors, exposure to behavioral and metabolic risk 
factors, and access to and quality of health care may all be useful for improving health overall 
and reducing geographic inequalities. Targeting behavioral and metabolic risk factors may 
be particularly profitable given the strength of the relationship between variation in these 
risk factors and variation in life expectancy and the evidence that the relationship between 
socioeconomic factors and life expectancy is mediated largely via these risk factors. 
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SAMenVATTInG
Het is bekend dat er regionale verschillen bestaan in risicofactoren van de gezondheid, in 
gezondheidsuitkomsten en in sterftepatronen in de Verenigde Staten (VS). Er is echter nog 
weinig bekend hoe deze gezondheidsindicatoren verschillen tussen kleine geografische 
eenheden. Staten in de VS zijn administratief onderverdeeld in ongeveer 3100 “counties”. 
Metingen van (risicofactoren van de) gezondheid en sterfte op het niveau van deze counties 
is belangrijk om tenminste drie redenen: het is van belang voor professionals in de volksge-
zondheid en voor lokale beleidsmakers; geografische verschillen in gezondheidsindicatoren 
kunnen helpen bij het identificeren en reduceren van vermijdbare gezondheidsverschillen; 
en begrip van de variatie in gezondheid tussen kleine geografische eenheden kan leiden tot 
beter inzicht in de onderliggende oorzaken van gezondheidsproblemen.
Dit proefschrift beantwoordt deze onderling aan elkaar gerelateerde vragen. Ten eerste 
wordt onderzocht of methoden kunnen worden ontwikkeld die problemen met kleine 
aantallen aankunnen, tegelijkertijd rekening houden met bias in beschikbare data, en zo tot 
voldoende nauwkeurige schattingen kunnen leiden van (risicofactoren van) de gezondheid 
en sterfte in counties in de VS. Ten tweede wordt onderzocht in hoeverre de prevalentie van 
(risicofactoren van) gezondheid en sterfte tussen counties in de VS varieert, en of de ongelijk-
heid tussen counties in deze uitkomsten toe- of afgenomen is in de afgelopen jaren. Ten 
derde wordt bestudeerd welk deel van de variatie in de levensverwachting tussen counties 
kan worden verklaard door variatie in sociaaleconomische factoren, ongezond gedrag en 
metabole risicofactoren, en door toegang tot en kwaliteit van de gezondheidszorg. 
In dit proefschrift zijn eerst “small area” modellen ontwikkeld voor het schatten van de 
prevalentie van roken, excessief alcoholgebruik, diabetes, een slecht ervaren gezondheid, 
en van doodsoorzaakspecifieke sterfte en de levensverwachting in counties. Gegevens van 
het Behavioral Risk Factor Surveillance System (BRFSS), een jaarlijks afgenomen telefonische 
enquête uitgevoerd door het Centers for Disease Control and Prevention, werden gebruikt 
voor het schatten van de prevalentie in roken, alcoholgebruik, diabetes en een slecht ervaren 
gezondheid. Voor het schatten van de doodsoorzaakspecifieke sterfte van 21 elkaar uitslui-
tende doodsoorzaken en de levensverwachting in counties, is gebruik gemaakt van data van 
de sterfteregistraties van het National Vital Statistics System (NVSS). Verder zijn correcties 
voor verschillende vormen van bias in deze databronnen geïmplementeerd in de modellen. 
Tenslotte zijn de schattingen die met de modellen werden verkregen gebruikt om ruimtelijk 
patronen te beschrijven, geografische ongelijkheid te kwantificeren, veranderingen in de 
omvang van deze ongelijkheden over de tijd te bestuderen, en de oorzaken van de variatie 
tussen counties te verkennen. 
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Hoofdstukken 2-5 beschrijven de ontwikkelde small-area modellen voor het schatten van de 
prevalentie van risicofactoren en diabetes gebaseerd op de BRFSS data, en sterftecijfers uit 
de NVSS database. Een empirische strategie voor de validatie, gebaseerd op gesimuleerde 
data voor kleine geografische gebieden die waren afgeleid van geobserveerde data in rela-
tief grote gebieden, is gebruikt om te testen hoe goed de modellen presteerden in counties 
met een verschillende bevolkingsgrootte. Voor modellen gebaseerd op de BRFSS data werd 
gevonden dat de verwachte fout voor de gemodelleerde prevalenties in counties klein was, 
ten opzichte van gangbare prevalenties en de omvang van de variatie in prevalenties tussen 
counties. Voor modellen gebaseerd op de NVSS data werd gevonden dat schattingen een 
minimale bias hadden, een relatief hoge nauwkeurigheid en goed gecalibreerde 95% ”on-
zekerheidsintervallen” hadden. In beide gevallen produceerden de modellen nauwkeuriger 
resultaten voor counties met grotere steekproeven of populaties, maar werkten zij ook goed 
voor counties met een kleine populatie. Vergelijkbare small-area modellen zijn vermoedelijk 
nuttig voor het schatten van een variëteit van gezondheidsuitkomsten op het niveau van 
counties in de VS en voor vergelijkbare regionale gebieden in andere landen. 
Deze hoofdstukken beschrijven ook methoden voor het corrigeren van verschillende vormen 
van bias in de data, die werden gebruikt voor het genereren van de schattingen. Het gaat 
hierbij in het bijzonder om de bias die wordt veroorzaakt doordat een deel van de potentiële 
BRFSS deelnemers niet telefonisch kon worden bereikt omdat ze geen mobiele telefoon 
hadden (voor 2011), om bias door veranderingen in de formulering van items tussen verschil-
lende ronden van dataverzameling in de BRFSS, bias die wordt veroorzaakt door zelfrappor-
tage van niet-gediagnosticeerde gezondheidsproblemen, en de bias die wordt veroorzaakt 
door niet plausibele of onduidelijke doodsoorzaken in de doodsoorzakenregistratie. Deze 
correcties zijn vaak moeilijk formeel te valideren omdat databases met een gouden stan-
daard niet bestaan, vooral niet op het niveau van counties. Het proefschrift laat echter zien 
dat correcties voor deze vormen van bias kunnen worden uitgewerkt en toegepast in de 
context van small area analyses, en daarmee de indruksvaliditeit van de schattingen duidelijk 
verbeteren vooral ten aanzien van trends over de tijd en vergelijkingen met databronnen op 
landelijk niveau.
Hoofdstukken 2-7 gebruiken de schattingen van de prevalentie van roken, excessief alcohol-
gebruik, diabetes, de doodsoorzaakspecifieke sterftecijfers, levensverwachting en ervaren 
gezondheid om ruimtelijke patronen te beschrijven, en om de omvang van en trends in 
geografische ongelijkheid te kwantificeren. Voor alle gezondheidsindicatoren die werden 
bestudeerd bestond aanzienlijke variatie tussen counties in de bestudeerde tijdsperiode. Dit 
was zowel het geval voor maten van de absolute als de relatieve ongelijkheid. Er was ook 
grote variatie in trends over de tijd. Voor de meeste gezondheidsindicatoren konden zowel 
counties worden geïdentificeerd met een toename als met een afname in de prevalentie. 
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Vooral voor doodsoorzaakspecifieke sterfte varieerde de patronen naar doodsoorzaak soms 
zelf substantieel, waarmee wordt benadrukt dat het zinnig is zowel afzonderlijke doodsoor-
zaken als samengestelde maten van de volksgezondheid (zoals de levensverwachting) te 
bestuderen. 
Hoofdstuk 6 richtte zich specifiek op trends in geografische ongelijkheid in de levensver-
wachting. Tussen 1980 en 2014 daalde de absolute ongelijkheid tussen counties in sterfte 
voor kinderen (van 0 tot 5 jaar) en van kinderen, adolescenten en jong volwassenen (van 
5 tot 25 jaar), maar nam de ongelijkheid onder volwassenen van 65 jaar en ouder toe. Dit 
resulteerde in een toename van geografische ongelijkheid in de levensverwachting over 
deze periode; in 2014 varieerde de levensverwachting meer dan twintig jaar tussen counties. 
Hoofdstuk 8 vergeleek de veranderingen in geografische ongelijkheid voor alle andere 
gezondheidsindicatoren die in dit proefschrift werden bestudeerd tussen 2002 en 2012. De 
absolute geografische ongelijkheid nam toe voor alle gezondheidsindicatoren, maar daalde 
voor een slecht ervaren gezondheid en voor “binge drinken”. Deze toename in geografische 
ongelijkheid voor diverse gezondheidsindicatoren vormt een bron van zorg, omdat ze een 
indicatie kunnen zijn van toenemende ongelijkheid op het individuele niveau.
Hoofdstuk 6 bestudeerde tenslotte ook de mate waarin variatie in sociaaleconomische 
factoren, ongezond gedrag, metabole risicofactoren en gezondheidszorggerelateerde 
factoren de variatie in levensverwachting tussen counties kan verklaren. Afzonderlijk 
bestudeerd verklaarden sociaaleconomische factoren (armoede, inkomen, werkloosheid, 
opleidingsniveau en ras/etniciteit) 60% van de variatie in de levensverwachting. Obesitas, 
ongezond gedrag (lichamelijke inactiviteit, roken) en metabole risicofactoren (hypertensie 
en diabetes) verklaarden 74% en gezondheidszorggerelateerde factoren (percentages 
verzekerden, de kwaliteit van de zorg en het aantal artsen per hoofd van de bevolking) ver-
klaarden 27% van de variatie in de levensverwachting. Alle drie groepen samen verklaarden 
74% van de variatie, maar de bijdrage van sociaaleconomische factoren was in dit model 
niet statistisch significant en de bijdrage van gezondheidszorggerelateerde factoren werd 
in dit model aanzienlijk verkleind. Dit impliceert dat een aanzienlijk deel van de variatie in 
levensverwachting tussen counties kan worden verklaard door variatie in ongezond gedrag 
en metabole risicofactoren, en dat veel van het verband tussen sociaaleconomische factoren 
en de levensverwachting wordt verklaard door deze risicofactoren. Beleidsmaatregelen 
gericht op de verkleining van geografische ongelijkheid in sociaaleconomische factoren, 
blootstelling aan ongezond gedrag en metabole risicofactoren, en toegang tot en kwaliteit 
van de gezondheidszorg kunnen bijdragen aan het verbeteren van de volksgezondheid en 
het terugbrengen van de geografische ongelijkheid. Maatregelen gericht op gezond gedrag 
en metabole risicofactoren kunnen hierbij van bijzondere waarde zijn, vanwege de sterkte 
van het verband tussen variatie in deze risicofactoren en variatie in levensverwachting, en 
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het bewijs dat het verband tussen sociaaleconomische factoren en levensverwachting wordt 
verklaard door deze risicofactoren. 
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